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Abstract 
The intrauterine period is a vulnerable period of development. Any adverse environment can permanently change the 
body’s organ structure and function, expressed as an increased disease risk later in life. Studies show that variability in 
growth patterns in early life is associated with obesity and other cardiovascular diseases in adulthood, but the genetic and 
environmental determinants of these processes are largely unknown. 
The main objectives of this study were to identify genetic and environmental pre- and postnatal factors associated with 
early growth in infancy and childhood and later metabolic outcomes in adulthood from the Northern Finland Birth 
Cohorts (NFBCs).  
Several maternal and paternal factors, such as height, smoking, parity and pre-eclampsia, had direct association with faster 
postnatal height growth, some of which had their association mediated by size-at-birth variables. It was observed that an 
obesogenic environment in utero and during a child’s growth exerts a ‘programming’ effect on the glucose-insulin axis as 
well as other cardio-vascular risk factors in adolescence. Moreover, the study shows that Leukocyte Telomere Length 
(LTL) at 31 years, a marker for aging, is inversely associated with multiple measures of adiposity in both men and 
women, and that a BMI increase in women from childhood to adulthood is associated with shorter telomeres at age 31. 
Two new genetic variants in/near SBNO1 and HMGA2 genes are associated with infant head circumference, which may 
indicate influence of brain growth and neurodevelopment via early life. Variants in/near LEPR-LEPROT, FTO, TFAP2B 
and GNPDA2 showed an age-dependent association with adiposity in early childhood, while three loci (FTO, TFAP2B 
and GNPDA2) had their effect on adult adiposity mediated by early growth phenotypes.     
This study emphasises the clinical importance of early growth markers as they may inform public health policy aimed at 
improving the pre-pregnancy environment and to monitor childhood growth during the first few years of development.    
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Overall Aim, Scope and Structure of thesis  
Overall Aim of the thesis 
There is convincing evidence supporting Barker’s hypothesis on the ‘fetal programming of adult 
disease’ and its continuum; the Developmental origins of health and disease (DOHaD) hypothesis. 
As presented in this thesis, the work on Barker’s hypothesis concluded that several genetic and 
environmental prenatal and postnatal factors may pre-program long-term health during in utero 
development. More specifically, in terms of metabolic health, it was understood that genetic, 
environmental and nutritional factors  influence early fetal development, altering  hypothalamic 
development and function that permanently may ‘reset’ to high energy efficiency to promote the 
rapid gain of weight in childhood. Conversely, if fetal malnutrition occurs late in gestation, when 
adipocyte cell division is occurring more rapidly, then accrual of body fat is inhibited by a reduced 
number of adipocytes. 
 
Many complex diseases generally considered to be due to adult ‘lifestyle’ are now recognized to 
have a significant developmental origin. Developmental processes, acting in part through genetic 
mechanisms, can have echoes on structure and physiology of complex metabolic diseases such as 
obesity which can possibly be transmitted across generations.  Some observations suggest that the 
fetal and early postnatal environment may provide a snapshot of the environment in which 
individuals grow and could be an amalgam for different factors affecting development of 
overweight and obesity in an individual. The main aims of this thesis, in brief:  
 
1) The overall aim of this thesis was to investigate the putative role of genetic and 
environmental prenatal and postnatal factors associated with early growth in response to 
programming in in utero and postnatal. The work focuses on understanding, from a 
developmental point of view, how growth during early childhood may be associated with 
obesity in later life.  
2) The thesis utilises novel analytic strategies and methods for growth modeling in two 
population-based longitudinal studies of Northern Finland to develop rapid growth 
phenotypes which are proxies for the growth phase. My focus has mainly been on three time 
periods – birth, infancy and early childhood. A more detailed comparative description of 
growth modeling was conducted for an initial part of the research which was presented in 
the MSc Dissertation by me (Appendix Note 2).   
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3) The thesis also aimed to understand if ‘programming’ during in utero and ‘programming’ 
during the postnatal development period exerts different risk on an individual’s metabolic 
profile.  
4) To examine the genetic variants underlying head circumference and early life growth and 
that how they associated with adulthood adiposity-related factors. To explore possible 
mechanisms underlying these associations and to understand if any of the early growth 
factors mediates the association between genetic variants and later health.  
Scope of the thesis  
The field of research based on the ‘fetal development’ of disease hypothesis has expanded 
significantly and has made major progress over the last 20 years. The studies based on this 
hypothesis have demonstrated a clear link between intra-uterine environment, early growth and later 
health outcomes. However, research has not been able to establish the connection between the 
effects of predictor factors, such as mother’s health and environment during in utero, and birth size 
or early growth patterns.  
Genome-wide studies have been very successful in uncovering several genetic variants associated 
with complex diseases. These studies now need to expand to explain the pathways related to these 
disease phenotypes. It is important that the current studies investigate not only the disease endpoints 
at certain ages but also trajectories of phenotypic changes to understand the longitudinal variations 
in the etiology of disease.  
The availability of prospective population-based studies with longitudinal phenotype data has now 
become extremely valuable for epidemiological research. Diverse phenotypic information has been 
collected in the Northern Finland Birth Cohort 1966 (NFBC1966) and NFBC 1986, including 
repeated early growth measurements. When combined with genotype data, this gives an excellent 
opportunity to study the genetic background of complex traits such as obesity, however, 
collaboration with other studies is essential to ensure adequate statistical power to identify 
associations.  
This study focuses on growth phenotypes – size-at-birth (such as birth weight, birth length and head 
circumference), peak height velocities (PHV) at infancy, the timing of adiposity peak (AP) and 
rebound (AR) in childhood. I have also investigated anthropometric and metabolic phenotypes 
(height, body mass index (BMI), and waist circumference, and blood pressure, lipid and glucose 
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measurements) in adolescence, which are influenced by growth and are also associated with the risk 
of obesity. Figure 1 gives an overview of the DOHaD hypothesis pathway which the thesis 
addresses, highlighting the key prenatal factors which were investigated to understand the in utero 
programming and then postnatal factors which can also program the developmental stages during 
childhood.  One way to start answering questions on genetic factors of longitudinal growth is to fit 
biologically motivated growth curves to longitudinal growth measurement data, then to derive 
interpretable and biologically meaningful growth parameters (e.g. PHV and timing of AR) from 
these data. These parameters can then be used as outcomes in genetic association analyses. 
 Results from these analyses are synthesised, interpreted and discussed in a wider context. In 
addition, future challenges in the field of genetic epidemiological studies, in particular in the 
DOHaD field, are discussed.  
However, the scope of this thesis was restricted, due to research priorities, data availability, and 
space and time limitations. The analyses using comparisons for longitudinal growth were not 
included in subsequent chapters of this thesis. For easier interpretability, a concise explanation of 
growth models on height/weight and BMI was presented from NFBC 1986. The genome-wide 
studies conducted in this thesis examined common genetic variants which have an allele frequency 
>= 0.01. The low frequency variants were not explored as it would require new methodology that 
was outside the scope of this thesis. Genome studies were conducted using additive genetic models, 
which assumed the alleles frequency to be coded as 0, 1 and 2. This has been a standard procedure 
for meta-analysis in large collaborations. Other alternative approaches such as Mendelian 
Randomisation, gene-gene interaction and gene-environment analysis were beyond the scope of this 
thesis. More complex growth modeling methodologies, such as SITAR or Structural Equation 
Modeling (SEM), were omitted from the thesis due to time constraints.  
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Figure 1. An overview of the developmental programming hypothesis followed in this thesis. The  figure shows pathways which were investigated in 
this thesis to understand the role of pre-natal genetic and environmental factors which may lead to in utero programming affecting smaller size at 
birth and accelerated childhood growth. Both of which have been associated to affect metabolic syndrome factors in later life. Furthermore, 
postnatal environment may also insert programming effect on accelerated postnatal growth and lead to adverse metabolic profile in adulthood.  
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Structure of the thesis  
The thesis is divided into four main parts which correspond to `Background', `Subjects and Method', `Study-
specific results ' and `Overall conclusion'. 
 
Chapter 1 provides some background to the subject matter covered in the thesis. The general concepts of 
“Developmental Origins of Health and Disease (DOHaD)” hypothesis and human growth phases are described. 
A brief introduction of obesity, which is the central theme of the project, is also discussed. The chapters give a 
brief summary of genetic variations and the application of genome-wide approaches in studies of obesity, with a 
brief introduction to telomeres and why they need to be studied in obesity.  
 
Chapter 2 examines the existing literature related to DOHaD, growth patterns in early life and their association 
with obesity, phenotypes which have been related to obesity, and genetic studies on early life phenotypes 
relating to obesity. In particular the literature review focuses on published studies investigating the association 
between prenatal, postnatal, early growth factors and childhood, adulthood obesity-related phenotypes. 
Additionally, current studies exploring genetic and early life factors associated with adverse adult health are 
also presented. 
 
Chapter 3 presents the overall objective, hypothesis and research questions of the thesis.  
 
Chapter 4 introduces the two main study populations; Northern Finland Birth Cohorts (NFBCs) 1966 and 1986. 
It also gives an overview of the statistical methods used for the epidemiological and genome-wide association 
analyses. It describes the growth modeling of height, weight and body mass index (BMI) during childhood, 
based on longitudinal growth data, used to calculate the growth phenotypes considered as outcome variables in 
the association analyses.  
 
Chapter 5 presents results from association studies conducted on prenatal predictors and various outcomes at 
birth, during infancy, childhood. It describes an investigation into the association between prenatal predictors, 
size at birth and infant peak height velocity (PHV). This investigation places an emphasis on mediation by size 
at birth variables, on PHV in infancy in the NFBC 1986. This chapter then describes an association study 
between pre-pregnancy maternal body mass index (BMI) and adolescent metabolic factors. Finally describing 
an investigation on Leukocyte Telomere Length (LTL) and adiposity-related factors in childhood and adulthood 
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in NFBC1966. The chapter also presents results from genome-wide association studies (GWAS) conducted on 
infant head circumference (HC) and early growth phenotypes of peak height and weight velocities (PHV, PWV) 
during the first year of life, BMI at adiposity peak (AP) in infancy, BMI and age at adiposity rebound (AR)  in 
childhood. NFBC (1966 and 1986) results were incorporated into meta-analyses combining several GWAS 
from the early growth and genetics (EGG) consortium.  
 
Chapter 6 presents the overall summary of methodologies used, conclusions from each study performed as well 
as the strengths and weakness of the studies. The thesis gives a broad background by presenting studies from 
published literature which have investigated several prenatal, postnatal, genetic and environmental factors to 
understand the underlying cause of childhood and adulthood obesity. However, the literature review also shows 
that there is a gap which needs to be filled. Each study included in this thesis provided evidence towards the 
‘programming effect’ in the development of obesity. This chapter also summarises further work being 
undertaken and the work that can be carried out in the future.  
 
The Appendix gives additional tables and reproduces papers, manuscripts by written by myself, which are either 
submitted or to be submitted to journals.  
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Chapter 1: Introduction 
This chapter gives a brief background of the epidemiological basis for the research undertaken. It gives an 
overview of the stages of growth, definition of obesity and genetic architecture of complex diseases. The 
purpose of this chapter is to provide a historical context for the research presented in this thesis. 
1.1.   Background 
More than twenty years ago, the Clinical Epidemiologist Prof David Barker, highlighted a link
2
 between 
geographic distribution of infant mortality and later adult mortality. His pioneering research led the way, 
forming the basis of the fetal origin of adult diseases (FOAD) hypothesis or Barker’s hypothesis. This 
hypothesis states that small size at birth or in infancy is associated with an increased adult death rate from 
chronic diseases such as cardio-vascular disease (CVD), obesity and Type 2 diabetes (T2D). Barker’s 
hypothesis has now been expanded to incorporate a wider framework of life course approaches relating to 
chronic disease epidemiology, called “The Developmental Origins of Health and Disease (DOHaD)” 
hypothesis. The DOHaD hypothesis states that multiple adverse in utero conditions programme individual 
health; resulting in the development of diseases in later life. It contributes significantly to the understanding of 
how the adverse fetal environment influences health in childhood and adulthood, including the effects of 
nutritional changes during gestation and infancy together with stress during pregnancy  
 
Several epidemiological studies
3-6
 have outlined that adiposity during infancy and childhood may have an 
intermediating role between the pre-natal environment and obesity in later life. These studies established that 
there are “sensitive” or “critical” periods during fetal development and in early childhood, during which 
physiological alterations may be linked with increased risk of childhood and adulthood obesity
7
. In the last 
decade, there have been numerous studies on rapid growth and obesity, although their epidemiological 
interpretation has been limited due to several reasons
8-10
. For example, these studies had no consensus on the 
quantification of growth rapidity or focused on growth measures from one time period in a cross-sectional 
design for measuring rapid growth, which does not take into account that there may be variations in growth 
patterns at different childhood stages. Similarly, few studies have considered gender differences, which is 
important given that the growth rate between males and females is fairly different. 
 
With the availability of dense longitudinal data, a larger prospect for testing the DOHaD hypothesis in life-
course approach has emerged. The longitudinal data benefits the development of complex statistical models to 
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understand growth changes during childhood and adolescence, and allows the fitting of growth models to 
individual growth data. These complex statistical growth models provide functional parameters that follow the 
biological pattern of growth, for example the rate of growth (also called growth phenotypes) and quantify 
infliction points during growth phases. Several studies have emphasized the significance of growth modeling 
and have associated growth phenotypes with the risk of metabolic diseases such as obesity
11-13
 and other 
metabolic phenotypes later in life
14,15
.  
 
There is a vast amount of research on rapid growth, and its determinants, associated with the development of 
obesity in later life. These aspects are very important in order to understand the disease mechanisms as well as 
for preventive purposes because it has been shown that body mass tend to “track” from early childhood into 
adult life. However, there is little evidence about prenatal links between rapid growth in longitudinal study 
design and adult health. In particular, it is largely unknown how prenatal determinants affect early childhood 
growth, or how early childhood growth may mediate the effects of prenatal determinants on adult phenotypes.   
 
Genes play an important role in determining the appearance and behaviour of an organism. The ultimate 
outcomes in an organism are mostly the combination of these genes and their interaction with environmental 
exposure. The availability of HapMap data
16
, the Encyclopedia of DNA Elements (ENCODE) project
17
 and 
more recent “1000 Genomes” project18, has made it possible to associate between common forms of genetic 
variations, single nucleotide polymorphisms (SNPs) , and the occurrence of diseases such as obesity. However 
there are still a great deal of complexities to be explored, multidisciplinary research is needed to be understand 
the genetic and environmental factors associated with childhood growth. Certainly, longitudinal studies on early 
childhood growth remain very limited. 
 
1.2 .   Growth 
Human growth is a complex process characterised by an increase in size or mass of tissue over time, which is 
regulated through hormones secreted by the endocrine system. The metrics of growth can be defined as a 
change in any one of the anthropometric parameters. The anthropometric parameters for which measurements 
may be routinely recorded include head circumference, height, weight, waist/hip circumference, skinfold 
thickness and body composition. Growth can be an excellent indicator of nutritional and health status in 
individuals and is routinely measured in the clinical setting to review a child’s healthy development. Any 
PhD Thesis 
 
25 
 
deviation from the typical growth trajectories may indicate a particular health problem in an individual and 
regular follow-up could aid in early detection of the problem. Height and weight growth is generally a very 
regular process, although growth in weight is generally less regular than growth in height. Females are generally 
shorter and weigh less than males.  
Monitoring growth has two purposes:  
1) If there is growth retardation due to any medical, nutritional or developmental problems, routine assessments 
of growth patterns will ensure early identification and intervention.  
2) Monitoring growth of infants and children undergoing medical care allows for the evaluation and adjustment 
of dietary intake or use of nutritional therapies, when required. 
1.2.1 Stages of growth  
Growth from the fetal period until adolescence (and adulthood) is usually separated into four different stages by 
differences in growth velocities and patterns: 1) intra-uterine period (very high growth velocity overall), 2) 
infancy (postnatal growth “spurt”), 3) childhood (decreasing growth velocity, “levelling-off” and 4) adolescence 
(second postnatal growth “spurt”). 
The intra-uterine growth spurt depends on nutrients plus oxygen supply for cell division; the key adaptation 
made by the fetus in response to a lack of supply in any of these, is a reduction in the rate of cell division in 
tissues. The interpretation of these trends is that relatively small babies have suffered some degree of 
intrauterine growth retardation (IUGR). In addition to affecting overall size, IUGR is often associated with 
growth asymmetries or disproportional head circumference due to the preferential allocation of limited energy 
resources to the growth of the brain.  
 
Infancy is defined as the period between the second postnatal month and 2 years; it is characterised by a high 
growth velocity immediately after birth and rapid deceleration thereafter until about 2 years of age. This is 
followed by childhood, characterised by a period of slow deceleration of growth velocity that lasts until the 
onset of puberty. During childhood the spurts in growth occur in two stages; the first stage sees a slight, sudden, 
growth increase (peak) and the second sees a sudden growth decrease (rebound).  
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During puberty the adolescent growth spurt provides marked growth acceleration, then after a period of peak 
velocity, growth decelerates until it finally ceases. Adolescence is marked by an increasing growth velocity, 
which generally occurs earlier in girls than in boys. In terms of the magnitude of growth velocity, the growth 
spurt after infancy is much weaker compared to the prenatal period and infancy, further stressing the importance 
of the present study.  This study will be able to explain some biological pathways, otherwise not possible, 
without extensive growth modeling. 
 
1.2.2 Growth Modeling of Longitudinal data 
Tanner, a famous epidemiologist working on human growth, first suggested that fitting a curve to an 
individual’s growth data is the best way to extract maximum information on an individual’s health19 (Figure 2). 
Indeed, epidemiologists have since attempted to find mathematical models which fit the growth measurements 
and thus summarise   growth data.  Growth models can be successful in reducing large amounts of growth data 
into more meaningful parameters, which can then be used to compare growth between individuals and 
populations. The overall aim of growth models is to fit the simplest possible model; which may provide 
biologically interpretable parameters. There have been several models that have been used to describe human 
growth; some using specific anthropometric variables over a specific age range, while others use more general 
statistical modeling techniques.     
 
1.3.  Obesity  
 
Obesity is a complex multi-factorial disease, characterized by abnormal or excessive fat accumulation in 
adipose tissue, affecting the health of the individual. Obesity occurs when energy intake from food and drink 
consumption is greater than energy expenditure, resulting in the accumulation of excess fat. It arises as a result 
of the interplay between behavioural, environmental and genetic factors, and can reveal very different 
individual responses to the same nutritional intake or physical activity. Obesity has been associated with various 
early-onset adult cardio-vascular health complications. In last 20 years, obesity has been predicted to increase 
the risk of type 2 diabetes (T2D) by 44%, ischemic heart diseases by 23% and different cancers by 7-41%
20
, 
also contributing towards substantial overall morbidity and mortality in later life
21
.  
 
Obesity has now become a major public health challenge in both developed and developing countries
22
. The 
World Health Organization (WHO) reported
22
 that the worldwide prevalence of obesity nearly doubled between 
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Figure 2. The three phases of growth in height from birth to adulthood in an individual according to 
Tanner, 1989
19
. The black line represents the growth pattern of an individual from birth to adulthood 
and the grey line represents the growth variations that may occur in an individual due to nutrition 
changes. The figure has been adapted from Tanner, 1989
19
.  
 
 
 
 
 
 
 
 
 
PhD Thesis 
 
28 
 
1980 and 2008. In the UK, the prevalence tripled in the last 25 years, with a recent health survey showing over 
30% of children and approximately 60 % of adults are either overweight or obese. This alarming rise in obesity 
causes various physical
23
 and psychological
24
 problems, increasing an individual’s risk of developing a number 
of chronic diseases.  
 
1.2.3 Measures of Obesity 
The most common measurement to assess overweight and obesity status is body mass index (BMI), defined as 
weight (kg)/height (m)
 2
. The international task force for obesity (IOTF)
25
 and WHO
26
 recommends BMI cut-
points to classify weight status in both children and adults. Other indicators commonly used to determine 
aspects of obesity include skin fold thickness, waist circumference, and waist to hip ratio. The skin fold 
thickness refers to the measurement of subcutaneous fat located directly behind the skin and is measured by 
calipers, grasping a fold of skin and subcutaneous fat
27
. Skin fold thickness is mainly used to determine relative 
fatness and percentage body fat. The waist circumference (WC) is a measurement of the circumference of the 
waist with a measurement of WC in men > 94 and WC in women > 80 indicating an increased risk of health 
problems
28
. The waist to hip ratio (WHR) examines the fat distribution and according to guidelines from the 
WHO, abdominal obesity status can be identified as a WHR > 0.90 in men and > 0.85 in women
28
. More 
recently it has been suggested that body fat mass, measured by dual energy x-ray absorptiometry, provides a 
more accurate estimate of adiposity status than BMI
29
.  
 
1.2.4 Childhood Obesity 
Childhood and adolescent obesity are major issues in modern societies, with an alarming rise in European 
countries, such as the UK. The WHO predicts that patterns of overweight/obesity in children will continue into 
early adulthood for over 60% of European populations
30
. The main reason for this alarming rise in childhood 
obesity is suggested to be the increased availability of high-fat food and reduced physical activity
31
. Efforts 
towards understanding contributors to the childhood obesity epidemic have become essential to both scientific 
and clinical communities, and more effort is being directed towards prevention strategies. It should be noted 
that while an internationally accepted definition (from the WHO) exists for adult obesity, there is no similar 
definition for childhood obesity based on BMI, as the body mass index in childhood changes with age.  
 
Previous epidemiological studies have outlined various risk factors for childhood obesity, such as parental 
obesity, more than 8 hours spent watching television per day at 3 years of age, rapid growth during infancy, 
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height-weight z-score in childhood, large weight gain in early life, a high birth weight and short sleep duration. 
There is also evidence that childhood obesity is associated with the timing of puberty. Childhood obesity has 
been consistently found to be associated with most of the major cardio-vascular risk factors in adulthood
32
.   
 
It is well established
33
 that tracking obesity patterns from childhood to adulthood may provide valuable 
information on overweight children, who may be at high risk of becoming overweight in early adulthood as this 
can be associated with adverse health problems in later life. However, it has also been observed that not all 
obese children became obese adults.      
 
1.2.5 Adulthood obesity 
Adult obesity has sharply increased during the 1990s and 2000s with the 2011 Health Survey in England 
showing that obesity, defined in BMI terms, rose between 1993 and 2011 in men from 13% to 24% and in 
women from 16% to 26%
34
. It is predicted that the prevalence of obesity may increase to 60% of adult men and 
50% of adult women by 2050
34
.  
 
Maternal pre-pregnancy obesity and gestational weight gain is one of the top risk factors positively associated 
with obesity in offspring, both in childhood and in adulthood. Studies from the individuals exposed to famine in 
utero during World War II showed that mothers who suffered famine periconceptually and in the first trimester 
of pregnancy gave birth to babies who later had an increased risk of childhood obesity
35
. It was hypothesized by 
Rooij et al, 2010, that under-nutrition during the first months of gestation, when the central nervous system is 
formed in the fetus, generates better metabolic efficiency to compensate for the energy deficit
36
. This energy 
sparing system would lead to excessive fat storage when enough food is available. However, the links between 
the nutritional state of the mother and predisposition to obesity in children needs to be further investigated. 
   
1.4  Genetic variation 
Human DNA is a double stranded molecule that gets translated by cells to produce chains of amino acids known 
as genetic code. Whilst the discovery of the structure and function of DNA provided vast understanding of gene 
function, it did not lead to knowledge about how DNA influenced the behavior of the cells. Sequencing of the 
human genome in 2003
37
 was therefore a major development in understanding how genetic variation relates to 
human health and diseases. Most complex human diseases, such as CVD and obesity, are multifactorial caused 
by the effect of both multiple genes (polygenic) and environmental factors. Genes are influenced to a varying 
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degree, by the environment (depending on the population), which is called heritability. The measure of the 
expression of a trait is relative to the environment an organism has experienced.  
 
1.5 .   Genetic epidemiology studies on obesity 
Obesity has been shown to result from the interplay between genetic and environment factors.  Studies show 
that polymorphisms in various genes controlling appetite and metabolism predispose individuals to obesity 
under certain dietary conditions. Although genetic mutation is currently considered rare, variations in these 
genes may predispose individuals to common obesity. Genetic epidemiology examines many common genetic 
variants in different individuals to see if any variant is associated with a trait. These studies usually focus on 
associations between single nucleotide polymorphisms (SNPs) and traits from complex diseases, such as 
obesity. Genetic studies on childhood obesity started by investigating single-gene mutations in the monogenic 
form of obesity, which is both rare and severe. However, further studies have shown that the genetic 
architecture of common obesity is due to a network of gene (polygenic) and gene-gene interactions. 
Studies of twins and adopted children indicate that genetic factors have a much stronger effect than 
environmental factors on changes in BMI of children up to the age of 18 years
38
. Longitudinal cohort studies 
have shown a strong correlation between parental BMI and the BMI of their offspring in both childhood and 
mid-adulthood
39
. Therefore, genetic epidemiological methods for the gene discovery of complex traits, such as 
obesity, can be divided into two broad classes: hypothesis-driven (for example, candidate gene studies) and 
hypothesis-free approaches (for example, genome-wide linkage studies and genome-wide association studies). 
Some of these are outlined below:  
1.5.1 Candidate gene studies  
Candidate gene studies use a hypothesis-driven approach to conduct genetic association studies focusing on 
associations between genetic variants (selected on known biological and physiological functions of obesity) and 
related traits. Candidate-gene studies include functional and positional candidates based on data derived from 
animal models, cellular systems, or extreme/monogenic forms of obesity. Considered together, the candidate 
gene studies provide suggestive evidence that multiple genes are involved in the predisposition to obesity. The 
discoveries from these studies have been used in physiological experiments to   study the functional 
consequences of the identified genetic variants. However, previous candidate-gene studies were grossly 
underpowered and when replicated in large-scale studies using meta-analytical approaches, a definitive effect 
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for most of the variants could not be identified. As the results from such studies have been unreliable, there is a 
case for the application of the genome-wide approach to search for the genetic determinants of obesity. 
1.5.2 Genome-wide association linkage studies 
Genome-wide linkage studies (GWLS), typically using a 10-centimorgan (cM) (measure of genetic distance) 
marker density usually containing 400 microsatellite markers evenly covering the entire human genome, 
identifies broad intervals of several mega bases that might contain hundreds of susceptibility genes for diseases 
of interest. Linkage analysis has being extremely successful in identifying genes causing monogenic disorders 
in obesity. However when compared to common complex diseases, linkage analysis has been less powerful and 
its success limited. In addition the relative high cost and family data requirements make linkage analysis more 
restricted in practice. Linkage analysis has provided insights into strongly associated genes with large 
phenotypic effects identified by fine-mapping the regions around the peaks of linkage without any pre-existing 
knowledge of the underlining trait being studied. GWLS has identified several single-genes for the monogenic 
and syndromic forms of obesity, which are both rare and severe, but it had limited success in detecting 
polygenes. Failure to replicate associations at many loci in the studies suggested that the variants have only a 
small genetic effect when taken alone. 
 
1.5.3 Genome-wide association studies  
The genome-wide association studies (GWAS) approach has revolutionized the field of genetic epidemiology 
by screening the whole genome at a very high resolution, covering hundreds of thousands of genetic variants. 
GWAS offers a new approach by identifying important regulatory elements of the genome as well as the genetic 
variants that disrupt these. Either of these could impart a predisposition to complex disease. The GWAS 
approach has only been made possible due to the discovery of human genome
37
 and International HapMap 
projects
16
(a large-scale effort aimed at understanding human sequence variation). These projects
16
 have enabled 
the development of unprecedented technology and tools to investigate the genetic basis of complex diseases. 
Since much of human diversity is due to single base pair variations together with variations in copy number 
throughout the genome, current advances in single-base extension (SBE) biochemistry and 
hybridization/detection of synthetic oligonucleotides now make it possible to accurately genotype and quantify 
allelic copy number. There is now a revolution occurring in SNP genotyping technology, with high quantity 
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genotyping methods allowing large volumes of SNPs to be genotyped in large cohorts of patients and controls, 
enabling large-scale GWAS of complex diseases.  
 
1.5.4 Gene-environment interaction studies 
It is accepted that human embryonic development is determined by both fetal genes and the intrauterine 
environment, which in turn depends on the maternal genes and health behaviour. Genetic and environmental 
factors interplay in different scenarios to cause complex diseases. This interplay may function via fetal genes to 
increase susceptibility to diseases or via the mother’s genes causing less favourable environments for 
development. Different scenarios could arise, such as those based on interaction between environmental 
exposure and fetal or maternal genes, or interaction between fetal and maternal genes or through a combination 
of several scenarios. This shows that gene-environment (G x E) interaction studies are an important topic in 
human genetics as they can further explain the heritability of complex diseases. 
  
G x E interaction studies are in the early stages of development but have been successful in providing evidence 
demonstrating that certain exposures have different effects in different populations or ethnic groups or in 
individuals with different genetically determined phenotypes. For example, G x E interaction studies on risk of 
melanoma has shown that fair skinned individuals are at higher risk than dark-skinned individuals and that there 
is an interaction between ultraviolet light and skin pigmentation
40
.  
 
The term ‘interaction’ has been very loosely used in G x E interaction studies. The biological definition of 
‘interaction’ is the joint effect of two factors that act together in a direct physical or chemical reaction and co-
participation of two or more factors in the same causal mechanism of disease development. In statistics, 
interaction is usually defined as a relationship between two or more independent variables modified by other 
variables.  However, G x E studies has a few limitations. The sample size required to identify statistically 
significant interaction is much higher than the sample size required to identify marginal effects. The 
methodological requirements for G x E studies are greatly driven by the research question and thus may have 
in-built sample bias. A number of study designs and analytical methods have been proposed for testing G x E 
interactive effects, including case-control, case-only and case-parent approaches, each with its own strengths 
and weaknesses. 
 
 
PhD Thesis 
 
33 
 
1.5.5 Telomere Length 
Telomeres are non-coding functional, repeat sequences at the ends of chromosomes [5(TTAGGG) n-3]. 
Telomere function is to stabilize the chromosome during mitosis, prevent aberrant recombination, and protect 
the chromosomes from end-degrading enzymes. After each cell division, however, telomeric base pairs are lost 
due to the inability of DNA polymerase to fully replicate chromosome ends. This “end replication problem” 
would have disastrous results were genetic information to be contained in the chromosome tips. Thus, the 
highly repetitive telomere sequences serve to protect chromosomes from loss of essential coding sequences. The 
obligatory loss of telomere DNA with each cell division thus serves as a “mitotic clock” which marks the 
number of cell divisions that have taken place. Telomere length is heritable, and appears to differ among 
individuals, even at birth. 
 
In recent times, telomere length has been associated with obesity
41
. It has been suggested that oxidative stress, 
associated with obesity
42
, can shorten telomeres, and this can be dangerous to healthy cells. Shortening of 
telomere length is a known mechanism of premature cellular death and loss of longevity, however, not much is 
known about the role of telomere length in childhood obesity and later life factors. 
 
1.6  Summary 
In summary, obesity is a complex disease that has now become a major public health challenge globally. Both 
childhood as well as adult obesity is on the rise in developing as well as developed societies. Several studies 
have consistently indicated that obesity-mediated cardiovascular morbidity in adulthood may have its origins in 
childhood obesity. Therefore, research towards understanding contributors to the childhood obesity epidemic 
has become essential so that effort can be directed towards appropriate prevention strategies.  
Based on the DOHaD hypothesis, several epidemiological studies have outlined that there are “sensitive” or 
“critical” periods during fetal development and during childhood, during which rapid growth may be linked to 
higher childhood and adulthood obesity risk factors. The studies on rapid growth and obesity, using either 
average measurement of growth parameters such as weight/height over the life course or cross-sectional data for 
measuring rapid growth have limitations in terms of epidemiological interpretation. Longitudinal studies 
address this key limitation by providing the dense growth data necessary to test the DOHAD hypothesis. 
Complex statistical models have been developed to understand growth rate in early childhood, and fitted to the 
dense growth data from longitudinal studies. These models provide functional parameters, such as growth 
velocity (growth phenotypes), which have been associated with later risk of obesity. Studies on these growth 
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phenotypes emphasize the importance of investigating growth velocities between childhood growth points, 
among other things, and their association with later metabolic phenotypes at 31 years of age.  
 
Whilst obesity is highly heritable and arises from the interaction between genetic, environmental and 
behavioural factors, epidemiological research has not explored associations of growth patterns in terms of 
genetic and environmental factors. Recent genetic epidemiological methods for the gene discovery of complex 
traits, such as obesity, are either hypothesis-driven (for example, candidate gene studies) or hypothesis-free (for 
example, genome-wide association studies). Lately, telomere length has also been associated with obesity and it 
has been suggested that the oxidative stress associated with obesity can shorten telomeres, and this can be 
dangerous to healthy cells. However, not much is known about the role of telomere length in childhood obesity 
and later life factors. 
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Chapter 2: Review of the literature 
This chapter describes the literature review undertaken on the developmental origins of health and disease 
(DOHaD) paradigm and several hypotheses related to it . Over the years, ‘Barker's fetal origin’ hypothesis has 
evolved and developed further by several epidemiological studies. In this literature review, I focus on published 
studies which form the basis for the research performed in this thesis, and give an overview of the current 
knowledge in the field. This literature review establishes a theoretical framework and the methodological basis 
to explain the importance of the work conducted in this study.  
2.1.   The Developmental origins of health and disease (DOHaD) approach 
The DOHaD approach evolved from the ‘fetal origin’ hypothesis, which suggested that infant growth was 
associated with adult mortality
43
. Several reviews present the summary of the genesis of the developmental 
origin hypothesis
44
, presenting a strong link between the fetus and adult diseases. Barker’s hypothesis 
stimulated great worldwide interest in developmental plasticity, although with advance in research it was felt 
that a broader scope of developmental cues were required. Gillman et al, 2007
45
, summarised a report on the 
DOHaD ‘paradigm’, suggesting that the ‘fetal origin’ hypothesis can be expanded to incorporate a 
multidisciplinary enterprise that can look beyond the oocyte and development into other areas of 
epidemiological research to answer questions.  
As observed during the course of this literature review, there is an overwhelming publication on the DOHaD 
paradigm. In this literature review, I focus on giving an overview of the most heavily cited ideas to develop 
good background information for my thesis. I present studies which have been previously published showing 
links between prenatal factors with intra-uterine environment, rapid growth with adult adiposity factors but not 
all together. This chapter will give a brief background on the hypothesis which the thesis has utilised for 
conducting analyses.       
2.1.1. Background  
One of the initial epidemiological study on the ‘fetal origins’ of CVD was described by Kermack et al, 193446. 
Kermack et al, summarised using demographic information from England and Wales from 1845, Scotland from 
1860, and Sweden from 1751 that the death rates of adolescents and adults depended on the individual’s body 
composition that one acquired during the first 15 years of life. This gave epidemiologists a historical 
perspective, associating mortality with geographic location. In 1962, Neel et al
47
, first proposed the idea of the 
“thrifty gene hypothesis”, suggesting that individuals are genetically predisposed to diabetes48, discussed in 
PhD Thesis 
 
36 
 
detail in section 2.1.2.  In the same year, McCance et al, 1962, introduced the concept that nutrition in infancy 
may have a long-term influence on, or “program” as later coined, adiposity in rats49. In 1976, Ravelli et al50, 
proposed a landmark article, using the Dutch Hunger Winter Study, demonstrated that association between 
nutritional restriction in utero and development of obesity in later life
50
. This was followed by a paper by 
Forsdahl et al, 1977
51
, which reported that the incidence of adult atherosclerotic heart disease is correlated with 
the infant mortality rate. Lucas et al,1991, introduced the term “programming”, suggesting that early-life 
experiences exert long-term effects on later phenotypes
52
.  
Against a backdrop of these epidemiological developments, Barker et al, 1993, developed the “fetal origin” 
hypothesis, which states that coronary heart disease originates through adaptations that the fetus makes during 
in utero nutritional deprivations
2,53
. In particular, an inverse association between birth weight (BW) and adult 
death rate from ischemic heart disease was identified. A possible reason for this inverse association was that the 
organ system was compromised by deprivation during fetal development, and therefore is unable to successfully 
respond to high-calorific diets during their life-time, leading to higher risk of adult disease. Several other 
epidemiological studies supported the association between BW and CVD. Further on, studies associated low 
BW with high adulthood BMI and higher risk of CVD, indicating a possible combined effect of early-life and 
later-life exposures
54-56
. Huxley et al, 2000, estimated that with each kg increase in BW the blood pressure 
ddecreases by 2-5 mm Hg
57
, suggesting that impaired fetal growth may lead to raised adult blood pressure. 
Table 1, presents the historical and prospective cohorts which initiated the research on ‘fetal origin’ hypothesis.  
These historical life-course approaches provided a good base to understand the effect of fetal life on the 
development of chronic diseases, however, these studies only emphasized association at two time points, one at 
birth and one in later life, which was not enough to infer the intrauterine and postnatal influence on CVD. 
Overall, it was not clear exactly which periods are important or even whether increase or decrease of rapid 
growth is harmful. There were also discrepancies in the definition of catch-up growth; the standard 
interpretation was referred to only first 6-12 months after birth, which did not cover the postnatal environment 
factors influencing growth. Therefore, it was suggested that more focus should be given to serial growth data to 
determine which periods of growth contribute most to the adverse risk of CVD. In summary, three possibility 
were proposed which may have an independent effect on increased CVD disease risk, first to determine rapid 
postnatal growth, second was to understand the factors related to fetal growth restriction and third a combined 
effect of the two. Several hypotheses were proposed based on these new focuses; relevant hypotheses for this 
thesis are discussed below.   
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Table 1. The key historical and prospective cohort studies used in research on the fetal developmental origins of adult disease. 
  Birth Cohorts Country Period Of Births n Reference 
Historical birth cohorts         
  Uppsala Academic Hospital cohort Sweden 1915-29 14611 Leon et al 
  Caerphilly cohort Wales 1920-35 2512 Elwood et al 
  Hertfordshire birth cohort England 1931-9 3000 Syddall  et al 
  Helsinki birth cohort Finland 1934-44 15846 Eriksson et al 
  Boyd Orr cohort UK 1918-39 4999 Martin et al 
  Dutch Hunger Winter cohort The Netherlands 1943-7 3307 Lumey et al 
  Aberdeen children of the 1950's cohort Scotland 1950-6 12150 Leon et al 
  Human Capital Study* Gautemala 1962-72 2393 Grejeda et al 
  
    
  
Prospective birth cohorts 
   
  
  1946 National birth cohort UK 1946 5362 Wadsworth et al 
  1958 British birth cohort UK 1958 17416 Power & Elliott 
  New Delhi birth cohort India 1969-72 8181 Bhargava et al 
  Vellore birth cohort India 1969-73 10670 Antonisamy et al 
  1970 British birth cohort UK 1970 16571 Elliott & Shepherd 
  Pelotas 1982 birth cohort Brazil 1982 5914 Victoria & Barros 
  Cebu Longitudinal Health Nutrition Survey The Phillipines 1983-4 3080 Tudor-Locke 
  Birth to twenty birth cohort South Africa 1990 3273 Richter et al 
  Avon Longitudinal Study of Parents and Children England 1991-2 Approx 14000 Golding et al 
  Pelotas 1993 birth cohort Brazil 1993 5249 Victoria et al 
*Not all those in the cohort were recruited at birth.
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2.1.2. The ‘thrifty’ gene and phenotype hypothesis 
Neel et al, 1967 was the first to suggest the ‘thrifty’ gene hypothesis, explaining that a fetus stores fat when 
there is sufficient availability of nutrients and allows re-utilisation when there is starvation
48
. Adding to this, 
twin studies from 1980s suggesting the role of genetics in T2D, with monozygotic twins showing 100% 
concordance
58
. Hales and Barker, further added to the idea called ‘thrifty’ phenotype, which emphasises the 
importance of epidemiological association between poor fetal nutrition and infant growth and the subsequent 
development of adverse metabolic health through the mechanisms of developmental plasticity
59
.  It was 
suggested that poor fetal nutrition produced permanent changes in glucose-insulin metabolism, which when 
combined with the effects of obesity, ageing and physical inactivity, are the most important factors in 
determining an adverse metabolic profile in adult life. A recent study by Jones et al, 2009, show that although 
the underlying mechanisms remain unexplained, the observations supporting the ‘thrifty’ phenotype hypothesis 
can be reproduced in both animal and human models 
60
. However, there are critical differences between the 
‘thrifty genotype’ and ‘thrifty phenotype’ hypotheses. The ‘thrifty’ genotype hypothesis suggests that genes 
react differently in response to its environmental stimuli while the ‘thrifty’ phenotype hypothesis suggests that 
genes undergo adaptation due to continued environmental changes. 
2.1.3. Postnatal growth acceleration hypothesis 
The concept of fetal programming suggests the idea that there are critical periods during fetal development, 
where a ‘stimulus or insults’ can have long-term effects on the health of an organism. There has been much 
interest in the so called critical window during which ‘programming’ effects might be exerted61. Experimental 
studies indicate that infants who were fed with growth-promoting enriched diets, had greater risk of developing 
an adverse metabolic profile
62
. Further research on preterm and full-term infants suggested that growth 
acceleration in infants is associated with later insulin resistance and blood pressure
63-65
. These findings lead to a 
proposal by Singhal et al, 2004, of the ‘postnatal growth acceleration hypothesis’, states that an adverse long-
term effects of early programming is cardio-vascular disease
63
. Singhal explains that growth acceleration is a 
continuous process from in utero to adolescence, and restriction during fetal growth can be relative to genetic 
growth potential. A fetus which undergoes growth restrictions during in utero may have postnatal growth 
acceleration by a nutrient enriched diet which can have adverse long-term effects. This hypothesis was 
supported by consistent findings from animal data showing that early postnatal nutrition and faster growth led to 
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higher propensity of metabolic syndrome
63
. Similarly, comprehensive reviews on studies in humans also 
ddemonstrated support for this hypothesis
63,66-68
.  
2.1.4. Genetic susceptibility hypothesis 
The genetic susceptibility hypothesis is a recent hypothesis based on underlying genetic links with birth size and 
metabolic diseases in adulthood. It uses the developmental plasticity concept, proposing that genetic changes 
occurring during critical time windows of development in the fetus can lead to irreversible morphological and 
functional changes and higher susceptibility to disease later in life. The ‘fetal insulin hypothesis’ states that 
paternal insulin resistance results in impaired insulin-mediated growth in the fetus as well as insulin resistance 
in adult life suggesting it may be genetically determined
69
. This hypothesis has been supported by studies on 
rare monogenic variants that were associated with both low BW and altered insulin secretion or resistance later 
in life
70,71
. These findings are interesting as the factors for parental diabetes do not directly influence the intra-
uterine environment but there is some evidence from life-course studies that after the birth of offspring there is 
an inverse association between offspring weight and maternal insulin resistance
72
 and diabetes
70
. However, the 
evidence supporting this hypothesis remains weak. For example, twin studies examining this hypothesis have 
been inconclusive overall and population-based genetic association studies conducted before the genome-wide 
era have produced conflicting results
64
. Recent studies have also indicated that at least some of the association 
between the BW of individuals and their later risk of diabetes may be genetic, and therefore may not susceptible 
to modification by interventions that influence intra-uterine development
73
. Furthermore, these inferences are 
now increasing; pointing towards the epigenetic inheritance of disease risk. 
2.1.5. Epigenetic modification 
In recent years, human and animal studies indicate that disturbances during critical periods of prenatal and 
postnatal development, due to nutritional and other environmental stimuli influence developmental pathways, 
which induces permanent changes in disease susceptibility
74
. Currently genetic and environmental factors that 
influence disease susceptibility, due to disruptions of energy homeostasis and metabolic regulation, are 
explored. Researchers are now increasingly interested in exploring the epigenome, which may be acting as the 
interface between gene-environment interactions and changes in gene expression. There is an increasing body 
of evidence suggesting that the brief environment influences during early-life development can cause permanent 
changes in epigenetic modification leading to induction of human diseases 
75
.  
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2.2.   Growth patterns in early life and obesity 
Over the last decade, life-course epidemiological research has been focused on identifying determinants of 
growth patterns and CVD, such as, obesity and T2D. Previous studies suggest the concept of ‘critical’ or 
‘sensitive’ periods of growth during early life, which can alter functional changes in an individual’s health. In 
this review, I collect evidence from studies conducted on growth patterns and later outcomes into four growth 
periods 1) the intra-uterine period, 2) infancy, 3) mid-childhood and 4) adolescence.  However, growth patterns 
during adolescence are not discussed in this review due to time restrictions and will be at looked in the future.  
 
2.2.1 Intra-uterine period 
The structure and timing of the critical periods are considered important factors in predicting long-term health. 
Observations from previous epidemiological studies show that growth restriction during fetal growth can alter 
infant growth and have been shown to have different metabolic consequences in adult life
76
. Important studies 
indicating links between intra-uterine periods has been discussed above under the ‘fetal origin’ hypothesis.  
 
2.2.2 Infancy  
Infancy has been characterised as the postnatal period during which rapid growth occurs. It commences after the 
first neonatal weeks (first 2 weeks). Various definitions of infancy have been proposed in studies using infant 
data. For consistency of results, this literature review uses the period between birth and 2 years as the definition 
for ‘infancy’. Several studies refer to postnatal weight gain or height gain as ‘catch-up growth’; however, in this 
thesis ‘catch-up’ has been used in context of an individual’s growth in height or weight to reach its genetic 
potential. Prader et al, 1963, was the first to introduce the term, “catch-up”, in infants who were exposed to 
stress during in-uterine growth, leading to deviations in growth trajectory
77
. Further studies confirmed this link 
between infancy rapid growth and intra-uterine constraint
78-81
. Studies on appropriate for gestational age (AGA) 
children in both developed and developing countries, supported associations between rapid infant growths with 
metabolic diseases
82
. Other research have highlighted links between AGA infant exhibiting rapid growth and 
adult hypertension 
57,83
, coronary heart disease 
84
, and T2D or noninsulin- dependent diabetes (NIDDM) 
85
.  An 
overall review on size-at-birth and postnatal rapid growth associates higher blood pressures in low birth weight 
(LBW) and high infant growth
57
. In summary, all evidence indicated that infancy forms an important critical 
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period during which a combination of low BW and high growth centile can be indicative of a greater risk for 
future obesity and perhaps of other associated morbidities. 
 
2.2.3 Childhood  
Childhood is defined as the period of slow deceleration of growth velocity that lasts until onset of puberty. 
There have been several studies conducted on growth during childhood and later health factors. However, for 
this thesis, I was only interested in exploring the role of adiposity peak (AP), the time when BMI reaches its 
peak, and adiposity rebound (AR), the time when BMI reaches its nadir. Both AP and AR have been suggested 
to have associations with adiposity in later life. Rolland-Cachera et al, 1984, was first to describe the term 
“adiposity rebound (AR)”, suggesting that there is an association between timing during which the BMI reaches 
its nadir (AR) and adiposity in adolescence and young adulthood 
86
. This inverse relationship between the 
timing of AR and adiposity in later life has been confirmed in a number of other longitudinal studies
87-89
, which 
remains even after adjusting for parental obesity 
3,90
. Some studies also show links between faster infant height 
with AR, suggesting that obese children tend to be taller as well as fatter and heavier
91-93
.  Thus, whilst there is 
clear evidence that early childhood AR predicts later obesity, it is not clear that this association is entirely 
independent of parental and early-life BMI, which are themselves related to the risk of obesity. At this point the 
evidence does not clearly suggest if adiposity rebound can be considered as a critical period for the 
development of obesity.  
 
2.3  Other phenotypes related to obesity 
2.3.2 Maternal BMI 
Maternal BMI has been reported as the most significant marker for offspring obesity by several epidemiological 
studies. Studies have shown maternal obesity affects both mother and offspring, which in the offspring, the 
implications could be either intermediate or long-term, such as congenital anomalies, small for gestational age, 
fetal overgrowth, preterm birth and neonatal mortality 
94-96
. It is now widely acknowledged that maternal BMI 
has a significant impact on infant body weight, although the mechanisms underlying the biological pathways are 
still unclear. Reviews on various epidemiological studies have shown that maternal body composition is 
strongly associated with visceral adipose tissue in offspring, which is associated with insulin resistance, 
dyslipidemia, systemic inflammation, diabetes, hypertension, myocardial infarction and all-cause mortality.  
PhD Thesis 
 
42 
 
Children of obese mothers are at increased risk of developing metabolic syndrome regardless of birth weight 
97
. 
It has been shown that maternal obesity directly links to higher metabolic syndrome factors, such as non-fasting 
glucose levels and insulin resistance and leptin concentration, in young adults (particularly male offspring)
98-101
. 
Data from animal studies indicates that maternal obesity is related to increased appetite in the offspring. Whilst 
it could be predicted that the increased appetite may be the causal effect of obesity in the later life of the 
offspring, the pathway for the increased birth weight due maternal obesity still cannot be explained.  
2.4   Genetic Studies on early life phenotypes related to obesity 
2.4.1 Background 
The first evidence linking genetics to common obesity came from Feinleib et al, 1977, indicating a possibility 
that the observed familial aggregation for obesity could be genetic rather than environment 
102
. Subsequently, 
studies from family, twins and adopted children showed that there was a 40-70% inter-individual variation in 
the BMI, particularly fat mass distribution, within the same population that shares the same environment which 
had a heritability value
103-107
, although the heritability estimation varied within different population according to 
methodology and sample size.  
With increasing evidence of the genetic heritability of the obesity trait, many researchers started to study the 
genetics of obesity as a polygenic association.  In this review, I focus on two genetic association approaches 
which have been used across the field of complex human genetics; the candidate-gene and genome-wide 
association studies.   
2.4.2 Candidate gene studies 
Table 2 presents an update on all the candidate genes which have been shown to be associated with obesity-
traits in childhood. In 2006, an update from the human obesity gene map by Rankinen et al, 2006, reported 127 
candidate genes were associated with obesity-related traits, of which only eight of the candidate genes were 
identified in children
108
. Furthermore, Walley et al in 2004 and 2009, also reviewed the published candidate-
genes associations in children
109,110
.  
Although, results on candidate genes studies in children has been equivocal as most of the studies studying 
obesity-related outcomes in children focused on replicating candidate genes in adult studies. For example, two 
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Table 2: Recent candidate genes identified for association with obesity in children
1
.  
Chromoso
me 
Location 
Regional 
Gene(s) 
Gene name 
SNP 
type 
phenotype measured References year 
1 1p31 LEPR Leptin receptor Coding 
BMI, fat mass, 
overweight 
Clement
111
 1998 
4 4q31 NPY2R Neuropeptide Y receptor Y2 Coding Obesity Siddiq
112
 2007 
5 5q15 PCSK1 proprotein convertase subtilisin/kexin type 1 Coding Obesity Benzinou
113
 2008 
6 6q22 ENPP1 ectonucleotide pyrophosphatase/phosphodiesterase 1 Coding Obesity Meyre
114
 2005 
6 6q14 CNR1 cannabinoid receptor 1 (brain) Coding Obesity Benzinou
113
 2008 
7 7q22.3 NAMPT nicotinamide phosphoridbosyltransferease Coding Severe Obesity Blakemore
115
 2009 
8 8p12 ADRB3 Adrenoceptor beta 3 Coding 
BMI, body weight, 
WHR, Fat mass 
Farooqi 
116
 2003 
18 18q22 MC4R Melanocortin 4 receptor Coding 
BMI, body fat, fat mass, 
WHR 
Hinney
117
 2003 
16 16q12.2 FTO Fat mass and obesity associated Coding Early on-set obesity Meyre
118
 2009 
16 16q22-q23 MAF v-maf avian musculoaponeurotic fibrosarcoma oncogene Coding Early on-set obesity Meyre
118
 2009 
10 10p12 PTER Phosphotriesterase related Coding Early on-set obesity Meyre
119
 2009 
18 18q11.2 NPC1 Niemann-Pick disease, type C1 Coding Early on-set obesity Meyre
119
 2009 
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studies -  one by Haworth et al, 2008, found no evidence of 10 candidate genes at various ages in children while 
Podolsky et al, 2007, reported multiple associations in 11 candidate genes from adult studies
120,121
. Therefore, it 
was acknowledged that more comprehensive studies that examined the association of all common variations in 
a gene were required
1
. 
2.4.3 Genome-wide association studies (GWAS) 
The foundation of understanding the role of genes involved in obesity was started by Zhang et al, 1994 and co-
workers. They cloned and characterized the ob genes in ob/ob and db/db strains of mice highlighting the role of 
leptin in control of food intake
122
. The first GWAS was performed on 86, 604 SNPs were analysed in 694 
participants from family studies, and one SNP rs7566605 near INSIG2  was suggested to associated with 
obesity, which was validated in the independent replication stage
123
.  
The true GWAS era was introduced in 2007, and so far four waves of large-scale high-density GWAS for BMI, 
a marker of overall adiposity, have been performed, identifying 32 loci that reached genome-wide significance. 
Most of these have been studied on white Europeans and adults only. The first obesity GWAS wave resulted in 
the suggestion of four susceptibility loci. FTO was originally highlighted in a GWAS of type 2 diabetes
124
, 
however , adjustment for BMI revealed that the association was mediated through obesity in two different  
studies
125,126
. Furthermore, FTO locus has also been found to be associated with obesity-related traits in white 
European children and adolescent
118,127-129
, and other ethnic decent
130-132
. In the second GWAS wave, the 
GIANT (Genetic investigation of Anthropometric Traits) consortium performed meta-analysis of ~17000 
Caucasian individuals and identified variants in or near MC4R associating with measures of obesity and waist 
circumference
133,134
.  
The third wave included studies identifying variants in or near TMEM18, SH2B1, KCTD15, NEGR1, GNPDA2, 
MTCH2 , BDNF, SEC16B, FAIM2, ETV5 and MAF
119,135,136
 genome-wide significantly associated with BMI. 
Another four novel loci were identified in a parallel GWAS strategy, focused on measures of fat distribution 
using waist circumference and WHR adjusted for BMI: LYPLAL1, TFAP2B, MSRA and NRXN3 
137,138
. The 
fourth obesity GWAS was dominated by two meta-analysis by GIANT on BMI 
139
 and WHR
140
.  These 
identified 18 and 13 novel loci, shown Figure 3. Overall, WHR variants had a stronger association in women 
than in men, confirming the sex difference in distribution of fat. Further studies identified three new loci for 
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extreme obesity in children and adolescents, SDCCAG8 and TNKS
141
, one loci KCNMA1 found in an adult 
population
142
. In total, 43 loci were proposed which may predispose overall adiposity and 18 loci to visceral fat 
accumulation
143
. Of these, 32 BMI and 14 waist/WHR variants were genome-wide significant, and one variant 
(MAF) associating with morbid obesity
143
.  
In recent years, after successful identification of adult adiposity variants, the focus has now shifted to identify 
common childhood obesity, which is not widely studied. In one of the latest effort, Bradfield et al, 2010, 
performed a GWAS meta-analysis of totally 5530 cases and 8318 controls, using age- and gender-matched 
measures of BMI, identifying two loci, OLFM4 and HOXB5, in common childhood obesity
144
. However, in 
understanding common variants of childhood obesity, studying the extremes of the BMI distribution might be 
just one way to further unravel obesity genetics. More functional studies are needed to fully characterise the 
functions of genes in relation to childhood obesity. This thesis fills the gap of understanding on genetic variants 
relating to early life ‘programming’ and provides further evidence towards genetic backgrounds of complex 
diseases.  
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Figure 3: Showing the waves of GWAS on adult obesity with different obesity related phenotypes. 
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2.5 Leukocyte telomere length (LTL) and obesity  
Leukocyte Telomere length (LTL) has been suggested as a biomarker of human aging. LTL is 
supposed to be associated cellular senescence which has been predicted to be associated with onset 
and development of cardio-vascular diseases (CVD) such as atherosclerosis 
145
.  Although 
conflicting results had been published on LTL, two researchers clarified with twin same-sex models 
that co-twins with shorter LTL were more likely to die first 
146
 
147
 supporting the role of LTL as a 
biomarker. Further studies supported association between telomere lengths, independently of age, 
and cardio-vascular diseases
148,149
.  Although shortening of telomere length is not the cause of the 
onset of a CVD, it has been shown that there is a significant relationship between telomere length 
and leukocyte and vascular tissues that may affect the tissue related to CVD
150,151
.  
Shorter telomere in peripheral blood has also been suggested to associate with obesity, and 
oxidative stress and inflammation could be the underlying mechanisms for this association
152-156
. 
This has been supported from longitudinal studies as well, reflecting that weight loss is associated 
with longer telomere length and rectal mucosa in obese men 
157
. In children, initial small-scale 
studies of telomere length and childhood obesity presented contradictory results in comparisons to 
adults
158,159
. Lee et al, 2011, showed an inverse association between adiposity and telomere length, 
however, they also stressed on utilizing longitudinal studies to establish a causal association 
between early life adiposity and biological aging
160
. Later, Sidorov et al, 2008, using models for 
weight-gain charts from birth to 20 years showed that LTL shortening happened in an age-
dependent manner
161
. More recently, Buxton et al, 2011, demonstrated that obese girls and boys 
have significantly shorter leukocyte telomere compared to their non-obese counterparts, 
emphasizing the adverse risk of childhood obesity on adulthood health.   
2.6 Summary 
The concept of “critical” or “sensitive” periods of growth, during which the antecedents of chronic 
degenerative diseases may be initiated, has been investigated in hundreds of publications over the 
last decade. The approach that has emerged within this review combines classic axiological and 
epidemiological methods within a life-span perspective that identifies accumulating and interacting 
risks that manifest from prenatal life onwards.  
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The current study proposes to form the basis of a fuller understanding of patterns of growth from 
birth to adolescence and the identification of factors that exert their influence on obesity in later life. 
The main goal is to bridge the gap by developing statistical models to study human growth from 
birth until adolescence and integrate both genetic and environmental factors that underlie growth 
trajectories leading to obesity. 
In summary, the above literature provides ample evidence that exposures in genetic and 
environmental factors can have long-term effects on the development of diseases such as obesity in 
the future. However, only few investigators examined the critical interplay between genes, 
environment and early pre- and postnatal events in the development of obesity. Even fewer studies 
have utilized human only data to model this effect of genetic and environmental factors together, as 
most of these have been done on animals.  These studies emphasize the importance of identifying 
factors within the pre- and postnatal period that promote and those that inhibit the development of 
obesity.  
However, recent work on telomere attrition provides a new area of investigation that may 
eventually delineate causal connections between early growth and later disease. 
 
To resolve the effects of rapid growth and obesity, dense growth measurements throughout the 
postnatal life are needed, as well as complex statistical models to take into account the dependency 
between consecutive growth measurements in each individual 
64
. Sovio et al, 2009, demonstrated 
this through their study by deriving peak height velocity from parametric growth curves fitted to 
longitudinal height growth data to test their association with known genetic height variants
12
. 
Recent work on infant growth velocities and their association with later risk of obesity 
14,61
 has 
shown that determinants of height and weight growth during these early life periods need to be 
studied. A recent example by Tzoulaki et al, 2010, has shown the importance of studying postnatal 
infant growth and associating it with later metabolic profile at 31 years of age [8]. Such studies 
form the basis for this thesis to further add to the understanding of various prenatal and postnatal 
factors, which may influence postnatal infant growth, and may have an indirect effect on later 
health.  
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Chapter 3: Objective, hypotheses and research questions 
The overall aim of this work was to gain new insights into the genetic and environmental factors 
leading to obesity risk. These insights may potentially help in developing new means of effective 
prevention and treatment of obesity in the future. The focus of the thesis was to understand the 
association between prenatal predictors, size-at-birth, early growth factors and their genetic 
determinants.  
3.1   Main objective 
1)  To understand the role of size-at-birth in the association, testing mediation by size-at-birth, 
between prenatal predictors and peak height velocity (PHV).  
2) To identify the role of the obesogenic environment in utero and during childhood on metabolic 
health of the offspring. It was also to distinguish the causal effect of ‘in utero programming’ by pre-
pregnancy maternal weight, and ‘postnatal programming’ by obesogenic environment during 
childhood and adolescence.  
3) To examine leukocyte telomere length (LTL) at 31 years and its associations with childhood and 
adulthood adiposity-related measurements.  
4) To identify the role of genetic variants on head circumference (HC) in a GWAS design, and to 
check if infant head circumference mediates the association between genetic variants and adult 
height. 
5) To identify the role of genetic variants for early adiposity phenotypes in GWAS design, and if 
early adiposity phenotypes mediates the association between genetic variants and adult BMI.  
3.2    Study-specific hypotheses 
The hypotheses tested in this thesis were:  
1) Several prenatal predictors associate with size at birth and infant height growth. Also, the 
size at birth mediates the association between prenatal predictors and infant height growth. 
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2)  Maternal weight exerts a ‘programming’ effect on fetal growth, size-at-birth as its marker, 
and later metabolic phenotypes in adolescents. The postnatal obesogenic environment 
during childhood adds to this adverse risk.  
3) Leukocyte Telomere length (LTL), a biomarker for age-related diseases, is associated with 
childhood and adulthood adiposity related measures. Longitudinal change in BMI over 
childhood to adulthood may have the effect of shortening telomere length. 
4) The common genetic variants associated with infant HC variations. These variants result in 
smaller head size which may be associated with adulthood stature and related risk factors. 
5) Common genetic variants influence the variation in early growth phenotypes, such as peak 
weight and height, age/BMI at adiposity peak (AP) and age/BMI at adiposity rebound (AR). 
The early growth phenotypes also mediate the association between these genetic variants 
and adulthood BMI, leading to risk of diseases such as obesity.    
3.3    Research questions for the thesis  
1) What are the maternal, paternal and environmental determinants of early growth velocities? 
What is the evidence for an association between prenatal predictors, size at birth and infant 
growth? Is infant growth velocity associated with later metabolic health in adults?  
2) Are these associations with prenatal predictors a reflection of the intra-uterine environment 
affecting size at birth? More specifically, does size-at-birth act as mediator between the 
association of prenatal predictors and infant growth phenotypes? 
3) What is the role of the postnatal environment in generating the association between infant 
growth and subsequent adult health?   
4) Is there a difference between adolescent metabolic phenotypes born to overweight/obese 
mothers during pre-pregnancy compared to adolescents of overweight/obese mothers after 
child’s birth?  Is there is a programming effect or postnatal environmental effect on the 
offspring’s overweight/obese mothers?  
PhD Thesis 
 
51 
 
5) What is the association between telomere length (a biomarker for age-related diseases) and 
childhood or adulthood adiposity related measures? Is there any evidence that change in 
BMI over childhood to adulthood may have an effect on the shortening of telomere length?  
6) What are the genetic factors associated with infant head circumference? Do these genetic 
variants also associate with adulthood phenotypes such as height, brain size? Is there a 
mediating link between infant head circumference and adulthood phenotypes?  
7) What are the genetic factors associated with early growth phenotypes? Do these genetic 
variants also associate with adult adiposity phenotypes, such as BMI? What are the other 
disease phenotypes associated with these genetic variants? Is there an inter-link between 
these disease phenotypes and obesity? What is the correlation between published adult BMI-
associating SNPs and early growth phenotypes? Do these early growth phenotypes mediate 
the association between genetic variants and adult adiposity phenotypes such as BMI?  
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Chapter 4: Methods and Materials 
This chapter introduces the study populations and statistical methods used for the epidemiological 
and genome-wide association analyses in Chapter 5. Section 4.1.1 provides information on the two 
primary study populations used in this thesis, the Northern Finland Birth Cohort 1966 and 1986 
(NFBC1966 and NFBC1986). Section 4.1.2 describes the growth modeling of height, weight and 
body mass index (BMI) during childhood, based on longitudinal growth data, used to calculate the 
growth phenotypes considered as outcome variables in the association analyses in Chapter 5. 
Section 4.1.3 provides details of the other phenotypes used in the analyses in Chapter 5 on the 
NFBC1966 and NFBC1986 data, and confounding variables. Section 4.4 describes the statistical 
analysis conducted on association analysis and preliminary stages of genome-wide association 
studies (GWAS). 
 
4.1   Description of primary cohorts for analysis   
The core data used in this thesis is comprised mainly of individuals born in Northern Finland in the 
1960s and 1980s that form part of the Northern Finland Birth Cohort (NFBC) studies. The NFBC 
study is an epidemiological and longitudinal research program initiated by Professor Paula 
Rantakallio, University of Oulu, in 1965. The aim of the study was to investigate biological, social 
and behavioral risk factors for preterm birth, low birth weight and determinants of later 
development, diseases and disorders.  The present data derives from two cohorts of mothers who 
lived in Oulu and Lapland, the northernmost provinces of Finland, with an expected date of delivery 
between 1
st
 January to 31
st
 December 1966, known as NFBC1966, and between July 1
st
 1985 and 
June 30
th
 1986 known as NFBC1986. In both studies, mothers and children have been followed up; 
since mothers enrolled at their first antenatal clinic visit (in NFBC1966 on average on the 16
th
 
gestational week, in NFBC1986 from the 10
th
 gestational week onwards and on average on the 12 
the gestational week)
63,66,162. The NFBCs have one of the world’s most dense early growth data 
collections, with measurements from birth until adulthood. These cohorts include vast amount of 
data related to subjects’ living circumstances and well-being, diseases, genetic, metabolic and other 
biological measures from early pregnancy
66,163
. The Ethics committees of the University of Oulu 
and Northern Osthrobothnia Hospital District have approved the study in accordance with the 
Declaration of Helsinki. 
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4.1.1 Northern Finland Birth Cohort 1966 (NFBC 1966) 
The Northern Finland Birth Cohort 1966 (NFBC1966) was recruited through maternity health 
centres and data was collected from women living, during pregnancy, in Finland’s two 
northernmost provinces, Oulu and Lapland, with expected deliveries between the 1st of January to 
the 31st of December 1966 (n=12,055 mothers). A high proportion of women (approximately 80%) 
first attended the clinics by the 16th gestational week; from this point onwards the measurements 
related to the course of pregnancy are available (by midwives). The questionnaires on baseline 
socio-demographic, health behavioural (e.g. smoking) and other background information were 
administered between the 24th and 28th gestational weeks. Data on the course of the pregnancies and 
birth were obtained from maternity cards filled in and updated by midwives at each antenatal visit 
and from hospital records.  
 
In NFBC1966, a total of 12,231 babies were born, of which 12,058 alive and 173 stillborn. The 
study population has a high coverage of 96.3% of all eligible births in the area during the catchment 
period. All cohort members are Finns (white Caucasians), and less than 1% of these are Gypsies or 
Lapps. Birth outcomes were collected at delivery by trained medical staff and entered in their 
medical records. This data was immediately transferred to the study specific forms and returned to 
the research centre in Oulu. The children were then followed up, using questionnaires, clinical 
examinations, child welfare cards from birth to ages 1 and 14 and clinical examination at 31 years, 
covering information on growth, development, health, measures of function (such as lung function, 
physical performance, blood pressure), lifestyle and socio-economic indicators164.  The written 
informed consents were requested at the age of 31 for the follow-up in 1997, where they consented 
to the use of current and previously collected data for scientific research.  
 
The NFBC1966 also provides rich sources of data from blood samples and DNA of its 5,753 
subjects, which is described in more detail, together with description of the genetic data of the 
NFBC1986, in section 4.3. Data from the NFBC1966 cohort was analysed throughout the current 
work and described in Chapter 5. 
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4.1.1.1    Height and weight measurements in children and adolescents 
Data on the height and weight growth of each child was collected from records obtained from 
communal health clinics and using questionnaires at the age of one year when nurses provided the 
information on child growth and development as well as at the age of 14 years.  On average, 7 
height measurements were obtained per person from birth until age 2 years in NFBC1966 and 15 
measurements per person from 2 years until adulthood (~ 16 years). This growth data was not 
available for all individuals in the NFBC data base (although available on paper files), as growth 
measurements was entered for those with DNA available at 31 years (maximum N=5,753) because 
of plans for genetic studies of growth and development. The copies of original child health clinic 
records  were requested from the health care centres, institutions and archives , but around one 
quarter of the records were missing over the years, with the final number of records for those with 
DNA samples amounting to N=4,311. The number of measurements of height and weight varied 
between the individuals which were taken into account in the analyses. Growth curves were fitted to 
derive clinically meaningful growth phenotypes, such as growth velocities for the genetic and other 
association analyses.  
4.1.1.2    Follow-up at 14 and 31 years 
All individuals alive at 14 years were contacted by postal questionnaire to collect information on 
their growth and health, health behaviour (smoking, drinking, and physical activity), school 
performance and family’s social circumstances. The target population, all alive, was 11,637.  Of 
them 11,541 adolescents were traced with their recorded address and questionnaires were sent. If 
the adolescent did not respond, then a questionnaire (N=754) was sent to the parents of the 
adolescents. To get all possible information, a similar questionnaire was sent to the regional school 
offices and to the school nurse if the children or their parents did not respond. After these efforts the 
final response rate was 97%.   
In 1997, individuals alive at 31 years of age; and that could be traced, were invited for follow-up by 
a postal questionnaire on health, lifestyle and socio-economic status (N=11,541), and all individuals 
who were resident in Northern Finland or had moved to the capital city Helsinki, area (N=8,463), 
were invited to a clinical examination. The response rate of the postal questionnaire was 75% 
(N=8,600) and for the clinical examination 71% (N=6,007). Trained nurses performed the clinical 
examination, collecting anthropometric and other clinical data as well as  samples for  metabolic 
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phenotypes including, height, body mass index (BMI), waist-circumference (WC), high density 
lipid (HDL), cholesterol, triglyceride, glucose, systolic blood pressure (SBP) and diastolic blood 
pressure (DBP), as described below. 
 
1) Anthropometric measures at 31 years 
BMI was calculated from weight and height measurements, using the formula of weight (kg)/height 
(m)
2165
. WC was measured at the level midway between the lowest rib margin and the iliac crest. 
SBP and DBP were measured by trained nurses using a mercury sphygmomanometer following a 
standardized procedure and on-going quality control. Two readings of SBP and DBP were recorded 
and the average of the two measurements was used for the association analyses
66
. 
 
2) Blood sampling 
The blood samples were taken after overnight fasting and drawn between 8.00-11.00 AM and stored 
at -70°C until analysed. The glucose analysis was performed by radioimmunoassay with 
commercial reagents (Pharmacia Diagnostics, Uppsala, Sweden) within 7 days. The other samples 
were analysed within 24 hours in Oulu University Hospital laboratory by using on-going 
internal/external quality control.  Enzymatic assays of fasting serum glucose, insulin, triglycerides 
(TG), total cholesterol (TC), and high density lipoprotein cholesterol (HDL-C)were carried out 
using Hitachi 911 automatic analyser and commercial reagents (Boerhringer Mannheim, 
Mannheim, Germany) in the accredited laboratory of Oulu University Hospital (Oulu, Finland).  
 
The fasting plasma concentration of low density lipoprotein cholesterol (LDL-C) was measured by 
the Friedewald equation: [LDL-C] = [Total C] - [HDL-C] - ([TG]/2.2)
166
. Insulin resistance was 
assessed using the homeostasis model assessment (HOMA-IR) and calculated using the following 
formula: HOMA-IR (mmol/L x µU/ml) = fasting glucose (mmol/L) x fasting insulin (µU/ml)/22.5. 
Pancreatic ß cell function was determined using the homeostasis model assessment of β-cells 
(HOMA-B) and calculated by the following formula: 20 × fasting insulin (μIU/ml)/fasting glucose 
(mmol/ml) − 3.5 (http://www.dtu.ox.ac.uk/homacalculator/).  
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4.1.2 Northern Finland Birth Cohort 1986 (NFBC1986) 
The younger cohort, Northern Finland Birth Cohort 1986 (NFBC1986), was also recruited from the 
same region, Oulu and Lapland, with an expected date of delivery between the 1st July 1985 and the 
30th June 1986. Information on health and socio-economic status was collected through 
questionnaires handed out at the first antenatal visit, on average in the 12th gestational week and 
returned by the 24th gestational week if still pregnant. Overall, data collection in this younger cohort 
followed that of the twenty years older NFBC1966 with some modifications and availability of new 
technology such as ultrasound examinations during pregnancy.   
 
The recruited women had 9,362 deliveries, and information was collected through maternity health 
centers with 99% coverage of births in the area
65
. In total, 9,479 children were born of which 9,432 
were live-born and 47 still born. Obstetric and birth data was obtained from hospital records and 
maternity cards were filled in and updated by midwives at each antenatal visit. Data concerning 
maternal medical characteristics, including pre-pregnancy body mass index (BMI; kg/m2), were 
collected via antenatal records at the time of inclusion and were either self-reported or measured 
when mothers attended the clinics. Birth outcomes were collected at delivery by trained medical 
staff, entered into the medical records and into the study-specific forms which were returned to the 
research center in Oulu. The cohort was followed-up by postal questionnaires, hospital records and 
register data at the ages of 7 and 8 (questionnaires to the parents and teachers) as well as the ages of 
15 and 16 (questionnaires to the parent and adolescents and a clinical examination). At the ages of 
15 and 16, the cohort members and their parents gave written informed consent. The University of 
Oulu Ethics Committee and the Ethical Committee of Northern Ostrobothnia Hospital District have 
approved the study.  
 
4.1.2.1    Height and weight measurements per person in children and adolescents 
The height and weight growth data was entered from scanning or from the paper copies of original 
records obtained from health clinics. The data in the original records was filled in by the study 
nurse, following procedure described in the protocol. On average there were 11 height 
measurements and 13 weight measurements in infancy during first year of life and 9 measurements 
from childhood to adolescent. After combining all the data, those with missing values, double 
entries and unclear values were set to be missing. Similar to NFBC1966, growth curves were fitted 
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to derive clinically meaningful growth phenotypes, e.g. growth velocities for the genetic and other 
association analyses.  
 
4.1.2.2    Follow-up at 16 years 
The cohort was followed-up by postal questionnaire when offspring were 15 to 16 years old, 
between May 2001 and June 2002 (80% responded), and then by invitation for clinical examination 
between August 2001 and June 2002 (74% attended).  Target population, those alive with known 
address (N=9,215), were contacted by postal questionnaire to collect information on their growth 
and health, health behaviour (smoking, drinking, physical activity), school performance and 
family’s social circumstances.  7,344 replies on questionnaires from adolescents and 6,985 replies 
on questionnaire from parents were received. The target population, all alive and known address 
(N=9,215), were invited for clinical examination; 6,798 responded, covering 74% of target 
population. Trained nurses performed the clinical examination, collecting anthropometric and other 
clinical data as well as  samples for  metabolic phenotypes including, height, body mass index 
(BMI), waist-circumference (WC), high density lipid (HDL), cholesterol, triglyceride, glucose, 
systolic blood pressure (SBP) and diastolic blood pressure (DBP), as described below. 
 
Of the NFBC1986 individuals who provided blood samples at the 16 year of age follow-up DNA 
was extracted for 6,266 individuals and genotyping for the present study was performed with 
Genetics group at Imperial College London, UK, in Pasteur Institute Laboratories, Lille, France or 
in KBiosciences, UK, depending on the study. Details are given below in section 4.3.  
 
Anthropometric measures  
The clinical examinations were conducted by teams of trained nurses. The following information 
was recorded: weight, height, waist and hip circumferences, sitting height, spirometry, blood 
pressure, pulse rate, skin prick test, physical activity and questions about puberty, nutrition, 
smoking and use of alcohol. Adolescent BMI (kg/m
2
) and waist-to-hip ratio (WHR) were calculated 
from the height and weight recorded at the clinical examinations. The stages of puberty were 
assessed via the Tanner scale and the age of menarche was assessed using a questionnaire in the 
clinical examination. In the NFBC 1986 seated blood pressure (BP) was measured in the 
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adolescents (after 15 min rest) by using an oscillometric blood pressure meter Omron 705C, (or a 
mercury sphygmomanometer if previous failed). Two readings of SBP and DBP were recorded and 
the mean of the two measurements was used for the association analyses. 
5 Blood sample 
The blood sample was taken at the age of 16 years, and the serum samples were stored at -70C. 
Enzymatic assays of fasting serum glucose, insulin, triglycerides (TG), total cholesterol (TC), high 
density lipoprotein cholesterol (HDL-C), apolipoprotein A1 and apolipoprotein B were carried out 
using Hitachi 911 automatic analyzer and commercial reagents (Boerhringer Mannheim, 
Mannheim, Germany) in the accredited laboratory of Oulu University Hospital (Oulu, Finland). The 
fasting plasma concentration of low density lipoprotein cholesterol (LDL-C) was measured by the 
Friedewald equation: [LDL-C] = [Total C] - [HDL-C] - ([TG]/2.2). 
In NFBC1986, as for NFBC1966, insulin resistance was assessed using the homeostasis model 
assessment (HOMA-IR) and calculated using the following formula: HOMA-IR (mmol/L x µU/ml) 
= fasting glucose (mmol/L) x fasting insulin (µU/ml)/22.5. Pancreatic ß cell function was 
determined using the homeostasis model assessment of β-cells (HOMA-B) and calculated by the 
following formula: 20 × fasting insulin (μIU/ml)/fasting glucose (mmol/ml) − 3.5 
(http://www.dtu.ox.ac.uk/homacalculator/).  
  
4.2    Variables (or exposure) selected from the NFBC1966 and NFBC1986 
Phenotype and other variable  selections  in this study was based on  a prior knowledge from 
previous published studies 
68
 and on expert knowledge of my supervisors (Prof Marjo-Riitta and Dr 
Paul O’Reilly). Phenotypes selection were study-specific, and are described below, based on if the 
data was collected prenatally or postnatally. The prenatal period includes the maternal and paternal 
variables of the individual included in the study, while postnatal period includes data on 
individual’s birth, infancy, childhood and adolescent. One of the studies also utilised the data on 
maternal and paternal variables when the adolescent was 16 years old and has been described under 
the postnatal period. Table 3, describes each variable in detail per study. A more extensive data 
exploration was done for the MSc dissertation (given in Appendix Note 2) for selection of variation 
(or exposures).      
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4.2.1 Prenatal period – Maternal and paternal  
Variables on prenatal period were obtained from questionnaires administered by mid-wives when 
pregnant mothers attended the maternity clinics or from medical records (maternity cards).  The 
questionnaire, medical records and population registry provided data on maternal age, height, 
weight, parity, hypertensive disorders, and smoking during pregnancy, marital status and SES. 
Maternal pre-pregnancy and paternal BMI (kg/m
2
) was calculated by weight in kilograms divided 
by height in meters squared. Maternal SES and hypertensive complications during pregnancy were 
re-classified to make them more interpretable and comparable between the NFBCs (details of the 
reclassification are given in Appendix Note 1).  
4.2.2 Postnatal period  
Birth  
Data on birth was collected from the hospital records soon after delivery. Individual’s birth weight 
(BW), birth length (BL), head circumference (HC), and gestational age (GA) was obtained from 
birth records prospectively at the time of birth. The BW was given in grams (converted to kg where 
appropriate) and gestational age (in weeks according to the mother’s last menstrual period, for all in 
NFBC1966 and in 16% of the sample in NFBC1986; by ultrasound examination in 84% of the 
NFBC1986 sample) were clinically measured according to standard procedures at the time of 
delivery. 
Infancy, childhood and adolescent 
Data on postnatal height and weight growth in infancy and childhood has been described above for 
each of NFBCs in section 4.1.1.1.  
Adolescent variables were obtained from questionnaires completed at 14 years in NFBC1966 and at 
16 years in NFBC1986. Adolescent BMI (kg/m
2
) and waist-to-hip ratio (WHR) were calculated 
from height and weight recorded at clinical examinations. The stage of puberty was assessed via the 
Tanner scale and the age of menarche was recorded for the females. The Tanner scale is a physical 
measurement for sexual development in puberty. In girls, the Tanner scale is based on their breast 
size, shape and pubic hair distribution. In boys the Tanner scale is based on the size and shape of 
the penis and scrotum, and on their pubic hair development.  
PhD Thesis 
 
60 
 
Data on maternal and paternal weight, height and SES were also collected via the postal 
questionnaire at 14 years in NFBC1966 and at 16 years in NFBC1986.  
Adulthood 
Adulthood height and weight was measured at the clinical examination at 31 years in NFBC 1966. 
Adult BMI was calculated by weight in kilograms divided by height in meters squared and 
presented in units’ kg/m2.  Data on smoking, parity and SES was collected by the postal 
questionnaire at 31 years preceding the clinical examination.  
  
4.3    Growth modeling: application of parametric methods 
4.3.1 Descriptive analysis of growth data 
The description of the data and genome-wide association analyses of growth data are presented in 
Chapter 5, section 5.1 and 5.2. For the purpose of modeling and to reflect the literature that defines 
the three stages of growth
167
,  the data was divided into three categories: 0-2 years for infancy, 2 to 
13 years for childhood and 13 to 16 years for adolescence. This thesis only covers the growth data 
for infancy and childhood. The adolescence data was used for training purposes but not described in 
this thesis. Individuals with at least three data points available within these time periods were 
selected for analysis. Mean and standard deviation (SD) of height, weight and BMI was calculated 
at each age interval. The analysis was sex-stratified, as males have a higher body size than females 
at most ages, and growth velocities differ, particularly during puberty, as shown previously
168
. The 
differences between males and females were tested by the Student t-test in univariate analyses, with 
P < 0.05 considered as significant.  
 
From a statistical perspective fitting growth curves has various advantages compared to the analysis 
of serial measurements over time in a cross-sectional manner. It allows the estimation of rate of 
change, for example height growth velocity over time in each individual, and the estimation of 
biologically meaningful parameters such as the timing of peak growth. Curve fitting summarises a 
large amount of raw anthropometric data into a few constants or function parameters and thus 
serves as a data reduction technique, which is useful in defining biologically meaningful phenotypes 
for the association analyses. The resulting fitted curve helps to describe typical growth in the 
sample. The growth curve evens out the fluctuations in the data caused by measurement errors and  
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Table 3. Variables used in the analyses in this thesis from NFBC 1966 and NFBC 1986. 
Variables Unit/categories Study and notes 
Prenatal period   
Maternal   
height cm Height information was collected 
from questionnaire when mother 
first visited maternity clinic. 
weight kg Weight information was collected 
from questionnaire when mothers 
first visited the maternity clinic. 
BMI kg/m
2
 Calculated from reported height 
and weight. Divided into 
a)underweight b) normal c) 
overweight d) obese using IOTF 
classification 
age years Age was collected from the 
questionnaire when the women 
first visited the maternity clinic. 
Continuous variable 
parity a) 0; b)1; c)2; d)3; 
e)>=4 
Categorical variable 
marital status at birth a) married; 
b)unmarried/cohabiting; 
c) divorced/widow 
Unmarried and cohabiting were 
grouped together due to small 
sample size 
SES a)white collar; b)blue 
collar; c)farmer 
If mother's SES was missing then 
father's occupation. I used three 
categories in my analyses. A 
detail on how the variable was re-
classified is given in Appendix. 
education a)primary; 
b)vocational; 
c)secondary; 
d)university 
 
smoking at 2nd month of pregnancy a) non-smoker; b) 
smokers 
Maternal smoking at 2nd month 
of pregnancy was collected from 
questionnaire, and the mother 
smoking was categorised as a 
non-smoker (<1 cigarettes per 
day) or smokers (>=1 cigarette per 
day). 
hypertensive complications during pregnancy a) normotensive;  
b) gestational 
hypertension;  
c) pre-eclampsia;  
d) chronic 
hypertension;  
e) super-imposed pre-
eclampsia;  
See Appendix Note 3.   
PhD Thesis 
 
62 
 
f) proteinuria 
weight gain during pregnancy kg Collected during ante-natal checks 
by maternal nurses 
   
Paternal   
weight kg Collected when pregnant mothers’ 
visited  
height cm  
BMI kg/m
2
 Divided into a)underweight b) 
normal c) overweight d) obese 
using IOTF classification 
SES a) white collar; b) blue 
collar; c) farmer 
 
   
Birth   
Birth weight kg  
Birth length cm  
BMI kg/m
2
 Divided into a)underweight b) 
normal c) overweight d) obese 
using IOTF classification 
Gestational age weeks  
Head circumference cm  
   
Infancy   
height cm  
weight kg  
peak height velocity cm/year Calculated from growth models, 
as presented below Section 4.3. 
peak weight velocity kg/year Calculated from growth models, 
as presented below section 4.3. 
   
Childhood   
height cm  
weight kg  
Age and BMI at adiposity peak (AP) years, kg/m
2
 AP=adiposity peak derived from 
fitted growth curves 
Age and BMI at adiposity rebound (AR) years, kg/m
2
 AR=adiposity rebound derived 
from fitted growth curves 
   
Adolescent   
BMI kg/m
2
  
age at menarche years  
Fasting glucose mmol/L  
Fasting insulin mmol/L  
PhD Thesis 
 
63 
 
Triglyceride mmol/L  
Total cholesterol mmol/L  
HDL and LDL mmol/L  
Apoprotein AI mmol/L  
Apoprotein B mmol/L  
SBP/DBP mmHg SBP and DBP were measured 
twice with a mercury 
sphygmomanometer in a sitting 
position from the right arm after 
15 minutes of rest. The average of 
two measurements was used. For 
those on medication for 
hypertension, 15 mmHg and 
10mmHg were added to the 
recorded SBP and DBP values, 
respectively 
Adulthood   
BMI kg/m
2
 Calculated as weight/height ^2 
Body adiposity index (BAI) % fatness Calculated as hip circumferences 
(cm)/height(m) ^1.5 and 
subtracted by 18, as described by 
Bergman et al, 2011. 
smoking a) light (<10 
cigarettes/day); b) 
heavy smokers (>= 10 
cigarettes/day) 
The adulthood smoking was used 
in the study for association 
between LTL and childhood and 
adulthood measurements. Non-
smokers were combined with light 
smokers, as there was no 
association between LTL and 
non-smokers. 
SES a) Farmer; b) self-
employed; c) white 
collar; d) blue collar 
 
Parity a)0; b) 1; c) 2 or more Number of live births.  
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other sources of variation. The individual growth curve gives an estimate of the variable of interest 
(e.g. height) at each time point between observed measurements, and in effect interpolates a value 
for all the ‘missing’ measurements169. 
 
The modeling of growth has been an extensive task.  Consequently this task was shared between 
team members; Dr. Ulla Sovio and I.  In this thesis, in terms of growth modeling, I have mainly 
focused on and consequently described here the growth modeling for infants and young children in 
the NFBC1986. However, the analyses in this thesis utilize the growth modeling from NFBC1966, 
which was conducted by Dr. Ulla Sovio and other team members. The modeling of later childhood 
and adolescent growth parameters has also been performed in NFBC1986 but not included in the 
study, as it was not part of the analyses for this thesis.  
 
4.3.2    Inclusions, exclusions and data included in growth modeling 
The growth modeling analyses were restricted to singletons, as multiple births are associated with 
smaller size at birth and higher growth velocities in early life
170
. The growth data were checked and 
outliers removed by Dr Marika Kaakinen and Dr Ulla Sovio in the project centers in Oulu and in 
London. Any measurements that indicated downward growth in height or that did not fall within the 
age interval were omitted from the descriptive analyses. Individuals with at least three height 
measurements between birth and two years of age were selected for growth modeling, since growth 
velocity estimation is unreliable with a low number of measurements.  
 
4.3.3 Models for infant height and weight growth in the Northern Finland Birth Cohort 
1986 (NFBC1986) 
The infant growth modeling was first performed within NFBC1966 longitudinal data. A detailed 
comparison of the different models available, and those most suitable for longitudinal data for 
NFBC1966, was undertaken both by me and by Dr Ulla Sovio as described previously
11
 . A detailed 
report on the comparison of models in NFBC1986 was performed by me for the MSc Dissertation, 
as presented in Appendix Note 2. Parametric modeling was applied, as it can reflect what is known 
biologically, and is easy to interpret. Utilising Dr Sovio’s approach, I initially compared two 
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parametric growth models relevant for modeling of infancy and early childhood weight and height 
measurements in NFBC1986. The first was a three-parameter Count model and the second a four-
parameter Reed1 model, as described by Simondon et al, 1992 154, and these were compared in 
terms of the residual standard deviation (RSD) and Akaike Information Criteria (AIC). Both were 
fitted to height and weight growth data from 0-2 years in the NFBC1986155. The four-parameter 
Reed1 model 156 gave a better fit than the three-parameter Count152in both girls and boys of the 
NFBC1986. This result was consistent with the modeling approach used in NFBC1966 analyses 
and a previous study from a population in Simondon,1992
171
 .  
 
The four-parameter Reed1 model was used for infant height and weight modeling. Reed1 growth 
curves were fitted for each sex using nonlinear random effects models, allowing both fixed and 
random effects for each function parameter 156. The nlme function in R program (version 2.4.1) 
was used to fit the models. As Reed1 model is not defined at birth, therefore a modified version 
which includes an additional parameter to account for changes in height/weight growth after birth, 
as described in Simondon et al 154, was used. The model was defined as: 
Y = A + Bt + C ln(t+1) + D/(t+1)  
where, t is the postnatal age at the time of modeling, Y is the height reached at age t and A, B, C 
and D are the function parameters. The function parameter A relates to the baseline height at birth, 
B to the linear component of the growth velocity, C to the decrease in the growth velocity over 
time, and D to the inflection point that allows growth velocity to peak after birth rather than exactly 
at birth. The best-fitting curves for each individual were estimated by the maximum likelihood 
method 12. The growth velocity curves were estimated as first derivatives of the height or weight 
growth curves. The growth phenotypes were derived from the velocity curves for height at the 
maximum velocity, that is, peak height velocity in infancy (PHV). Similarly the estimate of peak 
weight velocity in infancy (PWV) was defined as the maximum value of the weight velocity curve 
(Figure 4 A and B).  
4.3.4. Models for growth in body mass index (BMI) in the Northern Finland Birth cohort 
1986 (NFBC1986) 
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The initial data preparation for model selection on body mass index (BMI) in infancy and childhood 
was previously considered in detail by Dr Ulla Sovio at Imperial College London, Dr. Nicholas 
Timpson at Bristol University and Ms. Nicole Warrington at the University of Western Australia, 
Perth. A detailed description on the selection of BMI growth modeling in NFBC1966 is given in the 
doctoral thesis of Sovio, 2011
11
. The comparative statistical models used for longitudinal childhood 
BMI growth was recently published by Ms Nicole Warrington, University of Western Australia
13
.  
For work described in this thesis, I have only utilised age and BMI growth modeling in NFBC1986 
infant and childhood BMI growth model. However, the work in thesis also utilises BMI growth 
models from NFBC1966 as part of the research in Chapter 5, section 5.1.3 and 5.2.2, which were 
calculated by Dr. Ulla Sovio, details for which are given in her doctoral thesis
11
.  
In summary, due to the complexities in modeling BMI longitudinally, the data was divided into two 
age windows: 2 weeks to 18 months (infancy) and 18 months to 13 years (childhood). These cut-
offs points were chosen based on biological phases of growth and from the growth curves in the 
NFBC1966
172
. Measurements taken in the first two weeks of life were excluded due to potential 
decrease in BMI especially during the first week of life and to avoid the error in the growth curve 
modeling that this may have introduced.  
For infancy growth model (0 – 1.5years), the mid-point for age was 0.75 years (about 9 months), 
which was close to the average age when BMI reaches its peak.  For childhood growth model (1.5 – 
13 years) the mid-point for age was 7.25 years, which was on average the age shortly after that at 
which the BMI reaches its minimum. BMI measurements for both infancy and childhood were right 
skewed and hence log transformed to improve the statistical model in infancy and childhood.  
Linear mixed effects (LME)
173
 models were fitted using sex, gestational age and their interactions 
with age as covariates, with baseline BMI as the random effects and change in BMI over time as 
slope. In addition to a linear age effect, quadratic and cubic terms for age were included to account 
for non-linearity of change in BMI over time.  
The model specification by age window:  
1) Infancy. For calculations of age and BMI at adiposity peak (AP) in infancy, the analysis was 
restricted to singletons with at least three BMI measures from two weeks to 18 months of age. The 
model is as follows:  
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log (BMI (kg/m2)) = β0 + β1 Age + β2 Age2 + β3 Age3 + β4 Sex + u0 + u1 (Age) + ε 
where β0, β1, β2, β3, β4 are the fixed effects terms, u0 and u1 are the individual level random 
effects and ε is the residual error. Age at AP was calculated from the model as the age at maximum 
BMI between 0.25 and 1.25 years.  
 
2) Childhood. For modeling of age and BMI at adiposity rebound (AR) in childhood, the analysis 
was restricted to singletons with BMI measurements, from 18 months to 13 years (Figure 4C). The 
model is as follows: 
log (BMI (kg/m2)) = β0 + β1 Age + β2 Age2 + β3 Age3 + β4 Sex + β5 Age * Sex + β6 Age2 * Sex 
+ u0 + u1 (Age) + ε 
where β0, β1, β2, β3, β4, β5 and β6 are the fixed effects, u0 and u1 are the individual level random 
effects and ε is the residual error. Age at AR was calculated as the age at minimum BMI between 
2.5 and 8.5 years (Figure 4 C).  
The work from the BMI growth modeling in infancy and childhood in NFBC1986, contributed to 
the research in Chapter 5, section 6.2 for genome-wide association analysis on early growth 
phenotypes. For the same study, I also provided support and conducted growth modeling in other 
cohorts which included, ALSPAC, COPSAC, INSI and LISA, SWS, details of which are given in 
Chapter 5, section 5.2.2.   
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Figure 4. Graphical illustration of height, weight and BMI growth patterns (or early growth phenotypes) in NFBC 1986. A) Peak Height Velocity (PHV); B) Peak Weight 
Velocity (PWV); C) Age and BMI at Adiposity Peak (AP) and Rebound (AR). The growth curves for males are in blue and for females in red.  
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4.4    Genetic data for GWAS 
4.4.1 Description of genetic data for  Northern Finland Birth cohort 1966 (NFBC1966) and 1986 
(NFBC1986) 
 
The NFBC 1966 individuals who provided blood at 31 years and gave consent for use of data were eligible 
for genotyping (N=5,753). IIlumina’s HumanCNV370-Duo Analysis BeadChip was used to obtain genome-
wide data, which contains tag SNPs derived from the HapMap European-derived (CEU) sample
174
. The 
genome-wide data consisted of over 318,000 SNPs and about 52,000 markers to target approximately 
14,000 copy number variants (CNV) regions, giving a total of over 370,000 markers. The Beadstudio 
algorithm was used for calling the genotypes. Sample and SNP quality control (QC) was completed by Drs. 
Susan Service and Chiara Sabatti at the University of California, USA, Dr. Inga Prokopenko at the 
University of Oxford, United Kingdom, and Marika Kaakinen at the University of Oulu, Finland
163
. 
Imputation was performed using IMPUTE software version 3.1, applying information call threshold of >0.4 
and MAF threshold of >1%. In total, over 2.5 million SNPs were analysed
163
. In addition, several SNPs 
were separately genotyped for candidate gene studies and for replication purposes using TaqMan SNP 
genotyping assay (Applied Biosystems, Warrington, UK) according to the manufacture’s protocol. After 
quality control (QC) and imputation of the data (April 2008), the final data was for 5,402.  
 
In NFBC1986, DNA was extracted for 6,266 individuals who provided blood samples at 16 years of age 
follow-up. Eleven SNPs were directly genotyped which were then used in the replication stage of genetic 
association studies (of section 5.2.1 and section 5.2.2) in this thesis. Genotyping was performed with 
Genetics group at Imperial College London, UK or in Pasteur Institute Laboratories, Lille, France. Some 
genotyping for replication in genetic association studies was performed by KBiosciences Ltd (Hoddesdon, 
UK) using their own novel system of fluorescence-based competitive allele-specific PCR (KASPar). 
Genotyping success rate for all SNPs was >95.0% and none of the SNPs deviated from Hardy-Weinberg 
equilibrium (all P-values>0.0001).  The genetic association studies were performed for this thesis as part of 
a large consortium, early growth genetics (EGG), which involved contributions from other datasets to 
participate in the study. This contribution increased the statistical power for genome-wide analysis and made 
the results robust. A short summary of other datasets used in the thesis are described below.   
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4.4.2 Description of other cohorts participating in Genome –wide association studies (GWAS) 
 
Avon Longitudinal Study of Parents and Children (ALSPAC)  
ALSPAC is a prospective study, which recruited pregnant women with expected delivery dates between 
April 1991 and December 1992 from Bristol UK. The ALSPAC data was collected from four clinical exams 
at 6 weeks, 9 months, 18 months and pre-school and follow at the ages of 7, 8, 9, 10, 11, ~12 and ~14 years. 
Height and weight measurements were taken at each of these time points when individuals visited clinics. 
Height was measured to the last complete mm using the Harpenden Stadiometer. Weight and bioelectrical 
impedance were measured using the Tanita Body Fat Analyser (Model TBF 305). Weight was measured to 
the nearest 50g. All proposals for new data collection and policies for data handling and analysis were 
approved by ALSPAC’s own Law and ethics and by Local Research Ethics Committees (LRECs). Ethical 
approval for the study was obtained from the ALSPAC Law and Ethics Committee and the Local Research 
Ethics Committees.   
 
For the GWA analysis in Chapter 5, section 5.2, n=3,714 participants (discovery sample) were genotyped 
using either the Illumina 317K or 610K genome-wide SNP genotyping platforms by the Wellcome Trust 
Sanger Institute, Cambridge, UK and the Centre National de Génotypage, Evry, France. A common set of 
SNPs (present in both genotyping platforms) were extracted and the resulting raw genome-wide data was 
subjected to standard quality control methods. Individuals were excluded on the basis of having incorrect 
sex assignments; minimal (0.34) or excessive (0.36) heterozygosity; disproportionate levels of individual 
missingness (>3%) and evidence of cryptic relatedness (PI HAT >0.11). The remaining individuals were 
assessed for evidence of population stratification by multidimensional scaling (MDS) analysis, using CEU, 
YRI, JPT and CHB individuals from the HapMap as reference ethnic groups. Only those clustering with the 
CEU individuals were included. The underlying population stratification was thereafter controlled by using 
the first two EIGENSTRAT derived ancestry informative covariates (EIG-PC1 and EIG-PC2) as well as any 
additional EIGENSTRAT derived ancestry informative covariates that were correlated with the phenotype 
(EIG-PC3 for g-men; EIG PC9 for exr.XY; EIG-PC4 for prn-alL; EIG-PC10 for ls-pg; EIG-PC5 for PC3; 
EIG-PC5 for PC11; EIG-PC9 for PC9).  
 
SNPs with a minor allele frequency of <0.5% and call rate of <97% were removed. Furthermore, only SNPs 
which passed an exact test of Hardy-Weinberg equilibrium (P>5x10
-7
) were considered for analysis.  The 
resulting dataset consisted of 3,233 individuals and 285,531 SNPs. We then conducted imputation with 
MACH 1.0 Markov Chain Haplotyping software17; using CEU individuals from phase 2 of the HapMap 
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project as a reference set (release 22). The final imputed dataset consisted of 3,233 subjects, each with 
2,543,887 imputed autosomal markers (http://www.bristol.ac.uk/alspac/).  
 
Cambridge Baby Growth Study (CBGS) 
The CBGS cohort recruited pregnant mothers attending a single antenatal centre in Cambridge UK, 
representative of the South Cambridgeshire population. A trained paediatric research nurse approached and 
recruited mothers’ at their first antenatal clinic appointment during early pregnancy. In total N=1,662 babies 
born between the years of 2001 to 2009 were selected. A paediatric research nurse measured the offspring at 
birth, and months 3, 12, 18 and 24. The study was approved by the local Cambridge research ethics 
committee and all mothers gave informed written consent. The data used in this study were based on 556 
infants where DNA samples were available from cord blood samples collected at birth. Individual SNP 
genotyping was performed by TaqMan (Applied Biosystems) at the MRC Epidemiology Unit, Cambridge 
UK. For all SNPs, call rates were >99% and Hardy Weinberg Equilibrium P-values >0.05 
(http://www.medschl.cam.ac.uk/paediatrics/pages/growthstudy.htm).  
 
Children’s Hospital of Philadelphia (CHOP) 
CHOP recruited infants born from 2006 to 2010 at the Children's Hospital of Philadelphia, in the Greater 
Philadelphia area. The cohort consisted of 1,445 obese children and 2,802 lean children of European 
ancestry. All of the participants had their blood drawn in to an 8ml EDTA blood collection tube and were 
subsequently DNA extracted for genotyping. All subjects were biologically unrelated and were aged 
between 2 and 18 years old. This study was approved by the Institutional Review Board of the Children's 
Hospital of Philadelphia. Parental informed consent was given for each study participant for both the blood 
collection and subsequent genotyping. Self-reported ethnicity was confirmed by multidimensional scaling 
methodologies. The high throughput genome-wide SNP genotyping was performed using the Illumina 
Infinium™ II HumanHap550 BeadChip technology (Illumina, San Diego), at the Center for Applied 
Genomics at CHOP. We used 750ng of genomic DNA to genotype each sample, according to the 
manufacturer’s guidelines (http://www.chop.edu/). 
 
Copenhagen Study on Asthma in Children (COPSAC) 
The COPSAC cohort recruited mothers with a history of asthma and the cohort total was 411 babies. The 
newborns were enrolled at the age of 1 month, the recruitment of which was previously described in detail. 
Each newborn was assessed at the COPSAC clinical research unit at six monthly intervals; additional visits 
were arranged immediately upon the onset of symptoms. All growth parameters were measured and 
obtained by the COPSAC doctors and history was obtained using structured questions and closed response 
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categories. The study was approved by the Ethics Committee for Copenhagen (KF 01-289/96) and The 
Danish Data Protection Agency (2008-41-1754) and informed consent was obtained from both parents. High 
throughput genome-wide SNP genotyping were performed using the Illumina Infinium™ II HumanHap550 
v1, v3 or quad BeadChip platform (Illumina, San Diego), at the Children’s Hospital of Philadelphia’s Center 
for Applied Genomics. Further details can be found on www.copsac.com. 
 
Danish National Birth Cohort (DNBC) 
The DNBC were collected for 92,274 pregnant women recruited between 1996 and 2002, and their children 
were followed through childhood and adolescence. The BMI data was collected when the infant was 18 
months old. The mothers were asked to report height and weight from the child exams at age 5 and 13 
months of age. For the purpose of research in this thesis, the observation closest to age 9 months was used in 
the analysis of growth modeling and anlaysis. Genotype data were performed with the Illumina 660 Quad 
chip, and genotypes for all SNPs from the HapMap phase 2 CEU reference set were imputed with MACH 
1.0. The analysis was based on 861 children (447 boys, 414 girls). The local Ethics Committee approved the 
study. Details for this data collection are described at http://www.dnbc.dk. 
 
Étude des Déterminants pré et postnatals du développement et de la santé de l’ENfant (EDEN)  
The EDEN cohort is an ongoing study of pre- and post-natal determinants of children’s growth and 
development. The cohort enrolled 2,002 mother-child pairs at two centers in France, Nancy and Poitiers, and 
continued follow-ups with the children until their fifth birthday.  The study was approved by the ethics 
committee (CCPPRB) of Kremlin Bicêtre (France) and by the Data Protection Authority “Comission 
Nationale de l’Informatique et des Libertés” (CNIL). DNA was extracted from cord blood samples collected 
in 1,367 of the 1,907 births. Individual SNP genotyping was performed by TaqMan (Applied Biosystems) at 
the MRC Epidemiology Unit, Cambridge UK. For all SNPs, call rates were >99% and Hardy Weinberg 
Equilibrium P-values >0.05 (eden.vjf.inserm.fr).  
 
The Exeter Family Study of Childhood Health (EFSOCH) 
The EFSOCH is a prospective study, set up to test the fetal insulin hypothesis, and to identify genetic 
polymorphisms that play a role in determining birth weight and early postnatal growth.  The study recruited 
1,017 families from a postcode-defined area in central Exeter, with inclusion criteria were; a homogeneous, 
non-diabetic, UK Caucasian cohort. Detailed anthropometric measurements were taken from both parents at 
28 weeks' gestation, and from their children at birth, 12 weeks, 1 year and 2 years of age. Insulin and other 
biochemical analysis were measured in fasting parental samples and an umbilical cord blood sample taken at 
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delivery. Parental and offspring DNA were extracted to allow molecular genetic analysis of candidate genes 
implicated in fetal growth. Local Ethics Committee approved the study. 
 
The Generation R Study (GenR) 
The GenR Study is a population-based prospective cohort study, with children born between April 2002 and 
January 2006 recruited to participate in the study. This study is designed to identify early environmental and 
genetic determinants of growth, development and health from fetal life until young adulthood and has been 
described previously in detail
175,176
. Detailed measurements of height and weight were performed using 
ultrasound and physical examinations, biological samples and advanced imaging techniques. Analysis was 
restricted to Caucasian individuals with genome-wide data and sufficient growth measurements available for 
growth modeling (N=2,227). Length was measured to the nearest millimeter and weight was recorded by 
well-trained staff in community health centers using standardized procedures. The study has been approved 
by the Medical Ethics Committee of the Erasmus Medical Center, Rotterdam. Written informed consent was 
obtained from all participants or their parent(s). Cord blood for DNA isolation was available in 59% of all 
live-born participating children. Individuals with sex-mismatch or missing cord blood samples were 
excluded. Individual genotype data were extracted from the genome-wide Illumina 610 Quad 
Array51(http://www.generationr.nl). 
 
Helsinki Birth Cohort Study (HBCS) 
  The HBCS is a prospective birth cohort which includes individuals 4,630 boys and 4,130 girls born at the 
Helsinki University Central Hospital between the years 1934 and 1944. Serial measurements of height and 
weight until age 12 were extracted from child welfare clinics and school health clinic records, with an 
average of 10 measurements between birth and 2 years, and 8 measurements between 2 and 11 years of age. 
A representative set of 928 males and 1075 females (59 and 70 years old) returned for clinical examinations, 
between 2000 and 2002, when adult stature was measured and blood was taken for DNA extraction.  HBCS 
has been approved by local ethics committees. Genotyping was performed on the Illumina 670 Quad chip 
and calling was done with the Illuminus algorithm at the Sanger Centre on a total of 1566 samples.  Pre-
imputation quality control filters included: call rate 95%, MAF > 0.01, HWE 1x10-6.  Closely related 
individuals were screened by examining pair-wise IBD estimates. >0.2 IBD-sharing was used as cut-off.  
Population stratification was examined using multidimensional scaling analyses, but there were no outliers.  
Imputation was performed with MACH, and the analysis software was MACH2QTL.  Post-imputation 
quality control filters were R2HAT >0.3 and MAF  >0.01 
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Lifestyle – Immune System – Allergy Study (LISA) 
LISA is a population-based prospective birth cohort study on lifestyle-related factors on the immune system 
and the development of allergies in childhood. Individuals born healthy, mature (gestational age over 37 
weeks) and with a birth weight over 2500g were recruited between December 1997 and January 1999 
(N=3,097 in Munich, Leipzig, Wesel, and Bad Honnef, Germany to participate in the study. Weight, length, 
and head circumferences were measured highly time-resolute by the family physician during the first two 
years of life. Head circumference measurements were scaled to the nearest centimeter and obtained via 
medical records. DNA was collected at the age 6 & 10 years and analysed using the Affymetrix Human SNP 
Array 5.0 for each individual. After quality control (MAF>1%, HWE>0.01, call rate per SNP and person 
>95%) genome-wide data was imputed using BRLMM-P algorithm in IMPUTE 
177
.  Local Ethics Committee 
approved the study.  
 
The Raine Study 
The Raine Study was a randomized controlled trial to evaluate the effects of repeated ultrasounds in 
pregnant women in Perth, Western Australia. In total, 2,900 pregnant women prior their 18
th
 week gestation 
were recruited between 1989 and 1991 at the King Edward Memorial Hospital (Perth, Western Australia). 
Women were randomized to repeat ultrasound measurements at 18, 24, 28, 34 and 38 weeks gestation or to a 
single ultrasound assessment at 18-weeks. Children have been assessed at average ages of 1, 2, 3, 5, 8, 10, 
14 and 17. DNA was collected at the 14 and 17 year follow-ups. The study was conducted with appropriate 
institutional ethics approval, and written informed consent was obtained from mothers at all follow-ups and 
participants at the 17 year follow-up. DNA was collected using standardized procedures from 74% of all 
adolescents who attended the 14 year follow-up on and a further 5% from the 17 year follow-up 
measurements. Genotype data was extracted from the genome-wide Illumina 660 Quad Array for each 
individual. Analysis was restricted to individuals with genome-wide data and BMI 
(http://www.rainestudy.org.au/). Local Ethics Committee approved the study.   
 
INfancia y Medio Ambiente [Environment and Childhood] Project (INMA) 
INMA is a population-based birth study; cohorts were established in several regions of Spain following a 
common protocol. This analysis uses the INMA cohorts of Valencia and Sabadell (Catalonia) established 
between 2003 and 2006. This project aims to study the associations between pre- and postnatal 
environmental exposures and growth, health, and development from early fetal life until adolescence. 
Pregnant women were recruited for the project during the 1st trimester of pregnancy at public primary health 
care centers or public hospitals. Detailed measurements were performed using ultrasounds, physical 
examinations and biological samples. Informed consent was obtained from all participants and the study was 
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approved by the Hospital Ethics Committees in each participating region. Cord blood for DNA isolation was 
available for 909/1409 (64.5%) of all live-born participating children and 752 of these samples were selected 
for the genome-wide genotyping using the HumanOmni1-Quad Beadchip (Illumina). Sex-mismatch rate 
between genome based sex and midwife recorded sex was 0, indicating that possible contamination of 
maternal DNA was extremely low (http://www.proyectoinma.org/presentacion-inma/en_index.html).   
 
The Physical Activity and Nutrition in Children (PANIC) Study 
The PANIC Study is a long-term controlled exercise and diet intervention study in a population sample of 
512 primary school children conducted by the University of Eastern Finland. Baseline examinations at the 
ages of 6-8 years were performed in 2007-2009. Half of the children were allocated into the exercise and 
diet intervention group and the other half to the control group. The 2-year follow-up examinations at 8-10 
years of age (participation rate 86%) were done in 2009-2011. Physical activity and inactivity, 
cardiorespiratory and musculoskeletal fitness, nutrition, overweight, obesity, body composition, fetal and 
early childhood growth and development, metabolic, cardiovascular, musculoskeletal and cognitive 
functions were assessed comprehensively at baseline and the 2-year follow-up. After the 2-year 
examinations, the intervention group will continue with a less intensive exercise and diet intervention until 
adulthood. The children will be re-examined in adolescence and early adulthood. DNA was collected at the 
baseline and 2-year follow-up and analyzed using the Metabochip array. The PANIC Study protocol was 
approved by the Research Ethics Committee of the Hospital District of Northern Savo in 2006. Both 
children and their parents gave their written informed consent (http://www.lastenliikuntajaravitsemus.fi/5).  
 
The Southampton Women’s Survey (SWS) 
The SWS study enrolled female patients aged 20-34 years between 1998 and 2002 by general practitioners 
in Southampton. Of those women recruited into the study, N=12, 583 (75%) agreed to be interviewed by a 
research nurse, and all interviews were conducted between April 1998 and October 2002. Women who 
subsequently become pregnant were recruited into the pregnancy phase of the SWS. They visited the SWS 
Ultrasound Unit at the Princess Anne Hospital in Southampton at 11, 19 and 34 weeks gestation where fetal 
and placental size and blood flows were measured using ultrasound.  At 11 and 34 weeks, the women were 
interviewed by research nurses, and anthropometric measurements of the baby were made within 48 hours of 
birth.  By the end of 2007, when the pregnancy follow-up stopped, N= 3,159 babies had been born to SWS 
women.  Cord blood samples were obtained at birth from which DNA has been extracted. The children were 
followed up at home at 6 months, 1, 2, and 3 years of age. Thereafter a subsample was seen at 4 years and 
further subsamples at 6, 8 and 10-12 years are currently being assessed. At all visits body composition is 
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assessed by anthropometry and/or DXA. Buccal swabs are being taken at the 6, 8 and 10-12 year visits from 
which further DNA is being extracted.  The Southampton Women's Survey has received approval for all 
stages of the study from Southampton and South West Hampshire Local Research Ethics Committee 
http://www.leu.soton.ac.uk/sws/). DNA was extracted from Kbiosciences, Hoddesdon, Herts, UK.   
4.5    Data analysis and statistical methods 
4.5.1 Association analysis 
An analysis plan was prepared for each association study and it included a detail description of the study 
design and the planned data analysis (Appendix Note 4).  
4.5.1.1 Descriptive analysis 
The selected variables from NFBC 1966 and NFBC 1986 were examined for distribution to check for any 
possible errors.  Histograms were developed to look for any outliers and extreme values were removed to 
prevent a skewing of results. The variables were transformed accordingly by looking at their distribution 
plots. SAS procedure PROC PLOT was used for producing scatter plots for independent and dependent 
variables. The continuous variable mean and standard deviation (SD) were presented and percentage 
distributions for each category in the categorical variables were given. Missing records for variables in the 
sample data set were also presented as percentage of total. SAS procedure PROC MEANS and PROC FREQ 
in version 9.2 (SAS Institute Inc. 2010) were used to perform this analysis. Possible errors were checked 
against original records and if there were errors in data then a missing value was inserted (for example an 
impossible height). Once the data was cleaned, distribution tables were noted. This gave the characteristics 
of the study population. For each analysis, an outcome and exposure variable/variables were specified and 
confounders were selected by a priori or by expert advice.  
4.5.1.2 Regression analyses  
The representativeness of each sample selected was examined in detail to reveal any potential bias due to 
dropout (that is, unit non-response) for each study sample.  The item non-response were analysed according 
to the study to make sure the data was not biased and there were no differences between complete datasets 
and incomplete data sets (those with missing values). For univariate and multivariate regression analysis, the 
complete case approaches were considered, missing values from each were removed. Detail on 
representativeness and item-nonresponse are explained within individual sections of Chapter 5, as per the 
requirements of the analysis.  Correlations were calculated using PROC CORR procedure to check for 
multicolinearity problems and Pearson product-moment correlation coefficient for variables were calculated.  
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Assumptions of the linear regression model were tested by evaluating plots of residual vs. predicted values, 
reviewing scatter plot matrix showing all dependent against all independent variables. A two-sided P < 0.05 
were used to denote statistical significance. The Benjamin-Hochberg procedure was considered for false 
discovery rate at P < 0.05 which was statistically significant 
178
. Bonferroni corrections for multiple 
comparisons were calculated, with P <0.05 considered as statistically significant. 
4.5.1.3 Multiple imputation 
Multiple imputations were considered to recover the statistical power and reduce selection bias due to item-
nonresponse in the full model. The number of imputations (m=20) were based on the recommendations by 
Graham et al 
179
 for a data set with the fraction of missing information of 10-30% and a low (<1%) tolerance 
for power fall-off. Imputed data sets were analysed using multiple regression with SAS PROC REG, and 
analysis results were pooled together for inference with SAS PROC MIANALYZE. Earlier work done in a 
simulation study in the NFBC 1966 demonstrated how MI can reduce bias and increase statistical power 
when data is missing at random, and even when data is not missing at random 
180
.  The association analyses 
of the NFBC1986 data did not show any difference between the results based on imputed dataset compared 
to those based on the non-imputed dataset. Therefore, I do not use the imputed data for my analyses.  
4.5.1.4 Mediation 
Mediation analyses were conducted using investigative methods described by Baron and Kenny
181
 as well as 
formal significance tests of the indirect effect by the Sobel test
182
. According to Baron and Kenny, 1986, 
there is a set of three criteria which need to be fulfilled to establish mediation:  1) the exposure significantly 
associated with the outcome, 2) the outcome significantly associated with the mediator, and 3) that the 
mediator substantially reduces the estimate coefficient for the association between outcome and exposure. If 
the effect size is reduced by >10% then the partial mediation is considered, however, if mediator-adjusted 
coefficient of the exposure approaches null (0) then complete mediation is considered.  
 
Sobel test was used to test the mediation effect in the models. Sobel, et al, 1981, hypothesised that the 
association between independent variables and dependent variables is in-directly via the mediator. When the 
mediator is added to the model, between the independent variables and dependent variables, the effect of 
association is decreased showing the mediation. An online webpage for Sobel test were used to assess if the 
mediation effects were significant (http://quantpsy.org/sobel/sobel.htm).  
 
Over the years, more sophisticated analytical methods have been developed for testing mediation, and Baron 
and Kenny’s (with Sobel’s test) casual steps approach has been criticized on multiple grounds183. 
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Importantly, it has been shown from stimulation studies that testing for intervening variable effects reduces 
the power and that the quantification of casual steps is not based on the intervening effect. More recently, 
there have been proposals for several new analytical opportunities for testing mediation, for example, 
bootstrapping
184
 and M-test
185
. Although these methods have been more robust in calculating mediation, it 
was beyond the scope of this thesis to compare results from Baron and Kenny’s method against these new 
methodologies.    
 
4.5.2 Genetic association analysis 
A detailed description of how genome-wide association studies (GWAS) has been previously described by 
Bush et al, 2012
186
. A detailed analysis plan was prepared for each genetic association study including the 
motivation for the analysis and the planned study design (see Appendix Note 4). Briefly, two genetic 
association analyses on head circumference (HC) and early growth phenotypes were conducted. These 
analyses were divided into three stages: i) Stage 1 or discovery stage consisting of meta-analysis of studies 
with genome-wide data available and ii) Stage 2, replication or follow-up, consisting of a meta-analysis on 
leading SNPs (selected from discovery stage), and iii) Stage 3 or combined stage consisting of the procedure 
when discovery stage and replication is meta-analysed together.  
At discovery stage, each study applies a Hardy-Weinberg Equilibrium (HWE) cut-off within the study and 
an overall HWE P > 1 x 10
-4
 cut-off for overall discovery, meta-analysed data was also applied. SNPs with 
poor imputation quality were excluded if minor allele frequency (MAF) < 5%, Call rate < 98%, r
2 
< 0.3 for 
MACH and proper info<0.4 for IMPUTE). The additive association analysis was run using bioinformatics 
software such as PLINK
187
 or SNPTEST
188
, which supports various statistical alternatives for analysis. The 
discovery study beta estimates with their standard errors(SE) were meta-analysed using the inverse-variance 
weighting method in the METAL software
189
. Double genomic control
190
 was applied to the individual study 
results in Stage 1 to adjust the statistics generated within each cohort and then adjust the overall Stage 1 
meta-analysis statistics. A Manhattan plot is created to identify top SNP P-values from the discovery meta-
analysis. This is a scatter plot with X-axis showing the genomic co-ordinates’ and Y-axis showing the 
negative logarithm (denoted by log-10(P)) of the associated SNP P-value for each SNP
191
. I have also used 
regional association plots to show individual SNPs in the region of interest. A regional association plot is 
similar to a Manhattan plot but uses a limited section of genome with X-axis that shows the position of the 
SNP on the chromosome and the Y-axis shows the negative logarithm for the associated SNP P-value
192
. 
Study heterogeneity, within each study, were quantified to determine the degree to which studies differ. For 
study heterogeneity, the Q statistics and the I
2
 index, which represents the approximate proportion of the 
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variability in coefficient, were calculated. The I
2 
values were categorized as, low (<25), medium (>25 and 
<75), and high (>75) heterogeneity. If high study heterogeneity were observed, then associations for overall 
directional consistency between all the studies were checked. Furthermore, GWAS analyses removing 
studies contributing to wide confidence interval were run to see if results were driven only by them.  Finally, 
both fixed and random effect models were tested to check the difference in results.   
In Stage 2, SNPs are followed up in individuals from independent dataset with in silico or de novo 
genotyped data available for replication. All Stage 2 studies provided beta estimates and standard errors for 
association. The effect estimates were oriented to the forward strand of the NCBI build 36 reference 
sequence of the human genome, consistently using the alphabetically higher allele as the coded allele. Effect 
estimates and standard errors were combined across the stage 2 studies using an inverse-variance weighting 
method in the METAL software
189
. To address the problem of winner’s curse, the replication sample size 
was kept to a sufficient size to detect the effect of susceptibility allele. Same GWAS design was applied as 
closely as possible in the replication sample.  
In the combined stage, a meta-analysis of Stage 1 and 2 results was undertaken using inverse-variance 
weighting method using two software: METAL software
189
 and usually replicated using another software, 
such as R software program (version 2.14.2; http://www.r-project.org/), to remove any errors or bias due to 
software. Associations with P < 5 x 10
-8 
were considered as genome-wide significant and P< 5 x 10
-6
 were 
considered as suggestive association. Informed consent was obtained from all Stage 1 and Stage 2 study 
participants (or parental consent, as appropriate). Data exchange facilities were provided by the AIMS 
server
193
. All study protocols are approved by the local ethics committees as appropriate.  
4.6    Software 
For the purpose of growth modeling, I used R software (http://www.r-project.org/). R software is a free 
software environment for statistical computing and graphics. It runs on the UNIX platform or in Windows 
platform. The quantile-quantile plots, Manhattan plots and forest plots for genetic association studies were 
developed using packages from R software. For regional plot, I used the LocusZoom tool. LocusZoom is a 
tool to plot regional association results from GWAS.  For other statistical analysis, for example, descriptive data 
analysis or association analysis, I used SAS version 9.1, software (SAS Institute, Inc. Cary, North Carolina).  
 
In genetic association studies, SNPTEST
188
 version2.5 program was used for genome-wide linear additive 
models
188
. The METAL software was utilised for meta-analysis of large datasets
189
.  
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4.7    Summary 
 
This chapter describes the two main datasets used for analysis, the Northern Finland Birth Cohorts (NFBCs) 
1966 and 1986, referred to as NFBC1966 and NFBC1986. It also describes the NFBC1986 growth modeling 
and the restrictions applied to the number of individuals selected for growth modeling. The availability of 
dense longitudinal data from the NFBCs 1966 and 1986 is one of the main strengths of this thesis. It 
provided the platform necessary to model growth data and derives biologically meaningful parameters for 
further analysis.  
As part of my training for this doctoral work, I undertook extensive research to understand the various types 
of models and comparisons for both NFBC datasets. However, only relevant information has been included 
in this thesis. It was most useful to have Dr Ulla Sovio’s expertise and guidance during the early days of 
growth modeling as my initial work used her NFBC1966 methodology for fitting models.  The growth 
modeling was an essential part of this thesis and this chapter gives a brief outline of the models. Extensive 
details were already published as part of my master’s dissertation194 and also as part of  Dr. Ulla Sovio’s 
doctoral thesis
11,172
.  
 A short description of genetic data from NFBCs (1966 and 1986) is given in this chapter. The imputation 
and quality control of overall genetic data for both NFBCs was performed by other team members at 
Imperial College London and elsewhere; hence, only relevant information about study-specific quality 
control is described in this chapter.  Contributions of other cohorts from EGG consortium for genetic 
association analysis are described in the chapter. I provided advice and contributed to the development of 
growth models for several cohorts participating in genetic analysis studies.  
The statistical methods described in this chapter relate to the general approach taken for this thesis. Study-
specific statistical approaches have been described in results section as appropriate.    
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Chapter 5:  Study-specific results and discussions  
This chapter presents results from association and genetic association studies conducted on prenatal 
predictors and various outcomes at birth and during infancy and childhood. The section (5.1.1) describes an 
association analysis between various prenatal predictors, size-at-birth and peak height velocity (PHV), with 
an emphasis on mediation by size-at-birth variables on PHV in infancy in NFBC 1986. Section 5.1.2 
describes an investigation into the association study between pre-pregnancy maternal body mass index 
(BMI) and adolescent metabolic factors. In this section, I describe work performed in collaboration with 
researchers from King’s College London. This work was designed as a translational study, for which I (as 
part of the team from Imperial college, London) performed analysis on human data, discussed in this 
chapter, and the team from King’s College, London, performed similar analyses on murine data (not 
discussed here).Section 5.1.3 describes an investigation on leukocyte telomere length (LTL) and adiposity-
related factors in childhood and adulthood in NFBC1966. I describe an association analysis performed on 
mean LTL and adiposity related measures in childhood and adulthood.  This work was performed in 
collaboration with Dr Jess Buxton, Imperial College London, to be submitted as a scientific paper to 
PlosONE in 2014. The genetics association studies (section 5.2) present the genetic association for head 
circumference and early growth phenotypes in various populations.  
5. 1   Association analyses 
5.1.1.   Association between prenatal predictors and postnatal height growth velocity in infancy is 
mediated by size-at-birth  
5.1.1.1    Introduction 
Fetal life is an important stage of development for future adult health
2
. Adverse factors during fetal life can 
lead to smaller size-at-birth and accelerated postnatal growth in infancy
96,195
. Both of these associate with an 
increased risk of cardiovascular disease (CVD), obesity and type 2 diabetes in adulthood
66,196
. Several 
epidemiological studies have reported prenatal risk factors for small size-at-birth such as lower maternal 
socio-economic status (SES), maternal smoking, deprived living conditions, under-nutrition and infections 
during pregnancy
64,189,197
. However, none have considered the relationships between these prenatal risk 
factors and postnatal growth in infancy with size-at-birth variables as potential mediators, in order to 
disentangle the potential causal pathway.   
This study hypothesises that multiple prenatal predictors are associated with accelerated height growth in 
infancy, and may have their effect mediated through intra-uterine environment. The size-at-birth variables; 
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birth weight (BW), birth length (BL) and birth body mass index (BMI), were used as a proxy for the intra-
uterine environment
198
. Several epidemiological studies associate size-at-birth (BW, BL and birth BMI) with 
various adverse risk factors in mothers
199
 and with the long term health of their offspring
200
. The study uses 
the NFBC1986 data to evaluate the association between prenatal predictors, size-at-birth and accelerated 
growth in infancy, quantified as peak height velocity (PHV). A detailed description on how the NFBC 1986 
data was used to model PHV is described in Section 4.3.3.  The main objective of this study is to understand 
the pathway(s) that links prenatal factors with accelerated growth in infancy. Previous studies show that 
accelerated postnatal growth associates with adverse cardio-vascular health, therefore it would  be an 
important risk factor to study
201
.  Consequently, the aim of the study was to investigate the relationship 
between multiple prenatal predictors and PHV, and PHV’s association with size-at-birth variables. 
Additionally, the study also investigates if the association is indirect via size-at-birth with size-at-birth 
acting as a mediator. 
5.1.1.2.   Study specific material and methods 
Details on the collection of variables are given in Chapter 4. The variables were selected based on 
information from previously published epidemiological studies and expert knowledge.  The study sample 
(n=5,577) was representative of the full cohort, as shown in Representativeness. More detailed information 
on missingness and the analysis on item non-response in both cohorts are in the Item non-response. 
 
Representativeness 
The attributes of the NFBC 1986 individuals included in the analyses (N=5,577) were evaluated by 
comparing the included group with the remainder of the cohort traced and alive at the time of invitation to 
the clinical examination at age 15/16 years (N=3,171). The proportion of children of single mothers (16% 
vs. 21%), mothers who had completed only primary education (25% vs. 29%) and smoking mothers (20% 
vs. 26%) was lower in the included group than in the remainder. The proportion of mothers in manual work 
(blue collar; 33% vs. 38%) and fathers in manual work (14% vs. 18%) was also lower in the included group. 
There was a trend towards a higher number of previous deliveries in the mothers of the included children 
compared to the remainder of the cohort while no significant trend was observed with respect to maternal 
BMI at P < 0.05. Maternal height and hypertensive complications were distributed equally and did not differ 
in the inclusion group and the remainder (P=0.30). Mothers of included children were on average eight 
months older than the rest of the mothers. The proportion of girls was higher in the included group than in 
the remainder of the cohort (51% vs. 45%). The child’s BL, birth BMI and GA did not differ between the 
included and remaining group in the analyses (P=0.64). The overall results suggested that the included 
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individuals did not differ significantly from the remainder of the cohort, showing a good sample of the 
population. 
 
Item non-responses or missing data 
The item non-response of the NFBC 1986 individuals with complete dataset (N=5,577) was evaluated by 
comparing individuals who had complete data on all variables selected for analysis (complete cases) with 
those who had missing information on one or more variables (incomplete cases). As shown in Table 4, 
mother’s age at pregnancy, weight, height, pre-pregnancy BMI had a variable range for missing data 
(between 0.9% to 2.3%), however overall the mean for complete cases and incomplete cases did not differ 
(P < 0.05).The proportion of children of married mothers (85% vs. 74%) and mothers with secondary 
education (55% vs. 40%), and the proportion of children of farmer mothers (6% vs. 2%) and fathers (8% vs. 
3%) was higher in complete cases than in incomplete cases. The mothers of children who had complete data 
were less often nulliparous (32% vs. 37%) and more often primiparous (34% vs. 29%) than the mothers of 
children who had incomplete data. Maternal smoking was lower in complete cases than in incomplete cases 
(19% vs. 23%). Children with complete data were on average 0.2 cm longer and they were born 0.2 weeks 
later than children with incomplete data. 
 
Statistical analysis  
Descriptive statistics are presented as the mean and standard deviations (SD) for continuous variables and 
percentages of categorical variables are in the available dataset (Table 4). PHV was log-transformed for the 
association analyses since it had a right-skewed distribution, therefore, results were presented as the 
percentage change in PHV per one unit change in the predictor variable. To account for the missing 
measurements in the derived growth parameters, the regression models were weighted by the number of 
measurements per person assuming a linear relationship between the number of measurements and the 
accuracy of estimated PHV. A weighted linear regression allows the parameter estimates to determine the 
contribution of each observation to the final parameter estimates, hence accounting for the assumptions 
made during growth modeling. All the analyses were run separately for males and females due to their 
different growth trajectories (Appendix Note 2). A two-sided P < 0.05 was used for statistical significance in 
all association tests.  
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Figure 5. A framework for the mechanisms in the association between the prenatal predictors and PHV.  
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For tests of association, a multivariate linear regression model was used. The first step was to examine the 
direct association between the outcome with potential predictors and mediator (Figure 5). The first set of 
models used the Univariable model between PHV with prenatal predictors and size-at-birth variables (Table 
5). The second set was multivariable models between prenatal predictors and size-at-birth variables, adjusted 
for gestational age (GA), presented in Table 6.  
 
Finally for testing mediation, Baron and Kenny’s method of mediation181 was applied in the analysis. Details 
on Baron and Kenny’s method have been described in Section 4.2.3.4. The first two steps of association 
analysis (Table 5 and 6) supported the first two steps of mediation by Baron and Kenny. For the third step, 
four separate models were fitted to examine mediation roles by size-at-birth variables between prenatal 
predictors and PHV (see Figure 5, Table 7). Model 1 included PHV association with the prenatal predictor 
adjusted for gestational age (GA); Model 2 included the model 1 with BW as mediator and adjusted for GA; 
Model 3 included the model 1 with BL as mediators and adjusted for GA; and finally model 4 included 
model 1 with birth BMI as mediator and adjusted for GA. The size-at-birth variables were fitted separately 
to distinguish the roles of BW, BL and birth BMI separately and adjusted for GA as confounder for each 
size-at-birth variable. Reviews of previous studies show that GA has been associated with both prenatal 
predictors and size-at-birth variables, hence it was included in the analyses as a confounder202. Sobel’s test 
was used to test the significance of mediation association with Psobel<0.05 considered as statistically 
significant.  
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Table 4. Characteristics of the NFBC 1986 data set.  
 
NFBC 1986 (n=5,577) 
  All Males
a
  Females
a
 Missing  P
b
 
(n=5577) (n=2741) (n=2836) (%) 
Maternal            
Age at pregnancy, years 28.0(5.5) 28.0(5.4) 28.0(5.5)   0.8 
Weight, kg 59.5(9.6) 59.3(9.5) 59.6(9.7) 1.8 0.26 
Height, cm 163.2(5.5) 163.3(5.4) 163.1(5.5) 0.9 0.3 
Pre-pregnancy body mass index, kg/m
2 c
 22.3 (3.4) 22.2(3.3) 22.4(3.4) 2.3 0.11 
     % Underweight  (<18.5) 5 7 7     
     % Ideal weight (18.5-24.9) 79 75 74     
     % Overweight (>24.9) 9 13 13     
     % Obese (>30) 5 3 4     
% Marital Status       0.2 0.44 
     Married 83 83 82     
     Unmarried/cohabiting 16 16 17     
     Divorced/widow 1 1 1     
% Socio-economic status       3 0.15 
     White collar 26 27 28     
      Blue collar 66 66 64     
      Farmer 5 5 5     
% Education       11.9 0.32 
     Primary education 8 8 9     
     Vocational education 28 25 25     
     Secondary education 53 47 47     
     University 9 7 8     
% Smoking at 2 months of pregnancy       0.5 0.54 
     No 80 80 80     
     Smoker 20 19 20     
% Previous Deliveries       0.4 0.28 
     No previous deliveries 33 33 33     
     1 previous delivery 33 32 34     
     2 previous deliveries 18 19 18     
     3 previous deliveries 6 6 6     
     More than 3 previous deliveries 9 9 9     
% Hypertensive complications in pregnancy       1.8 0.25 
     Normotensive 78  78 78     
     Gestational hypertension 5 5 5     
     Pre-eclampsia 3 3 3     
     Chronic hypertension 5 5 5     
     Superimposed pre-eclampsia 2 1 2     
     Proteinuria 5 5 6     
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Paternal            
Weight, kg 75.1(9.6) 75.1(9.4) 75.1(9.8)   0.85 
Height, cm 176.8(6.2) 176.9(6.1) 176.6(6.3)   0.06 
Body mass index, kg/m
2 c
 24.0(2.7) 24.0(2.7) 24.1(2.7)   0.39 
     % Underweight (<18.5) 16 17 16     
     % Ideal weight (18.5-24.9) 58 57 58     
     % Overweight (>24.9) 24 24 24     
     % Obese (>30) 2 2 3     
% Socio-economic status       5.4 0.98 
      White collar 29 32 32     
      Blue collar 59 56 56     
      Farmer 7 6 7     
Infant           
Birth weight, kg 3.6(0.5) 3.6(0.5) 3.5(0.5)   <0.0001 
Birth length, cm 50.6(2.2) 51.0(2.1) 50.2(2.1) 0.7 <0.0001 
Body mass index, kg/m
2 c
 14.0 (1.3) 14.0(1.3) 14.0(1.3) 0.7 0.38 
     % Underweight (<10
th
 percentile) 6 5 6     
     % Ideal weight (10
th
-80
th
 percentile) 80 79 80     
     % Overweight (>80
th 
percentile) 10 10 10     
     % Obese (>90
th
 percentile) 5 5 5     
Gestation age, weeks 39.5(1.5) 39.4(1.5) 39.5(1.5) 0 0.32 
PHV, cm/year 50.6 (2.2) 55.3 (6.7) 51.2 (7.1) 0 <0.0001 
a 
Values for continuous variables are given as means and standard deviations (SD) and categorical variable as 
percentage. 
b 
P for comparison between the sexes. 
c
 Calculated from the IOTF on BMI classification
203
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5.1.1.3   Results 
5.1.1.3.1   Subject Characteristics 
Table 4 shows the details on prenatal predictors, size-at-birth and PHV characteristics for an overall study 
sample and then by males and females in the NFBC 1986. The mothers’ average age at pregnancy was 28.0 
years in the overall sample. Pre-pregnancy weights and height in mother were similar in both male and female 
offspring (P=0.26; P=0.30; respectively). Mothers of both sexes were, on average, 163.2 cm tall and weighed 
59.5 kg before pregnancy. The average pre-pregnancy BMI was 22.3 kg/m2 overall, and no difference between 
mother’s BMI of males and females was observed (P=0.11). 79% mothers were of normal weight, 5% were 
underweight, 9% were overweight and 5% were obese (using WHO cut-offs). High proportions of mothers were 
married (83%), with 16% of mothers single or cohabiting and 1% divorced or widowed. In the socio-economic 
status (SES), a high proportion of mothers (66%) were classified as blue collar workers, 26% were white collar 
and 5% of the mothers were farmers. Most mothers were educated to secondary level (53%), 8% had at least 
primary education, 28% attained vocational education and 9% had been to university. The proportion of mothers 
who smoked during the 2nd month of pregnancy were similar in both males and females (P=0.54) with only 
20% of mothers smoking while 80% were non-smokers. 
 
Both nulliparous (no previous deliveries) and primiparous (one previous delivery) mothers were equally 
distributed (33%). About 18% of mothers had 2 previous deliveries, with 6% of mothers having 3 previous 
deliveries and 9% of mothers with more than 3 previous deliveries. No difference in the distributions of the 
groups was observed between sex (P=0.28). The hypertensive complications during pregnancy were similarly 
distributed in both males and females (P=0.25) with approximately 78% of mothers normotensive, 5% of 
mothers had gestational hypertension, 3% had pre-eclampsia, 5% had chronic hypertension, 2% had 
superimposed pre-eclampsia and 5% had proteinuria.  
 
Father’s weight, height and BMI were similar in both males and females. Fathers weighed an average of 75.1 
kg, had an average height of 176.8 cm and an average BMI of 24.0 kg/m2. 58% of fathers were classified as 
normal weight, 16% as underweight, 24% as overweight and 2% as obese, with the distribution similar in both 
sexes (P=0.39). Fathers’ SES was distributed as: 59% blue collar, 29% white collar and 7% farmers. Their 
education and smoking status were not recorded in NFBC 1986, therefore unavailable for analysis.  
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The mean birth weight (BW) was 3.6 kg for all the participants from the study, and BW in males and females 
differed by 100 g (P <0.0001). The mean birth length (BL) was 50.6 cm, with males being 8 mm taller than 
females (P < 0.0001). The average birth body mass index (BMI) in the overall study sample was 14.0 kg/m2. 
The birth BMI was not significantly different in males and females (P=0.38), with up to 80% children being 
normal weight, 5% underweight, 10% overweight and 5% obese, the cut-offs were selected according to IOTF 
guidelines203. The average gestational age (GA) was 39.5 weeks in all samples. The mean PHV was 50.6 
cm/year in overall study population, which differed between sexes, with an average of 55.3 cm/year in males 
and 51.2 cm/year in females (P < 0.0001). 
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Table 5. Univariate association of infant PHV with prenatal and size at birth variables.  
NFBC 1986 
 Males  Females 
 B
#
 se 95% CI
#
 P
$
  B
#
 se 95% C
I#
 P
$
 
Maternal            
Age, years 0.00 0.04 0.00 0.00 0.9876  -0.15 0.05 -0.24 -0.06 <.0001 
Weight, kg -0.01 0.01 -0.03 -0.05 0.4274  -0.03 0.03 -0.08 0.02 0.2727 
Height, cm 0.32 0.04 0.24 0.50 <.0001  0.32 0.05 0.23 0.41 <.0001 
Body mass index, kg/m
2
 (ref = normal weight )            
  Underweight  0.13 0.90 -1.63 1.90 0.8827  2.93 1.00 0.97 4.90 0.0037 
  Overweight -1.94 0.69 -3.30 -5.77 0.0046  -0.28 0.77 -1.79 1.24 0.7156 
  Obese -4.89 1.33 -7.50 -13.37 0.0002  -2.67 1.34 -5.29 -0.05 0.0417 
 Marital Status (ref = married)            
  Unmarried/cohabiting 2.04 0.62 0.83 2.24 0.0011  2.00 0.67 0.68 3.32 0.0031 
  Divorced/widow -0.11 2.61 -5.21 -7.61 0.9664  1.77 2.43 -2.99 6.53 0.4643 
SES (ref = white collar)            
  Blue collar 0.88 0.53 -0.15 0.23 0.0949  -0.24 0.58 -1.39 0.90 0.6753 
  Farmer -1.52 1.19 -3.86 -6.37 0.1953  -2.29 1.28 -4.79 0.22 0.0683 
 Education (ref=primary)            
  Vocational education -0.53 0.97 -2.43 -3.79 0.5808  -1.51 1.01 -3.49 0.46 0.1279 
  Secondary education 0.92 0.92 -0.87 -0.79 0.3129  -0.90 0.94 -2.75 0.94 0.3323 
  University 0.03 1.21 -2.34 -3.38 0.9795  -2.06 1.26 -4.54 0.42 0.0976 
Smoking at 2 months of pregnancy (ref=no)            
  Smoker 0.94 0.25 0.45 1.12 0.0002  2.95 0.64 1.71 4.20 <.0001 
 Previous Deliveries (ref=no)            
  1 previous delivery -2.11 0.56 -3.20 -5.71 0.0001  -3.73 0.61 -4.92 -2.54 <.0001 
  2 previous deliveries -2.10 0.65 -3.38 -5.98 0.0011  -4.04 0.74 -5.49 -2.60 <.0001 
  3 previous deliveries -4.74 1.00 -6.70 -12.14 <.0001  -5.91 1.12 -8.11 -3.71 <.0001 
  More than 3 previous deliveries -4.03 0.93 -5.86 -10.56 <.0001  -7.31 1.01 -9.29 -5.33 <.0001 
 Hypertensive complications in pregnancy (ref=normotensive)            
  Gestational hypertension 1.61 1.31 -0.96 4.19 0.2195  0.78 1.58 -2.30 3.87 0.6177 
   Pre-eclampsia 8.62 1.58 5.52 12.40 <.0001  12.48 1.79 8.98 15.99 <.0001 
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  Chronic hypertension 3.34 1.52 0.37 2.24 0.0292  3.19 1.79 -0.32 6.70 0.0772 
  Superimposed pre-eclampsia 2.02 2.79 -3.45 -3.97 0.4676  0.81 2.23 -3.56 5.17 0.7157 
  Proteinuria  -0.67 1.09 -2.81 -4.41 0.5380  0.22 1.09 -1.92 2.35 0.8409 
Paternal            
Weight, kg 0.03 0.01 0.01 0.03 0.0034  0.36 0.04 0.27 0.44 <.0001 
Height, cm 0.13 0.02 0.09 0.20 <.0001  0.13 0.03 0.07 0.18 <.0001 
Body mass index, kg/m
2 
(ref=normal)            
   Underweight 1.13 0.73 -0.30 0.14 0.1223  1.13 0.73 -0.30 2.56 0.1223 
  Overweight -0.55 0.63 -1.78 -2.87 0.3729  -0.55 0.63 -1.78 0.67 0.3729 
  Obese -1.31 1.67 -4.58 -7.32 0.4253  -1.31 1.67 -4.58 1.96 0.4253 
SES (ref=white collar)            
  Blue collar 0.07 0.51 -0.93 -1.31 0.8930  0.50 0.57 -0.62 1.62 0.3826 
  Farmer -1.46 1.01 -3.44 -5.74 0.1453  -0.41 1.11 -2.59 1.76 0.7076 
Infant            
Birth weight (BW), kg -4.12 0.17 -4.46 -8.57 <.0001  -10.52 0.45 -11.41 -9.63 <.0001 
Birth length (BL), cm -1.15 0.04 -1.23 -2.37 <.0001  -3.05 0.00 -3.05 -3.05 <.0001 
Birth body mass index (BMI), Kg/m2 -1.05 0.08 -1.20 -2.28 <.0001  -2.41 0.00 -2.41 -2.40 <.0001 
 
#Beta, se and 95% CI were presented in % change as PHV was log-transformed to reduce right skewness.  
$Significance was considered at P<0.05.
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5.1.2.2   Sex stratified association between prenatal factors, size-at-birth variables and PHV (Table 5)  
 
Table 5 shows that an increase in mother’s age associated with 0.15% lower PHV in NFBC 1986 females (P < 
0.0001), but did not associate in males (P=0.98). Mother’s weight did not associate with PHV in both sexes 
(P=0.42 and P=0.27, respectively). However, mother’s height showed a strong positive association with PHV in 
both sexes (P<0.0001 for both), confirming previous findings that mother’s height may contribute via the 
intrauterine environment or via genetic influence to the development of infant height growth204. Mother’s higher 
pre-pregnancy BMI groups showed an inverse association with PHV in both set of offspring, using the normal 
group as reference. Males born to overweight or obese mothers had lower PHV than offspring of normal weight 
mothers (β=-1.94%, CI: (-3.30, -5.77) and β=-4.89%, CI: (-7.50, -13.37); respectively), but offspring of 
underweight mothers did not associate with PHV (P=0.88). Females born to underweight mothers had higher 
PHV (B=2.93%, CI: (0.97, 4.90)) than offspring of normal mothers, while female offspring of obese mothers 
had 2.67% lower PHV than offspring of normal mothers, supporting maternal weight hypothesis205. Mother’s 
marital status associated with PHV, and children of single or cohabiting mothers had 2% higher PHV than 
children of married mothers in both sexes (P=0.001 and P=0.003, respectively). Their SES or education did not 
significantly associate with PHV in either of the sexes (Table 5).  
 
Mothers’ smoking during the initial 2 months of pregnancy strongly associated with PHV in both sexes, male 
offspring of mothers who smoked had 0.94% higher PHV than offspring of non-smoker mothers (P=0.0002). 
The strength of the association was much stronger in females, where offspring of smokers had 2.95% higher 
PHV than offspring of non-smokers (P<0.0001). This is the first study which associates maternal smoking with 
PHV, suggesting a link between smoking during pregnancy, intrauterine growth retardation (IUGR) and 
accelerated growth after birth to catch-up to their genetic potential. This study confirms that male and female 
offspring of smoking mothers had different associations206. There was a clear trend towards a lower PHV by the 
increasing number of previous deliveries in both (Ptrend <0.0001 for both males and females), this fits well with 
the previous results that bigger babies grow more slowly207. The hypertensive complications in pregnancy 
associated with PHV, both maternal pre-eclampsia and chronic hypertension predicted a higher PHV in males 
(P<0.0001 and P=0.03, respectively), but only pre-eclampsia associated with higher PHV in females 
(P<0.0001).  
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As expected, father’s higher weight and height were both associated with higher PHV in both sexes, as height 
and weight are both genetically determined phenotypes204. Although, both father’s BMI and SES did not 
associate with PHV in the sexes at P<0.05 significance.  
 
All three size-at-birth variables (BW, BL and birth BMI) had a stronger inverse association with PHV in both 
sexes (Table 5). For each 1kg increase in BW, PHV was on average 4.12% lower in males (β = -4.15%, CI: (-
4.46, -3.78), P < 0.0001) and 10.52% lower in females (β = -10.52%, 95% CI: (-11.41, -9.63), P < 0.0001). 
Similarly, for each 1cm increase in BL, PHV was reduced by 1.15% in males (β= -1.15, 95%CI: (-1.23, -1.07), 
P < 0.0001) and 3.05% for females (β=-3.05, 95% CI: (-3.26, -2.84), P < 0.0001). Birth BMI was also inversely 
associated with PHV in both sexes, with every 1 kg/m2 increase in Birth BMI, PHV reduced by 1.05% in males 
(β=-1.05%, 95% CI: (-1.20, -0.90) , and P < 0.0001 and 2.41% (β=-2.41%, 95% CI: (-2.78, -2.03) , P < 0.0001) 
in females (Table 5).  
 
5.1.2.3   Sex stratified association between prenatal predictors and size-at-birth factors adjusted for 
gestational age (Table 6, A and B) 
 
In both sexes, maternal age was associated with higher BW, BL and birth BMI (P < 0.0001, P = 0.03 and 
P<0.0001, respectively), consistent with previous findings suggesting that with age mothers gain weight and 
give birth to bigger babies208. Maternal weight, height and pre-pregnancy BMI were positively associated with 
size-at-birth variables in both sexes (P <0.05 for all) (Table 6), except the association between offspring of 
obese mothers did not associate with BL in males (P=0.19) and female offspring of overweight mothers did not 
associate with BL (P=0.07). Mother’s marital status associated with all size-at-birth variables significantly 
(P<0.0001 in both sexes), with results showing that unmarried or cohabiting mothers gave birth to smaller size 
offspring in comparison to married mothers in both sexes (Table 6A). The maternal SES in both male and 
female offspring, associated negatively with BW (P=0.03 in males and P=0.01 in females) and with BL (P=0.04 
in males and P=0.0009 in females) but did not associate with birth BMI (P=0.12 in males, P=0.66 in females), 
especially blue collar mothers who had smaller BW and BL in their offspring compared to the white collar 
mothers in both sexes (Table 6A). These results are in line with previous studies suggesting a link between 
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mother’s SES and smaller size-at-birth209. In female offspring, mother’s education associated positively with BL 
(P=0.009) but negatively with birth BMI (P=0.04) in female offspring, while no association was observed in 
male offspring (P>0.05 for both). No association between BW and maternal education was observed in both 
sexes (P>0.05) (Table 6A and B).  
 
Maternal smoking status during the 2nd month of pregnancy was significantly associated with all three size-at-
birth variables in both sexes (P<0.0001 for BW and BL in both sexes, P=0.0002 for birth BMI in males and 
P<0.0001 in females), however the strength of the association was stronger in females than males (Table 6A 
and B). Mother’s parity (previous delivery) significantly associated with all size-at-birth variables in both sexes 
(Ptrend for all < 0.001), except for male offspring of mothers who had 3 or more pregnancies, which did not 
associate with BL (P=0.12). Mother’s hypertensive complications during pregnancy associated with size-at-
birth factors, but the association varied positively and negatively for each category separately between males 
and females. For example, mother’s gestational hypertension associated with 0.1 kg smaller BW (P=0.003) and 
0.35 kg/m2 lower birth BMI (P=0.0006) in males but not in females (P=0.36 and P=0.54). Mother’s pre-
eclampsia strongly associated with smaller size-at-birth variables in both sexes (Table 6A and B), which shows 
consistency with previous findings57. In male offspring chronic hypertension associated with smaller BW 
(P<0.0001), while in female offspring proteinuria in mothers were associated with BW (P=0.030) and birth 
BMI (P=0.007).  
 
Similarly to mothers, the fathers weight and height was associated with all size-at-birth variables in both sexes 
except for father’s height which did not associate with birth BMI in both sexes (P=0.27 in males and P=0.36 in 
females). Paternal BMI associated with all size-at-birth variables in females (P<0.05) but only with BW and 
birth BMI in males (see Table 6A and B).  Male offspring of overweight fathers had higher BW and birth BMI, 
while female offspring of overweight fathers was associated positively with all size-at-birth variables at P<0.05 
significance. Similarly, male offspring of obese fathers had 0.13 kg higher BW than offspring of normal weight 
fathers (P=0.03). Father’s SES associated with smaller BW in females (P=0.03) but no association with males 
was observed, suggesting that females from lower SES may be at a more adverse risk than males. 
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Table 6: A. Association between prenatal predictors and size-at-birth factors (birth weight (BW), birth length (BL) and birth BMI), adjusted for 
gestational age (GA) in NFBC 1986 Males. 
A NFBC 1986 Males (N=2741) 
 Birth weight (Kg)  Birth Length (m)  Birth BMI (kg/m2) 
 β 95% CI P  β 95% CI P  β 95% CI P 
Maternal              
Age, years 0.01 (0.01, 0.01) <.0001  0.02 (0.00, 0.03) 0.0314  0.02 (0.01, 0.03)  0.0002 
Weight, kg 0.01 (0.01,0.01) <.0001  0.03 (0.02, 0.04)  <.0001  0.02 (0.02, 0.03)  <.0001 
Height, cm 0.01 (0.01, 0.02)  <.0001  0.07 (0.06, 0.08) <.0001  0.01 (0.01, 0.02) 0.0009 
Body mass index, kg/m2 (ref= normal weight)             
     Underweight   -0.13 (-0.20, -0.07) <.0001  -0.29 (-0.55, -0.02) 0.0358  -0.32 (-0.50, -0.15) 0.0003 
     Overweight  0.10 (0.05, 0.15) <.0001  0.28 (0.07, 0.48) 0.0087  0.25 (0.11, 0.38) 0.0003 
     Obese  0.19 (0.09, 0.29) 0.0001  0.26 (-0.14, 0.66) 0.1995  0.60 (0.34, 0.85)  <.0001 
Marital Status (ref=married)             
     Unmarried/cohabiting -0.15 (-0.20, -0.11)  <.0001  -0.53 (-0.71, -0.34)  <.0001  -0.31 (-0.43, -0.19)  <.0001 
     Divorced/widow -0.14 (-0.32, 0.05) 0.1562  -0.11 (-0.87, 0.65) 0.7812  -0.52 (-1.01, -0.02) 0.0410 
SES (ref=white collar)             
      Blue collar -0.04 (-0.08, -0.01) 0.0265  -0.16 (-0.31, 0.00) 0.0491  -0.08 (-0.18, 0.02) 0.1186 
      Farmer 0.05 (-0.03, 0.14) 0.2220  0.01 (-0.34, 0.36) 0.9536  0.21 (-0.01, 0.44) 0.0670 
Education (ref=primary education)             
     Vocational education -0.06 (-0.13, 0.01) 0.0805  -0.14 (-0.43, 0.14) 0.3219  -0.01 (-0.18, 0.16) 0.9009 
     Secondary education -0.05 (-0.12, 0.02) 0.1394  -0.04 (-0.31, 0.23) 0.7899  -0.02 (-0.19, 0.14) 0.7630 
     University -0.02 (-0.11, 0.07) 0.6421  0.14 (-0.22, 0.50) 0.4380  -0.05 (-0.27, 0.17) 0.6624 
Smoking at 2 months of pregnancy (ref= non-smoker)             
     Smoker -0.14 (-0.18, -0.10) <.0001  -0.62 (-0.79, -0.45) <.0001  -0.21 (-0.32, -0.10) 0.0002 
Previous Deliveries (ref=no previous delivery)             
     1 previous delivery 0.13 (0.09, 0.17) <.0001  0.29 (0.12, 0.45) 0.0008  0.34 (0.23, 0.44)  <.0001 
     2 previous deliveries 0.19 (0.15, 0.24) <.0001  0.40 (0.20, 0.59) <.0001  0.51 (0.38, 0.63) <.0001 
     3 previous deliveries 0.14 (0.06, 0.21) 0.0003  0.23 (-0.06, 0.53) 0.1233  0.38 (0.19, 0.58)  <.0001 
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     More than 3 previous deliveries 0.24 (0.18, 0.31) 0.0345  0.47 (0.19, 0.75) 0.0010  0.69 (0.51, 0.87)  <.0001 
Hypertensive complications in pregnancy (ref=normotensive)             
     Gestational hypertension (GH) -0.11 (-0.19, -0.04) 0.0032  -0.25 (-0.56, 0.06) 0.1108  -0.35 (-0.55, -0.15) 0.0006 
     Pre-eclampsia (PE) -0.23 (-0.33, -0.14) <.0001  -0.81 (-1.20, -0.43) <.0001  -0.55 (-0.80, -0.30)  <.0001 
     Chronic hypertension (CH) -0.23 (-0.33, -0.14) <.0001  0.11 (-0.21, 0.43) 0.5038  0.08 (-0.12, 0.29) 0.4320 
     Superimposed pre-eclampsia (SP) -0.02 (-0.16, 0.12) 0.8062  0.17 (-0.40, 0.74) 0.5559  -0.20 (-0.57, 0.17) 0.2883 
     Proteinuria (PR) 0.02 (-0.06, 0.10) 0.5564  0.00 (-0.32, 0.33) 0.9845  0.09 (-0.12, 0.30) 0.4043 
Paternal              
Weight, kg 0.01 (0.01, 0.01) <.0001  0.03 (0.03, 0.04)  <.0001  0.01 (0.01, 0.02) <.0001 
Height, cm 0.01 (0.01, 0.01) <.0001  0.05 (0.04, 0.06)  <.0001  0.00 (0.00, 0.01) 0.2679 
Body mass index, kg/m2 (ref= normal weight)             
      Underweight   -0.01 (-0.05, 0.04) 0.7420  -0.17 (-0.36, 0.02) 0.0769  0.05 (-0.08, 0.17) 0.4466 
      Overweight  0.07 (0.03, 0.12) 0.0004  0.16 (0.00, 0.33) 0.0554  0.20 (0.09, 0.31) 0.0004 
      Obese  0.13 (0.01, 0.24) 0.0308  0.38 (-0.09, 0.85) 0.1134  0.30 (-0.01, 0.60) 0.0556 
 SES (ref = White collar)             
      Blue collar -0.02 (-0.06, 0.02) 0.2992  -0.10 (-0.25, 0.05) 0.1806  -0.02 (-0.12, 0.08) 0.7055 
      Farmer 0.02 (-0.05, 0.10) 0.5403   -0.07 (-0.37, 0.24) 0.6717   0.14 (-0.05, 0.34) 0.1470 
 
#Beta, se and 95% CI were presented in % change as PHV was log-transformed to reduce right skewness.  
$Significance was considered at P<0.05. 
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Table 6. B. Association between prenatal predictors and size-at-birth factors (birth weight (BW), birth length (BL) and birth BMI), adjusted for 
gestational age (GA) in NFBC 1986 Females.  
 
B.  NFBC 1986 females (N=2836) 
 Β# 95 % CI# P  β# 95 % CI# P  β# 95 % CI# P 
               
Maternal                
Age, years 0.01 0.01 0.01 <.0001  0.02 0.02 0.02 0.0024  0.02 0.02 0.02 <.0001 
Weight, kg 0.01 0.01 0.01 <.0001  0.04 0.03 0.05  <.0001  0.02 0.02 0.03 <.0001 
Height, cm 0.01 0.01 0.02 <.0001  0.08 0.07 0.09  <.0001  0.01 0.01 0.02 0.0003 
Body mass index, kg/m2 (ref= normal weight)                
     Underweight   -0.24 -0.30 -0.18  <.0001  -0.55 -0.81 -0.29  <.0001  -0.34 -0.52 -0.17 0.0001 
     Overweight  0.09 0.04 0.13 0.0005  0.18 -0.02 0.38 0.0747  0.19 0.05 0.32 0.0057 
     Obese  0.25 0.16 0.33 <.0001  0.65 0.30 0.99 0.0002  0.59 0.36 0.82 <.0001 
Marital Status (ref=married)                
     Unmarried/cohabiting -0.12 -0.16 -0.08 <.0001  -0.40 -0.58 -0.23 <.0001  -0.24 -0.36 -0.12  <.0001 
     Divorced/widow -0.10 -0.25 0.05 0.2002  -0.43 -1.05 0.19 0.1752  -0.19 -0.60 0.23 0.3818 
SES (ref=white collar)                
      Blue collar -0.05 -0.08 -0.01 0.0144  -0.25 -0.40 -0.10 0.0009  -0.02 -0.12 0.08 0.6686 
      Farmer 0.02 -0.06 0.10 0.6548  -0.05 -0.38 0.28 0.7628  0.09 -0.13 0.31 0.439 
Education (ref=primary education)                
     Vocational education -0.01 -0.07 0.05 0.739  0.02 -0.02 0.07 0.8669  -0.17 -0.36 0.02 0.0793 
     Secondary education 0.02 -0.04 0.08 0.5569  0.23 -0.01 0.47 0.0631  -0.18 -0.36 -0.01 0.0438 
     University 0.05 -0.03 0.13 0.2155  0.43 0.11 0.75 0.0094  -0.16 -0.39 0.08 0.19 
Smoking at 2 months of pregnancy (ref= non-smoker)                
     Smoker -0.17 -0.21 -0.13  <0.0001  -0.72 -0.89 -0.56 <0.0001  -0.27 -0.38 -0.16  <0.0001 
Previous Deliveries (ref=no previous delivery)                
     1 previous delivery 0.15 0.11 0.18 <0.0001  0.31 0.15 0.47 0.0002  0.44 0.33 0.55 <0.0001 
     2 previous deliveries 0.17 0.13 0.22 <0.0001  0.39 0.20 0.58 <0.0001  0.46 0.33 0.59 <0.0001 
     3 previous deliveries 0.21 0.14 0.28 <0.0001  0.42 0.12 0.71 0.0054  0.58 0.39 0.78 <0.0001 
     More than 3 previous deliveries 0.26 0.20 0.33 <0.0001  0.62 0.35 0.88 <0.0001  0.70 0.53 0.88  <0.0001 
Hypertensive complications in pregnancy (ref=normotensive)                
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     Gestational hypertension (GH) -0.04 -0.11 0.04 0.3598  -0.16 -0.47 0.16 0.3269  -0.07 -0.28 0.15 0.54 
     Pre-eclampsia (PE) -0.12 -0.22 -0.02 0.0162  -0.59 -0.99 -0.19 0.0038  -0.36 -0.63 -0.09 0.0083 
     Chronic hypertension (CH) 0.02 -0.06 0.09 0.6716  0.20 -0.10 0.51 0.194  -0.06 -0.27 0.14 0.559 
     Superimposed pre-eclampsia (SP) 0.02 -0.09 0.14 0.7079  0.19 -0.29 0.66 0.4344  0.05 -0.27 0.37 0.7768 
     Proteinuria (PR) 0.08 0.01 0.14 0.033  0.15 -0.14 0.43 0.3096  0.26 0.07 0.46 0.0072 
Paternal                 
Weight, kg 0.01 0.00 0.01  <0.0001  0.03 0.02 0.03  <.0001  0.01 0.00 0.01 0.0022 
Height, cm 0.01 0.00 0.01  <0.0001  0.04 0.03 0.06  <.0001  0.00 0.00 0.01 0.366 
Body mass index, kg/m2 (ref= normal weight)                
      Underweight   0.00 -0.05 0.05 0.9827  -0.06 -0.25 0.13 0.548  0.03 -0.10 0.16 0.6666 
      Overweight  0.06 0.02 0.10 0.0033  0.21 0.04 0.37 0.0132  0.12 0.01 0.23 0.026 
      Obese  0.04 -0.06 0.15 0.45  -0.14 -0.57 0.29 0.5274  0.23 -0.06 0.52 0.1221 
 SES (ref = White collar)                
      Blue collar -0.04 -0.08 0.00 0.0328  -0.14 -0.29 0.00 0.0557  -0.06 -0.16 0.04 0.2059 
      Farmer -0.01 -0.08 0.06 0.8211  -0.03 -0.32 0.25 0.8286  -0.04 -0.23 0.15 0.7033 
#Beta, se and 95% CI were presented in % change as PHV was log-transformed to reduce right skewness.  
$Significance was considered at P<0.05. 
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5.1.1.2.4    Sex-stratified association showing the potential mediation roles by size-at-birth 
between prenatal factors and PHV (Table 7 A and B) 
Tables 7A and 7B show the four models compared to understand the role of mediation by size-at-birth 
variables in the relationship between prenatal predictors and PHV. Comparing effect size for the four 
models, it was observed that mother’s age in female offspring showed an indirect effect via all size-at-
birth variables but not in male offspring (Table 7A, 7B; model 1 vs 2, 3 and 4). In female offspring, 
after adjustments with individual size-at-birth variables in the models, the effect size for each of the 
association between maternal age and PHV was reduced by > 10% suggesting mediation by size-at-
birth variables which were confirmed by Sobel’s test (Psobel < 0.05 for all size-at-birth variables). 
Maternal weight in Model 1 did not associate with PHV in either sex, however, after adjustments with 
size-at-birth variables the association turned significant indicating mediation by these factors (Table 
7A,B; model 1 vs 2,3 and 4, Psobel < 0.05 for all). Maternal height did not show significant association 
after adjustments of size of birth variables in each model for both sexes, suggesting no mediation by 
any of these variables (Psobel > 0.05). Maternal BMI showed mediation with PHV by BW and birth 
BMI in males (Psobel <0.05) but not in females. 
 
The association between male PHV and overweight mothers was mediated by birth BMI (Psobel <0.05), 
but was not mediated in females (Psobel>0.05). Similarly association between PHV and obese mothers, 
suggested mediation by BW and birth BMI (Psobel <0.05) but not by BL (Psobel >0.05) and no significant 
association was observed in female offspring (Psobel > 0.05). The association between female offspring 
of single/cohabiting mothers and PHV in female offspring mediated by all size-at-birth (model 1 vs 2,3 
and 4), whereas boys born to single/cohabiting mothers had their association mediated only by birth 
BMI (Psobel<0.05). Mother’s SES and education did not show any mediation by size-at-birth variable 
after Sobel’s test (Psobel >0.05).  
 
Association between offspring of mothers smoking during the initial 2 months of pregnancy and PHV 
were mediated by birth BMI in males (Psobel <0.05), and in females the association were mediated by 
both BW and birth BMI (Psobel <0.05). Maternal parity showed mediation by all size-at-birth factors in 
both sexes except mothers with 2 previous deliveries did not show mediation by BL (model 1 vs 2, 3 
and 4), which could be due to small sample size for this category. For the hypertensive complication 
during 
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Table 7. A. The association between prenatal factors and PHV (model 1) and the mediating role of size-at-birth variables in NFBC 1986 
males 
NFBC 1986 Males (N=2741) 
 A Model1a Model 2a Model 3a Model 4a 
  Beta 95% CI  Beta 95% CI  beta  95% CI  beta  95% CI 
 
 
Maternal                        
 
 
Age, years -0.03 ( -0.06 0.00 ) 0.0859 0.00 ( -0.03 0.03 )  0.00 ( -0.03 0.03 )  -0.02 ( -0.05 0.02 ) 
 
 
Weight, kg -0.01 ( -0.02 0.01 ) 0.6017 0.03 ( 0.01 0.05 ) 
b
 0.02 ( 0.00 0.04 ) 
b
 0.02 ( 0.00 0.04 ) 
b
 
Height, cm 0.16 ( 0.12 0.19 ) <.0001 0.21 ( 0.17 0.24 )  0.23 ( 0.20 0.26 )  0.16 ( 0.13 0.19 ) 
 
 
BMI, kg/m2 (ref= normal 
weight) 
                       
 
 
  Underweight   -0.02 ( -0.73 0.68 ) 0.9447 -0.41 ( -1.08 0.27 )  -0.29 ( -0.95 0.37 )  -0.19 ( -0.89 0.51 ) 
 
 
   Overweight  -0.83 ( -1.37 -0.29 ) 0.0027 -0.53 ( -1.05 -0.01 )  -0.59 ( -1.10 -0.08 )  -0.72 ( -1.25 -0.18 ) 
b
 
  Obese  -2.24 ( -3.25 -1.21 ) <.0001 -1.70 ( -2.68 -0.71 ) 
b
 -2.11 ( -3.07 -1.14 )  -2.05 ( -3.06 -1.02 ) 
b
 
Marital (ref=married)                        
 
 
  Unmarried/cohabiting 0.77 ( 0.29 1.26 ) 0.0019 0.32 ( -0.15 0.79 )  0.30 ( -0.16 0.76 )  0.61 ( 0.13 1.10 ) 
b
 
  Divorced/widow 0.09 ( -1.91 2.13 ) 0.9283 -0.31 ( -2.22 1.64 )  -0.01 ( -1.89 1.91 )  -0.19 ( -2.17 1.84 ) 
 
 
SES (ref=white collar)                        
 
 
   Blue collar 0.41 ( 0.00 0.83 ) 0.0492 0.28 ( -0.11 0.68 )  0.27 ( -0.12 0.66 )  0.38 ( -0.03 0.79 ) 
 
 
   Farmer -0.79 ( -1.71 0.14 ) 0.0944 -0.63 ( -1.51 0.26 )  -0.78 ( -1.64 0.09 )  -0.68 ( -1.59 0.25 ) 
 
 
Education (ref=primary )                        
 
 
  Vocational education 0.06 ( -0.70 0.82 ) 0.8835 -0.14 ( -0.86 0.60 )  -0.07 ( -0.78 0.65 )  -0.03 ( -0.79 0.74 ) 
 
 
  Secondary education 0.69 ( -0.03 1.42 ) 0.0604 0.54 ( -0.16 1.24 )  0.65 ( -0.03 1.33 )  0.58 ( -0.14 1.31 ) 
 
 
  University -0.03 ( -0.98 0.93 ) 0.9499 -0.09 ( -1.00 0.82 )  0.12 ( -0.77 1.02 )  -0.11 ( -1.05 0.85 ) 
 
 
Smoking (ref= no)                        
 
 
  Smoker 0.84 ( 0.38 1.29 ) 0.0003 0.42 ( -0.02 0.86 )  0.26 ( -0.17 0.69 )  0.71 ( 0.26 1.17 ) 
b
 
Previous Deliveries 
(ref=no) 
                       
 
 
  1 previous delivery -0.92 ( -1.35 -0.49 ) <.0001 -0.56 ( -0.97 -0.14 ) 
b
 -0.65 ( -1.06 -0.24 ) 
b
 -0.74 ( -1.18 -0.31 ) 
b
 
  2 previous deliveries -1.01 ( -1.51 -0.50 ) <.0001 -0.46 ( -0.96 0.03 )  -0.64 ( -1.12 -0.16 ) 
b
 -0.76 ( -1.27 -0.25 ) 
b
 
  3 previous deliveries -2.15 ( -2.91 -1.38 ) <.0001 -1.77 ( -2.51 -1.02 ) 
b
 -1.97 ( -2.69 -1.25 ) 
b
 -2.00 ( -2.76 -1.23 ) 
b
 
  More than 3 previous 
deliveries 
-2.08 ( -2.79 -1.37 ) <.0001 -1.40 ( -2.09 -0.70 ) 
b
 -1.71 ( -2.39 -1.03 ) 
b
 -1.79 ( -2.52 -1.07 ) 
b
 
Pregnancy complications 
(ref=normotensive)
c
 
                       
 
 
  GH 0.18 ( -0.62 0.99 ) 0.6612 -0.15 ( -0.92 0.64 )  -0.07 ( -0.84 0.70 )  -0.03 ( -0.84 0.79 ) 
 
 
  PE 1.82 ( 0.82 2.84 ) 0.0004 1.14 ( 0.17 2.12 ) 
b
 1.05 ( 0.08 2.02 )  1.50 ( 0.48 2.53 ) 
b
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  CH 0.23 ( -0.61 1.07 ) 0.5944 0.34 ( -0.47 1.15 )  0.33 ( -0.47 1.13 )  0.27 ( -0.57 1.11 ) 
 
 
  SP 0.65 ( -0.85 2.18 ) 0.3957 0.60 ( -0.84 2.07 )  0.80 ( -0.62 2.24 )  0.54 ( -0.95 2.06 ) 
 
 
  PR -0.17 ( -1.02 0.68 ) 0.6941 -0.10 ( -0.92 0.72 )  -0.16 ( -0.96 0.65 )  -0.12 ( -0.97 0.73 ) 
 
 
Paternal                         
 
 
Weight, kg 0.04 ( 0.02 0.06 ) 0.0004 0.16 ( 0.13 0.19 )  0.07 ( 0.05 0.09 ) 
b
 0.04 ( 0.02 0.07 ) 
b
 
Height, cm 0.13 ( 0.10 0.16 ) <.0001 0.06 ( 0.04 0.08 ) 
b
 0.18 ( 0.15 0.21 ) 
b
 0.13 ( 0.10 0.16 ) 
 
 
BMI, kg/m2 (ref= normal 
weight) 
                       
 
 
  Underweight   0.50 ( 0.00 1.01 ) 0.0516 0.48 ( -0.01 0.96 )  0.33 ( -0.15 0.81 )  0.33 ( -0.15 0.81 ) 
 
 
  Overweight  0.10 ( -0.34 0.54 ) 0.6597 0.32 ( -0.10 0.75 )  0.23 ( -0.19 0.65 )  0.23 ( -0.19 0.65 ) 
 
 
  Obese  -0.85 ( -2.08 0.38 ) 0.1762 -0.47 ( -1.65 0.72 )  -0.52 ( -1.67 0.65 )  -0.52 ( -1.67 0.65 ) 
 
 
 SES (ref = White collar)                        
 
 
Blue collar -0.09 ( -0.49 0.31 ) 0.6535 -0.15 ( -0.53 0.23 )  -0.18 ( -0.55 0.20 )  -0.09 ( -0.49 0.30 ) 
 
 
Farmer -0.70 ( -1.48 0.09 ) 0.0828 -0.63 ( -1.38 0.13 ) 
 
 -0.78 ( -1.52 -0.04 ) 
 
 -0.65 ( -1.43 0.14 ) 
 
 
 
a Model 1 = PHV~ prenatal predictors (PP)  + GA, Model 2 =PHV~ PP + BW + GA, Model 3=PHV~ PP + BL+GA, Model 4=PHV~ PP+Birth BMI +GA;  
 b Sobel test P < 0.05 
cGH = gestational hypertension, PE= pre-eclampsia, CH = chronic hypertension, SP = superimposed pre-eclampsia, PR = proteinuria 
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Table 7. B. The association between prenatal factors and PHV (model 1) and the mediating role of size-at-birth variables in NFBC 1986 
females.  
  NFBC 1986 Females (N=2836)   
      B.  Model1a Model 2a Model 3a Model 4a 
  Beta 95% CI  Beta 95% CI  beta  95% CI  beta  95% CI 
 
 
Maternal                        
 
 
Age, years -0.22 ( -0.31 -0.14 ) <.0001 -0.12 ( -0.21 -0.04 ) 
b
 -0.12 ( -0.20 -0.04 ) 
b
 -0.20 ( -0.28 -0.11 ) 
b
 
Weight, kg -0.02 ( -0.07 0.03 ) 0.4693 0.08 ( 0.03 0.13 ) 
b
 0.09 ( 0.04 0.14 ) 
b
 0.09 ( 0.04 0.14 ) 
b
 
Height, cm 0.38 ( 0.29 0.46 ) <.0001 0.52 ( 0.44 0.60 )  0.63 ( 0.55 0.71 )  0.40 ( 0.32 0.49 ) 
 
 
BMI, kg/m2 (ref= 
normal) 
                       
 
 
Underweight   1.62 ( -0.22 3.50 ) 0.0845 0.20 ( -1.56 1.98 )  0.20 ( -1.50 1.93 )  1.24 ( -0.60 3.12 ) 
 
 
 Overweight  -1.13 ( -2.52 0.27 ) 0.1135 -0.44 ( -1.78 0.93 )  -0.74 ( -2.04 0.57 )  -1.00 ( -2.38 0.41 ) 
 
 
Obese  -2.90 ( -5.23 -0.51 ) 0.0178 -0.92 ( -3.22 1.43 )  -1.17 ( -3.38 1.10 )  -2.15 ( -4.50 0.25 ) 
 
 
Marital (ref=married)                        
 
 
Unmarried/cohabiting 2.95 ( 1.70 4.22 )  <.0001 1.93 ( 0.74 3.15 ) 
b
 1.71 ( 0.55 2.89 ) 
b
 2.48 ( 1.23 3.75 ) 
b
 
Divorced/widow 2.69 ( -1.71 7.30 ) 0.2343 1.86 ( -2.33 6.24 )  1.56 ( -2.49 5.78 )  2.46 ( -1.90 7.02 ) 
 
 
SES (ref=white collar)                        
 
 
 Blue collar 0.07 ( -0.99 1.14 ) 0.9002 -0.31 ( -1.32 0.71 )  -0.58 ( -1.56 0.41 )  0.06 ( -0.99 1.12 ) 
 
 
 Farmer -2.94 ( -5.16 -0.66 ) 0.0117 -2.79 ( -4.92 -0.61 )  -2.85 ( -4.93 -0.72 )  -2.62 ( -4.85 -0.33 ) 
 
 
Education (ref=primary)                        
 
 
Vocational  -0.52 ( -2.32 1.32 ) 0.5775 -0.61 ( -2.33 1.14 )  -0.46 ( -2.14 1.24 )  -0.54 ( -2.33 1.29 ) 
 
 
Secondary  -0.13 ( -1.82 1.60 ) 0.8848 0.03 ( -1.59 1.67 )  0.54 ( -1.04 2.15 )  -0.11 ( -1.80 1.60 ) 
 
 
University -1.83 ( -4.05 0.45 ) 0.1153 -1.40 ( -3.53 0.78 )  -0.76 ( -2.85 1.38 )  -1.98 ( -4.18 0.28 ) 
 
 
Smoking (ref= no)                        
 
 
Smoker 2.94 ( 1.75 4.14 ) <.0001 1.55 ( 0.41 2.70 ) 
b
 0.89 ( -0.22 2.01 )  2.45 ( 1.26 3.65 ) 
b
 
Previous Deliveries 
(ref=no ) 
                       
 
 
1 previous delivery -3.97 ( -5.03 -2.91 )  <.0001 -2.92 ( -3.96 -1.87 ) 
b
 -3.25 ( -4.25 -2.25 ) 
b
 -3.61 ( -4.68 -2.53 ) 
b
 
2 previous deliveries -4.45 ( -5.72 -3.16 )  <.0001 -3.21 ( -4.46 -1.93 ) 
b
 -3.48 ( -4.69 -2.27 ) 
b
 -4.02 ( -5.31 -2.72 ) 
b
 
3 previous deliveries -6.81 ( -8.68 -4.89 )  <.0001 -5.32 ( -7.17 -3.43 ) 
b
 -5.81 ( -7.58 -4.00 ) 
b
 -6.29 ( -8.18 -4.36 ) 
b
 
More than 3 previous 
deliveries 
-7.86 ( -9.53 -6.16 )  <.0001 -6.04 ( -7.70 -4.34 ) 
b
 -6.38 ( -7.97 -4.76 ) 
b
 -7.22 ( -8.92 -5.50 ) 
b
 
Pregnancy complications 
(ref=normotensive) 
                       
 
 
GH 1.33 ( -0.90 3.62 ) 0.2431 1.03 ( -1.10 3.21 )  0.94 ( -1.13 3.04 )  1.27 ( -0.94 3.53 ) 
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PE 5.88 ( 2.94 8.89 )  <.0001 4.83 ( 2.04 7.69 ) 
b
 3.98 ( 1.28 6.76 ) 
b
 5.12 ( 2.20 8.12 ) 
b
 
CH 0.63 ( -1.51 2.82 ) 0.5661 0.77 ( -1.29 2.86 )  1.18 ( -0.82 3.23 )  0.57 ( -1.55 2.74 ) 
 
 
SP -3.25 ( -6.36 -0.03 ) 0.0482 -3.07 ( -6.06 0.01 )  -3.11 ( -6.08 -0.05 )  -3.53 ( -6.69 -0.27 ) 
 
 
PR 0.04 ( -1.93 2.05 ) 0.9667 0.67 ( -1.24 2.61 )  0.28 ( -1.58 2.18 )  0.23 ( -1.75 2.26 ) 
 
 
Paternal                         
 
 
Weight, kg 0.12 ( 0.06 0.17 ) <.0001 0.17 ( 0.12 0.22 ) 
b
 0.49 ( 0.42 0.57 ) 
b
 0.37 ( 0.29 0.44 ) 
b
 
Height, cm 0.36 ( 0.28 0.44 ) <.0001 0.43 ( 0.35 0.50 ) 
b
 0.19 ( 0.14 0.24 ) 
b
 0.13 ( 0.08 0.18 ) 
b
 
BMI, kg/m2 (ref= 
normal) 
                       
 
 
Underweight   1.13 ( -0.21 2.48 ) 0.0996 1.13 ( -0.15 2.43 )  0.89 ( -0.35 2.15 )  0.89 ( -0.35 2.15 ) 
 
 
Overweight  -0.58 ( -1.70 0.56 ) 0.3211 -0.08 ( -1.17 1.02 )  -0.05 ( -1.11 1.02 )  -0.05 ( -1.11 1.02 ) 
 
 
Obese  -0.56 ( -3.53 2.49 ) 0.7143 -0.23 ( -3.08 2.71 )  -0.90 ( -3.65 1.92 )  -0.90 ( -3.65 1.92 ) 
 
 
 SES (ref = White collar)                        
 
 
Blue collar 0.78 ( -0.26 1.84 ) 0.1430 0.47 ( -0.54 1.48 )  0.39 ( -0.58 1.38 )  0.69 ( -0.35 1.74 ) 
 
 
Farmer -0.49 ( -2.48 1.54 ) 0.6341 -0.55 ( -2.46 1.39 ) 
 
 -0.39 ( -2.25 1.51 ) 
 
 -0.35 ( -2.34 1.67 ) 
 
 
 
a Model 1 = PHV~ prenatal predictors (PP)  + GA, Model 2 =PHV~ PP + BW + GA, Model 3=PHV~ PP + BL+GA, Model 4=PHV~ PP+Birth BMI +GA;  
 b Sobel test P < 0.05 
cGH = gestational hypertension, PE= pre-eclampsia, CH = chronic hypertension, SP = superimposed pre-eclampsia, PR = proteinuria 
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pregnancy, mother’s with pre-eclampsia showed mediation by all size-at-birth variables in female offspring 
(Psobel<0.05), but only with BW and birth BMI in male offspring (Psobel <0.05). Father’s weight and height 
were mediated by all size-at-birth variables in female offspring as tested by Sobel’s test (Psobel <0.05), 
however, in males mediation was only observed by BL and Birth BMI (Psobel <0.05). Father’s BMI and SES 
did not show any mediation by any of the size-at-birth variables after testing for Sobel’s test (Psobel  >0.05), 
which may indicate that fathers BMI may account for high muscular mass rather than fat mass.  
 
5.1.1.4   Discussion 
This study examines a wide selection of prenatal predictors which associate with size-at-birth and PHV. 
Moreover, mediation by size-at-birth which was assumed to influence association between prenatal 
predictors and PHV was also investigated. This is a novel study as it uses longitudinal growth models to 
determine individual growth velocities in NFBC1986. The NFBCs are an ideal source for such growth 
modeling purposes, as they provide large numbers of serial height measurements, and a rich set of prenatal 
factors, which enables a detailed study of the prenatal and postnatal predictors of early growth velocity as 
shown by Tzoulaki et al, 201014.  
 
One of the biggest strengths of this study was the use of longitudinal data to measure height growth 
acceleration. As discussed previously, fitting appropriate growth models has added advantages as they 
provide biologically meaningful parameters and summarise a large amount of raw anthropometric data into 
functional parameters at time periods of interest210. Moreover, this is the first study which uses a 
comprehensive set of prenatal factors to understand the mechanisms behind interrelationships between 
prenatal factor, size-at-birth (proxy for fetal growth) and postnatal immediate outcome. The study shows that 
due to adverse in utero environment a fetus may not be able to reach its genetic growth potential, and this 
“damage” is compensated by increased postnatal growth. This study demonstrates how important these 
prenatal factors are for early growth and how they may later impact wellbeing and health.   
 
The results of this study are consistent with previously reviewed literature, confirming an inverse association 
between size-at-birth variables on infant rapid postnatal growth, also called catch up growth67,211,212. 
However, results from most previous studies have been ambivalent. With studies mostly focusing on the 
associations between size-at-birth variables, rapid weight gain and adverse health outcomes in adulthood, 
such as obesity or metabolic syndrome57,95, none tried to trace the causal pathway connecting prenatal 
predictors with rapid growth. Moreover these studies use an average of height/weight growth over two or 
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more time periods as an indicator of rapid postnatal growth61, which makes direct comparison between 
studies difficult. There was no previous study that had tried such longitudinal modeling before, using PHV. 
With different definitions for rapid growth, one cannot assess the relative contribution of each potential 
growth phase during which the individuals catch up or drop below their genetic growth potential.  
 
The study showed an inverse association between size-at-birth variables and PHV, which was much stronger 
in females than males. The result is in line with the growth acceleration hypothesis that smaller babies 
experience faster infant postnatal growth, and also suggests a possible temporal effect in terms of the 
strength of the association201. Results indicated that maternal age, weight, height, pre-pregnancy BMI, 
marital status, smoking during the initial 2 months of pregnancy, parity, pre-eclampsia, chronic 
hypertension, father’s weight and height were significantly associated with PHV, independently of size-at-
birth variables. This means that adjustment for size-at-birth factors did not completely remove the 
associations although there was partial mediation observed for many of the prenatal determinants of 
postnatal growth velocity. Consistent with published literature65,68, the study also found prenatal predictors 
associated with size-at-birth variables.  
 
Size at birth mediated the relationship between various prenatal predictors and PHV, with males and females 
showing varying degree of mediation for the prenatal predictor. Maternal age associated with lower PHV 
and mediated by all size-at-birth variables but only in females. Maternal age has been associated with larger 
babies and it is known that larger babies grow slowly, hence the results from this study is consistent with 
observed process. However, maternal age has been also associated with favorable height growth in 
children213 as well as childhood hypertension214. Keeping this in mind, the result of this study can therefore 
indirectly indicate that association between maternal age and low PHV may affect later health, although 
further studies will be required to understand this association in depth.   
 
Maternal weight did not associate with PHV in either sex which could be due to some exogenous factors215, 
however, once adjusted for size-at-birth variables, the association turned to significant mediation shown by 
size-at-birth variables in both sex. This result fits well with the maternal weight hypothesis, which states that 
maternal pre-pregnancy weight affects the intra-uterine environment which indirectly affects infant growth. 
It was also observed that paternal weight and height in the female offspring showed a clear trend of 
mediation by size-at-birth variables, although there was no such trend for males. It is a well-known fact that 
parental anthropometric measurements are genetically inherited by offspring204,216, however results from this 
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study indicate that there may be a sex interaction between inheritances of anthropometric measures, which 
needs to be analysed further in future.   
 
Higher maternal pre-pregnancy BMI associated with a higher PHV. There was a clear trend that maternal 
BMI groups had a negative or positive association with PHV in both sexes. For example, infants of 
underweight mothers were born small and therefore had higher PHV in comparison to infants of lean 
mothers suggesting that these infants catch-up to compensate for a small size-at-birth to reach their genetic 
potential for growth. Similarly, infants of overweight and obese mothers are born large and therefore have 
slower postnatal growth than infants of normal mothers. These individuals catch-down to reach their genetic 
potential.  Interestingly, it was observed that mediation between maternal BMI and PHV only associated in 
males but not in females.  
 
Maternal marital status associated with higher infant height growth. Female infants showed mediation by all 
size-at-birth variables, but in males the association was only mediated by birth BMI. This result is in line 
with a previous study, which showed that mother’s SES and marital status may affect the intra-uterine 
nutritional environment during fetal development, making these individuals small at birth217. Similarly, 
mothers smoking during pregnancy also associated with higher infant height growth. The association in 
female infants shows mediation by BW and birth BMI but in male infants this association was mediated 
only by birth BMI. Although, this result was in agreement with a previous study 218, this study accounts for 
the longitudinal variation in height also showing a sex interaction.  
 
Maternal parity had a consistent, strong association with PHV, in all groups, even after adjustment for other 
size-at-birth variables showing partial mediation by them. Ong et. al, 2002, have already previously reported 
that maternal factors such as weight gain and smoking during pregnancy and parity are associated with the 
catch-up growth 218, and this study confirms the findings. Studies have also shown that firstborn babies are 
born small and hence gain weight more rapidly during the first year of life than other siblings 66,219. The 
current study shows a similar trend, with slower infant height growth as number of children increases.   
 
Pre-eclampsia was found to be mediated by all size-at-birth variables in both sexes except for BL in males. 
This is similar result to that by Srinivas et al, 2009, who demonstrated that intrauterine growth retardation, 
occurs in pre-eclampsia followed by rapid postnatal growth220.  
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One of the limitations of this study was that it accounted for the error in PHV estimations by weighting the 
number of measurements per person. This process assumes that the reliability of the growth data has a 
proportional relationship with the measurement frequency. These are broadly reasonable assumptions, but 
they are difficult to verify using this data alone12. Moreover, although the study considered an extensive set 
of prenatal factors which may influence infant height growth, no adjustment for variables such as maternal 
infections during pregnancy, postnatal infections and other diseases as well as infant feeding could be 
addressed in this study.  There was no information about mother’s diet, lifestyle, breastfeeding or overall 
child’s nutrition in NFBC 1986 therefore these could not be analysed in this study.  
 
To conclude, this study of a large population-based Finnish birth cohort supports the hypothesis that babies 
with smaller birth sizes have faster infant growth and mediates the relationship between prenatal predictors 
and postnatal height growth. Several maternal and paternal factors were directly associated with faster 
postnatal height growth, some of which had their association mediated by size-at-birth variables. The 
clinical importance of this effect should be evaluated as it may inform public health policy aimed at 
improving the pre-pregnancy environment and also at monitoring infant’s growth during the first few years. 
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 5.1.2.   The effect of an obesogenic environment in utero and during childhood on 
metabolic health in adolescents.  
5.1.2.1.    Introduction 
There has been a dramatic increase in the prevalence of obesity in women of reproductive ages in the last 20 
years
221
, with the WHO predicting that one in five women are obese at the time of their antenatal check in 
the UK
222
. Maternal obesity has been identified as an independent risk factor for adverse health 
consequences in both mother and child during the prenatal and postnatal period. Overweight and obese 
mothers have been found to have a higher risk of pre-eclampsia and gestational diabetes mellitus
223
 during 
pregnancy, poor mental health and several chronic diseases, such as T2D and cardiovascular diseases in later 
life
224
.  
Babies born to overweight or obese mothers are usually large for gestational age (LGA)
225
. These mothers 
have high incidences of obstetric complications during birth, and a higher incidence of neonatal deaths 
compared to newborns of lean mothers
226
. Recent reviews suggests that high pre-pregnancy maternal weight 
associates with an altered offspring metabolic profile including higher blood pressure and adverse lipid 
profile
222
, although these studies are underpowered and  consider the pre-pregnancy weight. Studies have 
found evidence of correlation between parental obesogenic environment and weight status of children at 
various ages, suggesting an association between parental obesogenic environment and adiposity in 
children
227
.  
Childhood obesity increases the probability of adverse psychological, social and metabolic health 
consequences during childhood and later life, which could reduce the quality of life of an individual 
228
.  
Maternal overweight and obesity, both at conception and during childhood, has been independently 
associated with offspring adiposity and insulin resistance 
97,229-231
. One of the limitations for these studies is 
that they have not considered the role of postnatal lifestyle influences on this association, hence making it 
difficult to prove the causal link between pre-pregnancy weights with offspring metabolic profile.  
 
Animal studies support the ‘developmental programming hypothesis’ here, which proposes that maternal 
nutrition during fetal development exerts a ‘programming’ effect on the offspring’s obesity, metabolic and 
behavioral abilities later in life
232-235
. In humans, similar studies to study the ‘development programming’ 
effect are challenging. The complex nature of the potential interaction between genetic, behavioral and life-
style factors in pre- and post- environments, makes it difficult to segregate the contribution of each of these 
independently
236
. Most previous studies have focused on comparing either the anthropometric or metabolic 
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phenotypes for overweight /obese mothers vs. lean mothers, or birth outcomes of their newborn. No 
previous study has investigated the long-term effects of maternal overweight/obesity during in utero and 
during childhood on adolescent metabolic health
233,234,237
. Such studies are important, as they will be able 
give public health clinicians the opportunity to identify pregnant mothers who are at risk for prenatal 
programming of obesity
238
.  
Considering limitations from other studies on maternal obesity effect on offspring, the current study tests the 
hypothesis that both the prenatal and postnatal ‘obesogenic’ environment predisposes offspring of O/O 
mothers to adverse metabolic health, and that these environments effect, either in combination, or 
independently the offspring’s metabolic phenotypes. The main objective was to use an experimental study 
design by Samuelsson et al, 2008, 
232
 and apply on human data using longitudinal data from the NFBC 1986. 
The aim was to support ‘developmental programming’ of obesity in offspring within the four groups of 
mothers by comparing insulin-resistance, lipid and blood pressure outcomes of adolescents.  
The overall study was conducted as a trans-disciplinary approach to establish the consequences of maternal 
overweight and obesity during pregnancy in both humans and mice. The murine model is not discussed here, 
however, comparisons between human and mice models is an ideal research in translational studies since 
various animal studies show that models in mice have been able to mimic a wide range of human disease 
and health problems. In addition, it is technically possible to conduct experiments in mice model, which may 
not be possible in humans.  
5.1.2.2.    Study-specific methods and material 
NFBC 1986 has been an ideal dataset for this study, as its dense longitudinal data from the start of 
pregnancy to adolescent health at 16 years is ideal for replicating the experimental murine model for this 
study. The details on data collection of anthropometric and metabolic variables (used for analyses in this 
study) are described in Chapter 4, Section 4.2. The comparison between groups and results were presented 
as two groups based on whether the metabolic function related to glucose-insulin axis or to cardiovascular 
risk factors. The glucose-insulin axis included fasting glucose, fasting insulin, HOMA-IR and HOMA-B. 
The metabolic phenotypes related to cardio-vascular risk factors included Triglyceride, total cholesterol, 
HDL, LDL, Apoprotein, Aproprotien B, SBP, DBP. Details on how these variables were calculated are 
given in Chapter 4, section 4.2.  The description of study specific inclusion, exclusion and methods is given 
below.  
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Inclusion and exclusions 
The flowchart showing the division of the four study groups for mothers of N=5,739 offspring with fasting 
blood and maternal BMI data available are shown in Figure 6. The offspring sample was restricted to 
singletons that had fasting glucose data available at 16 years of age. Underweight mothers (BMI < 18.5 
kg/m2), mothers who refuse the use of data, and those with missing weight or height data were excluded 
from the analysis. Using the International Obesity Task Force (IOTF) cut-off, a BMI of between 18.5 kg/m2 
and 25 kg/m2 was classified as ‘normal’ (N) and a BMI of over 25 kg/m2 was classified as ‘overweight or 
obese’ (O)25. The overweight and obese mothers were grouped as one, as health outcomes of children born 
to both overweight and obese mothers are prone to a similar direction and grouping gives us a larger sample 
size
239
.   
First, the offspring were divided into ‘N’ and ‘O’ groups according to mother’s BMI at the start of 
pregnancy. Next, the N and O groups were further divided into four groups based on mother’s BMI when 
offspring were 16 years, resulting in four groups:  Normal-Normal (N/N), Normal-overweight or obese 
(N/O), overweight or obese-Normal (O/N) and overweight or obese-overweight or obese (O/O) groups. In 
this study, maternal BMI represents a proxy for the obesogenic environment that affects offspring’s health 
since the nutritional information during pregnancy and during childhood was not available for analysis in the 
NFBC1986.  
Statistical methods 
Summary statistics of the adolescence metabolic phenotypes were reported as means with 95 % confidence 
interval (CI) for continuous variables and percentages for each group for the categorical variable. The main 
tests compared the mean of each group O/O, O/N, N/O with the reference group (N/N) to find if any of the 
metabolic outcomes were elevated within the groups and if there was a significant difference between the 
groups, indicating the effect of an obesogenic environment in utero or during childhood. Analysis of 
Variance (ANOVA) was used to test high variance between different maternal groups, which provided an 
overall Panova value for variability within the groups. Tukey posthoc tests were performed to check pair-wise 
comparisons between the groups. The ANOVA requirements of normality and equal variances were tested 
for each group, Dunnett’s t-test was performed. All statistical tests of hypotheses were two-sided, applying a 
threshold for significance of P < 0.05 after Bonferroni corrections.  
The initial analyses were adjusted for maternal parity, weight gain during pregnancy and socio-economic 
status (SES), paternal BMI and SES, gestational age in weeks (GA), Tanner stage (scale to represent 
pubertal development) and age at menarche as potential confounding factors. All of these potential 
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confounders have been shown to be associated with maternal BMI. Adjustments for maternal parity, weight 
gain during pregnancy and socio-economic status (SES), paternal BMI and SES did not modify the 
associations; therefore these covariates were not adjusted to maintain high sample size. The final analyses 
were adjusted for three potential cofounders: GA, Tanner stage and age at menarche (females only), as they 
had a significant (P<0.05) modification of the association between outcome and explanatory variables. The 
analyses were sex-stratified, as previous studies confirmed that metabolic phenotypes differ between 
adolescent males and females
240
. Moreover, one of the aims of this study was also to investigate if there is 
any interaction between maternal BMI group and sex. 
5.1.2.3.    Results  
Descriptive statistics 
Table 8 shows the characteristics of the sample population by maternal BMI groups according to offspring’s 
sex. At the start of the pregnancy, 75% of mothers were normal (“N”) and 16% of mothers were overweight 
or obese (“O”), while the remaining 7.3% underweight mothers were removed from the analysis. Within the 
normal BMI group of mothers, 65% remained normal 16 years later (N/N) while 35% of became O/O (N/O). 
In the O group of mothers, 8% had normal BMI 16 years later (O/N) and 92% remained O/O (O/O). The 
remaining 1% mothers, who were underweight when their offspring were 16 years old, were again removed 
from the analysis. The underweight mothers were removed as they had a smaller sample size compared to 
other groups, and the offspring of the underweight mothers have other threats (or concerns), which may have 
deviated from the hypotheses in this study.  The N/N groups were considered as the reference group in both 
sexes. 
Male offspring 
a) Maternal characteristics 
The O/O mothers of male offspring were older (31 years) compared to the other three other groups, with an 
average maternal age of approximately 28 years in the study sample. The average BMI at the start of 
pregnancy in mothers was 20.9 kg/m2 in N/N mothers, 22.5 kg/m2 in N/O mothers, 27 kg/m2 in O/N  
mothers and 27.9 kg/m2 in O/O mothers. The maternal weight gain during pregnancy supported our 
assumption that BMI at the start of pregnancy is a proxy for nutritional environment in utero, with N/O 
mothers gaining the most weight during pregnancy in comparison to the other three groups, an average of 
14.9 kg. The O/O mothers had the highest parity among the groups, with an average of 2.4 children born to 
these mothers compared to 1.5 born to both N/O and O/N and 1.1 born to N/N mothers (Panova < 0.0001). 
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The maternal BMI when offspring were 16 years old was 22.5 kg/m2 in N/N mothers, 27.3 kg/m2 in N/O 
mothers, 24 kg/m2 in O/N mothers and 30.9 kg/m2 in O/O mothers.  
b) Paternal characteristics 
The paternal BMI at birth observed the same trend as maternal BMI, with an average BMI in husbands of 
N/N mothers of 23.9 kg/m2, 24.2 kg/m2 in N/O mothers, 24.4 kg/m2 in O/N mothers and 24.8 kg/m2 in 
husbands of O/O mothers. Father’s BMI when offspring were 16 years old showed a slightly different trend 
to their BMI at offspring’s birth, with husbands of N/O mothers and husbands of O/O mothers showing a 
similar average BMI of 27 kg/m2.  
c) Newborn characteristics 
Within all groups the average gestational age (GA) was approximately 39 weeks. The BW of newborns 
varied significantly between groups, with newborns of N/N being the lightest with an average of 3.6 kg and 
newborn of N/O, O/N and O/O mothers heaviest with an average BW of 3.7 kg (Table 9).  
d) Adolescent at 16 years 
The adolescent BMI at 16 years and WHR followed the same trend as the mothers’ and fathers’ BMI, with 
children of O/O mothers having an average ~ 2 kg/m2 higher BMI at 16 years and 0.02 higher WHR than 
children born to N/N mothers. Offspring of N/O mothers were significantly different to offspring of O/O and 
N/N mothers for both BMI and WHR, indicating that both environments, in utero and postnatal, may 
influence anthropometric outcomes. The Tanner scale was an average of 4.2 for the male offspring sample, 
and did not differ significantly between the groups (Panova =0.7488)  
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Figure 6. Study groups according to maternal BMI in the Northern Finland Birth Cohort 1986 
(NFBC 1986). Offspring who participated in clinical examinations were stratified according to the 
maternal BMI at the start of pregnancy and maternal BMI when offspring were 16 years of age. The 
maternal BMI definition of N (normal weight) and O (overweight and obese) were based on IOTF 
criteria
25
. 
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 Females 
a) Maternal characteristics  
Similarly to males, the average maternal age was 28 years and the O/O mothers were the oldest compared to 
the three other groups. The average BMI at the start of pregnancy was 20.9 kg/m2 in N/N mothers, 22.5 
kg/m2 in N/O mothers, 26 kg/m2 in O/N mothers and 28.1 kg/m2 in O/O mothers. Following the pattern in 
male offspring, the N/O mothers of females gained the most weight during pregnancy in comparison to the 
other three groups, an average of 14.3 kg, justifying the assumption that maternal BMI acts as a proxy for 
the obesogenic environment in utero (Panova P<0.0001). The maternal BMI when offspring were 16 years 
followed the same pattern as BMI at the start of pregnancy, with an average BMI of 22.6 kg/m2 in N/N 
mothers, 27.5 kg/m2 in N/O mothers, 23.8 kg/m2 in O/N mothers and 31.4 kg/m2 in O/O mothers.  
b) Paternal characteristics 
The paternal BMI showed the same trend as maternal BMI, with an average BMI in husbands of N/N 
mothers of 23.9 kg/m2, 24.2 kg/m2 in N/O mothers, 24.4 kg/m2 in O/N mothers and 24.8 kg/m2 in 
husbands of O/O mothers. The paternal BMI when the offspring were 16 years, showed a slightly different 
trend to their BMI at birth but a similar trend to male offspring, with husbands of N/O mothers showing the 
highest average BMI of 26.9 kg/m2 in comparison to all other groups, representing the postnatal obesogenic 
environment.    
c) Newborn characteristics 
The average GA was approximately 39 weeks in all groups. The BW of newborns varied significantly 
between groups (Panova P=0.0021), with newborns of N/N mothers lightest and newborns of O/O mothers 
the heaviest (Table 9). It was observed that the average BW for newborns of N/N and O/N mothers were 3.5 
kg, whereas BW for newborn of N/O and O/O were 3.6 kg, suggesting that newborns of mothers with the 
same postnatal obesogenic environment show similar birth characteristics, which could be due to some 
influence of in utero obesogenic environment on BW.  
d) Adolescent at 16 years 
The BMI at 16 years in females varied slightly from their male offspring, as offspring of O/N mothers had 
the highest BMI of 22.6 kg/m2, although this estimate is less accurate due to low numbers in the group. The 
O/N mothers have the smallest sample size and thus may not be representative of the total population of O/N
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Table 8: Summary characteristics of study population in Northern Finland 1986 Birth Cohort (NFBC 1986).  
 
\  N/N (n=2,311) N/O (n=1,243) O/N (n=54) O/O (n=691) Panova
* 
  Mean 95% CI Mean 95% CI Mean 95% CI Mean 95% CI   
%N 53%   30%   1%   16%     
Males                   
Maternal                   
Maternal Age (years)  27.6 (27.3, 27.9) 28.4 (28.0, 28.9) 28.3 (26.4, 30.2) 31 (30.4, 31.6) <0.0001 
BMI at start of pregnancy (kg/m
2
)  20.9 (20.8, 21.0) 22.5 (22.3, 22.6) 27 (26.1, 28.0) 27.9 (27.6, 28.2) <0.0001 
Weight gain during pregnancy 13.5 (13.2, 13.7) 14.9 (14.5, 15.3) 12.3 (10.3, 14.4) 12.2 (11.6, 12.8) <0.0001 
Parity  1.1 (1.1, 1.2) 1.5 (1,3, 1.6) 1.5 (1,3, 1.6) 2.4 (2.2, 2.7) <0.0001 
BMI when offspring 16y (kg/m
2
)
 
 22.5 (22.5, 22.6) 27.3 (27.1, 27.5) 24 (23.7, 24.3) 30.9 (30.4, 31.3) <0.0001 
Paternal                   
BMI at birth (kg/m
2)  23.9 (23.7, 24.1) 24 (23.8, 24.3) 24.1 (23.7, 24.3) 24.9 (24.6, 25.2) <0.0001 
BMI when offspring 16y (kg/m
2
)  26 (25.8, 26.2) 26.9 (26.3, 27.6) 24.1 (24.1, 27.1) 26.9 (26.5, 27.4) 0.0011 
Newborn                   
Gestational age (weeks)  39.4 (39.4, 39.5) 39.5 (39.4, 39.6) 39.2 (38.4, 39.9) 39.4 (39.3, 39.6) 0.6149 
Birth weight (kg)  3.6 (3.6, 3.7) 3.7 (3.7, 3.7) 3.7 (3.4, 4.0) 3.7 (3.7, 3.8) 0.0044 
Adolescent at 16                    
Body mass index (BMI) (kg/m2)  20.8 (20.6, 20.9) 21.5 (21.2, 21.8) 21.6 (20.7, 22.4) 22.6 (22.1, 23.1) <0.0001 
Waist hip ratio (WHR) 0.8 (0.8, 0.8) 0.8 (0.8, 0.8) 0.8 (0.8, 0.8) 0.8 (0.8, 0.8) <0.0001 
Tanner scores
 
 4.2 (4.2, 4.3) 4.3 (4.2, 4.3) 4.2 (3.8, 4.5) 4.3 (4.2, 4.4) 0.7488 
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Females                   
Maternal                   
Maternal Age (years)  27.6 (27.3, 27.9) 28.4 (28.0, 28.8) 28.0 (25.4, 30.6) 29.9 (29.3, 30.6) <0.0001 
BMI at start of pregnancy (kg/m
2
)  20.9 (20.9, 21.0) 22.5 (22.4, 22.6) 26.0 (25.6, 26.4) 28.1 (27.8, 28.4) <0.0001 
Weight gain during pregnancy 13.4 (13.2, 13.6) 14.3 (13.9, 14.7) 13.6 (11.7, 15.5) 11.9 (11.3, 12.5) <0.0001 
Parity  1.2 (1.1, 1.3) 1.5 (1.3, 1.5) 2 (1.1, 2.9) 2.2 (2.0, 2.5) <0.0001 
BMI when offspring 16y (kg/m
2
)
 
 22.6 (22.5, 22.7) 27.5 (27.3, 27.7) 23.8 (23.2, 24.4) 31.4 (30.9, 31.9) <0.0001 
Paternal                   
BMI at birth (kg/m
2)  23.8 (23.7, 24.0) 24.3 (24.0, 24.5) 24.8 (23.0, 26.6) 24.7 (24.3, 25.0) <0.0001 
BMI when offspring 16y (kg/m
2
)  25.8 (25.7, 26.1) 26.9 (26.5, 27.2) 26.8 (24.7, 28.9) 26.4 (26.4, 27.4) <0.0001 
Newborn                   
Gestational age (weeks)  39.5 (39.5, 39.6) 39.5 (39.4, 39.6) 39.1 (37.8, 40.4) 39.3 (39.1, 39.5) 0.0897 
Birth weight (kg)  3.5 (3.5, 3.5) 3.6 (3.5, 3.6) 3.5 (3.2, 3.8) 3.6 (3.5, 3.7) 0.0021 
Adolescent at 16                    
Body mass index (BMI) (kg/m2)  20.7 (20.6, 20.8) 21.7 (21.4, 22.0) 22.6 (20.8, 24.4) 22.5 (22.1, 22.9) <0.0001 
Waist hip ratio (WHR) 0.8 (0.7, 0.8) 0.8 (0.8, 0.8) 0.8 (0.8, 0.8) 0.8 (0.7, 0.8) <0.0001 
Tanner scores
 
 3.7 (3.7, 3.8) 3.8 (3.8, 3.9) 3.9 (3.4, 4.4) 3.8 (3.7, 3.8) 0.4986 
Age at menarche
 
 12.6 (12.5,12.6) 12.4 (12.3, 12.5) 12.5 (12.0, 12.9) 12.4 (12.3, 12.5) 0.0043 
 
BMI, body mass index; CI, confidence interval 
*P value for the difference between groups 
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mothers. The BMI of offspring from N/O mothers, an average of 21.7 kg/m2,  significantly differed from the 
BMI of offspring of both O/O mothers, 22.5 kg/m2,  (Panova P=0.0006) and N/N mothers, 20.7 kg/m2,  
(Panova P<0.0001), suggesting that both in utero and childhood obesogenic environment have an added 
effect in females. The average WHR was similarly distributed as male offspring, with offspring of O/O 
mothers having the highest WHR of 0.78, although WHR between offspring of N/O differed with N/N 
mothers (P=0.011) and O/O mothers differed from the offspring of N/N mothers (P<0.0001). The Tanner 
scale was similar across the groups, with an average of 3.7 in all female offspring showing similar pubertal 
development within all groups (P=0.4986). Age at menarche occur at around 12.5 years in the overall 
sample, with offspring of N/O mothers being a significantly earlier age at menarche than offspring of N/N 
mothers (P=0.0085), suggesting that the childhood obesogenic environment may exert an effect on the age at 
menarche
241
.  
e) Association between obesogenic environment, glucose metabolism and insulin resistance   
Males 
The average fasting glucose in male offspring was 5.1mmol/L in all the groups, and was unaffected by the 
obesogenic environments during in utero and childhood (Panova =0.8970) (Table 9). The fasting serum 
insulin concentrations were elevated in all groups relative to offspring of N/N mothers (Panova=0.0015), 
with the highest observed in offspring of O/O mothers, which was significantly greater than both the N/O (P 
= 0.0007) and N/N mothers (P=0.0002). This variation in fasting insulin concentration indicates that the 
obesogenic environment in utero has an impact on insulin resistance. The early changes are reflected first in 
insulin whilst the glucose levels stay normal, O/N group differed in insulin but this may be insignificant due 
to low numbers.  
In addition, the two HOMA indices followed the same trend as fasting insulin, with offspring of O/O 
mothers having higher levels than offspring of N/O (PHOMA-IR=0.0001 and PHOMA-B=0.0001 
respectively) and N/N mothers (PHOMA-IR=0.0005 and PHOMA-B=0.0007 respectively), confirming the 
findings of serum insulin concentrations and suggesting that the maternal nutritional status during pregnancy 
‘programs’ insulin resistance and β-cell alteration in offspring.  
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Table 9: Influence of the pre- and post-natal obesogenic environment on the glucose-insulin axis in adolescent males and females 
Outcome variables N / N  N / O O / N  O / O  Global 
ANOVA 
N/N vs. O/O N/O vs. O/O 
  Mean (95% CI) Mean (95% CI) Mean (95% CI) Mean (95% CI) P P P 
Males                
Fasting glucose (mmol/L) 5.1 (5.1, 5.1) 5.1 (5.1, 5.2) 5.1 (5.1, 5.2) 5.1 (5.1, 5.2) 0.8970 1 1 
Fasting insulin (mmol/L) 9.9 (9.5, 10.3) 9.9 (9.3, 10.5) 11.3 (8.5, 14.1) 12.0 (11.2, 12.8) 0.0015 0.0002 0.0007 
HOMA-IR index 1.3 (1.2, 1.3) 1.3 (1.2, 1.3) 1.5 (1.1, 1.8) 1.6 (1.5, 1.7) 0.0012 0.0001 0.0005 
HOMA-B index 99.3 (96.4, 102.1) 99.7 (95.7, 103.7) 112.4 (94.4, 130.4) 113.5 (109.0, 120.1) 0.0006 <0.0001 0.0007 
Females                
Fasting glucose (mmol/L) 4.9 (4., 5.0) 5 (4.9, 5.1) 4.7 (4,1, 5.3) 4.9 (4.7, 5.0) 0.4285 1 0.6300 
Fasting insulin (mmol/L) 10 (9.6, 10.5) 10.5 (9.9, 11.1) 8.6 (5.4, 11.8) 11.2 (10.4, 12.0) 0.0753 0.0417 0.8300 
HOMA-IR index 1.3 (1.2, 1.4) 1.4 (1.3, 1.5) 1.1 (0.6, 1.6) 1.4 (1.3, 1.5) 0.2705 0.2998 1 
HOMA-B index 109.9 (106.9, 112.8) 113.9 (109.7, 118.1) 104.4 (82.6, 126.2) 121.7 (116.2, 127.2) 0.0006 0.0009 0.1046 
Legend: Adjusted mean and 95% confidence intervals by gestational age and tanner scale. Only statistically significant differences at P <0.05 between groups after Bonferroni correction are presented.  
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Females 
In females, the mean fasting glucose was an average of 5 mmol/L but there was no significant variability 
between groups (Panova=0.4285), indicating that fasting glucose was unaffected by the obesogenic 
environment either in utero or during childhood (Table 9). The fasting serum insulin concentrations were 
elevated in offspring of O/O mothers, with an average of 11.2 mmol/l, which was significantly higher than 
offspring of N/N mothers 10 mmol/l (P=0.0417); although, unlike in males, insulin concentrations for 
offspring of O/O mothers did not differ from that of the offspring of N/O mothers (P=0.8300). Females did 
not show a substantial change either in glucose or serum insulin concentrations and were unaffected by the 
obesogenic environment in utero.  
HOMA-IR levels were highest for offspring of O/O mothers, although there was no statistically significant 
variability between any of the groups (Panova=0.2705). The HOMA-B index was again highest in offspring 
of O/O mothers, with a significant difference between offspring of O/O mothers and N/N mothers 
(P=0.0009), but not between O/O and N/O mothers (P=0.1046), suggesting that there are other 
environmental factors that are responsible for the insulin-resistance difference in females.  
 
f) Association between obesogenic environment, adolescent lipids and blood pressure 
Males 
Fasting triglycerides (TG) concentration varied between the maternal BMI groups (Panova=0.0046) and, as 
expected, offspring of O/O mothers had the most elevated TG of the groups which significantly differed 
from offspring of N/N mothers (P=0.0036). The total cholesterol (TC) varied across groups 
(Panova=0.0008), being elevated in the offspring of N/O mothers and significantly different to the offspring 
of N/N mothers (P = 0.0088), suggesting that childhood obesogenic environment adversely affects TC levels 
in males. The overall high-density lipoprotein (HDL-C) varied between groups (Panova<0.0001), and was 
lowest in the offspring of O/O mothers and significantly different to that in the offspring of N/O mothers (P 
=0.0017), suggesting an impact via the in utero obesogenic environment. The alteration in low-density 
lipoprotein (LDL-C) concentrations was mirrored, similar to HDL-C variations, within all groups 
(Panova=0.03) but no significant differences between groups was observed. The serum apoprotein A-I 
concentrations varied significantly between groups (Panova< 0.0001) but there was no in-group differences. 
Similarly, apoprotein B concentration did not vary overall (Panova=0.07) and no significant difference 
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between the offspring of N/N, N/O, O/N and O/O mothers were observed for apoprotein A-I and B. The 
systolic blood pressure (SBP) and diastolic blood pressure (DBP) showed variability across all groups 
(Panova<0.0001 and Panova=0.0006, respectively) and were highest in the offspring of O/O mothers. 
However, none of the between-group comparisons were significant for SBP or DBP, indicating roles of 
other factors responsible for this variation which cannot be explained completely by the obesogenic 
environment (Table 10). 
Females   
The TG was similar across all groups in female offspring, with no significant variability across the groups 
(Panova=0.2521), unlike in males. The TC level was elevated in offspring of O/O mothers in comparison to 
N/N mothers, however no significant difference between O/O and N/N (P=0.7714) or for the overall groups 
(P=0.2096) was observed. Offspring of N/O mothers differed significantly in TC level from offspring of 
N/N mothers (P=0.04), which may be explained by the influence of the childhood obesogenic environment. 
The HDL-C did not show significant variability across the groups (Panova=0.0913). There was a 
statistically significant variability, although it was small magnitude-wise, in LDL concentration between all 
groups (Panova=0.0368) with N/O mothers showing significant differences between both offspring of O/O 
mothers (P=0.0295) and N/N mothers (P=0.0277), showing that the obesogenic environment in utero and 
childhood has an effect on LDL concentrations in females. The serum apoprotein (Apo) A-I did not show 
any variability between groups (Panova=0.2934) but apoprotein B concentrations vary between groups 
(Panova=0.0384), although none of the groups differed significantly from each other. Both SBP and DBP 
did not differ between groups (Panova=0.1271 and Panova=0.0677 respectively) in contrast to males, and no 
significant difference between groups was observed, indicating no effect of the obesogenic environment on 
blood pressure in female offspring in this sample (Table 10).  
Discussion 
This study was done as a part of study designed by Samuelsson et al, 2008, who aimed to look for a 
programming effect on mice and this study replicates the experimental design using human data
232
. This is 
the first study which looks at these factors in a more longitudinal way than previously published studies.  As 
it is difficult to develop a diet-induced experimental model in human, the study uses the NFBC dataset 
which is very dense and has several prenatal and postnatal data points available to test this hypothesis.  
There is increasing evidence for a trans-generational transmissibility of a risk for chronic diseases   
associated with common pre-gestational obesity. The nature of such an association between maternal 
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metabolic health during the childbearing period and the health of her offspring later in life is poorly 
understood owing to important genetic, social and behavioural contributing factors
242
. This study 
specifically intended to assess the influence of both pre-gestational and postnatal overweight and obese 
mothers and to study the potential sexual dimorphism into the response of metabolic phenotypes. It was 
previously reported that pre-pregnancy BMI in overweight women predicts their risk of obesity 20 years 
later
243
 exposing their child to an environment that may favor obesity. However the study observed that both 
the pre- and the postnatal exposure to maternal overweight may have a differential impact on an offspring’s 
BMI. The extent to which the pre-natal exposure to pre-gestational overweight carries a specific risk for the 
later development of T2D and/or CVD is yet to be identified.  
The fasting insulin, HOMA-IR, HOMA-B, triglyceride and Systolic blood pressure (SBP) differed 
significantly between offspring of mothers who remained lean (N/N) and those who were O/O throughout, 
but the difference was sex-stratified
244,245
. The mothers who were lean pre-pregnancy gained weight during 
pregnancy (N/O) and turned O/O showing an adverse profile within their adolescents. The characteristics of 
these mothers resonated with O/O mothers. 
The most important result this study shows is that, in male offspring, mothers who were lean pre-pregnancy 
but became obese in later life gained the most weight, and differed in the fasting insulin, HOMA-IR and 
HOMA-B from the O/O group
246
. This result distinctly demonstrates that it is not merely obesity which has 
a programming effect but that the weight gained during pregnancy in combination with obesogenic 
environment is the cause of this elevation.  Using the same dataset, Vaarasmaki et al, 2009, showed that 
adolescents of gestational diabetic mothers (GDM) mothers had symptoms of metabolic syndrome, with 
high WC and insulin level and homeostatic model assessment insulin sensitivity was lower in the offspring 
of women with GDM (OGDM) group
247
. Although this study has now been able to provide further evidence 
which supports that such changes not only occur in adolescents of GDM but in all O/O mothers, therefore, it 
is an indication that programming happens much earlier than the gestational stage. HDL and apoliprotein AI 
differs between N/O groups differed from O/O groups, suggesting that the characteristics of this group 
replicated very much that of O/O mothers and there is a hidden obesogenic environment which influences 
this group.
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Table 10: Influence of the pre- and post-natal obesogenic environment on cardiovascular risk factors in adolescents of the NFBC 1986 birth cohort. 
Outcome Variables N/N  N/O  O/N  O/O  Overall  
ANOVA 
 
N/N vs. O/O 
 
N/O vs. O/O 
 
N/O vs. N/N 
  Mean (95% CI) Mean (95% CI) Mean (95% CI) Mean (95% CI) P P P P 
Males                 
Triglycerides (mmol/L) 0.9 (0.8, 0.9) 0.9 (0.8, 1.0) 0.7 (0.4, 1.0) 1.0 (0.9, 1.1) 0.0046 0.0036 0.0929 1 
Total cholesterol (mmol/L) 4 (3.9, 4.1) 4.2 (4.1, 4.3) 3.7 (3.4, 4.1) 4.1 (4.0, 4.2) 0.0008 1 1 0.0088 
HDL (mmol/L) 1.3 (1.3, 1.3) 1.4 (1.3, 1.4) 1.3 (1.2, 1.5) 1.2 (1.2, 1.3) <0.0001 0.0734 0.0017 0.3350 
LDL (mmol/L) 2.4 (2.3, 2.4) 2.5 (2.4, 2.6) 2.2 (1.8, 2.5) 2.5 (2.4, 2.6) 0.0300 0.1858 1 0.0664 
Apoprotein AI (mmol/L) 1.3 (1.3, 1.3) 1.3 (1.3, 1.3) 1.2 (1.1, 1.3) 1.3 (1.2, 1.3) <0.0001 0.1489 0.0427 1 
Apoprotein B (mmol/L) 0.6 (0.6, 0.6) 0.7 (0.6, 0.7) 0.6 (0.5, 0.6) 0.7 (0.6,0.7) 0.0742 0.8817 1 0.2915 
SBP (mmHg) 119.7 (118.7, 120.7) 121 (119.6, 122.4) 120.7 (114.2, 127.1) 121.8 (119.9, 123.8) <0.0001 0.3815 1 1 
DBP (mmHg) 67.9 (67.3, 68.9) 67.9 (67.1, 68.8) 68.2 (64.1, 72.4) 68.7 (67.4, 69.9) 0.0006 1 1 1 
                  
Females                  
Triglycerides (mmol/L) 0.9 (0.8, 0.9) 0.9 (0.8, 0.9) 0.9 (0.6, 1.2) 0.9 (0.8, 0.9) 0.2521 1 1 1 
Total cholesterol (mmol/L) 4.4 (4.3, 4.5) 4.3 (4.2, 4.4) 4.2 (3.7,4.7) 4.4 (4.3, 4.5) 0.2096 1 0.7714 0.0369 
HDL (mmol/L) 1.5 (1.5, 1.5) 1.5 (1.4, 1.5) 1.5 (1.2, 1.6) 1.5 (1.4, 1.5) 0.0913 0.3283 0.3787 1 
LDL (mmol/L) 2.6 (2.5, 2.6) 2.5 (2.4, 2.5) 2.4 (1.9, 2.8) 2.6 (2.5, 2.7) 0.0368 1 0.0295 0.0277 
Apoprotein AI (mmol/L) 1.4 (1.4, 1.4) 1.4 (1.4, 1.4) 1.4 (1.3, 1.5) 1.4 (1.3, 1.4) 0.2934 1 1 1 
Apoprotein B (mmol/L) 0.7 (0.7, 0.7) 0.7 (0.6, 0.7) 0.7 (0.5, 0.7) 0.7 (0.6, 0.7) 0.0384 1 0.1419 0.0579 
SBP (mmHg) 109.1 (108.2, 110.1) 111.1 (109.7, 112.3) 109 (101.8, 116.2) 111.2 (109.4, 112.9) 0.1271 0.4808 1 0.1382 
DBP (mmHg) 66.5 (65.9, 67.1) 67.8 (66.9, 68.6) 64.7 (60.0, 69.4) 67.5 (66.4, 68.6) 0.0677 1 1 0.3096 
 Legend: Adjusted mean and 95% confidence intervals by gestational age and tanner scale. Only statistically significant differences at P <0.05 between groups after Bonferroni correction are 
presented. 
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The maternal pre-gestational obesity predisposes the offspring to a supplementary risk of being obese later 
in life. Critically onset-obesity induced by the obesogenic environment, such as diet after weaning, did not 
overcome the programmed changes induced by pre-gestational obesity. The study observed that some risk 
factors for T2D and CVD show specificity for maternal pre-gestational obesity and for sex. Suggestive 
additive effects are notably observed for fasting glucose and cholesterol. Most strikingly, for fasting insulin, 
the male offspring  showed very atypical responses and despite a greater body fat mass in O/O offspring 
compared to N/O, those male offspring with a double exposure had higher insulin sensitivity but not within 
fasting glucose.   
Whilst evidence establishing the programming of later health by maternal under-nutrition and fetal 
restriction is clear, the programming impact of fetal “overnutrition” on later health is questionable. The 
question of whether maternal gestational obesity relates to a problem of over nutrition is currently highly 
debatable and may be misleading. Our study excludes gestational diabetic individuals as they may confound 
our study results. Pre-gestational overweight mothers in human generally gained less weight than normal 
weight mothers and did give systematically gave birth to macrocosmic babies.  
The study has yet to clearly identify the metabolic impact of common pre-gestational overweight or mild 
obesity which exposed the developing offspring to a mixture of contributing factors with potential 
programming effects. Pre-gestational overweight mothers are at a high risk of developing pre-diabetic 
states
243
. The fetus is likely to be exposed to higher concentrations of insulin and growth factors compared to 
those of normal weight mothers with potential subsequent epigenetic and trophic alterations in various 
developing organs. One key issue will be to understand how this trans-generational transmissibility of 
diabetogenic and cardiovascular risks is related to changes in pancreatic, liver and cardiovascular functions. 
To our knowledge, this is the first study to demonstrate the difference between ‘programming’ due to 
maternal overweight/obesity during in utero and postnatal environment. Although the study accounts for 
wide metabolic anthropometric phenotypes and confounding factors, it was not possible to quantify for 
postnatal obesogenic environment due to lack of information on dietary and lifestyle factors from birth to 
adolescence in NFBC 1986. Although it is reasonable to assume that the mothers’ weight status may 
indicate an obesogenic environment during child’s growth; there could be other environmental factors which 
may have an effect that were not included. Therefore, further studies are required which can provide further 
information about nutritional and lifestyle status of mothers to justify such studies.  In conclusion, this study 
shows the importance of weight monitoring during pregnancy and also during developmental stages of 
offspring. 
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5.1.3.    Association of leukocyte telomere length at 31 years with adiposity-related anthropometric 
measurements at 31 years and change in BMI distribution from childhood to adulthood.  
 
5.1.3.1.    Introduction 
Studies show that accelerated leukocyte telomere length (LTL) attrition is associated with CVD factors such 
as obesity, smoking and sedentary life-style factors
248
. Evidence from epidemiological studies suggest that 
obesity linking pathways, such as systemic inflammation and oxidative stress, may also influence LTL 
length and function
249
. Most previous studies report an inconsistent association of LTL and adiposity 
measures in adulthood. An inverse association between LTL and body mass index (BMI), waist-to-hip ratio 
(WHR) and visceral fat in adults is shown  in some studies
152,154,156,160
, while others suggest no 
association
153,250
.  Studies indicate that this inverse association between adulthood LTL and adiposity 
measures may be more strongly associated in younger women (<30 years) compared to older women (>60 
years)
160
. Additionally, one study suggests that women with fluctuating body weight between 50-55 years 
251
 
may have a higher risk for shortening of LTL. 
 
More recent epidemiological studies show an association between childhood obesity with adulthood LTL
252
, 
however the number of studies investigating childhood obesity links with LTL are very limited, with results 
being equivocal
158,159,253
. Two cross-sectional studies, one in a European cohort aged 2-17 years 
253
 and 
another in Arab youth aged 5-12 years, have shown that severely obese children have a shorter mean LTL 
than those of their normal weight peers
159
. Another study suggests that this effect can only be observed in 
adults but not in children
158
. Moreover, none of the studies address the key issue, which is whether 
childhood obesity has an effect on adulthood LTL measures, given that it is an established fact that both 
child and adult adiposity-related phenotypes are associated with increased risk of age-related CVD
82,254
.  
 
In summary, there is a gap in understanding the longitudinal change in weight affecting LTL at 31 years. 
This study hypothesises that LTL at 31 years associates with childhood and adulthood adiposity measures, 
and that upward change in BMI from childhood to adulthood is inversely associated with LTL at 31 years. 
The main aim of this study was i) to understand the association between LTL at 31 years and childhood 
adiposity measures, ii) to confirm findings on LTL at 31 years association with adulthood adiposity-related 
phenotypes, and iii) to investigate association between LTL at 31 years and change in BMI from childhood 
to adulthood.  The objective of the study was to understand the relationship between LTL at 31 years with 
longitudinal variation in adiposity-related factors in childhood and adulthood. The study compared 
PhD Thesis 
 
125 
 
unadjusted and adjusted models, to investigate how these childhood and adulthood factors associated with 
LTL and if adjusting for confounders such as maternal parity and socio-economic status (SES) or 
individual’s smoking, and SES affects the association. The literature search on this topic suggested that there 
are no longitudinal studies such as this which had prospective longitudinal growth data with multiple 
measurements as well as prenatal and adult contributing or confounding factors. 
 
5.1.3.2.    Study specific methods 
Subjects and Study design 
The description of the study population, NFBC1966, is given in detail in Chapter 4, Section 1. Briefly, of the 
6,007 individuals who attended the clinical examination at 31 years n=5,753 individuals with DNA data 
were available at 31 years for the analysis in the current study (Figure 7). These individuals were combined 
with their available anthropometric data at 31 years, LTL measurements (n=5,620) and their childhood 
growth data (n=4,121). Participants who had missing LTL measurements or had missing adult BMI 
information (n=193) or less than 3 child growth measurements for growth modeling (n=190) were excluded 
from the analysis.  The study utilised three datasets for analysis to maximise sample size and for each 
analyses increase the statistical power. The first dataset was restricted to only those individuals who had had 
data available for childhood BMI at AR (5.5 years) and LTL measurements at 31 years (n=3,903). The 
second dataset consisted of those who had data available for LTL measurements and adult anthropometric 
measurements at 31 years (n=5,404). The third dataset was restricted to individuals with LTL measurements 
at 31 years and longitudinal variation in BMI (n=3,703). The selected sample was representative of the 
wider NFBC 1966 subjects and no differences between the complete dataset and incomplete dataset were 
observed when tested at P < 0.05. 
 
Variable selection and confounders 
The independent variables selected for analysis were divided into childhood (Age and BMI at adiposity 
rebound (AR)) and adulthood adiposity measures (WHR, BMI, BAI and BMI z-score difference). Several 
confounders, such as mother’s parity, socio-economic status (SES) and individual’s age at menarche, 
smoking and SES at 31years were selected based on the a priori selection method and on previous 
knowledge of the field. Details on collection of these variables from questionnaire and hospital records are 
given in Chapter 4. Measurements for childhood BMI at 5 years were limited in sample size therefore the 
study uses the BMI at adiposity rebound (AR) as a proxy for BMI at 5 years. The growth modeling method 
for age and BMI at AR is presented in Chapter 4, section 2.1. Many previous studies associated age and 
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BMI at AR with adolescent adiposity 
86
 and adulthood metabolic health 
14,255
 therefore, these parameters can 
be considered good markers for childhood obesity.   
 
The body mass index (BMI) was calculated as body weight in kilograms divided by height in meters squared 
(kg/m
2
). Waist-hip ratio (WHR) was calculated as waist circumference (cm) divided by height (cm). Body 
adiposity index (BAI) was calculated as (hip circumference (cm)/height (m))
 1.5
 -18, as described by 
Bergman et al, 2011
256
. The longitudinal variations in BMI from childhood and adulthood was calculated as 
the difference between the z-score of BMI at AR, around 5.5 years and z-score of BMI at 31 years, 
standardized to zero mean and 1 standard deviation (SD), calculated separately in males and females.   
 
The mean relative LTL was measured by Dr Jess Buxton, Imperial College as described previously
253
. In 
summary, a multiplex quantitative real-time PCR (qPCR)  method was used to measure the mean relative 
LTL in the genomic DNA samples prepared from peripheral blood
257
. The multiplex qPCR method provides 
a ‘T/S ratio’ for each DNA sample, which is the relative measure of the amplication of the telomeric DNA 
sequence (T) compared to that of a single copy of gene(S) in each test sample, normalized using a common 
reference DNA sample. The overall mean coefficient of variation (CV) for T/S values of duplicate test 
samples on the same plate was 5%, and the mean inter-run CV for selected samples was 6.2%. 
 
Statistical analyses 
The LTL measurements were selected as the main outcome.  LTL at 31 years were right skewed and hence it 
was log transformed to achieve normal distribution and to improve interpretability. Descriptive 
characteristics of the study samples are described in the overall study sample, and sex-stratified, with means 
and SD calculated for continuous variables and percentages calculated for categorical variables.  The 
Kolmogorov-Smirnov test was performed to test normal distribution of continuous variables. Pearson’s 
coefficient was then used to test for correlation between covariates; Student’s t-test for unpaired data was 
used to test the mean difference between sexes and the Chi square test for the difference in percentage 
distribution in categorical data with a Pdiff value of < 0.05 was considered statistically significant.  The linear 
regression model was used to estimate effect size of association between independent variables and the 
outcome.  
 
Two models were tested, 1) Unadjusted model, testing  association between log-transformed LTL and 
adiposity-related measurements from childhood and adulthood and 2) Adjusted model, testing association 
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between log-transformed LTL and adiposity-related measurements from childhood and adulthood 
controlling for maternal parity, SES, age at menarche (only females), SES, smoking and parity in offspring 
at 31 years. The estimated effects were reported as a percentage change in LTL by multiplying the 
exponential regression coefficients by 100. All statistical tests of hypotheses were two-sided with a 
significant association threshold of P < 0.05. The Benjamin and Hochberg method was used to address the 
issue of multiple testing, with a Pcorrected value of < 0.05 considered statistically significant
258
. 
 
5.1.3.3.    Results 
At birth measurements 
Table 11 shows the descriptive statistics for all participants, and by sex. Mother’s parity collected at birth 
was on average 3 children overall, and no difference between sexes was observed (Pdiff =0.7122). Mother’s 
socio-economic status (SES) collected at birth had similar distributions in both sexes with no significant 
difference observed (Pdiff =0.1522). 7% of children were born to mothers who were housewives, 17% 
belonged to white collar, 33% to blue collar and 43% were born to a manual worker or a farmer.   
 
Childhood measurements 
The mean age and BMI at adiposity rebound (AR) for all individuals were 5.7 years and 15.37kg/m2 in the 
sample population, however, there was a sex difference in the mean age and BMI at AR (Pdiff<0.0001 and 
Pdiff=0.0008, respectively). Males on average had 15.42 kg/m
2
 BMI at AR while females had lower BMI at 
AR, 15.33 kg/m
2 
(Pdiff =0.0008 for gender difference), and age at AR was earlier in females (5.6 years) than 
in males (5.8 years) (Pdiff <0.0001).  The BMI at AR were divided into categories according to IOTF 
guidelines for children
25
 with 5% of children being underweight, 80% normal weight, 10% overweight and 
5% were obese.  No gender difference was observed.  
 
Adulthood measurements 
The mean BMI at 31 years was, overall, 24.7 kg/m
2
, and it was observed that males had a 1.04 kg/m2 higher 
mean BMI than females (Pdiff <0.0001). Overall, 2% of individuals were classified as underweight, 58% 
normal weight, 31% overweight and 8% obese in both sexes; however adult males had a bigger proportion 
of overweight individuals than females. The mean WHR at 31 years in males (0.91) was higher than WHR 
of females (0.81) (Pdiff <0.0001), this result is consistent with previous findings showing that females have 
lower WHR than males
259
. BAI indicated a significantly higher percentage of fatness in females (28%) than 
in males (23%) (Pdiff <0.0001), this result was also consistent with another study suggesting that women 
carry more body fat than men 
260
. 
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Figure 7: Flowchart showing sample selection for the analysis from the NFBC 1966.  
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 Table 11 shows that males were more often heavy smokers (>10 cigarettes) than females (30% compared to 
12%) (Pdiff <0.0001). The SES distribution between males and females’ differed, with higher proportions of 
females being white and blue collared (Pdiff <0.0001) in comparison to men. Parity at 31 years was, on 
average, 1.26 children per individual in the overall sample and there was a significant difference between 
males and females observed (P <0.0001). Higher proportion of males (46%) than females had no children 
while females had more often 2 or more children (49%). The mean leukocyte telomere length (LTL) ratio 
was 1.12 in males and 1.17 in females, with females showing significantly longer LTL than males (Pdiff 
<0.0001). This association result also fitted with as previously suggested by Barrett et al in 2011
261
. The 
mean longitudinal variations in BMI z-score was -0.02 in males and -0.01 in females, both being within the 
normal distribution of z-score.  
 
Association between childhood adiposity measures and LTL at 31years (Table12) 
 
There was no association between age at AR with LTL at 31 years in either males (P = 0.0923) or females 
(P = 0.88) (Table 12). The adjustment for potential confounding factors did not substantially change the 
association  (Pcorrected =0.26 in males; Pcorrected =0.71 in females). BMI at AR associated positively with LTL 
at 31 years in females (P=0.0074), but not in males (P=0.79) (Table 12). After adjustments the effect size 
reduced (β=1.71%, 95% CI: (0.26% to 3.18%)) but the association remained significant even after multiple 
adjustments (Pcorrected = 0.0406). The results indicate that girls with higher BMI at AR at 5 years have longer 
LTL at 31 years. In males, no association was observed even after adjustments for potential confounding 
factors (Pcorrected = 0.68). 
 
Association between adulthood adiposity-related phenotypes and LTL at age 31 
 
The unadjusted model showed that LTL at 31 years associated with lower WHR at 31 years in both sexes (P 
= 0.0138 in males, P=0.0003 in females), demonstrated consistently in other studies
153,251
. However, after 
adjustments with confounders, the association remained significant in both males (Pcorrected =0.0490) and 
females (Pcorrected =0.0078), suggesting the independent (of accounted factors) association between LTL and 
WHR at 31 years. BMI also showed a negative association with LTL in males (P=0.0017) and females 
(P=0.0048), with the association being stronger in males. Adjustments for confounders reduced the strength 
of association in males (Pcorrected =0.0246), but no difference for females was observed (Pcorrected =0.0286).  
The percentage of fatness measured by BAI at age 31, was also inversely 
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Table 11: Descriptive characteristics of study participants in Northern Finland Birth Cohort (NFBC 
1966).  
  All    Males    Females      
  N Mean  N Mean  N Mean  Pdiff 
At birth                  
Maternal parity 5462 2.95 (2.28)  2639 2.93(2.29)  2823 2.97(2.26)  0.7122 
No previous pregnancy (%) 136 2  70 3  66 2    
1 previous pregnancy (%) 1731 31  843 31  888 31    
2 or more previous pregnancies (%) 3731 67  1796 66  1935 67    
Socio-economic status at birth 5438    2626    2812    0.1522 
Stay at home (%) 373 7  194 7  179 6    
White collar (%) 903 17  457 17  446 16    
Blue collar (%) 1812 33  865 33  947 34    
Farmer (%) 2350 43  1110 42  1240 44    
Childhood (5y)                  
Age at Adiposity Rebound (AR) (years) 3903 5.71(0.92)  1971 5.81(0.89)  1932 5.61(0.95)   <0.0001 
BMI at Adiposity Rebound (AR) (Kg/m2) 3903 15.37(1.07)  1971 15.42(1.00)  1932 15.31(1.13)  0.0008 
Underweight (%) 193 5  98 5  95 5    
Normal (%) 3138 80  1581 80  1557 80    
Overweight (%) 392 10  197 10  195 10    
Obese (%) 198 5  99 5  99 5    
Adulthood (31y)                  
Age at menarche (years) 2851         2851 12.92    
Waist-Hip Ratio (WHR) 5398 0.86 (0.08)  2679 0.91(0.06)  2719 0.81(0.07)  <0.0001 
Body mass index (BMI) (kg/m2) 5404 24.70(4.24)  2662 25.23(3.63)  2742 24.19(4.69)  <0.0001 
Underweight (%) 117 2   28 1   89 3     
Normal (%) 3069 58   1309 50   1760 65     
Overweight (%) 1647 31   1049 40   598 22     
Obese (%) 486 9   223 9   263 10     
Body adiposity index (BAI) (% fatness) 5277 25.60(4.58)  2615 23.01(2.90)  2662 28.15(4.50)  <0.0001 
Adult Smoking (distribution among smokers) 5252    2528    2724    <0.0001 
Light (%)   4174 79  1775 70  2399 88    
Heavy (%) 1078 21  753 30  325 12    
Socio-economic status 5534    2669    2865    <0.0001 
Farmer (%) 208 4  130 5  78 3    
Self-employed (%) 1312 24  731 27  581 20    
White collar (%) 3128 57  1441 54  1687 59    
Blue collar (%) 886 16.00  367 14.00  519 18.00    
Parity at 31years 5502 1.26 (1.29)  2646 1.03 (1.21)  2856 1.47(1.33)  <0.0001 
No previous child (%) 2184 39  1297 47  887 30    
1 previous child (%) 1117 20  506 19  611 21    
2 or more previous children (%) 2297 41  906 34  1391 49    
Leukocyte Telomere Length (LTL) 5598 1.14 (1.40)  2709 1.12(1.40)  2889 1.71(1.41)  <0.0001 
Longitudinal BMI difference (5 to 31 year) # 3683    1896 -0.02  1787 -0.01    
Sample sizes and means (standard deviation (SD)) are given for all continuous variables and sample sizes and category percentage are given for 
categorical variables.  
AR, adiposity rebound; LTL, leukocyte telomere length. BMI, body mass index - calculated as weight (kg)/ height (m)2. BAI, body adiposity 
index (% fat) - calculated as hip circumference (m) / height(m)1.5 – 18.  
Student’s t-test was performed for calculating gender differences, Pdiff.
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associated with LTL at 31 years in females (P=0.004) but not in males (P=0.16). Every 1 unit increase in % 
fatness, the LTL decreased by 0.48 % in females although after adjustment the association attenuated but 
remained significant (Pcorrected =0.02). 
 
Association between increase in BMI from childhood to adulthood and LTL at 31  
The longitudinal change in BMI z-score from 5 years to 31 years was inversely associated with LTL at 31 
years in females (P=0.0004) but not in males (P=0.2381). One unit increase in BMI z-score associated with 
about 3.08% decrease in LTL at 31 years in females, which strengthened to about a 4.7% decrease in LTL at 
31 years after adjustments with confounding factors, suggesting independent association in females (Pcorrected 
=0.0078). In males, the association between LTL at 31 years and BMI z-score did not change even after 
adjustments for confounder (Pcorrected =0.2681).   
 
5.1.3.4.    Discussion 
LTL has been proposed as a biomarker for risk of disease development in later life
262
, although this evidence 
is still debatable. However, as shown by reviews on telomere length and CVD risks factors, not many 
studies have shown consistent results regarding LTL association with CVD disease risk factors
262
, while 
most are underpowered. This is the first study to present such large samples for LTL measurements and it is 
unique as it uses growth modeling phenotypes to investigate the relationship between childhood adiposity-
related phenotypes and LTL in adulthood. The advantage of growth modeling has been discussed in detail 
previously. 
 
The major strengths of this study include: the uniform age and ethnicity of the participants, the even sex 
ratio and the consistency of the method used to obtain LTL data for a large number of samples. Although 
doubts have been expressed over the reliability of the qPCR method 
263,264
, the telomere measurements used 
here show the expected sex difference, and have previously been used in the identification of robust genetic 
associations for LTL 
265
.  
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Table 12. The unadjusted and adjusted associations between leukocyte telomere length (LTL) at 31 years and early life/adult adiposity related 
measures by sex. The beta (95% confidence interval) is given as percentage difference. The P < 0.05 is considered significant.   
 Unadjusted model  Adjusted model
d
 
  % difference 95 % CI P  % difference 95 % CI PAdjusted Pcorrected 
MEN            
Childhood (~5 years)            
Age at AR 1.47 -0.24 3.20 0.0923  1.22 -0.57 3.05 0.1836 0.2681 
BMI at AR 0.21 -1.28 1.73 0.7853  0.40 -1.20 2.02 0.6252 0.6820 
Adulthood (31 years)            
Waist-hip ratio (WHR) -0.44 -0.79 -0.09 0.0138  -0.42 -0.79 -0.04 0.0286 0.0490 
BMI (Kg/m2) -29.51 -43.31 -12.35 0.0017  -26.86 -41.97 -7.80 0.0082 0.0246 
Body adiposity index (BAI), % fatness -0.25 -0.76 0.13 0.1640  -0.29 -0.76 0.18 0.2234 0.2681 
BMI trajectory z-score -0.98 -2.58 0.65 0.2381  -1.08 -2.78 0.64 0.2179 0.2681 
           
WOMEN            
Childhood (~5 years)            
age at AR -0.12 -1.69 1.48 0.8818  -0.33 -2.07 1.44 0.7123 0.7123 
BMI at AR 1.84 0.49 3.21 0.0074  1.71 0.26 3.18 0.0203 0.0406 
Adulthood (31 years)            
Waist-hip ratio (WHR) -0.51 -0.78 -0.23 0.0003  -0.50 -0.79 -0.21 0.0008 0.0078 
BMI (Kg/m2) -23.04 -35.82 -7.71 0.0048  -22.03 -35.76 -5.37 0.0119 0.0286 
Body adiposity index (BAI), % fatness -0.48 -0.71 -0.14 0.0035  -0.44 -0.74 -0.13 0.0053 0.0212 
BMI increase z-score (5-31y) -3.08 -4.74 -1.40 0.0004  -2.91 -4.65 -1.15 0.0013 0.0078 
AR, adiposity rebound 
BMI, body mass index, calculated as weight (kg)/height(m)2. 
BAI, body adiposity index, calculated as hip circumference (m)/height (m)1.5 -18.  
BMI trajectories z-score were calculated from a difference between z-scores of BMI at AR and BMI at 31 years. 
dLinear regression model adjusted for maternal parity, SES at birth, SES at 31 years, smoking at 31 years, SES at 31 years, parity at 31 years and qPCR plate. Additionally, in females the model was also adjusted 
for age at menarche in addition to other confounding factors (given above).  
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The study shows that anthropometric measures from early childhood to adulthood associate with a shorter 
mean relative LTL in women at age 31, regardless of confounding factors. This study also confirms the 
inverse association of adulthood adiposity measures such as BMI and WHR at 31 years with concurrent LTL 
in both adult men and women. The BAI was also inversely associated with LTL at 31 years but only in 
females, which remained associated after adjustment for confounders. There was a clear indication that these 
adiposity-related measures showed stronger association in female than males.  
 
The inverse association between BMI, BAI and LTL at 31 years was consistent with several previous reports 
of an inverse relationship between measures of adiposity and concurrent telomere length
160,252,264,266
. The 
BAI is a new method for measuring body fat, although it remains inconclusive if this measure is a better 
indicator of adiposity than BMI
256,267
.  However, results from this study show that females may have a 
disproportionate fat distribution which could be linked with shortening of LTL, and is a marker for higher 
risk of CVD than in men
268
. Further work needs to be conducted to completely understand these findings. 
The study also identified a significant inverse association between WHR and LTL in adult males and 
females, which were consistent with a previous study that found WHR to be a significant predictor of a 
faster telomere shortening rate in a largely male cohort (>80%) 
153
. The results from this study suggest that 
both males and females with higher adiposity-related factors eventually drive themselves towards earlier 
aging and a greater risk for CVD.  
 
There was no evidence for an association between age at adiposity rebound (AR) and LTL at age 31 in 
either sex in this cohort, despite previous studies showing that earlier age at AR predicts poor metabolic 
health in adulthood 
255
. Interestingly, the study identified a positive association between BMI at AR and 
adult telomere length in women, which remained significant after correcting for maternal parity and SES at 
birth, age at menarche, adult SES, smoking status and parity at 31 years. It was evident that only a small 
proportion of children were overweight (10%) and obese (5%) in the NFBC1966 compared to normal group 
(80%), suggesting that being within a normal range of BMI may be beneficial for telomere length in 
adulthood. These results need further work to detangle the causal mechanisms behind this positive 
association between BMI at AR and LTL measurements.   
 
The main finding of this study was that a greater increase in a standardised BMI in women spanning from 
childhood to adulthood is associated with shorter telomeres at age 31. This result supports a previously 
published report showing that maintaining a healthy body weight helps maintain the LTL in women
251
. 
However, this study adds to this knowledge and suggests that women who maintain their longitudinal 
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variation of body weight from childhood (5 years) to adulthood (31 years) are in lower risk groups compared 
to women with fluctuating body weight.      
 
However, one of the limitations of the study was that as DNA samples were available for only one time-
point, it was not possible to study the association between longitudinal changes in BMI and telomere 
shortening rate over the same period. I was also unable to study the potential effects of interim changes in 
BMI between childhood and adulthood, and thus the influence of fluctuating adiposity levels during this 
time. Finally, it would have been interesting to investigate the effects of underweight (BMI < 18.5) on LTL, 
but I did not have sufficient numbers of such individuals available in this cohort.  
 
Despite these limitations, the study adds to the growing evidence supporting the hypothesis that factors 
associated with obesity may have similar effects on lifespan and cellular function to aging 
269
. Specifically, 
the results suggest that high levels of overall body fat in women and central adiposity in men are associated 
with accelerated ageing at the cellular level. The biological mechanisms that may underlie associations 
between LTL and increased BMI are currently unknown, although obesity is recognized as a state of both 
increased oxidative stress and low-grade inflammation; both processes that are believed to accelerate 
leukocyte telomere attrition 
264,270,271
.  
 
The findings from this study only provide an indication towards identification of risk factors. Further 
investigation should be carried out into the potential role of telomere length as a biomarker to assess the 
effectiveness of interventions to combat obesity, such as maintain healthy weight. Longitudinal studies are 
now required to further assess the long-term effects of weight gain after childhood on LTL, healthy aging 
and cardio-metabolic disease risk and to investigate the sex differences observed here.
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5. 2    Genome-wide association analyses 
This section presents results from genome-wide association studies (GWAS) conducted on infant head 
circumference (HC) and early growth phenotypes of peak height and weight velocities (PHV, PWV) during the 
first year of life, BMI at adiposity peak (AP) in infancy, and BMI and age at adiposity rebound (AR) in 
childhood. NFBC (1966 and 1986) results were incorporated into meta-analyses combining several GWAS from 
the early growth and genetics (EGG) consortium. The first section (5.2.1) describes the GWAS conducted on 
infant HC in the NFBCs (1966 and 1986). This EGG project was led by a team from Erasmus Medical College, 
The Netherlands (Dr. Taal as the lead analyst and myself as joint first author) and published in Nature 
Genetics
176
. Section 5.2.2 presents the GWAS conducted on early growth phenotypes in the NFBCs (1966 and 
1986). This EGG project was led by a team from Imperial College, London, UK (with myself as lead analyst) 
and a manuscript on the work has been submitted to Nature Communications. Details of my role in both studies 
are described in sections 5.2.1 and 5.2.2.   
5.2.1.    Genome-wide association study to find genetic variants affecting infant head circumference (HC)  
5.2.1.1    Introduction 
 
Most human brain development occurs in the first two years of life. It is thought that brain growth increases the 
pressure on the cranium, leading to growth of the skull and an increase in head circumference (HC).  This 
makes HC an indirect measure for the development of the brain
272
. Previous studies associated measurements of 
HC with intrauterine growth restriction (IUGR) in newborns
273
, linking HC to smaller birth weight
274
, 
cognitive
275
 and behavioral development
276
. Galton (1869) was the first to propose the association between HC 
and general mental ability (GMA)
277
, suggesting that head size could be an important factor in the relationship 
between intelligence and learning.  Further studies confirmed a strong positive correlation between HC and both 
brain volume and intelligence 
276,278-280
, although one study did not
281
. Among these studies, the most reliable 
findings may be from the within-family study 
279
 because it controls for most confounders, such as social class, 
parenting style, and general nutrition, giving a more accurate estimate of the relationship. Studies have also 
associated HC with mother’s education282, socio-economic status, and other variables known to be associated 
with variations in intellectual ability
283
.  
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HC is a complex trait with high estimated heritability (0.78 > R
2 
> 0.98), based on Smit et al, 2010
284
, which 
investigated Dutch and Australian twin families.  Based on current evidence and knowledge of 
neurodevelopment it is likely that both genetic and environmental factors affect brain development and also 
head size
285
. Several rare genetic mutations have been identified for HC, which has been linked to diseases, 
such as, microcephaly, autism and intelligence disability
286,287
.  None of these studies have investigated normal 
variation in HC.  
 
The aim of the present study is to identify common genetic variants that influence the population variation in 
infant HC and test if infant height mediates the association between any identified genetic variants and infant 
HC. The objective is to provide further insight into the molecular mechanisms that may be responsible for brain 
development. The hypotheses tested are: (1) there are genetic variants that determine HC at birth and in infancy, 
and (2) the associations between genetic variants and infant HC may have an indirect effect via infant height.  
The overall project was led by the team from Erasmus Medical College, The Netherlands (Dr. Taal as a main 
analyst). I was responsible for analysing data from the NFBC1966 and NFBC1986. My role in this study was to 
conduct 1) a discovery stage GWAS on NFBC1966 data, and 2) perform follow-up association analyses of the 
leading SNPs in the NFBC1986. I also conducted a mediation analysis in the NFBCs (1966 and 1986) as part of 
the project. In this chapter, I explain the discovery and replication stages and finally the combined analysis of 
all 13 participating cohorts. The mediation meta-analysis performed on the NFBCs (1966 and 1986) and 10 
other cohorts are also described. This chapter covers the topics directly relevant to this thesis and presents 
overall results which involved my participation.  
The Nature Genetics publication 
288
 includes further details, such as association analyses between genetic 
variants and both fetal head circumference and intra-cranial volume, however these have not been included in 
this chapter since the NFBC1966 and NFBC1986 did not contribute to those analyses. Further details on these 
association analyses can be found in Taal et al, 2010
288
. On the initiation of the study it was agreed that this 
EGG-consortium related work, where I and the Imperial College London team had a substantial role, would 
form part of my thesis (the NFBC data represented about 1/3 of the whole study population and 40% of the 
discovery sample).   
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Figure 8: Study design showing the analyses performed for GWAS on head circumference (HC). The 
boxes highlighted represent the analyses performed for the NFBCs (1966 and 1986).  
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5.2.1.2.    Study specific materials and methods 
The genotyping details of the NFBCs (1966 and 1986) and other cohorts have been described in detail in 
Chapter 4, section 4. In summary, with birth and infant head circumference (HC) the primary outcome was 
transformed into sex and age-adjusted standard deviation scores (SDS) using Growth Analyser software 
(https://www.growthanalyser.org/; Dutch Growth Research Foundation, Rotterdam, The Netherlands), which 
used reference growth curves from the Netherlands, 1997.  These sex and age-adjusted SDs were calculated, as 
the relationship between head circumference and age during infancy is non-linear, and the variance increases by 
age.  
As a general strategy, HC closest to 18 months (range 6-30 months) was selected for analysis if the cohort had 
multiple measurements. In the NFBCs (1966 and 1986), the closest measurements were available at 12 months. 
One child of multiple birth (first alive born) and premature subjects (NFBC 1966, N=358; NFBC 1986, N=496) 
(born before 37 weeks of gestation) were also included in the study to increase the sample size. Non-caucasians 
were excluded from the study.  
Statistical analysis 
Figure 8 shows all the analyses performed for the study, with boxes highlighted in red representing those 
performed in the NFBCs (1966 and 1986). In summary, approximately 2.5 million directly genotyped and 
imputed SNPs from infants of European descent from seven discovery GWA studies (N=10,768) were meta-
analysed (4, 287 subjects from NFBC1966). The associations were validated in six replication cohorts (N=8,321 
of whom 2,533 from NFBC1986). The final meta-analyses were performed by inverse-variance method 
(N=19,089).  
As shown in Figure 8, further analyses were performed to verify that the association between SNPs and infant 
HC were not confounded by other covariates which have previously associated to HC. Therefore, covariates 
such as height (cm), weight (kg) and age at measurement (years), breastfeeding (months), maternal educational 
level and sex were associated separately with HC and genetic variants, where data were available, using linear 
or logistic regression models.   
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Taal et al, 2010, also conducted the analyses for the association of the previously identified 180 adult height 
loci, published in Allen et al, 2010
289
 and HC in infancy, using a linear regression model on discovery meta-
analysis results. Results of P-value lower than 2.8 x 10
-4
 (0.05/180) was considered significant (Bonferroni 
correction). 
To investigate possible mediation effects of the genetic variants on HC through height, the study conducted 
linear regression analysis with, and without, adjustment for the height SD score. The mediation framework 
(seemingly unrelated regression analysis (STATA)
290
or a simple pathway analysis (MPLUS)
290
) using an 
additive model was performed to assess the direct and indirect SNP effects (mediated through height) on HC for 
each of the identified genetic variant using univariate  and multiple linear regression models. Furthermore, to 
test whether the associations between the SNPs and infant HC were similar in males and females, the analyses 
were repeated by sex. Where possible, the results were meta-analyzed to assess overall evidence of association. 
5.2.1.3    Results 
 
Study sample  
Table 13 shows the selected characteristics of study samples in infant HC GWAS; and results from discovery 
and replication analyses by the studies and overall. A more detailed table describing the cohorts, genotyping 
information and quality control cut-offs applied by each study is presented in the supplementary information of 
the published paper288. The range of age for individuals in participating cohorts varies from 11.8 to 18.1 months. 
All subjects were of European descent.  
 
Summary of overall discovery stage meta-analyses 
Overall, the discovery stage meta-analyses were performed on ~ 2.5 million directly-genotyped and imputed 
SNPs (Table 13). From the meta-analyses of seven studies (ALSPAC, CHOP, COPSAC, LISA (D), NFBC 1966 
and RAINE), top-three lead SNPs at P < 1.5 x 10-6 were selected for follow-up (Appendix Table 1). Two loci 
were on chromosome 12 and one on chromosome 17 (Appendix Table 2). Nine other loci associated with 
infant HC at P < 1 x 10-5 but were not taken forward for replication (Appendix Table 3).
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Table 13: Summary results for top-three loci associated with head circumference (HC) for each participating cohort. For each of the 13 
cohorts, the median age, total N, percentage of male, minor allele frequency (MAF), effect size (and SE), and P-value are shown as well as 
the latter for overall discovery stage, replication stage and meta-analysis results.  
Study Type Study Year(s) of 
birth 
Median 
age 
(months) 
Total N % male SBNO1 (rs7980687) nearest gene HMGA2 (rs1042725) near gene CRHR1/MAPT (rs11655470) 
      MAF Β 
(SD 
score) 
SE P-value MAF Β 
(SD 
score) 
SE P-value MAF Β 
(SD 
score) 
SE P-value 
Discovery ALSPAC(D) 1991-2 18.9         1,748  53 0.19 0.105 0.038 6x10-3 0.47 -0.071 0.031 0.02 0.41 0.114 0.031 3x10-4 
 CHOP 2006-10 18.5          1,008  59 0.20 0.041 0.058 0.48 0.48 -0.017 0.046 0.72 0.39 0.036 0.048 0.45 
 COPSAC 1998-2001 18.1             369  49 0.19 0.083 0.086 0.33 0.47 -0.026 0.065 0.69 0.42 0.159 0.063 0.01 
 Generation R 2002-6 13.1         2,240  52 0.21 0.064 0.031 0.04 0.49 -0.059 0.026 0.02 0.39 0.060 0.026 0.02 
 LISA(D) 1998-9 11.8             357  56 0.21 -0.045 0.077 0.56 0.48 -0.059 0.060 0.33 0.49 0.068 0.061 0.26 
 NFBC 1966 1966 12.3         4,287  49 0.20 0.181 0.041 1x10-5 0.49 -0.074 0.033 0.02 0.41 0.068 0.033 0.04 
 RAINE 1989-91 13.1             759  53 0.19 0.108 0.058 0.06 0.50 -0.179 0.043 4x10-5  -0.001 0.044 0.09 
Discovery meta-analysis          10,768    0.091 0.018 3.3x10-7  -0.072 0.014 6.6x10-7  0.070 0.015 1.4x10-6 
 ALSPAC 1991-2 18.9          3,163  51 0.20 0.042 0.030 0.16 0.49 -0.088 0.024 3x10-4 0.40 0.044 0.024 6x10-4 
 DNBC 1996-2002 12.1              
531  
54 0.20 0.120 0.070 0.09 0.45 -0.049 0.058 0.40 0.45 0.060 0.058 0.30 
Replication EFSOCH 2000-4 12.1             703  52 0.20 0.054 0.061 0.37 0.50 -0.019 0.046 0.67 0.41 0.027 0.046 0.56 
 INMA 2004-7 13.9             693  53 0.16 0.020 0.062 0.75 0.44 -0.029 0.045 0.52 0.36 0.022 0.046 0.64 
 GINI + LISA 1995-9 11.8             698  51 0.21 0.020 0.060 0.74 0.50 -0.092 0.049 0.06 0.40 -0.070 0.050 0.16 
 NFBC 1986 1985-6 12.0         2,533  48 0.22 0.082 0.035 0.02 0.49 -0.034 0.029 0.25 0.50 0.019 0.287 0.51 
Replication meta-analysis             8,321    0.055 0.018 2.5x10-3  -0.058 0.015 8.3x10-5  0.025 0.015 0.093 
Overall meta-analysis          19,089    0.074 0.013 8.1x10-9  -0.065 0.010 2.8x10-10  0.048 0.010 3.6x10-6 
MAF; Minor allele frequency, SE; standard error; β  is the difference in head circumference SD score per minor allele (additive model).  
P-value is obtained from linear regression of the SNP against infant head circumference (HC) SD score (additive model). All study samples were of European descent.  
Key to study names: ALSPAC (D), Avon Longitudinal Study of Parents and Children Discovery subset; CHOP, Children’s Hospital Of Philadelphia; COPSAC, Copenhagen Prospective Study on 
Asthma in Childhood; Generation R, the Generation R Study; LISA (D), Lifestyle – Immune System – Allergy Discovery subset; NFBC1966, Northern Finland Birth Cohort 1966; RAINE, The 
Western Australian Pregnancy Study; ALSPAC (R), Avon Longitudinal Study of Parents and Children Replication subset; DNBC, Danish National Birth Cohort; EFSOCH, Exeter Family Study Of 
Childhood Health; INMA, INfancia y Medio Ambiente [Environment and Childhood] Project; GINI+LISA (R), German Infant Study on the influence of Nutrition Intervention Munich + Lifestyle – 
Immune System – Allergy Replication subset; NFBC1986, Northern Finland Birth Cohort 1986.
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Table 14: Combined analyses of the top-three SNPs associating with head circumference (HC) with other phenotypes.   
Marker Nearest 
gene 
Head circumference in third trimester 
of pregnancy (SD score) 
Head circumference at birth (SD score) Intra cranial volume (ml)
a
 
    Total 
N  
Beta Se P-value Total N Beta Se P-value Total 
N 
Mean age at 
measurement 
(years) 
Beta Se P-value 
rs7980687_A SBNO1 3,781 0.089 0.029 1.9x10
-3
 17,330 0.05 0.012 5.2x10
-5
 8,175 67.5 0.72 2.03 0.72 
rs1042725_T HBGA2 3,781 -0.075 0.023 9.9x10
-4
 17,074 -0.031 0.1 1.9x10
-3
 8,175 67.5 -7.18 1.61 8.8x10
-6
 
rs11655470_T CRHR1 3,781 0.049 0.024 0.037 17,695 0.03 0.1 2.0x10
-3
 8,175 67.5 3.54 1.69 .036
#
 
MAF; minor allele frequency, Se; standard error, Β is the difference in head circumference SD score per minor allele. P value is obtained from linear regression:  the SNP and sex against the head 
circumference SD score in fetal life (additive model); SNP, sex and gestational age against birth head circumference SD score at birth (additive model); and SNP, age and sex against intracranial 
volume291 (additive model). All study samples were of European descent.  
aThe intra cranial volume additive model were run using data from Ikram et al, 2012291.  
# A variant further downstream (rs9915547; r2=0.22 with HapMap CEU) showed association at genome-wide significance (P=1.5 x 10-12) with adult intracranial volume291. 
 
Table 15: Association of top-three head circumference SNPs with infant height and weight. Of the total of 13 study cohorts, 12 study cohorts 
contributed to these analyses since data on infant height and weight were not available in one cohort.  
Index SNP Location Nearest gene Association between SNPs and infant height (SD 
score) 
 Association between SNPs and infant weight (SD 
score) 
N in the meta-
analysis 
Effect size (95% CI) P value  N in the meta-
analysis 
Effect size (95% CI) P value 
rs7980687 12q14.31 SBNO1 16,664 0.034 (0.009, 0.059) 7.3 x 10
-3
   16,532 0.038(0.013, 0.064) 3.3 x 10
-3
 
rs1042725 12q15 HBGA2 16,557 -0.042 (-0.063, -0.020) 1.5 x 10
-4
   16,457 -0.038(-0.059, -0.018) 2.9x 10
-4
 
rs11655470 17q21.1 CRHR1 16,512 -0.009(-0.030, 0.012) 0.38   16,392 0.005(-0.016, 0.025) 0.67 
95% CI; 95% Confidence interval. Effect estimates reflect the difference in head circumference SD score per minor allele.  
# The P value is obtained from a linear regression of the SNP against the head circumference SD score (additive model).  
## The P value is obtained from a linear regression of the SNP + the current height SD score against the head circumference SD score (additive model).  
All study samples were of European descent. Of the total of 13 study cohorts, 12 study cohorts contributed to these analyses since data on height and weight were not available in the CHOP 
(Children’s Hospital Of Philadelphia) study
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Figure 9 shows the Manhattan plot for the association at overall discovery stage. The locus at SNP rs7980687 
on chromosome 12 located in protein strawberry notch homo log 1 gene (SBNO1, P=3.3 x 10
-7
), associated with 
higher HC by 0.09 SDS per A allele (Table 13). The locus at SNP rs1042725 on chromosome 12 near high 
mobility group AT-hook 2 gene (HMGA2, P=6.6x10-7) associated with a decrease in HC by 0.07 SDS per T 
allele of the SNP. Finally, locus at SNP rs11655470 at chromosome 17 near corticotropin releasing hormone 
receptor1 gene (CRHR1, P=1.4x 10-6) associated with higher HC by 0.07 SDS per T allele of SNP (Table 13). 
Genomic control correction was applied to adjust for population stratification within each cohort (lambda value 
ranging from 1.007-1.054).  
Summary of overall replication stage meta-analyses 
The three top-SNPs or closely related proxy (HapMap R
2
), selected from discovery meta-analysis, were 
followed up in infants from six independent (ALSPAC, DNBC, EFSOCH, INMA, GINI + LISA, NFBC 1986) 
replication samples of European descent (N=8,321). The genetic data was generated either via direct genotyping 
of these top SNP or computed from in silico genome-wide data, as presented in published work
288
. The results 
at chromosome 12, for rs7980687 (P=0.003) and rs1042725 (P=8.1 x 10
-5
), gave consistent association, 
however SNP rs11655470 only had marginal evidence of association in the replication sample (P=0.09).  
Combined results  
Results from overall discovery and replication were combined, using inverse variance fixed effect meta-
analysis.  The combined results from discovery and replication samples (N=19,089), showed that SNPs at the 
rs7980687 (P=8.1 x 10
-9
) and rs1042725 (P=2.8x 10
-10
) associated with infant head circumference (HC) at 
genome-wide significance. SNP rs11655470 did not reach the genome-wide significance but  
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Table 16: Association of top-three SNP associating with head circumference (HC) at infancy, before and after adjustment for infant 
height.12 cohorts out of 13 contributed to these analyses.  
Index SNP Nearest gene Model 1. Association between SNP and head 
circumference (SD score) 
  Model 2. Association between SNP and head 
circumference (SD score) adjusted for infant height 
N in the 
meta-
analysis 
Effect size (95% CI) P value   N in the 
meta-
analysis 
Effect size (95% CI) P value 
rs7980687 SBNO1 16,664 0.065 (0.042, 0.088) 3.8 x10
-8
   16,664 0.057(0.035, 0.080) 3.8 x 10
-7
 
rs1042725  HBGA2 16,557 -0.063 (-0.082, -0.045) 3.5 x 10
-11
   16,557 -0.048(-0.066, -0.030) 1.3 x 10
-7
 
rs11655470 CRHR1 16,512 0.045 (0.026, 0.064) 3.6 x 10
-6
   16,512 0.048(0.030, 0.066) 1.4 x 10
-7
 
95% CI; 95% Confidence interval. Effect estimates reflect the difference in head circumference SD score per minor allele. 
# The P value is obtained from a linear regression of the SNP against the head circumference SD score (additive model). 
## The P value is obtained from a linear regression of the SNP + the current height SD score against the head circumference SD score (additive model). 
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showed suggestive association (P=3.8 x10
-6
). Each A allele of rs7980687 in SBNO1 was associated with a 0.07 
SD larger head circumference (95% CI: 0.049, 0.099); P=8.1 x 10
-9
) and each T allele of rs1042725 near 
HMGA2 with a 0.065 SD smaller head circumference (95% CI: -0.085, -0.045; P=2.8x 10
-10
). In terms of raw 
values, these alleles changed HC by around 1.2 mm and 1.0 mm per allele, respectively. The T allele of 
rs1165540 near CRHR1 did not reach genome-wide significance in the combined analysis, but was associated 
with 0.05 SD larger head circumference (95% CI: 0.028, 0.068, P=3.8 x10
-6
). A low heterogeneity was 
observed between the studies for all three SNPs (P>0.1, I2=5-33%).  
The associations between the top three SNPs and infant height and weight were also tested (Table 16). The 
signals in SBNO1 (P= 7.3 x 10
-3
) and near HMGA2 (P=1.5 x 10
-4
), associated with infant height (but not 
weight), were collected at the same time as the HC measurements. The variant near CRHR1 (P= 0.38) did not 
associate with infant height or weight.   
Association of adult height associated polymorphisms with head circumference 
The top two SNPs associated with head circumference (HC), rs7980687 in SBNO, rs1042725 near HMGA2, 
have also been associated with adult height289; therefore the study investigated the association between 180 
previously associated adult height variants with HC. The effect size estimates for the association between the 
SNP at HMGA2 and infant HC (0.065 SD, P= 2.8x10-10) were similar to that of adult height (0.060 SD, P= 
9.0x10-6) however the effect size between the SNP at SBNO1 was stronger for HC (0.074 SD, P= 8.1x10-9) than 
for adult height (0.035 SD, P= 5.9x10-6). Besides the SNPs at SBNO1 and HMGA2, 23 other height associated 
SNPs were nominally associated with HC in infancy. After applying the Bonferroni correction for multiple 
testing, tested at P < 2.8 x 10-4 for significance, besides SBNO1 and HMGA2, three signals at ZNFX1 (P=6.1 x 
10-6), OR2J3 (P=1.8 x 10-5) and ZBTB38 (P=1.8 x 10-4) showed significant association (Table 17).  
 
Mediation analysis  
To examine the role of mediation by infant height in the relationship between three top SNPs and HC, the direct 
and indirect (via height) SNP and HC associations were tested using a mediation analysis framework 
(seemingly unrelated regression analysis (STATA)
290
 or a simple pathway analysis (MPLUS)
290
) (Figure 10).  
Twelve studies out of 13 participated in the analyses; as one cohort (CHOP) did not have height measurements. 
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The adjustment for height reduced the strength of the effect size between HC and two of the three SNPs, 
suggesting that height may be mediating this relationship (Table 18). For example, the effect size for SNP 
rs7980687 reduced from 0.065 SD (95% CI: 0.042, 0.088) to 0.057 SD (95% CI: 0.035, 0.080), showing that 
the effect was partially mediated by infant height (12% variance explained). The effect size for SNP rs1042725 
reduced from -0.063 SD (95% CI: -0.082, 0.045) to -0.048 (-0.066, -0.030), demonstrating that the effect was 
partially mediated by infant height (24% variance explained). Moreover, the association at CRHR1 did not show 
significant association, indicating that there may be only a direct association between this locus and HC. The 
models were further adjusted with several potential confounding factors, which have been previously associated 
with HC or with height. First, the model was adjusted for the first two principal components to account for 
population stratification, but the associations remained unchanged. Then other confounders, such as 
breastfeeding, socio-economic status and education level, were also included in the model, but again these did 
not change the associations. Moreover, there was no evidence of interaction between these variants and sex or 
breastfeeding after Bonferroni correction at P < 0.05.  
5.2.1.4.    Study Specific Discussion 
This is the first GWAS on HC in infancy. The SNP rs7980687 and SNP rs1042725 were associated with infant 
HC at genome-wide level. These SNPs have previously been associated with adult height
289
. The SNPs were 
located in/near SBNO1 and HMGA2, respectively. The SBNO1 gene is a downstream component of the Notch 
signaling pathway that is known to function in the oncogenic process in humans
292
 and is shown to have an 
important role during embryogenesis and oogenesis in Drosophila
293,294
.  The Notch signaling is a molecular 
signaling pathway that plays an important role in the determination of cell differentiation
295
. Studies on 
Drosophila show that knocking this gene led to mal-development of the central nervous system
293
. This 
suggests that the gene may have an important role in affecting brain growth leading to skull growth and hence 
affecting HC. The SNP rs1042725 near HMGA2 was the one of the first variants to be associated with adult 
height
140
. The HMGA2 gene codes the high-mobility group AT-hook2 protein, which functions as an 
architectural factor, it is also an essential component of the enhanceosome and acts as a transcriptional 
regulating factor. Previous studies on mice, show that a complete knock-out of this gene associates with diet-
induced obesity
296
. The clinical implication of this gene is that it associates with a variety of cancers in 
humans
297,298
. Animal studies shows that a mutant HMGA2 in mice were unusually small, suggesting a role of 
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this gene in stature as well
299
.  Previous studies also associate head size with total body size
300
, it could also be 
possible that these two genes may function in regulation of skeletal growth and bone development, although the 
underlying mechanisms are largely unknown.     
The SNP near a promotor region of CRHR1-MAPT associated with infant HC in discovery stage but did not 
associate with adult height. This SNP did not reach genome-wide significance in the final combined meta-
analysis. The SNP was included in further analysis, despite marginal association with infant HC, as the SNP has 
shown to be associated with brain development and bone minerals. The CRHR1/MAPT gene encodes a G-
protein that binds with corticotropin neuropeptides releasing hormones for regulating the hypothalamic-
pituitary-adrenal pathway
301
. This SNP lies within a 900-kb region which corresponds to a conversion of four 
genes, such as CRHR1, MAPT, STH and GRN. All these SNPs have been associated to neurodegenerative 
diseases such as Parkinson’s, Alzheimer’s and fronto-temporal degeneration.  
The study identifies two novel genetic variants in or near SBNO1 and HMGA2 genes associated with fetal and 
infant HC measurements and adult height, another variant near CRHR1-MAPT showed marginal association 
with fetal and infant HC. All these genes are shown to be functional in regulations of skull development, 
skeleton growth and bone density, indicating that these variants could play an important role in adulthood 
stature. HC is a highly heritable trait and association of HC-associating genes to several neurological diseases, 
emphasise the importance of further work on these variants. Moreover, the role of mediation by HC between 
genetic variants and adult height also indicates that HC could be a significant marker for earlier disease traits. 
However, more detailed studies, and multi-ethnic cohort(s) participation, are needed to evaluate the effect of 
these SNPs at a wider population level.     
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Figure 9. Manhattan plot of discovery genome wide association meta-analysis (n=10,768), with three loci 
selected for replication. 
 
 
 
 
 
 Figure 10. Mediation of effects of genotype on head circumference through an indirect effect on height.  
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Table 17. Association of 180 known adult height variants with head circumference in infancy, the table 
shows only significant association after correction for multiple testing at P < 10
-4
.  
Chr  Position SNP Effect 
Height 
(SD) 
Effect head 
circumference 
(SD) 
Standard 
Error 
P-Value Gene EFFECT_OTHER 
3 142588260 rs724016
#
 -0.07 -0.054 0.015 1.8x10
-4
 ZBTB38 A/G 
6 29192211 rs3129109
#
 -0.032 -0.112 0.026 1.8x10
-5
 OR2J3 T/C 
12 122389499 rs11830103 -0.035 -0.08 0.018 5.9x10
-6
 SBNO1 A/G 
12 64638093 rs1351394 0.06 0.064 0.014 9.0x10
-6
 HMGA2 T/C 
20 47336426 rs237743 0.041 0.078 0.017 6.1x10
-6
 ZNFX1 A/G 
 
#Results reported for very closely related SNP (rs3117141 for rs 3129109, HapMap R2=1.000; rs6440006 for rs7224016, HapMap R2=0.967) 
These results are statistically significant after applying Bonferroni correction. P-value threshold for significance: 0.05/180=2.8x10-4 
 
 
 
Table 18. Mediation analysis for infant height influencing relationship between top-three SNPs and head 
circumference (HC).  
Index SNP N in meta-
analysis 
Total effect on head 
circumference (SD score) 
Indirect effect (through height) 
on head circumference (SD 
score) 
Direct effect on head 
circumference (SD score) 
  effect size (95% CI) P value effect size (95% CI) P value effect size (95% CI) P value 
rs7980687_A on 12q24         16,664  0.065 (0.042, 0.088) 3.8x10-8 0.088 (0.002, 0.014) 0.011 0.057 (0.035, 0.079) 3.8x10-7 
rs1042725_T on 12q15         16,557  -0.063 (-0.082,-0.045) 3.5x10-11 -0.015 (-0.021,-0.009) 5.6x10-7 -0.048 (-0.066,-0.030) 1.3x10-7 
rs11655470_T on 17q21         16,512  0.045 (0.026, 0.064) 3.6x10-6 -0.009 (-0.030, 0.012) 0.38 0.048 (0.030, 0.066) 1.4x10-7 
 
SD; standard deviation, 95% Confidence interval. Effect estimates reflect the difference in had circumference SD score per allele. 
# The P value is obtained from a mediation analysis framework seemingly unrelated regression analysis (STATA) or a simple pathway analysis 
(MPLUS) using an additive model.  
All study were of European descent. Of the total of 13 study cohorts, 12 study cohorts contributed to these analyses since data on height and weight 
were not available in the CHOP (Children’s Hospital Of Philadelphia) study.  
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5.2.2.    Association between common genetic variants and early growth phenotypes, linking childhood 
growth with adulthood obesity  
 
5.2.2.1   Introduction 
 
There are critical stages in an individual’s growth after birth that have been hypothesised as risk factors for 
several CVD diseases in adulthood 
302
. These critical stages during the growth trajectory include a period of 
rapid gain in height and weight in infancy (at around 2 weeks for height and 5 weeks for weight), the period at 
which body mass index (BMI) reaches its peak in early infancy (at around 9 months) called adiposity peak 
(AP), and the period when BMI reaches its nadir (between 5 and 7 years) called adiposity rebound (AR) 
7,10
. 
These early growth indicators have been quantified as Peak Weight Velocity (PWV), Peak Height Velocity 
(PHV), age and BMI at AP and at AR, using well-established growth models, described in Chapter 4, section 
4.2. Each of these early growth parameters have been previously associated with the risk of impaired metabolic 
health in both adolescence 
303
 and adulthood 
8,14,212
. However, little is known about the interplay between the 
common genetic variants affecting growth patterns during infancy and childhood; and metabolic homeostasis, 
the state of which influences cardio-metabolic disease in later life.   
Most previous studies into childhood BMI or obesity have focused on testing associations with genetic variants 
discovered in genome-wide association studies (GWAS) on adults 
38,129
, with one study having used a GWAS 
approach that investigated extreme  obesity (> 95% BMI levels) only. No studies, so far, have considered 
investigating the longitudinal effect of common genetic variants on early growth phenotypes in a GWAS 
design. To our knowledge, only one candidate gene study investigated the association of one variant at the FTO 
gene and early growth phenotypes with one variant
11
.  
The current study aims to identify common genetic variants associated with early growth phenotypes (PHV, 
PWV, age and BMI at AP and AR) by meta-analyzing five GWAS and twelve replication studies of European 
ancestry. The study also aims to investigate the nature of the relationship between genetic variants associating 
with early growth phenotype and adult BMI, and determining if early growth phenotypes mediate the 
association between the identified genetic variants and adult BMI.  This study was performed as part of 
collaborative work with the early growth and genetics (EGG) consortium. The consortium members provided 
GWAS and replication data from various cohorts, details of which are given in Chapter 4, section 4.3.  
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This EGG project was led by me from Imperial College. I was the main analyst, responsible for developing the 
analytical protocol, collecting analyses results for each cohort, providing troubleshooting assistance with any 
issues arising during the analyses process and conducting meta-analysis on all results. My role as part of the 
Imperial College team was to conduct 1) a discovery stage GWAS on NFBC1966 data, and 2) perform follow-
up association analyses of the leading SNPs in the NFBC1986. I conducted the combined meta-analysis for all 
three stages of the project; discovery, replication and joint. I provided input for analysing the growth parameters 
for five cohorts (ALSPAC, COPSAC, INSI, LISA and SWS). I performed the genetic susceptibility analysis 
using the discovery stage meta-analysis results. I also did a mediation analysis in the NFBCs (1966 and 1986) 
and then meta-analysed data from two other cohorts as part of the project. My work on this project, including 
contribution on pathway analysis from other team members of Imperial College, has been presented together in 
a manuscript to be submitted to Nature Genetics. As described earlier, it was agreed with members of EGG-
consortium that work related to this project would form part of my thesis.  
In this chapter, I explain the discovery and replication stages and finally the combined analysis of all 17 
participating cohorts. It also explains the genetic susceptibility analysis performed using discovery stage meta-
analysis results. The mediation meta-analysis performed on the NFBCs (1966 and 1986), and two other cohorts 
are described as well. 
5.2.2.2.   Methods and materials 
 
Details of the NFBC1966, NFBC1986, and other relevant EGG cohort, and genotype data provided are 
described in Chapter 4, section 4.1 and 4.3. In summary, singletons with available gestational age and at least 
three height and weight measurements were selected for the study. Early growth phenotypes were derived from 
sex-specific individual growth curves using mixed effects models of height, weight and BMI measurements 
collected longitudinally from birth to 13 years (Chapter 4, section 4.2). Early adiposity phenotypes were 
standardized to z scores within each study and adjusted for sex and gestational age (only applicable for peak 
height, peak weight and adiposity peak models).    
 
Statistical analysis  
As shown in Figure 11, six separate analyses were performed in the study. After genome-wide association 
studies were performed, in each of the discovery cohort data sets across the six early growth phenotypes 
separately, the results from each were combined in meta-analyses and the SNPs corresponding to the most 
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significant association genome-wide were selected for replication. The next step involved association analyses 
at the ‘replication SNPs’ among the replication cohort data sets, followed by meta-analyses of the replication 
stage results. The final step was to run combined meta-analyses of both the discovery and replication meta-
analyses results and to assess whether any SNP have association results that exceed the genome-wide 
significance level. Details on how meta-analysis genome-wide association studies (GWAS) are performed are 
given in Chapter 4, section 4.4.  
 
As well as the discovery of genetic variants associated with these early growth phenotypes, this study aims to 
provide insights into the relationship between the genetic determinants of early growth, adulthood BMI and 
other disease phenotypes by conducting the following three investigations: 1) examine the association of the 
identified SNPs with other disease phenotypes by interrogating the GWAS catalogue304, 2) assess the 
associations relating to the early growth phenotypes at the 32 loci found to be associated with adult BMI from 
the GIANT consortium139, 3) perform mediation analyses to investigate if early growth phenotypes influence 
the association between genetic variants and adulthood BMI.   
 
For each locus forest plots were developed, which provided the effect size for each individual study and overall, 
along with 2-sided 95% confidence interval. A test of heterogeneity assessed whether there was a difference in 
the effect size among cohorts. 
 
5.2.2.3   Results 
Study samples 
Table 19 shows the study samples used for these analyses. Characteristics of the study samples describing the 
mean early growth phenotypes, genotyping information and quality control cut-offs applied by each study were 
similar in all cohorts (data not shown). The study cohort-specific median age range selected for growth 
modeling from each of the cohorts was between 2 weeks to 13 years. The mean observed early growth 
phenotypes ranged from 40.9 cm/year to 52.6 cm/year for PHV, 11.6 kg/year to 12.9 kg/year for PWV, 0.5 years 
to 1.0 years for age at AP in infancy, 16.5 kg/m2 to 18.1 kg/m2 for BMI at AP, 4.7 years to 5.7 years for age at 
AR in childhood and 15.4 kg/m2 to 15.7 kg/m2 for BMI at AR.  
PhD Thesis 
 
152 
 
Figure 11: Flowchart summarising the study design and results for the discovery, replication and 
combined meta-analysis of GWAS across 17 studies of European Ancestry.  
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Discovery stage analyses 
In the discovery stage, the association statistics of five population-based studies (HBCS, NFBC1966, RAINE, 
GENR and LISA) were meta-analyzed across 2.5 million directly genotyped and imputed SNPs in singletons 
from up to 7,215 children of European ancestry (Table 19). Seven loci associated with BMI at AP, age at AR 
and/or BMI at AR in the overall discovery meta-analyses were considered for follow-up using the following 
selection criteria: four SNPs were selected based on having association results with P < 5 x 10
-7
, three SNPs 
were selected based on a combination of association results with P < 5x10
-6
, biological relevance, and quality of 
genotyping (Table 20). One further SNP for peak weight velocity (PWV) was included for follow-up, despite 
only a suggestive association result (P=5.91 x 10
-5
), due to its strong biological candidacy for BMI in a 
previous published study
135
.  
Figure 12 shows the Manhattan and quantile-quantile (QQ) plots for the genome-wide association results, on a 
–log10 scale, for the discovery stage for each of the early growth phenotypes. The Manhattan plot represented 
the P values of entire GWAS on genomic scales, with any P value below 5 x 10
-5
 colored in green. The QQ plot 
was the graphical representation of the number and magnitude of observed association (black) between 
genotyped SNPs and the early growth phenotypes, compared to assuming no association under the null 
hypothesis (red). There was not much deviation from the null hypothesis line (red) for PHV, PWV, age and 
BMI at AP however the QQ plot for age and BMI at AR showed a sharp deviation from the null hypothesis (red 
line) suggesting that the observed P values were clearly more significant than those expected under the null 
hypothesis.    
Two loci at SNP rs9436303 on chromosome 1 located near the leptin receptor gene (LEPR/LEPROT, P= 4.15 x 
10
-9
) and at SNP rs10515235 on chromosome 5 near the proprotein convertase subtilisin type 1 gene (PCSK1, P 
= 1.2 x 10
-6
), associated with BMI at AP in infancy (Table 20). 31 SNPs, in the well-studied obesity-related 
FTO gene on chromosome 16, showed the strongest associations with age at AR. SNP rs1421085 showed the 
strongest association of the 31 (P = 6.14 x 10
-8
) in the discovery stage and was thus taken forward to the 
replication stage rather than the most commonly studied FTO SNP rs9939609 which was also associated with 
age at AR (P= 1.6 x 10
-7
).  The rs9939609 was already genotyped in many studies and consequently was used 
as a proxy as it is in high LD (r
2
 = 0.96) with rs1421085.  
Two further SNPs associated with age at AR: one SNP rs2956578 on chromosome 5, in an inter-genic region 
between RAN binding protein 3-like (RANBP3L) and solute carrier family 1, member 3 (SLC1A3) (P = 6.7 x 
10
-8
), and one SNP rs2817419 at transcription factor AP-2 beta (TFAP2B) on chromosome 6 (P = 3.0 x 10
-6
), 
which has been found to be associated with waist circumference (WC) in adults
137
. For BMI at AR, one SNP 
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rs2055816 on chromosome 11 in the discs, large homolog 2 (DLG2) gene (P = 1.4x10
-7
) and one SNP 
rs10938397 on chromosome 4 near glucosamine-6-phosphate deaminase 2 (GNPDA2) gene (P= 3.1x10
-6
) were 
selected for follow-up. One SNP rs2860323 on chromosome 2, near the trans-membrane protein 18 gene 
(TMEM18, P=5.9 x 10
-5
), associated with PWV. This SNP rs2860323 was in high linkage disequilibrium (LD) 
(r2 = 0.85), with the previously published SNP rs6548238, reported as associated with adult BMI 
135
, and was 
thus selected for follow-up. No SNPs were associated with PHV or age at AP, even at P < 1 x 10
-4
, and hence 
were not included in the replication stage.  
Replication stage analyses 
The eight most strongly associated SNPs from each locus, or closely related proxy from HapMap Release 21 
(HapMap r
2
 = 0.8-0.96), were selected for replication (follow-up) in another twelve independent European 
population-based studies. These twelve European population-based studies used a mixture of in-silico data and 
de novo genotyped data in up to n=16,017 children (Table 19) for the analyses. Five top-SNPs show evidence 
of significant association in the replication samples, tested at P < 0.05 (Table 20).  Two loci, one at 
LEPR/LEPROT replicated at P < 6.66 x 10
-4 
and, one near PCSK1 replicated at P < 0.01 with BMI at AP in the 
replication sample. Two loci at FTO and at TFAP2B, remained significantly associated at P < 7.10 x 10
-24
 and at 
P < 1.83 x 10
-6
 with age at AR, in the replication sample. The locus in the inter-genic region between RANBP3L 
and SLC1A, did not replicate (P = 0.83). The locus at GNPDA2 associated with higher BMI at AR at (P=3.15 x 
10-4), while the locus at DLG2 did not associate with BMI at AR (P = 0.176) in the replication sample. The 
SNP at locus TMEM18 found to be associated with PWV in the discovery stage also failed to replicate in the 
second stage (P = 0.468). 
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Table 19: Characteristics of study populations and outcome phenotypes in the early growth GWAS.  
TYPE Study Country Birth years PHV/ 
PWV in Infancy 
BMI/ 
Age at AP 
BMI/Age at AR PHV 
 
PWV 
 
Age at 
AP 
(years) 
BMI at 
AP 
kg/m2 
Age at 
AR  
(years) 
BMI at 
AR 
kg/m2   N N N cm/year  kg/year  
Discovery HBCS Finland 1934-44 1449 1169 1555             
NFBC1966 Finland 1966 3149 2585 3459 52.63  
(3.99) 
12.92 
(2.34) 
0.74 
(0.05) 
18.05 
(1.08) 
5.71 
(0.93) 
15.37 
(1.09) 
RAINE Australia 1989-91 - - 1037 - - - - 4.81 
(1.27) 
15.49 
(1.05) 
LISA (D) Germany 1998-9 390 372 - 40.9 
(4.4) 
11.6 
(2.0) 
0.70 
(0.04) 
16.5 
(1.0) 
- - 
GENR Netherland 2002-6 2227 2088 - 48.40  
(8.03) 
11.94 
(1.96) 
0.71 
(0.04) 
17.55 
(0.75) 
- - 
meta-
analysis 
      7215 6214 6051             
Replication ALSPAC UK 1991-2 - 6357 6704 - - 0.77 
(0.05) 
17.55 
(1.78) 
- - 
CBGS UK   - 557 - - - 1.03 
(0.04) 
17.00 
(1.36) 
- - 
CHOP US 2006-10 - 233 - - - 0.84 
(0.15) 
17.92 
(4.12) 
- - 
COPSAC Denmark 1998-1 364 309 319 - - 0.61 
(0.18) 
17.54 
(0.89) 
4.7 
(1.3) 
15.44 
(0.96) 
DNBC Denmark 1996-2 - 861 - - - - - - - 
EDEN France   - 1127 - - - 1.02 
(0.08) 
17.5 
(1.5) 
- - 
EFSOCH UK 2000-4 -  600 - - - - 17.48 
(1.47) 
- - 
INMA Spain 2004-7 733 396 - - - - 16.69 
(1.43) 
- - 
LISA (R) Germany 1998-9 702 619 - - 11.6 
(2.1) 
- 16.7 
(0.6) 
- - 
NFBC1986 Finland 1985-6 3568 4206 4020 53.25  
(7.18) 
12.66 
(2.88) 
0.69 
(0.02) 
17.53 
(0.73) 
4.9 
(1.04) 
15.65 
(1.12) 
PANIC Finland   - - 433 - - - - 4.7(1.5) 15.7(1.3) 
SWS UK   - 1285 828 - - 0.52 
(0.04) 
17.56 
(1.53) 
5.30 
(1.04) 
15.73 
(1.24) 
meta-
analysis  
      5367 16550 12304             
Total        12582 22764 18355             
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Figure 12: Manhattan and Quantile-Quantile (QQ) plots of discovery stage results (N=7,215). The SNPs 
were filtered out if minor allele frequency <0.01, and adjusted twice by genomic controls, once within the study 
and then across the meta-analysis (lambda = 1.2). For each early growth phenotype, SNPs within loci with P < 
5 x 10
-5
 are displayed in green. The QQ plot of observed vs expected –log10P values are given in separate 
panels for each early growth phenotype. The black QQ lines represent the observed vs excepted associations for 
all SNPs. A. Peak height velocity (PHV), B. Peak weight velocity, C. Age at Adiposity peak (AP), D. BMI at 
adiposity peak (AP). D. Age at adiposity rebound (AR), E. BMI at adiposity rebound (AR). 
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Combined discovery and replication stage meta-analysis 
In the final combined meta-analysis of discovery and replication cohorts (n = 21,859), SNPs at (or near) 
LEPR/LEPROT, FTO, TFAP2B and GNPDA2 reached genome-wide significance (P < 5 x 10
-8
), while one SNP 
at PCSK1 showed association at P < 5 x 10
-6
 (Table 20). Each additional copy of G allele of SNP rs9436303 
within LEPR/ LEPROT (minor allele frequency (MAF) = 17-28%) were associated with a 0.07 SD (95% CI 
0.04, 0.09, Pcombined = 2.59 x 10
-8
) higher BMI at AP in the final meta-analysis. These effect sizes equate to 
approximate differences equivalent to an increase in BMI at AP of ~ 0.07 kg m
-2 
(95% CI: 0.04, 0.09) per allele. 
The C allele of SNP rs1421085 at FTO was associated with earlier age at AR by 0.12 SD [~ 1.44 months (95% 
CI (1.42, 1.46)), Pcombined = 3.12 x 10
-30
], which is directionally consistent with a cross-sectional study on BMI 
variation between infancy and childhood 
11
. Similarly, each additional copy of A allele of SNP rs2817419 at 
TFAP2B was associated with earlier age of AR by 0.08 SD [~ 0.96 months (95% CI (0.94, 0.98)), Pcombined = 
4.39 x 10
-11
]. An additional G allele at SNP rs10938397 in GNPDA2 was associated with higher BMI at AR by 
0.06 SD (95% CI: 0.04, 0.07) [~ 0.06 kg m
-2
, Pcombined = 3.15 x 10
-8
]. The SNP at PCSK1, which associated with 
BMI at AP at P = 5.11 x 10
-6
, increased BMI at AP by 0.05 SD [~ 0.05 kg m
-2
 (95% CI (0.03, 0.07)] per 
additional A allele of SNP rs10515235.  
Three loci, near TMEM18, in DLG2 and in inter-genic region between RANBP3L and SLC1A3, were not 
significantly statistically associated with early growth phenotypes in the final analysis.   
The four SNPs which reached genome-wide significance, and one SNP which showed suggestive association 
(combined as top-five SNP), were taken forward for further analyses described in the next sections. 
There was no evidence of heterogeneity for four locus (FTO, TFAPB2, GNPDA2 and PCSK1) between 
discovery and replication stage studies (P <0.05, I
2
 = 0%), except at one locus, LEPR/LEPROT (I
2
 = 67.3%, 
P<0.0001).  Forest plots for each locus and justification on model selection are presented in Appendix Table 6, 
Appendix Figure 2. The heterogeneity at this locus could be attributed to differences in the distributions of the 
number of BMI at AP measurements over time between cohorts, or may be due to unmeasured environmental 
factors influencing growth 
305
. However, applying the random effects model to the lead SNP at this locus did 
not change the significance of the association (P=0.0003), and the overall results for this locus showed 
directional consistency across studies.  
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Genetic susceptibility of the identified SNPs to other diseases  
To examine the role of shared genetic susceptibility with other disease phenotypes, the associations between the 
top-five SNPs and disease phenotypes reported in other studies was examined by searching the catalogue of 
published GWAS (http://www.genome.gov). Results for all genotype-phenotype associations where the 
reported SNPs were in linkage disequilibrium (LD) (r2 > 0.5), with lead SNPs identified here, were presented in 
Table 21. Table 21 shows that the genetic variants, rs1421085 in FTO and rs10938397 near GNPDA2 
associated with age at menarche in adolescent girls, as well as adulthood adiposity related phenotypes, such as 
weight, BMI, obesity, T2D, metabolic syndrome and osteoarthritis. Previous studies suggest that  age at 
menarche of adolescent girls is influenced by both birth weight and postnatal accelerated growth, while results 
from this study confirm that genetic variants affecting early growth phenotypes could also be associated with 
age at menarche
303
. The genetic variants in LEPR/LEPROT, TFAP2B and near PCSK1, in LD (r
2
 >0.5 cut-off) 
with the lead SNP, did not associate with other later-in-life adiposity-related phenotypes.  
The association between adult BMI SNPs and early growth phenotypes 
The associations between early growth phenotypes and the lead SNPs at 32 loci reported for adult BMI by the 
Genetic Investigation of ANthropometric Traits (GIANT) consortium 
139
 were investigated using data from our 
discovery meta-analysis results. The aim of this analysis was to understand if identified adult BMI-associated 
SNPs also have an association with early growth phenotypes. Table 23 shows that nine out of the 32 loci 
associated with one or more of the early growth phenotypes at significance of P < 1.6 x 10
-3
 (Bonferroni 
corrected P –value: 0.05/32) . For PWV, one locus near TMEM18 associated at P < 1.6 x 10-3. None of the 
SNPs associated with age at AP or PHV at P < 1.6 x 10
-3
. One locus near RBJ-ADCY3-POMC associated with 
BMI at AP at a P < 1.6 x 10
-3
. Eight SNPs in/near FTO, TMEM18, MC4R, GNPDA2, SEC16B, TFAP2B, 
FAIM2 and TNNI3K associated with age at AR at P < 1.6 x 10
-3
. The results were consistent with a previous 
study on FTO 
11
, showing that alleles that increased adult BMI were associated with earlier age at AR. There 
were associations with BMI at AR at seven loci in/near FTO, TMEM18, GNPDA2, SEC16B, RBJ, FAIM2 and 
TNNI3K, with the effects directionally consistent with adult BMI.  Figure 13 shows scatter plots of the 
regression coefficients corresponding to the 32 SNPs for each of the early growth phenotypes against those 
corresponding to adult BMI from the GIANT consortium study. The figure shows that adult BMI is correlated 
with age and BMI at AR but not for the other four growth phenotypes earlier in life, consistent with the 
correlations of the phenotypes reported previously 
11
. 
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Figure 13: Scatter plots of the effect size estimates (regression coefficients) corresponding to the 32 SNPs for each 
of the early growth phenotypes against those corresponding to adult BMI (in GIANT consortium study).  
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Table 20. Summary results from discovery meta-analysis of top-eight SNPs from five European cohorts, and with replication in 12 European 
cohorts  and the combined meta-analysis results in all 17 studies for early growth GWAS. 
      Discovery  Replication Combined Stage 
SNP Location Nearest gene Coded 
allele/other 
allele 
Coded 
allele 
freq. 
Measure B (SE) in 
SD units 
P N B (SE) in 
SD units 
P N B (SE) in 
SD units 
P N 
rs2860323 2p25.3 TMEM18 G/A 0.12 PWV 0.09 (0.02) 5.91E-05 7215 0.02 (0.02) 4.68E-01 5367 0.06 (0.02) 3.88E-04 12582 
rs9436303 1p31 LEPR/LEPROT G/A 0.22 BMI at AP 0.14 (0.02) 4.15E-09 5842 0.05 (0.01) 6.66E-04 16550 0.07 (0.01) 5.77E-09 22392 
rs10515235 5q15 PCSK1 A/G 0.21 BMI at AP 0.09(0.02) 1.23E-06 6210 0.03 (0.01) 1.50E-02 13652 0.05 (0.01) 2.41E-06 19862 
rs1421085 16q12.2 FTO C/T 0.25 AGE at AR -0.10 (0.02) 6.14E-08 6051 -0.13 (0.01) 7.10E-24 12122 -0.12 (0.01) 3.12E-30 18173 
rs2956578 5p13 intergenic 
region* 
A/G 0.69 AGE at AR -0.11 (0.02) 6.73E-08 6051 -0.01(0.01) 8.30E-01 12304 -0.04 (0.01) 1.16E-03 18355 
rs2817419 6p12 TFAP2B A/G 0.76 AGE at AR -0.10 (0.02) 2.96E-06 6051 -0.07 (0.01) 1.83E-06 12256 -0.08 (0.01) 4.39E-11 18307 
rs10938397 4p12 GNPDA2 G/A 0.35 BMI at AR 0.09 (0.02) 5.41E-06 6051 0.05 (0.01) 3.15E-04 12192 0.06 (0.01) 2.92E-08 18243 
rs2055816 11q14.1 DLG2 T/C 0.78 BMI at AR 0.13 (0.02) 1.41E-07 6051 0.03 (0.02) 1.76E-01 11815 0.07 (0.02) 5.11E-06 17866 
* intergenic region between  RANBP3L and SLC1A3
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Mediation analysis  
 
To examine the possible mediating role of early growth phenotypes in the relationship between the top five 
SNPs and adult BMI, we tested the direct and indirect associations using the Baron and Kenny procedure 
181
. 
These analyses were first conducted on the NFBC1966 and NFBC1986 datasets and then results were validated 
using two other European population-based cohorts (HBCS and RAINE). All the studies had available measures 
of adolescent and adult BMI at ages16, 18, 20 and 31 years in a sub-sample of up to 9,128 individuals. The final 
results, meta-analyzed among all four studies, are presented in Table 22 and a schematic summary is shown in 
Figure 14. Using the methodological strategy described in Shrout et al, 2002 
215
, a brief summary of which is 
given in Section 4.5, three models (direct, indirect) relevant to each locus were analysed, using the early growth 
phenotypes as potential mediators between the SNP and adult BMI in each model.  
From the direct effect model for SNP on adult BMI, two loci at LEPR/LEPROT and PCSK1 did not associate 
with adult BMI in this sample (P=0.79, P=0.86; respectively). Although, contrary to this result, recent studies 
show polymorphism at LEPR 
306-308
 and PCSK1
309
 associating with adulthood obesity-related factors and one of 
the reasons for non-significant association in this study could be small sample size. In the indirect model, 
adjusting for BMI at AP in association between SNP and adult BMI, did not change the SNP- adult BMI 
association (P=0.24, P=0.35; respectively), indicating no mediation by BMI at AP for the two loci, which was 
confirmed by Sobel test (Psobel = 0.142, Psobel=0.327; respectively).  
Two loci, rs1421085 and rs2817419, at FTO and TFAP2B associating with age at AR, significantly associated 
with adult BMI (P=1.03 x 10-12, P=6.52 x 10-8; respectively), confirming results from previous genome-wide 
studies135,137,139 (Figure 14). In the indirect model, adjusting for age at AR in the model between SNPs and adult 
BMI, the effect size reduced from 0.10SD to 0.03SD in FTO (Psoble =0.01) and from 0.10SD to 0.05 SD in 
TFAP2B (Psoble =1.92 x 10
-4), suggesting that age at AR may have mediated this relationship. Locus at 
GNPDA2, associating with BMI at AR, associated with adult BMI in this sample (P= 1.19 x 10-5) in the direct 
association. The strength of the association decreased after adjusting for BMI at AR from 0.06SD to 0.03SD 
(Psoble=0.02), suggesting that the BMI at AR may be mediating this association. 
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Table 21. Results of meta-analysis from mediation analyses of the five identified loci in four European population-based studies (N=9,128) in early 
growth GWAS.  
Effect           Sobel Test
a
 GIANT 
Consortium
#
 
  B in SD 
units 
SE 95% CI P P P 
Direct: LEPR on adult BMI -0.006 0.022 -0.037 0.048 7.917E-01 0.142 - 
Direct: LEPR on BMI at AP 0.070 0.010 0.050 0.090 2.592E-08    
Indirect: LEPR on adult BMI given BMI at AP* -0.025 0.022 -0.017 0.068 2.420E-01    
          
Direct: PCSK1 on adult BMI 0.003 0.015 -0.027 0.033 8.561E-01 0.327 - 
Direct: PCSK1 on BMI at AP 0.050 0.010 0.030 0.070 1.437E-06    
Indirect: PCSK1 on adult BMI given BMI at AP -0.014 0.015 -0.042 0.015 3.525E-01    
          
Direct: FTO on adult BMI 0.100 0.014 -0.127 -0.072 1.034E-12 0.008 4.75E‐120 
Direct: FTO on Age at AR -0.120 0.010 -0.140 -0.100 3.115E-30    
Indirect: FTO on adult BMI given Age at AR 0.027 0.011 -0.048 -0.006 1.297E-02    
          
Direct: TFAP2B on adult BMI 0.097 0.018 0.062 0.132 6.523E-08 0.001 2.90E‐20 
Direct:TFAP2B on Age at AR -0.080 0.010 -0.100 -0.060 4.388E-11    
Indirect: TFAP2B on adult BMI given Age at AR  0.053 0.014 0.025 0.081 1.952E-04    
          
Direct: GNPDA2 on adult BMI 0.064 0.015 0.093 0.035 1.190E-05 0.018 3.78E‐31 
Direct: GNPDA2 on BMI at AR 0.060 0.010 0.040 0.080 2.920E-08    
Indirect: GNPDA2 on adult BMI given BMI at AR 0.031 0.012 0.054 0.008 8.107E-03     
*Model for BMI at AP is adjusted for gender and gestational age. 
# Estimates for association between LEPR and PCSK1and adult BMI were not available in the GIANT paper. 
a Sobel (1982) test provides statistical method to assess the significance of the mediator in relation to independent variables and dependent variable.  
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Figure 14. Schematic diagram showing five loci selected from combined meta-analysis of early growth phenotype meta-analysis. The figure 
illustrates the relationships between SNPs and early growth phenotypes and that how early growth may mediate the association between 
FTO, TFAP2B and GNPDA2 loci and adult BMI (Table 22). The arrows represents the association between the SNPs and phenotypes; blue 
and black arrows show an association with P < 0.0001 significance and grey arrow an association of P<0.05. 
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5.2.2.4.   Discussion 
This is the first genome-wide meta-analysis association study on early growth trajectories, with a sample of up 
to 21,859 individuals of European descent.  The early growth phenotypes are selected as a proxy for the 
childhood adiposity variable; the advantages of using early growth phenotypes are that they summaries 
longitudinal growth data into a few functional parameters which presents the biological growth phase. This 
finding adds to the understanding of the underlying molecular mechanisms linking early growth phenotypes 
with increased risk of higher adult BMI, which is a risk factor for diseases such as obesity and T2D.  
The study finds four SNPs, in and near LEPR/LEPROT, FTO, TFAP2B and GNPDA2, associating with early 
growth phenotypes, such as BMI at adiposity peak (AP), age and BMI at adiposity rebound (AR),  at the 
genome-wide significance level (at P < 5 x10
-8
). One SNP near PCSK1 showed suggestive evidence (at 
P=2.41x10
-6
) for an association with infant BMI at AP. This SNP did not reach the genome-wide significance 
but it was included in further analysis, since PCSK1 has implications in the regulation of fat metabolism and 
insulin biosynthesis
113,310
 and has demonstrated a role in the development of obesity
113,311
. Three of the SNP, 
in/near FTO, TFAP2B and GNPDA2, have previously been associated with adult BMI
139
,  and in this study we 
show that the association between these variants and adult BMI may be mediated by age of adiposity rebound 
(AR) (Figure 14). Figure 14 gives a schematic diagram showing the association of five loci with early adiposity 
phenotypes.  
The SNP at LEPR/LEPROT associating with a higher BMI at AP, were located in an overlapping region of two 
genes, LEPR and LEPROT. The genes belong to the gp130 family of cytokine receptors that are known to 
stimulate gene transcription via activation of cytosolic STAT proteins. The function of these two genes, LEPR 
and LEPROT, is to encode the cellular receptor for leptin, a hormone involved in regulating appetite and energy 
balance
122
. Mutations at this gene has previously shown to be associated with C-reactive protein
312
, skeleton 
growth
313
, slower pubertal growth
314
, monogenic obesity 
111
, polygenic obesity and related metabolic 
complications
163,315-317
.  Leptin has been primarily expressed in central and peripheral nervous regions, and  
functions to regulate food intake 
318
. The longitudinal effect of SNP in LEPR/LEPROT on obesity is poorly 
understood
313,319
, the result from current studies suggest that genetic variants in LEPR/LEPROT may be 
involved in body mass development during early infancy.  Although, no direct association between SNP in 
LEPR/LEPROT  and adult BMI was found in either GIANT consortium
139
 or in this study at nominal 
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significance, it could not be confirmed if this SNP had a continued effect from infancy to adulthood or if SNP 
only affects infancy and early childhood.  Further, and more expansive, GWAS are required to understand the 
role of this gene.  
The results show that variation in FTO and TFAP2B is associated with earlier age at AR, and that variants near 
GNPDA2 are associated with higher BMI at AR. The FTO 
125
, TFAP2B 
320
 and GNPDA2 
321
 genes are 
expressed in the hypothalamus, suggesting a potential role for the hypothalamic-pituitary-adrenal axis (HPA) in 
body weight regulation. All three loci have been previously associated with childhood and adult BMI 
38
, but 
none have investigated their role in longitudinal variation in childhood BMI. One previous candidate-gene study 
on childhood growth patterns from within the same team at Imperial College London, demonstrated FTO’s 
association with earlier AR
11
 at genome-wide level and this current study confirms the association. The 
TFAP2B gene has been explored in terms of WC 
137
 and type-2-diabetes 
322
, and this study adds its association 
with earlier age at AR. According to a recent study by Mumby et al,201, a higher BMI at 20 years associates 
with earlier pubertal timing and adverse metabolic profiles in adults
323
 for FTO and GNPDA2 genes, 
emphasizing the importance of identifying risk indicators for high childhood BMI and adverse growth 
trajectories. Our search on the GWAS catalogue confirms that FTO and GNPDA2 are potentially involved, not 
only in the growth trajectory, but also in phenotypes related to metabolic health and disease, reproductive 
biology in women and bone disease. 
The role of these three genes on longitudinal variations of BMI is still unclear, and none examine the age at 
which these gene starts their development of body mass. A study by Haworth et al, 2008
120
, tested a variety of 
adult BMI associating candidate genes loci with childhood BMI at 4, 7 and 10 years but the results were 
inconclusive. This is the first study which presents three adult-BMI associating SNPs at FTO, TFAP2B and 
GNPDA2 also associated with child BMI and the effects of these three SNPs on adult BMI are partly mediated 
via age and BMI at AR at 5 years. The results suggest that these early growth phenotypes can be important early 
indicators in predicting later life obesity.   
The study also observed suggestive associations at genetic variants near PCSK1 with BMI at AP (P=2.41x10-6). 
Despite fundamental insights into the role of this gene in monogenic obesity113,311,  there are no previous 
analyses of its role in growth trajectories representing longitudinal growth patterns .  Because PCSK1 encodes 
an enzyme that has a key role in the biosynthesis of insulin and other hormones involved in regulating energy 
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metabolism, our finding may be important in linking infant growth with later obesity and so further 
investigation is warranted. 
 
Nine of the 32 adult BMI-loci reported by the GIANT consortium139 show evidence of association with one or 
more early adiposity phenotypes in our study. The other twenty three loci may not show association, either due 
to a difference in the design and power of the studies, or may only impact BMI later in life324. The scatter plots 
of effect size estimates further showed that while there are strong and significant correlations between the effect 
sizes of the early growth phenotypes at AR and adult BMI, consistent with the associations with the phenotypes 
themselves325, there are no significant correlations between the effect sizes of the other early growth phenotypes 
(PHV, PWV, age and BMI at AP) and those of adult BMI. These results suggest that genetic variants affecting 
adult BMI may often begin having an effect on adiposity related phenotypes  by  AR (~ 5yrs) but not as early as 
in the first year of life, a finding that agrees with previous reports11,120,129,326. 
 
One of the limitations of our study is that, despite being one of the largest GWAS in children, sample size was 
restricted by the availability of longitudinal growth data within the participating cohorts; however the study still 
had sufficient power to identify four loci at the genome-wide significance level. GWAS with even larger sample 
sizes will be required to identify other small-effect variants associated with early adiposity phenotypes. Our 
study might also be useful as a guide to similar studies in other ethnic groups.     
 
In conclusion, we have identified four genetic loci associated with early adiposity phenotypes at a genome-wide 
significance and one suggestive locus that did not reach genome-wide significance. Three of these loci associate 
with adulthood BMI in the present study, with effects partly mediated by early growth phenotypes. New insights 
into the biology of growth in childhood are valuable as they can guide the development and targeting of future 
therapies and interventions for weight management. Using childhood adiposity phenotypes derived from 
longitudinal growth models, we provide novel insights into the mechanisms linking early growth patterns with 
later metabolic health, and establish further evidence that genetic variants influencing adult adiposity have an 
impact on disease development from early on in life. 
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Table 22. The five loci associating with early growth phenotypes from the discovery meta-analysis compared with the published GWAS 
studies (from GWAS Catalogue). The table shows the top five early growth SNPs (index SNPs) with their equivalent variant in LD with the 
index SNP (R2 > 0.5) from all published GWAS studies mapped to nearest gene. We provide distance of variant from the index SNP, r
2
, risk 
allele, p values from early adiposity meta-analysis and GWAS catalogue, association to traits, direction of effect from early adiposity meta-
analysis references. These SNPs give us good indication of the genetic susceptibility of top-five early growth phenotypes SNPs with various 
disease traits.   
Early growth 
phenotypes 
Position In/ nearest 
Gene 
Index SNP GWAS 
Catalogue SNP 
Distance 
from 
index 
SNP 
R2 with 
index SNP 
Risk 
Allele 
P from 
early 
adiposity 
meta-
analysis 
P from 
GWAS 
catalogue 
Disease or Trait Direction 
of effect 
References 
BMI at AR 16q12.2 FTO rs1421085 rs7202116 20661 0.935 G NA 2.00E-10 Body mass index NA Yang J et al,2012 
        rs8044769 38181 0.549 C 5.96E-05 4.00E-06 Osteoarthritis - arcOGEN 
Consortium, 2012 
        rs9939609 19573 0.901 A 1.56E-07 1.00E-20 Type 2 diabetes - Perry JR et al, 2012 
        rs9922619 30817 0.806 T 1.56E-06 6.00E-08 Subcutaneous 
adipose tissue 
- Fox CS et al, 2012 
        rs9940128 200 0.905 A 9.87E-08 2.00E-09 Metabolic 
syndrome 
- Kristiansson K et al, 
2012 
        rs12149832 41954 0.868 A 1.13E-06 5.00E-22 Body mass index - Okada Y et al, 2012 
        rs8050136 15321 0.901 C 1.01E-07 3.00E-26 Adiposity + Kilpelainen To et 
al,2011 
        rs17817449 12413 0.901 NA 1.26E-07 2.00E-12 Obesity NA Wang K et al, 2011 
        rs1558902 2620 1 T NA  1.00E-07 Obesity NA Dorajoo R et al, 2011 
        rs9939609 19573 0.901 A 1.56E-07 3.00E-08 Menarche (age at 
onset) 
- Elks CE et al, 2010 
        rs8050136 15321 0.901 A 1.01E-07 4.00E-08 Body mass in 
chronic 
obstructive 
pulmonary 
disease 
+ Wan ES et al, 2010 
        rs1558902 2620 1 A 6.36E-08 5.00E-120 Body mass index - Speliotes EK et al, 
2010 
        rs11642841 44533 0.868 A 9.71E-07 3.00E-08 Type 2 diabetes - Voight BF et al, 2010 
        rs1558902 2620 1 A 6.36E-08 7.00E-13 Obesity (extreme) - Scherag A et al,2010 
        rs1558902 2620 1 NA 6.36E-08 5.00E-19 Waist NA Heard-Costa NL et al, 
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circumference 2009 
        rs9941349 24534 0.836 T 3.85E-07 6.00E-12 Obesity (extreme) - Cotsapas C et al, 2009 
        rs9939609 19573 0.901 A 1.56E-07 2.00E-07 BMI - Cho YS et al, 2009 
        rs8050136 15321 0.901 A 1.01E-07 1.00E-47 Body mass index + Thorleifsson G et 
al,2008 
        rs6499640 31277 0.205 A 1.69E-01 4.00E-13 Body mass index - Thorleifsson G et 
al,2008 
        rs8050136 15321 0.901 A 1.01E-07 5.00E-36 Weight + Thorleifsson G et 
al,2008 
        rs9939609 19573 0.901 A 1.56E-07 4.00E-51 Body mass index - Willer CJ et al, 2008 
        rs8050136 15321 0.901 NA 1.01E-07 2.00E-17 Type 2 diabetes NA Timpson NJ et al,2008 
        rs1121980 8293 0.905 NA 1.05E-07 4.00E-08 Body mass index NA Loos RJ et al,2008 
        rs8050136 15321 0.901 A 1.01E-07 7.00E-06 Type 2 diabetes + Zeggini E et al,2008 
        rs1121980 8293 0.905 T 1.05E-07 1.00E-07 Obesity (early 
onset extreme) 
- Hinney A et al, 2007 
        rs9930506 29511 0.806 A 1.64E-06 9.00E-07 Obesity-related 
traits 
+ Scuteri A et al,2007 
        rs9939609 19573 0.901 A 1.56E-07 2.00E-07 Type 2 diabetes - WTCCC, 2007 
        rs8050136 15321 0.901 A 1.01E-07 1.00E-12 Type 2 diabetes + Scott LJ et al,2007 
        rs8050136 15321 0.901 A 1.01E-07 7.00E-14 Type 2 diabetes + Zeggini E et al,2007 
        rs9939609 19573 0.901 A 1.56E-07 2.00E-20 Body mass index - Frayling TM et 
al,2007 
Age at AR 4p12 GNPDA2 rs10938397 rs10938397 0 1 G 5.41E-06 4.00E-31 Body mass index + Speliotes EK et 
al,2010 
        rs10938397 0 1 G 5.41E-06 3.00E-16 Body mass index + Willer CJ et al, 2008 
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Table 23: Associations between 32 SNPs associating with adult BMI from GIANT consortium (N=249, 796) and early adiposity phenotypes, 
within the Stage 1 GWA cohorts (N=7,215). Results are from linear regression of z-score of early adiposity phenotypes against SNP (additive 
model), adjusted for gender and gestational age (GA). The gestational age was only adjusted in PWV, age and BMI at AP. The β are given in 
SD units. Results for PHV were removed as none of the results were significantly associated and due to lack of space.  
   GIANT Consortium Early adiposity phenotypes GWAS 
      N PWV   Age at AP  BMI at AP  Age at AR  BMI at AR  
SNP Nearest gene Chr Beta SE P  β SE P β SE P β SE P β SE P β SE P 
rs1558902 FTO 16 0.39 0.02 4.80E-120 7215 -0.02 0.02 1.71E-01 -0.02 0.02 3.67E-01 -0.02 0.02 3.40E-01 -0.1 0.02 6.36E-08 0.09 0.02 5.29E-06 
rs2867125 TMEM18 2 0.31 0.03 2.77E-49 7215 0.08 0.02 6.90E-05 0.05 0.02 4.14E-02 0.07 0.02 5.23E-03 -0.08 0.02 9.20E-04 0.1 0.03 1.36E-04 
rs571312 MC4R 18 0.23 0.03 6.43E-42 7215 -0.01 0.02 6.49E-01 0.03 0.02 2.39E-01 -0.01 0.02 5.39E-01 -0.08 0.02 3.48E-04 0.05 0.02 2.90E-02 
rs10938397 GNPDA2 4 0.18 0.02 3.78E-31 7215 0.03 0.02 1.20E-01 0.01 0.02 6.86E-01 0.03 0.02 8.47E-02 -0.08 0.02 1.70E-05 0.09 0.02 5.41E-06 
rs10767664 BDNF 11 0.19 0.03 4.69E-26 7215 -0.01 0.02 4.83E-01 -0.03 0.02 1.67E-01 -0.02 0.02 4.81E-01 -0.05 0.02 2.31E-02 0.02 0.02 3.69E-01 
rs543874 SEC16B 1 0.22 0.03 3.56E-23 7215 0.02 0.02 2.24E-01 0.04 0.02 8.33E-02 0.02 0.02 4.69E-01 -0.09 0.02 1.39E-04 0.1 0.02 1.96E-05 
rs2815752 NEGR1 1 0.13 0.02 1.61E-22 7215 0.02 0.02 2.06E-01 0 0.02 8.22E-01 0.04 0.03 1.52E-01 -0.06 0.02 3.22E-03 0.04 0.02 5.50E-02 
rs713586 RBJ 2 0.14 0.02 6.17E-22 7215 0.04 0.02 2.63E-02 0.02 0.02 1.85E-01 0.06 0.02 8.06E-04 -0.06 0.02 1.58E-03 0.09 0.02 6.23E-07 
rs12444979 GPRC5B 16 0.17 0.03 2.91E-21 7215 0 0.02 8.70E-01 0.01 0.03 5.92E-01 0.02 0.03 3.61E-01 -0.02 0.03 4.22E-01 0.05 0.03 8.87E-02 
rs7359397 SH2B1 16 0.15 0.02 1.88E-20 7215 0 0.02 8.85E-01 -0.01 0.02 7.31E-01 0.01 0.02 7.55E-01 -0.04 0.02 5.58E-02 0.04 0.02 1.90E-02 
rs987237 TFAP2B 6 0.13 0.03 2.90E-20 7215 0.03 0.02 1.66E-01 0.04 0.02 9.91E-02 0.04 0.02 6.99E-02 -0.08 0.02 3.48E-04 0.07 0.02 2.09E-03 
rs2241423 MAP2K5 15 0.13 0.02 1.19E-18 7215 -0.01 0.02 4.88E-01 0.01 0.02 7.64E-01 0 0.02 8.37E-01 -0.03 0.02 2.17E-01 0.02 0.02 4.86E-01 
rs9816226 ETV5 3 0.14 0.03 1.69E-18 7215 0.06 0.02 7.28E-03 0.03 0.02 2.70E-01 -0.02 0.02 4.75E-01 -0.01 0.05 7.66E-01 0.02 0.03 4.08E-01 
rs7138803 FAIM2 12 0.12 0.02 1.82E-17 7215 0.05 0.04 1.62E-01 0.02 0.02 2.54E-01 0.01 0.02 7.08E-01 -0.08 0.02 1.88E-05 0.07 0.02 4.24E-04 
rs2287019 QPCTL 19 0.15 0.03 1.88E-16 7215 0 0.02 9.47E-01 -0.01 0.02 5.57E-01 -0.01 0.02 5.06E-01 -0.03 0.02 2.25E-01 0 0.02 9.16E-01 
rs1514175 TNNI3K 1 0.07 0.02 8.16E-14 7215 0.05 0.02 2.40E-03 0.01 0.02 6.76E-01 0.05 0.02 4.54E-03 -0.07 0.02 5.02E-04 0.06 0.02 1.17E-03 
rs13107325 SLC39A8 4 0.19 0.04 1.50E-13 7215 -0.05 0.05 3.23E-01 0.01 0.06 8.25E-01 0.03 0.05 5.95E-01 -0.02 0.06 7.54E-01 0.06 0.06 3.36E-01 
rs2112347 FLJ35779 5 0.1 0.02 2.17E-13 7215 -0.01 0.02 7.42E-01 0.01 0.02 4.59E-01 0 0.02 8.41E-01 0 0.02 8.11E-01 0 0.02 9.96E-01 
rs10968576 LRRN6C 9 0.11 0.02 2.65E-13 7215 0.02 0.02 3.39E-01 0.04 0.02 5.90E-02 -0.01 0.02 7.00E-01 -0.01 0.02 6.00E-01 0.02 0.02 2.08E-01 
rs3817334 MTCH2 11 0.06 0.02 1.59E-12 7215 -0.01 0.02 6.32E-01 0 0.02 9.64E-01 -0.02 0.02 1.68E-01 -0.02 0.02 3.44E-01 0.01 0.02 6.61E-01 
rs3810291 TMEM160 19 0.09 0.02 1.64E-12 7215 -0.01 0.02 5.68E-01 0.03 0.04 6.75E-01 -0.01 0.02 5.06E-01 -0.01 0.02 5.89E-01 0.03 0.02 1.67E-01 
rs887912 FANCL 2 0.1 0.02 1.79E-12 7215 0.01 0.02 5.78E-01 -0.02 0.02 3.00E-01 0.01 0.02 6.69E-01 -0.01 0.02 6.46E-01 0 0.02 9.27E-01 
rs10150332 NRXN3 14 0.13 0.03 2.75E-11 7215 0 0.02 9.82E-01 -0.02 0.02 2.98E-01 -0.02 0.02 4.77E-01 -0.03 0.02 1.96E-01 0.02 0.02 2.91E-01 
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rs13078807 CADM2 3 0.1 0.02 3.94E-11 7215 -0.02 0.02 4.52E-01 0 0.02 8.41E-01 0 0.02 9.85E-01 -0.03 0.05 7.75E-02 0.02 0.02 5.45E-01 
rs11847697 PRKD1 14 0.17 0.05 5.76E-11 7215 0.08 0.05 9.81E-02 0 0.06 9.94E-01 0.08 0.06 1.60E-01 -0.16 0.07 2.22E-02 0.13 0.07 6.88E-02 
rs2890652 LRP1B 2 0.09 0.03 1.35E-10 7215 0.01 0.02 6.42E-01 -0.01 0.02 6.29E-01 0.01 0.02 6.18E-01 -0.04 0.02 8.09E-02 0.06 0.02 9.58E-03 
rs1555543 PTBP2 1 0.06 0.02 3.68E-10 7215 0 0.02 7.64E-01 0 0.02 9.79E-01 0 0.02 9.37E-01 -0.06 0.02 2.86E-03 0.02 0.02 2.62E-01 
rs4771122 MTIF3 13 0.09 0.03 9.48E-10 7215 0.02 0.02 2.60E-01 0 0.02 8.26E-01 0.01 0.02 7.13E-01 -0.03 0.02 2.22E-01 0 0.02 9.22E-01 
rs4836133 ZNF608 5 0.07 0.02 1.97E-09 7215 0.01 0.02 5.48E-01 0 0.02 9.75E-01 0.01 0.02 4.76E-01 -0.02 0.02 3.72E-01 0 0.02 8.43E-01 
rs4929949 RPL27A 11 0.06 0.02 2.80E-09 7215 -0.02 0.02 1.35E-01 0 0.02 8.47E-01 -0.03 0.02 1.43E-01 -0.05 0.02 1.22E-02 0.01 0.02 7.59E-01 
rs29941 KCTD15 19 0.06 0.02 3.01E-09 7215 0.02 0.02 1.79E-01 0.01 0.02 6.12E-01 0.05 0.02 6.15E-03 -0.01 0.02 6.63E-01 0.02 0.02 3.62E-01 
rs206936 NUDT3 6 0.06 0.02 3.02E-08 7215 -0.02 0.02 4.08E-01 0.03 0.02 1.77E-01 0.01 0.02 6.98E-01 0.02 0.02 3.59E-01 -0.02 0.02 3.68E-01 
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Chapter 6: Conclusions 
The first part of this chapter provides a summary of the methodologies used, conclusions reached, and 
discussion of the strengths and weaknesses of each study in the thesis. The second part of the chapter outlines 
work currently being undertaken that follows on directly from sections within the thesis and also work planned 
for the future. The thesis provides a background to the research topic by presenting published studies that have 
investigated several prenatal, postnatal, genetic and environment factors to understand the underlying causes 
of childhood and adulthood obesity. The literature review shows that there is still a gap in knowledge that needs 
to be filled. Each study included in this thesis provides evidence towards the ‘programming effect’ in the 
development of obesity. Section 6.1 discusses the general conclusion for the thesis, Section 6.2 discusses the 
methodology used, Section 6.3 and 6.4 examine the strengths and weaknesses of the study and finally section 
6.5 discusses the further work from the thesis. 
6.1   General conclusions 
This is the first study that attempts to understand how prenatal predictors influence early growth, and how both 
the prenatal and postnatal environment can be responsible for the development of adverse metabolic health in 
later life. The study also confirms that leukocyte telomere length (LTL) is a biomarker of diseases associated 
with biological aging and that telomeres shorten in women who change substantially in body mass from 
childhood to adulthood. Furthermore, the study identifies several genetic variants associated with early growth 
measures, such as infant head circumference and early growth phenotypes: peak height and weight velocity, age 
and BMI at adiposity peak (AP) and age and BMI at adiposity rebound (AR). This study has shown that the 
effect of these genetic variants on adulthood life factors may be mediated via these early growth measures, 
indicating that these early growth measures could be important markers to explore in future in terms of 
individual health.  This is the first kind of study that utilises dense longitudinal data to analyse extensive 
prenatal predictors with postnatal growth and adulthood health. It is also the first study to utilise longitudinal 
growth modeling in a GWAS context.  
 
This study on prenatal predictors of infant height growth supports the hypothesis that smaller birth size results 
in faster postnatal growth. Moreover, it showed that several maternal and paternal factors, such as maternal age, 
weight, parity and smoking are directly associated with faster postnatal height growth. However, their 
association was found to be mediated by size-at-birth variables. The mediation by size-at-birth variables is 
indicative of an adverse intra-uterine environment during fetal development. The study provides evidence that 
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“damage” done during fetal development is compensated by increased early childhood growth, but can have an 
adverse effect later in life. These findings are important to public health knowledge and can be evaluated to 
form health policy aimed at improving the prenatal environment and also at monitoring an infant’s growth 
during the first few years. However, further work will be required to disentangle more complex relationships 
between these infant height growth parameters and to test if they are markers of CVD in adults. 
 
The findings from the study on the effect of an obesogenic environment in utero, and during childhood on 
adolescent metabolic health, highlights that there is still a gap in understanding the metabolic impact of 
maternal pre-pregnancy weight and postnatal obesogenic environment on offspring’s health. This study 
attempts to understand how various metabolic phenotypes maybe ‘programmed’ in utero or whether they are 
affected by an obesogenic environment during postnatal development. Recent rodent studies show the 
‘programming’ effect of the metabolic phenotypes in offspring and this study attempts to replicate the original 
findings from an experimental design using human observational data. The study indicates that the fetus of 
overweight and obese mothers will be exposed to higher concentrations of insulin and other adverse factors 
compared to the fetus of normal weight mothers, which could alter the development of key organs.  There is a 
growing body of evidence indicating a ‘programming’ effect by maternal weight on the future health of the 
offspring however it is extremely challenging to segregate the complex interaction between the maternal factors 
and the postnatal obesogenic lifestyle factors, to uncover the true causal mechanisms for this programming 
effect. Despite the fact that such research is at an early stage, the indications of such a programming effect by 
maternal weight are substantial.  
 
The study on the association of LTL at 31 years with adiposity-related anthropometric measurements and 
change in BMI distribution from childhood to adulthood suggests future investigation on the potential for using 
LTL as a biomarker for age related diseases such as CVD and obesity. Studies based on LTL measures can be 
effectively used to develop interventions to combat obesity, such as monitoring the maintenance of healthy 
weight in women and increased moderate physical activity
327
. The study shows that in women, a large increase 
in body mass after childhood (5years) to adulthood (31 years) may be detrimental and potentially result in 
earlier biological aging, which can be associated with CVD and obesity. Further longitudinal studies are 
required to replicate these long-term effects of weight gain after childhood on LTL, healthy aging and cardio-
metabolic disease risk and to investigate the gender differences observed here. 
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The GWAS to find genetic variants affecting infant HC identified two genetic variants in/near genes SBNO1, 
HMGA2 associates with infant HC that also associated with adult height. The study concluded that the 
associations between the genetic variants and adult height were mediated by HC. It is known that infant HC 
correlates with body size, and its role in regulation of body size is unknown. It has been proposed that the genes 
identified associating with HC also play a general role in skeletal growth and bone development. Moreover, one 
of the variants near CRHR1 did show suggestive evidence of association with HC, and this gene has been found 
to be directly associated with brain development and specifically with skull growth. This was confirmed by 
animal studies, showing that absence of CRHR1 gene can lead to mal-development of the central nervous 
system. Therefore, this study highlights that early brain growth may be associated with several neurological 
disease in later life and early markers such as infant HC needs to be further evaluated in larger samples and in 
samples of different ethnicity in order to confirm it as a marker for neurological diseases  
 
The GWAS on early growth phenotypes, linking childhood growth with adulthood obesity, identified four 
genetic variants at genome-wide level and one at suggestive level. Three of these variants also associated with 
adult BMI, with the effects of these three genetic variants being partly mediated via early growth phenotypes, 
such as age and BMI at adiposity rebound. These findings suggest that early growth phenotypes can be used as 
a robust marker to understand the pathogenesis of obesity in adolescence and adulthood. Additionally, these 
indicators can be used in the clinical setting to monitor and implement interventions early in life. These new 
insights into the biology of growth in childhood and how they affect adulthood factors will be valuable as they 
can guide the development and targeting of future therapies and interventions for weight management. 
6.2    Methodology considerations 
The NFBCs have been an ideal source of population-based study for growth modeling process. They provide 
some of the densest data available with frequent height and weight measurements from birth to adulthood. This 
data is excellent for modeling and developing growth parameters for analysis. The selected population was also 
representative of the wider Northern Finland population as shown in the analysis (Chapter 5, Section 2) when 
selecting sample for peak height velocity analysis.  The selection of a parametric model was done mainly on 
NFBC1966 data. Once selected, I applied the same model in NFBC1986. This was a collaborative effort from 
the team at Imperial. . The mean of early growth phenotypes was consistent with other participating cohorts, as 
seen in the GWAS of the early growth phenotype study, showing robust methodology. I also applied 
SuperImposition by Translational And Rotation (SITAR)
328
 model to NFBC data but it did not fit well with the 
data. It was beyond the scope of this thesis to present the comparison between SITAR and growth models 
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selected in NFBCs.   This model needs to be examined in detail in future work as well as other options for the 
analyses of longitudinal data, for example in terms of mediation
329
.   
6.3    Strengths of the study 
The thesis provides one of the biggest studies conducted on fitting of growth curves on dense longitudinal data, 
as the NFBCs has the world’s richest data in terms of data from early pregnancy until middle age with extensive 
genetic and other biological information. The NFBCs provide the ideal dataset for growth modeling at different 
age periods, such as infancy, childhood and adolescence. It also provided the most homogenous cohort in terms 
of ethnicity and a subsample available for the current study showed a high representativeness of the whole 
population. The GWAS analyses conducted were statistically powerful, and successful strategies were applied 
to identify the mediation of size at birth variables and early growth phenotypes.  
The growth phenotypes modelled in this thesis, especially adiposity peak (AP) and adiposity rebound (AR), are 
considered occurring during the important developmental stage in a life course, and any physiological 
alternation during these times can increase the risk of later obesity. The age of AR has also been strongly 
associated with adiposity in adolescence and adverse metabolic health in adulthood. While there is still debate 
over the importance of these infant and childhood growth phenotypes; and the role of mediation by growth 
phenotypes between prenatal predictors and later obesity, the results from this thesis confirms a strong 
association. It indicates their importance in being early markers of disease risk. It is still early days to reach 
conclusions and further experimental study is required to assess these early risk markers in more detail.  
6.4    Limitations of the study 
The study has many strengths but it also has some limitations. One of the limitations could be due to a bias 
caused by missing values To address the issue of missing values, the current study applies complete case 
analysis for the growth modeling which restricts analysis to the subsample of subjects with complete cases, 
excluding all individuals who have missing values for any of the variables being considered, whether outcome 
or explanatory. However, attrition analyses suggested that samples included in the analyses here were an overall 
representation for the rest of the population.   
Another limitation of this study is that maternal prenatal or postnatal nutritional information was not available 
within either NFBCs. Previous studies emphasize the role of maternal nutrition on birth outcomes 
330
. It has 
been proposed that nutrition in fetal life acts as the central stimuli for programming of susceptibility to adult 
diseases
331
. For example, the Dutch hunger winter study shows that women exposed to limited nutrition during 
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pregnancy had smaller size babies and increased risk of obesity and T2D in adult life
332
. Several animal studies 
also provide evidence on the biological plausibility of regulation of mammalian fetal growth due to maternal 
nutrition
333
. Although reviews show that results of maternal nutrition on size-at-birth studies are inconclusive, 
as many of these studies linking maternal nutrition to body proportions lack a sound experimental basis. As a 
solution, the analyses in this thesis were adjusted for an extensive set of confounders such as maternal SES and 
education known to be correlated with maternal nutrition.  
The thesis provides two robust GWAS identifying eight novel genetic variants associating with infant head 
circumference and early growth phenotypes. GWA studies have successfully identified multiple loci associated 
with common variants which potentially have clinical implications; however it has its own short comings. 
GWAS only detects the small structural variations at single nucleotide associating with disease phenotype, and 
the cumulative effects of multiple SNPs only explains a small fraction of an individual’s risk for that trait. 
Additionally, current GWAS does not account for any environmental variations in the association, and therefore 
can confound the association. Despite this shortcoming, GWAS has been most successful in identifying robust 
associations with structural variants. Newer methodologies and approaches have been proposed to counter these 
shortcomings, for example, gene-environment interaction studies, as briefly discussed in future work below.    
6.5   Future work 
The research as part of this thesis has given me a good basis to identify further projects that I am now interested 
in working on. During the course of my PhD and then for a year on MRC Centenary Award, I have managed to 
acquire expertise in the area of GWAS which I have utilized to expand my research interest into several other 
areas. In this section, I have outlined some of the research projects I am currently involved in as well as those 
that I would like to undertake in the future. 
6.5.1 Gene-environment (G x E)  interaction studies on pre-pregnancy maternal smoking and offspring 
birth weight (BW). 
The gene-environment (G x E) interaction studies are seen as the evolving methods of genetic epidemiology. 
Recently there has been a greater focus on these studies as they account for both genetic and environmental 
determinants to identify variants for common diseases
334
, reducing confusion caused by environment or taking 
into account its contribution. In this G x E study, we examine the effect of pre-pregnancy maternal smoking on 
offspring birth weight (BW). The effect of smoke during pregnancy has been identified as one of the strongest 
risk factors for a number of adverse birth outcomes, including intra-uterine growth restriction (IUGR)
335
. Babies 
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whose mothers smoked during pregnancy are on average 150 to 200g lighter at birth than babies with non-
smoking mothers
65,175
. Previous genetic studies have identified variations at CHRNA5-CHRNA3-CHRNB4 locus 
on chromosome 15q25, robustly associated with the quantity of smoking in those who smoke 
336-339
. Studies on 
women who smoked during pregnancy from the UK 
340
 and Netherlands 
176
 independently investigated 
association between the 15q25 variant and BW, showing reduction in BW with each additional copy of risk 
allele in women who smoked during pregnancy. However, both of these studies have been of limited power and 
potential association with fetal genotype has not been examined.  
 
This current study hypothesises that maternal smoking is strongly associated with BW and there is evidence that 
genetic variation may decrease BW due to pre-pregnancy maternal smoking. The study selected ten GWAS 
cohorts (1958 T, 1958 W, ALSPAC, GENR, INMA, LISA, NFBC1966, RAINE, TEENAGE and PANIC) with 
maternal smoking information available as discovery cohorts (N=17,569). Genotypes were obtained using high-
density SNP arrays and were then imputed for ~ 2.5 million HapMap SNPs 
16
. The study sample excluded 
individuals who were born prematurely, those without any gestational age (GA) information, multiple deliveries 
and still born. Moreover, individuals with low BW (less than <500g) were also excluded, as these children may 
have other factors influencing the association. Individuals with Non-Caucasian ancestry or mixed ancestry were 
also removed from the analysis.  
 
The outcome variable, BW (in grams), was quintile normalized adjusting for sex and gestational age (GA), 
major confounders, and then rescaled to the sample mean and standard deviation. Pre-pregnancy maternal 
smoking was divided into three categories: non-exposed group (those who never smoked and non-smokers) and 
exposed group (smokers). However, two different definitions of the non-exposed category were used in the 
analyses, to maximise the sample size. The never smokers were defined as mother’s who did not smoke in their 
lifetime. Non-smokers were defined as mothers who did not smoke at the start of the pregnancy and during 
pregnancy. Smokers were defined as mothers who smoked one or more cigarettes per day at any time during 
pregnancy. Mothers who smoked tobacco in a pipe and/or cigars were removed from the analysis. The analyses 
were also adjusted for principal components; to remove inflation of the test statistics due to population 
stratification.  
The linear additive models were run on QUICKTEST software
341
. Two sets of models were tested; main effects 
model stratified by maternal smoking groups and interaction model stratified by maternal smoking groups. In 
the main effects model, three different sets of models for never-smokers, non-smokers and smokers were fit for 
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transformed BW SD scores against genetic variants adjusting for gestational age, principal components and sex. 
The interaction model was fitted for transformed BW SD scores against and interaction term between genetic 
variant and smoking categories, with adjustments for GA, principal component and sex.  
In the discovery stage, before meta-analysis, SNPs with MAF of < 1% and poorly imputed SNPs (proper_info 
of <=0.4 (SNTEST) or R2 of <=0.3 (MACH2QTL)) were filtered out. Fixed-effect meta-analyses were 
independently conducted on each study and genomic-control was applied twice, once for each discovery cohort 
and another for final discovery meta-analysis to adjust the statistics generated within each cohort. Meta-analysis 
was performed using the METAL software by me (lead analyst), as part of team at Imperial College London 
and cross-validated by another team at Kings College London, using R software. Meta-analysis was performed 
using the inverse-variance method: a fixed-effect model was assumed. SNPs available in less than 2 cohorts and 
N < 1000 were excluded. Meta-analysis results were compared for main effect models and interaction models to 
select top-SNPs for follow up.  
 
From the final meta-analysis results, seven top-SNPs were selected for follow-up in another 12 independent 
studies. Table 24 presents the seven top-SNPs with information on the nearest gene, main effect P -value, 
interaction P-value, description of the gene selected and the functional role of the gene in published paper.  
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Table 24: SNP selected for maternal smoking and BW interaction G x E study for follow-up in 12 independent replication samples.  
Rank Chr Nearest gene Main effect , P value# Interaction, P value* Description and source Function 
1 2 KIF5C 7.56E-07 3.24E-05 Kinesin heavy chain 
isoform 5C; dbSNP 
maintaining motor neuron; cancer 
(Cardoso et al, 2009) 
2 7 PILRB 2.80E-06 1.56E-05 paired immunoglobin-
like type 2 receptor beta; 
dbSNP  
transmembrane receptor protein; 
cancer, autoimmune disorder (Wan 
et al, 2004; Thomas et al,2009) 
3 4 GRID2 1.76E-05 9.07E-04 glutamate receptor, 
ionotropic, delta 2; 
dbSNP 
neuronal apoptotic death; inherited 
diseases and cancer (Rozier et al, 
2004) 
4 2 LYPD6B 2.03E-05 2.77E-04 LY6/PLAUR domain 
containing 6B; dbSNP  
expressed in CNS;  ovarian cancer 
(Risinger et al, 2011) 
5 7 CALCR 2.62E-05 8.59E-04 calcitonin receptor; 
receptor for peptide 
hormone calcitonin; 
dbSNP  
maintaining calcium homeostasis; 
metabolic bone diseases (Wolfe et 
al, 2003) 
6 10 CCDC3 6.84E-05 1.56E-04 Coiled-coiled domain 
containing 3; dbSNP 
secreted by adipocytes and 
endothelial cells; obesity 
(Kobayashi et al, 2010) 
7 22 RAC2 9.62E-05 5.26E-06 Ras-related C3 botulinum 
toxin substrate 2; dbSNP 
control of cell growth, cytoskeleton 
reorganization, and the activation of 
protein kinases; human disease (Pai 
et al, 2010) 
# and *, The SNP were selected on a cut-off of P < 1 x 10-4 for main effects P-value and then their interaction P-value added (to double check association in interaction model as well), as presented in 
Table N. This step gave 222 SNPs. In the next step, LD for each SNP was calculated and SNPs were divided into blocks according to their genetic locations. Each top SNP from the block was selected 
for the Table above.  
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6.5.2.    Association between birth and infant size measures and testosterone levels in adolescent with poly-cystic 
ovary syndrome (PCOS) symptoms in the NFBC1986. 
Poly-cystic ovary syndrome (PCOS) can be diagnosed with the presence of hyper-androgenism(clinical and / or 
biochemical evidence of androgen excess) and chronic oligo-anovulation
342
. Obesity is strongly associated with 
PCOS
343
, with reviews outlining that due to a lack of cross-sectional and longitudinal studies it is not possible to 
evaluate the prevalence rate of this association. Interestingly, some recent animal studies support the theory that 
in utero androgen excess may be an important factor programming subsequent PCOS development during 
puberty
344-346
. None of the previous studies assessed the relationship between birth or infant size and 
testosterone levels, which is a marker for PCOS.  
The aim of this study is to determine the prevalence of hyper-androgenism in two large cohorts, NFBC1966 and 
ALSPAC, of post-menarchal adolescent girls followed prenatally and from birth in the UK and Finland. The 
study aims to determine the extent to which testosterone levels are related to early developmental changes such 
as prenatal androgen exposure, early postnatal weight gain, and other familial factors such as maternal history 
of PCOS. The study also investigated whether hyper-androgenism, independently of body mass index (BMI), is 
associated with cardiovascular risk factors during adolescence.  
The main objectives of the study were to investigate if the associations between early developmental influences 
and combined primary outcomes remained after adjusting for confounders such as age at menarche and 
adolescence, both of which are strongly correlated with both testosterone and PCOS. The study defined cases 
and control using PCOS definition from Rotterdam workshop
347
. The study excluded individuals who were on 
the contraceptive pill, or were diagnosed with diabetes or were pregnant. Testosterone levels were assessed in 
girls at age 15-16 years and were selected as outcome measures (N=3000 in NFBC1986). The testosterone 
levels were log-transformed to reduce right skewness; hence the results were presented as % change. The 
predictor variables selected were BW, height and weight at infancy, delta change in infant height and weight, 
peak height velocity (PHV) and peak weight velocity (PWV). The standard deviation scores (SDS) were 
calculated for infant height and weight using the WHO anthro software 
(http://www.who.int/childgrowth/software/en/).  
Three unadjusted and adjusted linear regression models were tested. In the unadjusted model direct association 
between testosterone levels and each of the predictors (BW, infant weight, infant height, delta weight, delta 
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height and PHV) was assessed. In the first adjusted model testosterone levels against predictors, adjusting for 
age at menarche, were assessed. In the second adjusted model, testosterone levels against predictors, after 
adjustments with age at menarche and adolescent BMI were assessed.  Table 25 shows the association between 
these three models in detail.  
Results show that, testosterone levels associated with weight, height and delta weight SD score at P<0.05 
(Table 25). An increase in one unit of SD score of weight, height and delta weight increased the testosterone 
levels by 5% (95% CI: 2% to 8%), 3% (95% CI: 0.4% to 5%) and 3% (0.6% to 6%), respectively. None of the 
other predictors, such as BW, delta height, peak weight or peak height velocity, associated with testosterone 
levels at nominal significance values of P<0.05. In model 2, after adjustments with age at menarche, selected as 
a confounder, the association remained significant for weight, height and delta weight SD score at P<0.05. An 
increase in SD score of weight, height and delta weight increased the testosterone level by 5 %( 2% to 8%), 3% 
(0.4% to 5%) and 3% (0.6% to 6%). However, in the last model, adjusting for BMI at 16 years the association 
between delta weight and testosterone level weakened and was non-significant (P=0.08). The association 
between weight and height SD score with testosterone levels remained unchanged. The testosterone level 
decreased to 4% (2% to 8%) by one unit change in weight SD score and no change in testosterone levels by one 
unit change in Height SD score( β=3% (0.4% to 5%)).  
These are preliminary results showing that testosterone level associates with infant height and weight but not 
with BW. A further study using ALSPAC showed that height growth between 3-7 years and 7-10 years 
associate with testosterone levels (data not shown). Also, weight growth during 1-3 years is shown to associate 
with testosterone levels. These are very important findings as the age groups which shows significant 
association are within when the infancy and childhood growth spurts occurs, as shown in the thesis. A future 
study will investigate the role of adiposity peak (AP) in association with testosterone levels. It is clear from 
various studies in this thesis that AP may be having an indirect association with obesity in adolescence and in 
adulthood. Hormones, such as leptin, associating with AP may play an important role in PCOS as well, as 
shown in a previous study that demonstrates exercise increases leptin levels in PCOS women
348
. Therefore, 
these findings could give further understanding regarding the pathways of PCOS in adolescents. 
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Table 25: Association between birth and infant size measures and testosterone levels at 15/16 years in the NFBC1986.  
  Unadjusted   Adjusted for age at menarche   Adjusted for age at menarche and 
BMI at 16 years 
  β 95% CI 
 
P- value  β 95% CI 
 
P-value  β 95% CI 
 
P-value 
BW SDS 0.008 -0.015 0.031 0.479   0.012 -0.015 0.031 0.314   0.005 -0.015 0.031 0.681 
Weight SDS 0.050 0.024 0.077 0.0002   0.049 0.024 0.077 0.001   0.043 0.024 0.077 0.004 
Height SDS 0.031 0.005 0.058 0.021   0.033 0.005 0.058 0.018   0.031 0.005 0.058 0.031 
Delta Weight 0.031 0.007 0.054 0.013   0.026 0.007 0.054 0.040   0.023 0.007 0.054 0.081 
Delta Height 0.013 -0.010 0.035 0.271   0.013 -0.010 0.035 0.292   0.014 -0.010 0.035 0.239 
Peak weight velocity (PWV) 0.005 -0.005 0.015 0.304   0.007 -0.005 0.015 0.176   0.006 -0.005 0.015 0.282 
Peak height velocity (PHV) 0.003 0.000 0.007 0.073   0.003 0.000 0.007 0.138   0.003 0.000 0.007 0.116 
 
SDS = standard deviation score; delta weight was calculated as a difference between BW and weight SDS; delta height was calculated as difference between BW and height SDS.  
β and 95% confidence interval (CI) were presented as % change in testosterone.  
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6.5.3.    A genome-wide association studies (GWAS) on maternal gestational weight gain to identify novel 
genetic variants.   
Maternal weight gain during pregnancy is an important risk factor for birth outcomes
349
. The study in this thesis 
confirms that maternal BMI programmes the offspring’s later metabolic health, both due to in utero 
‘programming’ as well as the childhood obesogenic environment. The study also showed that the obesity risk 
and associated cardio-metabolic risk is higher in children of overweight and obese mothers in comparison to 
children of lean mothers. Gestational weight gain (GWG) is a complex phenotype, it indirectly affects fetal 
growth via the in-uterine environment, which in turns influences the growth in childhood leading to adverse 
health effects in later life
90
. It is shown in studies that during the earlier period of pregnancy (up to ~18 weeks), 
the largest contribution to weight gain of the fetus is maternal fat deposition
350
 however, a recent study using 
ALSPAC data did not associate with previous maternal or offspring adiposity variants to GWG
350
. 
 
The aim of this study was to conduct a GWAS of both maternal and fetal genome-wide data to identify genetic 
variants associated with GWG. The study selected five GWAS cohorts (ALSPAC, RAINE, Gen R, TEENS, 
INMA and NFBC1966) with GWG available; is led by the ALSPAC team and I am contributing on behalf of 
NFBCs as an analyst. Genotypes were obtained using high-density SNP arrays and were then imputed for ~ 2.5 
million HapMap SNPs. The study included cohorts which had DNA available for both mothers and/or 
offspring. Several other inclusion criteria applied, for example maternal weight at three time points during pre-
pregnancy, during gestation and before delivery were included. The study excluded twins or multiples, pre-term 
pregnancies (excluding deliveries < 37 weeks gestation), stillbirths / miscarriage, congenital anomalies such as 
Downs syndrome. Only samples of Caucasian origin were included in the study.  
 
Three GWG variables were derived as outcome variables for the study – a total gestational weight gain 
(tGWG), early GWG per week gestation (eGWG) and late GWG per week gestation (lGWG). The three 
outcome variables were transformed to z-scores by subtracting the individual value subtracted by sample mean 
and divided by sample standard deviation. The association between each SNP and GWG variable was assessed 
in each study sample (including NFBC1966) using linear regression of GWG z-score against genotype, 
assuming an additive genetic model. This work is ongoing with follow-up SNPs for replication in NFBC1986 
awaited. 
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6.5.4.    The association between DNA methylation, early-life growth trajectories and adulthood 
metabolite levels. 
This work is an extension of the GWAS conducted on early growth phenotypes. The aims of this study were to 
investigate the metabolic and epigenetic modification of the genetic variants associating with early growth 
phenotypes and adult BMI. Although GWA studies identify a number of genetic polymorphisms associating 
with complex diseases, little can be inferred of the underlying pathways for the disease-causing mechanisms. 
Moreover, large populations are needed to provide enough statistical power for identification of new disease-
causing genetic variants. With the advances in gene expression and reduced costs, several new methodologies 
have been proposed to understand the causal mechanism of these disease-causing genetic variants. The studies 
on metabolomics measures can act as intermediary phenotypes (IP), which can associate a metabolite with 
disease end points and provide more details on potential pathways related to the etiology of the 
disease
351
(Figure 14). Additionally, more recently epigenetic modifications have also been described to 
understand the molecular reprogramming of a DNA sequence, which describes the change in gene expression in 
response to environmental stimuli, such as change in diet and in utero environment
352
. Moreover these 
epigenetic markers are suggested to sustain long term change in gene expression and phenotypic variability
353
, 
indicating more heritability of disease traits from parent to offspring.  
The results from GWAS conducted on early growth phenotypes identified five genetic variants (in/near 
LEPR/LEPROT, FTO, TFAP2B, GNPDA2 and PCSK1) regulating body weight, appetite and energy balance via 
the hypothalamic-pituitary-adrenal axis (HPA). Moreover, one SNP in LEPR/LEPROT regulates the growth 
hormone action in the liver and its over-expression reduces IGF-1 production, leading to growth retardation. 
Therefore the objective of this study is to understand the molecular mechanisms connecting these genetic 
variants with the metabolites and epigenetic markers, which may be associated with adverse health in 
adulthood. The main hypotheses which this study tests are: a) early growth parameters associate with 
metabolites and b) early growth phenotypes show epigenetic modification markers. The study aimed to use 
large-scale metabolomics data available in NFBC1966 (n=5500) for discovery stage analysis and then use 
NFBC1986 (n=6000) for validation. Within this ongoing work; the study will now extend to investigate the 
early growth phenotypes in DNA methylation data.  
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Figure 15: Schematic illustration of the role of intermediate phenotypes (IPs), such as metabolic traits or 
epigenetic markers, demonstrated by example of two genes that associated with early growth phenotypes 
and adult BMI, both markers for obesity. Adapted from Gieger et al, 2008
351
.  
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Appendix 
1 Appendix note 1. Reclassification of maternal socio-economic status (SES) in NFBC1986 
 
Maternal SES was re-classified into eight categories according to the occupation of the mother and 
father. It is well known that the socio-economic status (SES) according to occupation is a good 
reference to detect the general trends of difference in health. Since only few studies focus on related 
variables such as size of dwelling or number of persons per room, this study will exclude the related 
variables for current analysis. In the original status, maternal SES is classified based on maternal 
and paternal occupation as:  
 
1. Class I – Professionals (leading position) 
2. Class II – Professionals (Small entrepreneurs) 
3) Class III – Skilled worker 
4) Class IV (Unskilled worker) 
5) Farmer >=8 
6) Farmer <8 
7) Farmer's wife, size of the farm >=8 ha 
8) Farmer's wife, size of the farm <8 ha 
 
The classification 5 and 6 are derived from paternal occupation and was empty for this dataset. In 
future, this study would like to see the consequences for missing dataset. The distribution of 
frequencies for the maternal SES is shown in the table 3a and for analysis purposes was further 
grouped as shown in Table 3b.  
 
1. Class I and II – Professionals 
2. Class III and IV – Skilled and unskilled workers 
3. Class V, VI, VII and VIII – Farmer 
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2 Appendix Note 2. MSc Dissertation 
Abstract 
Background and aims: The aim of the study is to develop height growth models for 
prenatal/postnatal data to explore association between demographic, biological and socio-economic 
determinants of fetal and postnatal growth velocity (peak height velocity, PHV). This study 
explores applicability of existing growth models so that they could be later tested to study 
relationship between infant growth and health phenotypes.   
Methods: This study explored data on 9203 singleton individuals born in Northern Finland from 1 
July 1985 until 30 June 1986. A total of 5644 infants with full growth data were included for 
growth modeling and to analyse the relationship between prenatal biological and socio-
demographic factors and PVH from birth until 24 months of age.  Three different models were 
tested, one for prenatal growth (Rossavik model) and two for postnatal growth (Count and Reed 
models).   
Results: Reed 1 model was selected to develop postnatal height growth curves of boys and girls 
separately and showed good fit into the data (Goodness of fit, P<0.0001).  PVH was derived from 
the model as its first derivatives and was used as an outcome. Rossavik model did not fit well into 
the prenatal data; will need further development.  
Conclusion: It was observed that Reed 1 model was well fitted to the data. The association analyses 
showed that many potential determinants of early growth associated independently of other factors 
with PHV. It was slightly unexpected that many factors, particularly those related to size at birth, 
had such a strong negative association with PHV. Although this provides a first of its kind of study 
and a better understanding of association between determinants of fetal growth and growth velocity 
in infants, further work is needed to understand more complex relationship between early life 
course factors, potential markers of adult diseases, and growth velocity. 
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Introduction 
Growth 
Growth has been defined as increase in size or mass of tissue, primarily resulting at the cellular 
level (Thomson et al, 1971). This is a complex process which takes almost 20 years to complete and 
believed to be regulated through multiple endocrinological pathways. Growth descends from the 
combination of the genetic factors, the action of environment factors, and the interaction between 
the two. Silventoinen et al, 2006, show that 90% of variation of height in childhood and adulthood 
is explained by genetic factors. An individual obtains a genetic blueprint at conception that includes 
potential to achieve a particular size and shape, however, environment can alters this potential and 
reduce our ability to achieve them.  
Growth is majorly controlled by the hormones secreted by the endocrine system. The key hormones 
which play important function are: sex hormones (estradiol and testosterone), thyroid hormone, 
growth hormone, insulin-like growth factor-1(IGF1) and insulin. Sex hormones promote growth in 
height in childhood and early puberty and accelerate skeletal maturation and epiphyseal closure in 
late puberty resulting in lengthening of the long bones. Thyroid hormones are necessary for normal 
growth in early infancy and they stimulate osteoblast maturation and acceleration ossification by 
increasing the levels of growth hormone and IGF1. Growth hormone is the most important 
determinant of linear growth and it mainly acts by increasing the proliferation of chondrocytes 
directly and in concert with IGF1. Growth hormone increases the production of insulin, IGF1 and 
sex hormones which in turn reduce growth hormone release by a negative feedback system (Noel et 
al, 2004).  
The process of human growth is not uniform throughout life. Each region and part of body can be 
shown to have its own growth rate and this can vary according to age. Human growth occurs in 
spurts and can be divided into infancy, childhood and pubertal growth. Lampl et al,1992, 
demonstrates from his work done in human growth curve, that human growth may not be a 
continuous process but actually occur in short bursts of activity, called “saltation”, that punctuate 
periods of no growth, called “stasis”. Tanner et al, 1990, described the term “Growth velocity” or 
“height velocity” as the pattern created by changing rate of growth from the continuous distance 
curve of varying magnitudes. In recent times, velocity curve has become the preferred tool of 
studying individual growth pattern as it shows the growth in a clear and intuitive way. 
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Dimensions of growth 
 
Growth can be measured in terms of changes in one of the many anthropometric variables. 
However, Dietz et al, 1998, have shown that only height and weight are generally routinely 
measured in the clinical setting and included in medical records. This study will focus on height as 
the dimension of growth to advance the future studies on the role of growth velocity in diseases 
later in life. Height has also been shown as an excellent indicator of general child health and 
nutritional status which has been found to inversely associate with initially with total mortality, 
coronary heart disease, type 2 diabetes and cancer (Rolland-Cachera, 1995).   
 
Growth pattern in fetus and infancy  
 
According to “fetal hypothesis”, it is important to understand the fetal development and find 
patterns that can influence adverse effects in later life. Tanner, 1978, was the first to illustrated fetal 
growth in crown-heel length peaks at about 20 week gestation. Fetal growth is generally considered 
in terms of birthweight; therefore, there is considerably little information available on growth 
patterns in terms of size. Fetal length relies largely on two sources of information: extra uterine 
anthropometric measurements and intrauterine ultrasound measurement of fetus, therefore, in the 
study, it uses the details on the extra uterine anthropometric measurements of fetus as a marker for 
fetal length. 
The growth pattern in fetus follows a slope of decreasing velocity between 20
th
 and 30
th
 weeks of 
gestation, however, the rate at which the length of the fetus increases reaches a peak at 
approximately 120 cm/yr-1. Nevertheless, the only element that can be observed postnatal is the 
slope of decreasing velocity lasting until about 4 years of age. The velocity of in utero linear growth 
is maximal at about 18 wk gestational age in the human. At this time, the fetus grows four times 
more rapidly than at any time postnatal but the rate declines sharply during the last weeks of 
gestation.   
Infancy is a high velocity, rapidly decelerating, nutrition-dependent phase of growth. Cole, 2000, 
defined that adult height trends matches that at age 2 years, so that the increment in adult height has 
already been achieved by age 2 years. Hence Infancy in this study is defined as the period between 
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birth and 24 months of age. Infants grow very fast during the first year of life, at approximately 
25cm/yr; and surging the first half of this year, velocity may be even faster, around 30 cm/yr. 
However, growth does not occur at a regular rate and is episodic during infancy, where increase in 
length occurs in a few days which can be followed by quiet long periods of no growth.  At rather 
step and continuous deceleration can be observed from birth up to the third year. Thereafter, there is 
a much milder decay in velocity during school years before the adolescent growth spurt which is 
very weak compared to fetal and infancy growth. Growth during infancy is thought to be especially 
important because of high growth velocity and sensitivity to external factors in this age range 
(Waterlow, 1988; Forman et al, 1990).  
 
 
Why model growth?  
 
Hauspie et al, 2004, stated that for describing growth patterns, it is important to use mathematical 
modeling of the growth curve as they describe, summarize and quantify features that are usually 
based on longitudinal data for individuals. There are multiple reasons for studying human growth, 
but two main areas of interest can be distinguished. First, one is interested in obtaining age-
dependent reference curves for various somatic variables, usually based on cross-sectional data. The 
reference curve will be helpful in clinical setting to obtain comparable values at different ages. The 
second motivation is get a scientific understanding of the growth process over certain phases, such 
as, birth to adulthood. By fitting the growth model, one can also gain insight into functional 
relationship between the physical aspect of growth and the parameters provide e.g. biochemical 
concentrations, maturity indices etc.  
Although there are many mathematical ways to modeling the human growth curve, one particular 
model by Karlberg et al, 1989 is particularly relevant to the purpose of explaining biological 
factors. Karlberg, 1989, designed the Infancy-Childhood-Puberty (ICP) model, which reflects, the 
main physiological features of the growth process and is compatible with the underlying endocrine 
and biological influences (Figure1). This model defines infancy as a high growth velocity 
immediately after birth and rapid decelerating until about 3 years of age. It uses polynomial 
functions to describe the height velocity and the following gradual decelerations. This is followed 
by childhood, a period of lower, slowly decelerating velocity which lasts until the onset of puberty, 
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although a slight increase in velocity, referred to as the mid-growth spurt, occurs between age 6 and 
8 years in many children. This is defined by a second degree polynomial function that describes 
height velocity as following a gradual deceleration similar to infancy. The puberty component was 
modelled with a logistic expression describing additional growth induced by pubertal hormones 
which produce acceleration up to peak height velocity (PHV) and then a deceleration until end of 
growth.  
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Figure 1: Showing the three phases of postnatal growth, according to Karlberg et al, 1989. 
The growth curve is distinguished into an infancy cycle (beginning from birth and ending 
before 1.5 to 2 years), the childhood cycle and pubertal phase. The first of these “growth 
spurts” is called the juvenile or mid-growth spurt and second is called the adolescent growth 
spurt (Karlberg et al, 1989). Each phase is separately modelled and the figure presents the 
raw values for each growth curve. 
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Methods 
 Study population and design  
The NFBC 1986 study was originally set up to enable the study of the epidemiology of disease, risk 
factors for pregnancy outcomes and school achievements later in life. All expectant mothers of the 
Northern provinces of Oulu and Lapland, whose expected date of delivery was between the 1 July 
1985 and 30 June 1986, were eligible for the study. In total there were 9362 women, which made up 
99% of all births in the study area, with 9479 live and 47 still births, of these, 9203 were singletons 
births.   
In this study recruitment and data collection began in the 12
th
 week of pregnancy when the mothers 
visited their municipal maternity health centre, continuing after birth with main data collection at 7, 
8 and 16 years. Information on health and socio-economic situation was collected through specially 
designed self-completed questionnaires filled out by the expectant mothers. The questionnaires 
being handed out at the first antenatal visit were returned by the 24
th
 gestational week. All expectant 
women had maternity cards containing part of their medical records during pregnancy, filled in and 
updated by midwives on each visit during pregnancy, these and hospital records were used to 
extract obstetrical and birth data. Birth data were collected from the records after each delivery. 
Permission was taken from the children and their parents during the follow-up at 16 years.  
In the present study we excluded all multiple births (n=232), still birth (n=47) and those participants 
who had withheld consent of the study group. In total there were 9203 individuals for the final 
dataset of which 4726 were boys and 4477 were girls. This study restricted the analysis to birth to 
24 months of age, hence final analysis, selects 5466 infants, including 2799 boys and 2865 girls. 
Appendix A describes the nature of the dataset. 
 
Models 
Growth modeling has been seen to a useful method for summarizing childhood growth data and 
derives growth features of interest for further analysis. Table 2, represents previous models used to 
describe early growth (0-24 months) data. Parametric growth curve were fitted separately for boys 
and girls using nonlinear random effects models (Lindstrom & Bates, 1990). The best-fitting curves 
for each individual were estimated by maximum likelihood method. Height growth velocity curves 
were obtained as first derivatives of the height growth curves. Velocity curves were then used to 
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draw biologically meaningful parameters, such as, PHV. The NLME function in R program 
(version 2.7.0) was used to fit the model.  
Assumptions for non-linear regression were check for each model. The Gaussian distribution of the 
residuals was checked by scatter plot of height in infants, homoscedasticity was verified graphically 
by the inspection of residuals versus the predicted values and independence of residuals.  
The present study fitted three growth models - Rossavik model (Rossavik et al, 1984) for fetal 
growth data, Count model and Reed 1 model for birth to infant data(age 0-24 months). The models 
were selected for better fit to the data in terms of Akaike Information Criterion (AIC) and Bayesian 
Information Criterion or Schwarz Criterion (BIC) (Akaike, 1974; Schwarz, 1978). Both AIC and 
BIC are closely related to model selection by penalising for additional parameters. AIC gives an 
asymptotic unbiased estimate of the expected log likelihood and BIC uses Bayesian arguments to 
measures the efficiency of the parameterized model in terms of predicting the data. For the purpose 
of better fit age were expressed in months for both Count and Reed 1 model. 
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Table 2: Summary of model developed specifically for growth in infants. 
Model Year Dimension(s) 
modelled 
Parameters Growth model 
Jenss-Bayley 1937 Height, Weight Four parameter 
model 
Birth-6 years 
Count A-curve 1943 Height, Weight Three parameter 
model 
Birth-6 years 
Berkley-Reed 1973 Weight, Head 
circumference 
Four parameter 
model 
Birth-6 years 
Preece-Baines 1978 Height Five parameter 
model 
2 year-final adult 
height 
Bock-Thissen 1980 Height Six parameter 
triple logistic 
model 
1 year-final adult 
height 
Karlberg 1989 Height Three parameter 
model 
Birth-final adult 
height 
JPA-2 1992 Height Eight parameter 
model 
Birth-final adult 
height 
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The Rossavik model was chosen as it shows a good fit to fetal data as previously described by 
Simon et al, 1989. Berkley, 1982, compared the reliability, efficiency, precision and goodness-of-fit 
of the Count and Jenss-Bayley models and concluded that Jenss-Bayley model fitted the growth 
data better than Count model, especially prior to 1 year of age. However, for the purpose of this 
study, the aim was to compare a model on growth data which provides good fit for birth to 24 
month of data and Count model has been applied several times by previous study. Another model 
was selected on the basis of previous work by Simondon et al, 1992, who compared five growth 
models to fit weight data between birth and 13 months of age and concluded that Reed 1 model 
shows a better fit to the early height growth data than Kouchi, Karlberg or Jenss-Bayley model.  
 
Rossavik Model for Prenatal data 
 
Rossavik et al, 1984, developed a growth model capable of describing the individual growth curve 
standards for various fetal parameters using the data of ultrasound evaluations obtained between 15 
weeks to 30 weeks of menstrual age. The basis of Rossavik model uses polynomials, which are 
frequently used to describe fetal growth. The general form of polynomials used to describe fetal 
growth is:  
P = a0 + a1 (t) + a2 (t)
 2
 +  ... + an (t)
 n
 
Rossavik model uses this polynomial equation to fit a linear parameter growth curves with three-
dimensional parameter. This three dimensional parameter has been found to follow sigmoid-shaped 
curves similar to that for birthweight (Brenner et al, 1976). The general form of the Rossavik 
equation is:   
P = c (t)
 k+st 
Where P stands for the ultrasound parameter, k a fixed coefficient determined by the anatomical 
characteristics of the parameter, c is related to genetic regulators of growth and s represents an 
unknown regulatory system that modifies genetically determined growth and t is the duration of 
growth of the parameters.  Rossavik further defined a logarithmic form for his equation which can 
be easily estimated using least square fitting procedure and is linear function: 
Log P = log (c) + k log (t) + s t log (t) 
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The current study uses the log form to fit fetal height growth derived from the Symphysis-fundus 
(SF) measurements of fetus during pregnancy for the NFBC 1986 (NFBC did not have any more 
accurate measurement for fetal height). The SF distance is generally regarded as an acceptable 
screening instrument for antenatal detection of intrauterine growth retardation (IUGR), however, its 
validity as a screening instrument of IUGR still need to be investigated further (Steingrimsodottir et 
al, 1995). 
 
Count Model for Infancy 
 
The Count model (Count et al, 1943) is a linear model with three parameters which has been 
described to fit early childhood data fairly well: 
Y = A + Bt + C ln (t) 
Where Y is size, t is age, and A, B and C are the three functional parameters. The model is fitted by 
standard least square regression methods and is linear in its parameters. It was proposed for 
modeling anthropometric variables such as weight, height, and head circumference (Count et al, 
1943).  
Livshits et al, 2000, proposed a slightly modified version of Count Model in order to allow the 
inclusion of birth data:  
Y = A + Bt + C ln (t+1) 
Where Y is size, t is age, and A, B and C are the functional parameters.  This model has been 
previously been applied to infancy weight growth in developing countries (Kim and Pollitt, 1987; 
Wohlleb et al, 1983).  
Reed 1 model for Infancy 
 
The Reed 1 model (Berkley & Reed, 1989) is a four parameter extension of the three parameter 
Count model and its functional form is: 
Y = A + Bt + Cln (t) + D/t 
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Since this model is not defined at birth (t = 0), it was modified for this study to include birth (t = 0 + 
1).   
Y = A + Bt + Cln (t + 1) + D/ (t +1) 
where Y represents the height reached at age t and A, B, C and D are the function parameters and t is 
the postnatal age. Of the functional parameters, A is related to the baseline height at birth, B to the 
linear component of the growth velocity, C to the decrease in the growth velocity over time, and D 
to the inflection point that allows growth velocity to peak after birth rather than exactly at birth. The 
Reed 1 model is linear in its constants and can accommodate one or more inflection 
points(depending on the number of reciprocal terms), allowing the description of one or more 
periods of growth acceleration and thus fitting a wider variety of both normal and abnormal growth 
patterns in early childhood.  
 
Correlation between all variables (independent and dependent) selected for the 
study 
 
The spearman correlation coefficient was used to check the collinearity between the variables as it 
does not require the population to have a normal distribution, nor that the data is distributed with 
equal intervals - assumptions that need to be fulfilled when using Pearson correlation coefficients. It 
does however require that the variables are continuous. The correlation coefficient ranges from +1 
to -1, where a score of ±1 shows a prefect positive or negative linear relationship and a score of zero 
shows no association between the variables in question. Scatter plots were also used to look for 
possible linear or non linear relationships between dependent and independent variables (As 
explained in Appendix C). Variables whose correlation was not shown to be statistically significant 
were still included in our analysis if there was a biological plausibility or graphically a non-linear 
relationship was seen.  
The chi-square test (Χ²) was performed to examine association between those covariates chosen and 
outcome variables, that were both categorical in nature. Collinearity occurs when two variables are 
a near linear combination of one another. When this occurs in the process of performing linear 
regression, the predicted outcome will not be affected, the coefficients of the individual variables 
will, and therefore the contribution of an independent variable on the model will not be correctly 
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measured.   The variable that causes Collinearity can be left outside for the model or some 
interaction between the variables can be set. The independent variables, birthweight, birth length, 
infant’s BMI, gestational age, maternal age and maternal BMI were looked at.   
 
Univariate and Multivariate Analysis 
Building the model  
The statistical analysis begins with an exploration of univariate association between outcome and 
each exposure variable independently. Using the linear regression command LM in R univariate 
linear regression analyses was first performed with PHV as the only outcome variable and 
birthweight, birth length, infant’s BMI, maternal age, marital status, education, SES, height, weight 
and BMI (details in Appendix C). The SUMMARY command was used to examine the distribution 
of result between the outcome and exposure groups and scatter plot are given to check the 
association graphically. This study tested the association between each birth measurement 
(birthweight, birth length and infant’s BMI) separately; however, birthweight was excluded from 
the final analysis as it has high correlation with BMI and birth length. 
The next step was to understand factors which influence the association most between PHV and all 
birth length, while including all other variables as confounders (Appendix D). When categorical 
variables were used, the most common or the lowest measurement was marked as baseline for 
comparison. The final step was to compute a stepwise multivariate regression analysis, by analysing 
effect of each independent variable on the outcome variable (PHV) by adding one by one in the 
model. The objective of the multiple regression analysis was to predict the change in the outcome 
variable in response to change in the independent variable when added in succession.  
 
Testing the model 
Once the exposure variable to be included were finalised, the final model was tested using standard 
procedure. The results were interpreted by looking at the point estimates using their P-values and 
confidence intervals to check the level of significance. Significance was considered if the P-value 
was <0.05 and the 95% confidence interval did not cross the zero. The F-test was also looked at to 
examine the significance of the model itself, here also a value of <0.05 was considered significant. 
Model selection was based on significant improvement in the adjusted R-square for our models. All 
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models were then checked for independence, linearity, homoscedasticity and normality, which are 
assumptions for regression analysis. Normality was checked using QQ-plots and to check whether 
there is any notable homoscendesticy, we plotted residuals of the model against each predictor 
variable. 
 
Result 
The current study consists of 9302 singleton births with approximately 51% (n=4726) boys and 
49% (n=4477) girls and utilises the data collected for 99% (n=9431) live births in the original 
sample. For the purpose of the current final analysis, the postnatal data was restricted on the period 
from birth to 24 months of age (n=5644), of which, boys (n=2779) and girls (n=2865).  
 
Modeling of prenatal and infant growth 
Both Count and Reed model were fitted for the data. For Rossavik model concerning prenatal 
period each individual with at least four SF measurements four weeks apart were chosen for 
analysis. In spite of the original aim, Rossavik model could not be fitted by the non-linear 
procedure, as the extremely high parameter set for this procedure issued error correlations and 
aborted the fitting procedure.  
Table 3 presents the mean, median and standard deviation of residual variances for each growth 
model and parameter values obtained from the final fitted model (height units are in cm and age 
units are in months). Only paired comparisons for boys and girls were carried out because the aim 
was to rank the models according to their goodness of fit.  The closest fit for infancy growth was 
provided by Reed 1 model in comparison to Count model for both boys and girls with statistically 
significant results for the goodness of fit (P <0.0001).  The Residual Standard Deviation (RSD) for 
Reed 1 model was 0.90 in boys and 0.83 in girls. In Count model the RSD was 0.93 for both boys 
and 0.86 in girls. The RSD shows the goodness of fit measure, lower values of RSD in Reed 1 
model show that the fit to the data is closer. Both models are fairly robust towards the choice of 
starting values. The initial parameter values for the models were altered to test for absolute true 
minimum, the parameter for Count model were changed to a=50, b=0.4 and c=9.5 and the 
parameter in Reed 1 model were changed to a=48, b=0.5, c = 3.4 and d = -0.09, nevertheless, the 
fitted parameter values, AIC and BIC remained unchanged for both the models.   
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Count model shows a better RSD, but on examining the AIC and BIC for models, Reed 1 model 
gives a better fit for both boys and girls. Figure 2a, 2b presents predicted response trajectories and 
observed height curve with standard error for Count model and Reed 1 model separately for boys 
and girls. Peak height velocities estimated for all infants from the models separately for boys and 
girls are presented in Table 4. The three-parameter Count model had decreasing velocities 
throughout infancy, because no inflexion point is allowed by these models. The mean age at 
inflexion of the Reed curves was 0.7 months of age. 
PhD Thesis 
 
 219 
Table 3: Functional parameter values, Residual Standard deviation (RSD), Akaike Information Criterion(AIC) and Bayesian Information Criterion 
(BIC) for the Count model and Reed 1 model on infant height data using numeric minimization algorithm technique. Count model: Y=A + Bt + C 
ln(t); Reed 1 model: Y=A + Bt + C ln(t) + D/t. 
 Males (n=2779) Females (n = 2865) 
 Mean SD Standardized Within-Group 
Residual 
AIC BIC Mean SD Standardized Within-Group 
Residual 
AIC BIC 
   Min Median Max     Min Median Max   
Count      86057.2 86114.31      86994.94 87052.41 
A* 48.61 2.16      48.07 2.06      
B* 0.46 0.09      0.58 0.10      
C* 8.70 0.75      7.68 0.70      
Residual  0.93 -27.36 -0.003 19.23    0.86 -11.14 0.001 17.16   
Reed      84781.0 84854.44      85677.6 85751.5 
A** 46.37 1.73      44.19 1.75      
B** 0.39 0.09      0.45 0.10      
C** 9.86 0.51      9.65 0.51      
D** 3.14 3.58      5.56 2.99      
Residual  0.90 -28.36 0.003 19.71    0.83 -11.23 0.004 17.81   
Count model : A*- baseline height; B*- linear component of growth velocity; C*- decrease in growth velocity   
Reed 1 model: A**-baseline height;B**- linear component of growth velocity;C**- decrease in growth velocity;D**- inflection point 
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Figure 2a: Predicted (solid red curve) and observed (blue circles) response trajectories for 2865 girl infants with standard error bar for (a) Count 
model and (b) Reed 1 model. Note that the data shown is from birth to 24 months of age. 
a b 
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Figure 2b: Predicted(solid red curve) and observed(blue circles) response trajectories for 2799 boys with standard error bars for (a) Count 
model and (b) Reed 1 model. Note that the data shown is from birth to 24 months of age.
a b 
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 Phenotype (Outcome) Variable estimation and definition 
  
The outcome of interest was PHV for boys and girls derived from the growth models. Table 4 
shows the distribution and mean of outcome variable, PHV, in the study population from Count and 
Reed models. This study uses the PHV from Reed 1 model as it has a better fit to the data. Between 
boys and girls there was a significant difference in mean of 2.26 cm/age in months in the PHV. In 
boys, the PHV ranges from a minimum of 1.1 cm/month to a maximum of 25.31 cm/month and 
from  1.1  cm/month to a maximum of 17.0 cm/month for girls(from Reed 1 model). Figure 2 shows 
the distribution of PHV in boys and girls. PHV data was analysed separately for boys and girls to 
assess whether untransformed or log-transformed data gave a better fit to a Gaussian distribution 
(Figure 3). Means, medians, SD values, and indices of skewness and kurtosis were compared with 
transformed and untransformed data (Table 4). After log-transformation, data from boys and girls in 
infants were compared with unpaired t-tests. Compared to the PHV values from NFBC 1966(Sovio 
et al, 2009) these values were higher than expected and will need further review later because this 
data was newly used for these analyses. However, slight differences should not have major effect in 
the association analyses between prenatal/perinatal factor and infant growth. 
 
Discussion 
Growth models 
 
This study utilises data from NFBC 1986 to study the growth patterns in prenatal and postnatal 
growth in infants. It uses longitudinal height measurements with average 14 measurements per 
person obtained from health clinic records from the original cohort and chooses standard parametric 
approach to model growth data.  Fitting parametric models to growth data gives the advantage of 
natural biological interpretability from the obtained parameters and it appears to fit well with this 
data as well. For fetal data, the study uses Rossavik model to fit height growth curves using SF-
measurements with average of 4 measurements per person obtained from ultrasound examination of 
pregnant women from original dataset. The program sets initial values for its parameter and least 
square techniques to fit values. However, in the current analyses it was not possible to achieve a 
complete fit for Rossavik model on the data due to restraints in selection of technique for analysis, 
nature or prenatal growth data and time constraint for the project. In future, this study would like to 
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focus on developing technique for fitting Rossavik model for fetal growth and consider using 
factors which can give precise measurements for fetal size.  
The initial analysis was done using Reed 1 model, and the growth curves were compared with 
Count model for goodness of fit. Table 3 shows the results of the comparisons between models for 
infant height, showing significant RSD, AIC and BIC for both boys and girls in REED 1 model. 
The results were consistent with the model comparison on PHV for growth in another study by 
Sovio et al, 2009, where the Reed1 model showed the best fit for infancy data. The goodness of fit 
of the liner Count model was not satisfactory and showed age related bias, similar to what was 
shown by another comparison by Berkley, 1982. However, unexpectedly the mean PHV was higher 
than expected and needs further exploration as this data was used for the first time for these 
purposes. Moreover, this should not have any major effect on the results from the association 
analyses. 
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Table 4: Mean, median, SD values and unpaired t-tests for Peak Height velocity (cm/month) 
Outcome variable Boys(n=2779)  Girls(n=2865) P-value* 
Peak height velocity  Min Median Mean (SD) Max  Min Median Mean (SD) Max  
Count Model  4.6 9.2 9.2 (0.6) 12.1  4.8 8.3 8.3 (0.5) 11.1  
Reed Model  1.7 6.7 7.2 (2.5) 25.3  1.1 4.6 5.0 (1.7) 17.0  
Log transformed   0.1 1.9 1.9(0.3) 3.2  0.1 1.5 1.5(0.3) 2.8 <0.0001 
*P-value - derived from the un-paired t-test for the difference between boys and girls.  
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Methodological discussion 
There were approximately equal distribution of for boys (50%) and girls (51%) in the analysed dataset. Girls 
were 140g lighter than boys with significant results (P<0.0001). The regression analysis shows that the 
birthweight were inversely related to the outcome PHV with a reduction of 0.03 % in every 1g increase in 
birthweight in both boys and girls. This finding could combine with findings from previous studies, such as, 
Eriksson et al, 1999 and Forsen et al, 2000, showing that lower birthweight children and subsequently become 
overweight or obese either during childhood or adult life due to rapid increase in their growth pattern to catch 
up their genetically programmed potential. Gestation age, maternal age, maternal marital status and maternal 
education did not form a strong confounder between the association of PHV and birth length (Appendix D), 
however, it is important to include in the analyses in order to demonstrate any effect they would have had on the 
regression coefficient if acting as a confounder.  
It was observed that the children of mothers who either divorced or widowed had a positive association with 
PHV with an increase by 9 % in boys (P=0.007,95% CI 0.02,0.14) and 6.5 % increase in girls (p=0.01, 95%CI 
0.014,0.113).  PHV showed a relationship with maternal education so that the children of those mothers had a 
university degree had PHV of 5.3 % (P=0.03, 95% CI -0.103, -0.006) but the results were not significant in girls 
(P=0.24,95%CI -0.10,-0.0006). Baxter-Jones et al, 1999, examined in an 1921 Aberdeen birth cohort that 
growth in 1
st
 year of life is likely to reflect a number of environmental influences, some of which may continue 
to have effects throughout early life and beyond. However, in this analysis, adjustments for maternal SES did 
not show any significant results for boys or girls, which could be explained as poor SES stagnates growth in 
utero and may triggers catch up growth in later childhood which could be a factor for diseases in later life. 
Maternal alcohol consumption after 16 weeks showed positive association with in both boys and girls, although, 
this variable is of interest for the infant’s growth it was removed from the further analyses due to high number 
of missing values and time constraints related to this project. A new variable has been recently classified in 
NFBC 1986 dataset, which could be used for future analyses. 
Ong et al, 2001, examined the relationship the relationship between maternal smoking and size at birth and 
childhood growth between 0 and 5 y in a large retrospective birth cohort and concluded that infant’s of maternal 
smokers were symmetrically small at birth compared with infants of non-smokers, however, showed complete 
catch-up growth over the first 12 months. In this study when adjusted for smoking at 2
nd
 months of pregnancy, 
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shows a positive association with increase in PHV by 5 % in boys (P=0.002, 95% CI 0.01, 0.07) and 6 % in 
girls (P=<0.0001, 95% CI 0.029, 0.082). This is first evidence on how potential intrauterine growth retardation 
in utero due to environmental factors, such as, smoking, leads into change in speed of height growth. The 
smaller children grow faster to reach their genetic growth potential. Adding maternal height to the relationship 
with outcome PHV and main exposure birth length, it was observed that the association becomes even more 
significant when adjusted for all other factors in the regression model with an increase of 0.34% in both boys 
and girls (P =0.003).  
Limitations of this study 
The growth models were checked for true minimum by changing the initial parameters values but the analysis 
returned same results for all the parameters. It is important to check the true minimum as good starting values 
will often allow an iterative technique to converge to a solution much faster, also, if multiple minima exist or if 
there are several local minima in addition to an absolute minimum, poor starting values may results in 
convergence to an unwanted stationary point of the sum of squares surface. Hence for future growth modeling 
different strategies could be compared to see goodness of fit for these techniques, for example, model to see 
goodness of fit between parametric and non-parametric models.  
 
Addition of several confounding variables into the regression analyses decreases the power to detect the 
differences especially once stratified by sex. The relatively wide confidence intervals reflect this. In other 
words, it may not be possible to see the difference especially after adjusting for several confounders in spite of 
that there still might be a difference. Though this study population, with its large size and homogenous 
distribution is an ideal sample for longitudinal, prospective, observational studies, in this study we however had 
a few important limiting factors. The nutritional factor is an important factor for infants and no information was 
available on that. The final task involves the validation process of the regression model which could not be 
performed due to time constraints. The primary concern of this process is to ensure that the results are 
genralizable to the population and not specific to the sample used in estimation. In this analysis, the whole 
cohort data was selected and hence reduces any bias due to sampling.  
 Bias 
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As seen in previous work in the area, it impossible to fit growth models without dense measurement points. 
Longitudinal height measurements from birth to adulthood are rarely available in large population based studies 
and any replication of the results can be challenging. In many growth studies uses only a few measurements per 
child to calculate growth velocity (REF?), hence, do not provide measurements that are independent; thus 
variability estimators derived from these data sets are biased.  The current analysis shows high quality of 
measurements derived for growth in this cohort. This study avoids the problems of biased estimates by applying 
the statistical analysis to the entire longitudinal growth curve, rather than individual measurements or even pairs 
of measurements.  
 Missing Data 
Another important factor for bias is this study is due to missing data. In this study, missing data is not possible 
to state or mark any "missed appointments" as missing, since there are no pre-determined times when those 
appointments should have happened. Since the study uses unbalanced longitudinal growth data, which occur 
when there is no intention to observe the anthropometric variable at a common set of ages for each subject and 
"missing data" cannot be defined in the same way one defines missing data for a cross-sectional variable such as 
social class at birth (it either has a value or is missing). As a solution, the current study applies complete case 
analysis for the growth modeling which restricts analysis to the subsample of subjects with complete cases, 
excluding all individuals who have missing values for any of the variables being considered, whether outcome 
or explanatory.  
 Rounding Errors 
In this dataset, some of the selected variables had been over represented compared to those from specific places. 
Thus, to overcome this problem and to allow the results to be more representative at the population level, 
categorization was used. This inflated the under-sampled cases and deflated the over-sampled ones. However, 
the R program introduces some minor systematic rounding errors which were therefore, unavoidable. For 
instance, the regression coefficient values of -0.0003 was rounded to 0.01 with two decimal places; however, it 
is unlikely to have a significant impact on the results.  
  Measurement issues 
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The analysis examined for errors made in measuring outcome or exposure variables, and the implications of 
such errors for the results of statistical analyses. The current analysis does not report for instrumental errors, 
underlying variability, respondent errors, and data processing errors currently and would like to explore in 
future. 
 Future work 
This is the first analyses to try and understand the association between wide varieties of prenatally and infant 
growth factors. It uses longitudinal data collected over 20 years and is a novel study of its kind using extensive 
prenatal and perinatal growth data. In future, this study will focus on check on growth models and find 
biological or measurement reasons behind obtaining higher values for PHV when compared to other 
epidemiological studies in this area. There are numerous possibilities one could perform in further analysis in 
this area. One possibility could be to look for good fitting with other mathematical model in fetal data and 
perform a meta-analysis of epidemiological studies on growth.  
Analyses of the effects of the different covariates chosen here and possible covariate from other studies on the 
outcomes of growth velocity need to be examined further. Some factors, such as hypertension and gestational 
diabetes, could not be followed here due to time constraint can be possibly important in understanding the 
relationships for later health. This study would like to explore the replacement of missingness by multiple 
imputations in future work. As stated previously, many diseases in adulthood are being linked to prenatal 
development and childhood; further research will need to focus on utilising the growth velocity as a marker of 
growth patterns in early life in understanding specific character of growth abnormalities and diseases in later 
life.  
Conclusions 
 
In summary, after adjustment for all variables birth length as our main factor of interest was associated 
statistically significantly with PHV. The interest was, however, to study a broader spectrum of early life factors 
in relation to other birth measures and potential prenatal determinants of growth. The analyses showed that birth 
weight, gestational age, maternal age, maternal smoking and maternal height independently of other factors 
associate with PHV. This project has been highly ambitious in achieving the aims and objective and showed 
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that modeling of growth itself was even more challenging than originally expected and needs further work. 
Although this provides a basic understanding between the determinants of fetal growth and growth velocity in 
infants, further work needs to be done to understand more complex relationship between factors which are 
markers of adult diseases such as, hypertension and diabetes.  
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3 Appendix Note 3. Classification of hypertension disorder during pregnancy  
 
1. GH = gestational hypertension 
- BP 140/90 mmHg or more after 20th gestational week. Normal BP in the early pregnancy i.e. (<20th 
gestational week). No proteinuria.  
2. PE = pre-eclampsia 
- BP 140/90 mmHg or more after 20th gestational week. Normal BP in the early pregnancy i.e. (<20th 
gestational week). Proteinuria (no information on g/L) at least in one sample during pregnancy. 
3. Chronic hypertension 
a. BP elevated already in early pregnancy (<20th gestational week), 140/90 mmHg or more, and BP 
elevated also during whole pregnancy or after pregnancy (6weeks after pregnancy) 
b. Chronic hypertension (hypertension essentialis) diagnoses registered in questionnaire or taking 
antihypertensive medication.  
4. Superimposed pre-eclampsia 
- Chronic hypertension + proteinuria 
5. Proteinuria 
- Includes also women with Proteinuria (F8V023 ==2)! 
6. Normotensive 
- BP under 140/90 and is not included in any of the above mentioned groups. 
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4 Appendix Note 4. Example analysis plans  
 
I. EGG-GWAS within cohort additional analysis plan for infant HC 
In this document: 
1. Traits of interest 
2. Participating studies 
3. Number of subjects 
4. Genotyping + Imputation 
5. Model of association. 
6. Data exchange 
7. Analysis plan 
8. Proposed deadline 
 
Background:  
The main idea of this additional analysis is that the curve of head circumference growth follows a single 
percentile line during infancy. With this assumption we can widen the age window and thus increase the sample 
size. We chose to not include head circumference measurements below the age of 6 months, since the 
shape/size of the head might still be influenced by the delivery. Based on the data inventory, it seems that we 
will include the maximum number of subjects by using an age range of 6-30 months (median 18 months). 
Cohorts with more than one measurement per individual in this time window should use the measurement 
closest to the age 18 months. 
 
In infancy, the relationship between age and head circumference is non-linear and the standard deviation score 
changes over time. To standardize our outcome, it is best to create sex- and age-adjusted standard deviation 
scores for each head circumference measurement. For this purpose, we will need to use a reference curve. For 
this analysis we will use the reference curve of the Netherlands, 1997. These growth curves have been 
integrated in an easy to use software package called Growth Analyser. Since we are looking at the SNP 
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difference within each cohort, it does matter that your subjects are not from the Netherlands (1997). We are 
only using this software to standardize our outcome. 
 
1. Traits of interest 
Head circumference in infancy (HC18) (6 to 30 months). 
 
2. Participating studies (as of 26-01-2010) 
• ALSPAC (2,500) 
• Generation R (2,240) 
• NFBC66 (4,300) 
• Raine (759) 
• LISA (350) 
• CHOP (1733) 
• COPSAC (411) 
 
3. Projected number of subjects (as of 26-01-2010) 
• HC18 ~ 12,300 individuals 
 
4. Genotyping + Imputation 
• Genotyped SNPs (Affymetrix, Illumina, Perlegen) 
• Imputation HapMap Phase II CEU SNPs. Preferred release 22 of HapMap, build 36. Predefined marker 
filters to apply before imputation (HWEP>10-6, MAF>0.01, SNP-call>95%). Suggestion left open to cohorts to 
apply specific filters but should be reported. 
• Analyse all SNPs, no filtering on call rate/HWE/MAF/imputation quality (QC metrics to be reported, 
and filtering will be done at meta-analysis stage) 
 
5. Model of association 
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• Additive model (SNP coded as allele dose from 0 to 2), which accounts for genotype imputation 
uncertainty by use of linear regression onto estimated dose (as included in MACHQTL, ProbABEL, 
SNPTEST), adjusting for population structure and covariates. 
 
6. Data exchange 
• See separate RESULTS_FORMAT file for details of results file formatting and file naming. 
• Summary statistics to be uploaded to the AIMS system (link will be provided) 
• Only summary statistics will be transferred, not individual level genotype or phenotype data. 
 
7. Analysis outline 
• HC18 
• Transformation of outcome variable into sex- and age-adjusted standard deviation scores (SDS): use 
Growth Analyser (see text below). 
• If there are multiple measurements of an individual, please take the measurement nearest to 18 months. 
 
• Model: 
o HC18 SDS* = SNP  
o NOTE: YOU DO NOT HAVE TO ADJUST FOR SEX OR AGE ANYMORE! 
* Determined by Growth Analyser (see below) 
 
• Inclusions: 
o One of each twin (or any multiple births). This can be random, or based on best genotyping quality. 
o Premature subjects: children born before 37 weeks of gestation. Do not adjust for gestational age! 
 
• Exclusions: 
o Non-Caucasian 
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8. Deadline 
• The proposed deadline for uploading the within cohort results will be 15-02-2010 
 
GROWTH ANALYSER 
Creating SD scores using Growth Analyser (max. 15 minutes): 
Installing the program: 
1. Go to www.growthanalyser.org 
2. Click on ‘register’, and register your name. You will receive an e-mail confirmation and you will be 
asked to confirm you registration in the e-mail. 
3. Log in using your e-mail address and password. 
4. Go to ‘download’ and download the Growth Analyser. It’s available for most operating systems. 
5. Install Growth Analyser. 
6. Open the program. It will ask you some basic info and to enter another password. Once you’ve entered 
these, just cancel through any other options and you’ll be ready to analyse. 
Analysis: 
1. Open your data (.txt, .csv. and many others). Data needs to contain sex (coded 1 or 2), gestational age 
(weeks) and weight (kg). 
2. Go to the ‘analyse’ menu and then click on ‘standard deviation scores’. 
3. Click on  ‘reference’, and scroll down to ‘Netherlands’. Then choose the ‘head circumference for age’. 
Make sure that you indicate gender, age (years) and head circumference (cm) variables. 
4. Click ‘OK’. Now you should have an additional column in your table with SD scores, ranging from 
about -3 to +3. If not, make sure that your variables were set in the correct units. 
5. Save you new data set. 
6. If you have any questions, please e-mail me at d.mook@erasmusmc.nl 
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II. EGG Consortium Replication of GWAS Meta-Analysis Hits for Growth Parameters  
 
[A] ONE SNP REPRESENTING EACH SIGNAL GENOTYPED (=fetal genotype) 
 
NB: If the proxy SNP is already typed, use best proxy instead of LEAD SNP. Example: FTO rs9939609 (best 
proxy) has previously been typed. Use this instead of the untyped lead SNP rs1421085. If none of the SNPs 
have been previously genotyped, type the lead SNP. If the assay fails, use a proxy instead (primarily the best 
proxy).  
 
For adiposity rebound (AR) analyses: please analyse both Age at AR and BMI at AR. 
http://www.evachan.org/calc_snp_stats.R 
Table 1: SNP-phenotype pairs required for replication. 
 
PHENOTYPE SIGNAL LOCUS 
LEAD 
SNP 
BEST PROXY 
SNP 
2ND-BEST PROXY 
SNP 
PWV1 1 TMEM18 rs2860323 rs6548238 rs7567570 
BMI at AP 2 LEPR rs9436303 rs9436301 rs9436302 
BMI at AP 3 PCSK1 rs10515235 rs13153770 rs13158163 
Age at AR 4 FTO rs1421085 rs9939609 rs1558902 
Age at AR 5 RANBP3L/SLC1A3 rs2956578 rs2956577 rs2967066 
Age at AR 6 TFAP2B rs2817419 rs2635727 rs4715208 
BMI at AR 7 DLG2 rs2055816 rs7116340 rs1354397 
BMI at AR 8 GNPDA2 rs10938397 rs12641981 rs13130484 
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NB for GNPDA2, published SNP (rs10938397) was chosen as a lead SNP instead of the lowest p-value SNP 
(rs12641981).  
 
[B] ANALYSIS 
 
To enable meta-analysis using the inverse-variance fixed effects method (based on beta and SE), please perform 
the analysis outlined below for each SNP related to corresponding phenotype(s).  
 
For these analyses, dense growth measurements at specific age windows are needed.  
1. Peak weight velocity in infancy (PWV1) 
 
 The median number of measurements per person in the cohort should be at least 4 within the first 2 
years of life including birth (some individuals may have less than 4 but all those with less than 3 will be 
excluded from the analyses). The focus is on very early growth (PWV occurs at around 1 month of age), 
and therefore this cannot be reliably estimated in the absence of measurements at birth and the first few 
months of life (e.g. if all measurements are taken at 1-2 years of age, the cohort cannot take part in this 
analysis). 
 
 Derive PWV1 for each individual using Reed1 model (see specification in R below) for boys and girls 
separately. Fit the Reed1 model by sex on all weight measurements taken at 0-2 years of age, including 
birth weight. Assume both fixed and random component for all four parameters in the model. For each 
person, take the first derivative of the fitted distance curve to get the weight velocity curve, and take the 
maximum of this curve to get peak weight velocity (PWV) in infancy. 
 
 Transformation of outcome variable: First log-transform the outcome using natural logarithm: 
LOGPWV1 = LN(PWV1) 
 
PWV1 Z-score = ZLOGPWV1= [LOGPWV1 - mean]/standard deviation  
(based on the mean and SD of LOGPWV1 in the sample) 
 
 Model: 
PhD Thesis 
 
 
 
240 
 
ZLOGPWV1 = SNP + sex + gestational age  
 
- SNP = genotype 
- Sex: coded 1 for male, 2 for female 
- Gestational age in weeks 
- Additionally adjust the model for population structure, e.g. PCs 1-3 
 
 Exclusions: 
o Twins (or any multiple births) 
o Children born before 37 weeks of gestation (exclude <37 weeks, include >= 37 weeks) 
o Those with less than 3 weight measurements at 0-2 years of age 
 
NB Please see example R code for PWV modeling in File 2. 
2. BMI at adiposity peak (AP) in infancy 
 
 The median number of measurements per person in the cohort should be at least 4 at age 14 days – 1.5 
years (some individuals may have less than 4 but all those with less than 3 will be excluded from the 
analyses). The focus is on growth at 6-12 months where BMI peaks, and therefore cohorts that do not 
have any measurements at 6-12 months cannot take part in this analysis (see the note below).  
 
 Calculate BMI from height and weight measurements taken at the same time: BMI = weight [kg] / 
(height [m])
2
. Fit a cubic mixed effects model (see specification in R below) on LN(BMI) at 14 days – 
1.5 years in the whole sample, using sex as a covariate (this allows each sex a separate BMI baseline). 
When fitting the model, centralise age to 0.75 years. In addition to fixed effects, include random effects 
for the constant and the slope in the model. Assume autoregressive AR(1) within-person correlation 
structure between the measurements. For each individual, derive age and BMI at the point where the 
curve reaches its maximum, i.e. at infant adiposity peak (AP). It is enough to use the age window 0.25-
1.25 years for this (the population average should be near the mid-point, around 0.75 years, i.e. 9 
months). BMI at AP is likely to be skewed to the right and therefore a natural logarithmic transformation 
will be used: LOGBMIAP = LN(BMIAP). 
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 LOGBMIAP Z-score ZLOGBMIAP = [LOGBMIAP – mean]/standard deviation 
(based on the mean and SD of LOGBMIAP in the sample) 
 
 Model: 
 
 ZLOGBMIAP = SNP + sex + gestational age 
 
 Exclusions: 
o Twins (or any multiple births) 
o Children born before 37 weeks of gestation (exclude <37 weeks, include >= 37 weeks) 
o Those with less than 3 BMI measurements at 14 days - 1.5 years of age 
 
 Note: If you have on average less than 4 measurements at age 14 days to 1.5 years in your study but 
instead you have a single BMI measurement at 6–12 months of age, please fit the following model using 
the measurement closest to age 9 months (here called BMIAPproxy) for each individual: 
ZLOGBMIAPproxy = SNP + sex + age + age
2 
+ gestational age, where ZLOGBMIAPproxy = Z-score 
of LOGBMIAPproxy = [LOGBMIAPproxy – mean]/SD and age = measurement age (centered, i.e. 
observed age – population mean age). 
 
NB Please see example R code for BMI modeling in File 2. 
 
3. Adiposity rebound (AR) in childhood 
 
 The median number of measurements per person in the cohort should be at least 4 at age 1.5 - 13 years 
(some individuals may have less than 4 but all those with less than 3 will be excluded from the analyses). 
The focus is on growth at 4-7 years around adiposity rebound, and therefore cohorts that do not have 
any measurements at 4-7 years cannot take part in this analysis.  
 
 Calculate BMI from height and weight measurements taken at the same time: BMI = weight [kg] / 
(height [m])
2
. Fit a cubic mixed effects model (see specification in R below) on LN(BMI) at >1.5 – 13 
years in the whole sample, using sex as a covariate. When fitting the model, centralise age to 7.25 years. 
Include also sex-age and sex-age
2
 interactions. In addition to fixed effects, include random effects for 
the constant and the slope in the model. Assume autoregressive AR(1) within-person correlation 
structure between the measurements. For each individual, derive age and BMI at the point where the 
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curve reaches its minimum, i.e. at adiposity rebound (AR). It is enough to use the age window 2.5-8.5 
years for this (the population average should be near the mid-point, around 5.5 years). Age at AR 
(AGEAR) should be fairly normally distributed but BMI at AR is likely to be skewed to the right and 
therefore a natural logarithmic transformation will be used: LOGBMIAR = LN(BMIAR). 
 
 AGEAR Z-score = ZAGEAR = [AGEAR – mean]/standard deviation 
(based on the mean and SD of AGEAR in the sample) 
 LOGBMIAR Z-score ZLOGBMIAR = [LOGBMIAR – mean]/standard deviation 
(based on the mean and SD of LOGBMIAR in the sample) 
 Model 1:  
  ZAGEAR = SNP + sex  
 Model 2:  
 ZLOGBMIAR = SNP + sex  
 Exclusions: 
o Twins (or any multiple births) 
o Those with less than 3 BMI measurements at >1.5-13 years of age 
 
NB Please see example R code for BMI modeling in File 2. 
[C] RESULTS FILE FORMAT 
Please provide: 
1. EXCEL or TEXT file containing data in the following columns 
**Column headings and their descriptions** 
SNP rsNUMBER of SNP 
STRAND 
The strand on which the alleles are reported: we request SNPs to 
be aligned to the forward (+) strand of the chromosome on 
HapMap. State the strand as a single character: - or + 
N Number of individuals in the analysis for that SNP 
EFFECT_ALLELE Allele for which the effect (BETA) is reported (A/T/G/C) 
NON_EFFECT_ALLELE Second allele at the SNP 
EFFECT_ALLELE_FREQ 
Allele frequency of the allele for which the effect (BETA) is 
reported 
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BETA Effect size  
SE Standard error on the estimate of the effect size  
P_VAL The 2-sided p-value of the association test 
CALL_RATE 
Genotyping call rate for the SNP (N_successful_genotypes / 
N_attempted_genotypes)  
HWE_P Hardy-Weinberg P value in those genotyped  
 
2. README file containing 
a. Ancestry (e.g. European) and location (e.g. UK) of cohort 
b. How growth measurements were ascertained (e.g. self-report / clinical measure / medical 
records) 
c. Any genotyping QC in addition to call rate and HWE (e.g. % included duplicates and duplicate 
concordance) 
In addition, if a single BMI measurement at 6-12 months was used instead of estimated BMI at AP, 
give also details of the BMI distribution in the included sample (mean, SD, min, max). 
 
Please name files as follows: 
STUDY-PHENOTYPE-EGG-CONTENTS-DATE.txt 
STUDY is a short identifier for the population studied.   
PHENOTYPE is one of: 
“LOGPWV1”, “LOGBMIAP” (or “LOGBMIAPproxy”), “AGEAR”, “LOGBMIAR” 
DATE is the date on which the file was prepared, in the format “DDMMYYYY”. 
CONTENTS indicates whether the file is a README or RESULTS file. 
For example: 
NFBC1986-AGEAR-EGG-RESULTS-01082010.txt 
 
If you have any questions on growth modeling and derivation of the required parameters, please email: 
shikta.das08@imperial.ac.uk, nicole.warrington@uwa.edu.au AND h.taal@erasmusmc.nl  
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5 Appendix Table 1. The SNP selection criteria for candidate loci, utilised in GWAS of infant head 
circumference in Stage 1 (discovery) meta-analysis data, for validation in Stage 2 (replication). SNPs 
with P-value P < 1 x 10-7 or P < 1 x 10-5 in/near candidate genes were selected. One exception for peak 
weight velocity (PWV) was included with did not fulfill the selection criteria due to strong biological 
candidacy.    
CHR Phenotype Index SNP Proxy1 Proxy2 Nearest gene Top SNP 
m/a p-value 
Justification 
12 HC rs7980687 rs12322888 rs12316131 near SBNO1 3.3 x 10-7 Low P-value 
12 HC rs1042725 rs7970350 rs1351394 near HMGA2 6.6 x 10-7 Low P-value and biology. Known SNPs 
has been associated with height 
354
 and 
primary tooth development during 
infancy 
355
 
15 HC rs11655470 rs12938031 - near CRHR1/MAPT 1.4 x 10-6 Low P-value 
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6 Appendix Table 2. Description of the top-hit loci associated with infant head circumference. 
 
CHR Location Coded Allele Phenotype Index SNP Nearest Gene Other names Description Function of gene Type 
12 12q24 A/G HC rs7980687 near SBNO1 Sno; MOP3 Protein 
strawberry 
notch 
homolog 1 
 protein coding 
12 12q15 T/C HC rs1042725 near HMGA2 BABL; 
LIPO; 
HMGIC; 
HMGI-C; 
STQTL9 
high 
mobility 
group AT-
hook 2 
A non-histone chromosomal high mobility group (HMG) protein family. HMG proteins function as architectural 
factors and are essential components of the enhancesome. This protein contains structural DNA-binding domains 
and may act as a transcriptional regulating factor. Identification of the deletion, amplification, and rearrangement of 
this gene that are associated with myxoid liposarcoma suggests a role in adipogenesis and mesenchymal 
differentiation. A gene knock out study of the mouse counterpart demonstrated that this gene is involved in diet-
induced obesity. Alternate transcriptional splice variants, encoding different isoforms, have been characterized 
protein coding 
17 17q21 T/C HC rs11655470 near CRHR1 CRF1; 
CRHR; 
CRF-R; 
CRFR1; 
CRF-R1; 
CRFR-1; 
CRH-R1; 
CRHR1L; 
CRHR1f; 
CRF-R-1; 
CRH-R-1; 
CRH-R1h 
corticotropin 
releasing 
hormone 
receptor 1 
A G-protein coupled receptor that binds neuropeptides of the corticotropin releasing hormone family that are major 
regulators of the hypothalamic-pituitary-adrenal pathway. The encoded protein is essential for the activation of 
signal transduction pathways that regulate diverse physiological processes including stress, reproduction, immune 
response and obesity. Alternative splicing results in multiple transcript variants, one of which represents a read-
through transcript with the neighboring gene MGC57346. 
protein coding 
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7 Appendix Table 3. Loci associated with infant head circumference (P<1 x 10-5), which were not taken 
forward for replication.  
 
Index SNP Locus Effect on Head 
Circumference 
Se P value Nearest Gene Gene function 
rs3094072_C 6p21 0.103 0.022 1.5x10-6 HLA-L Part of the major histocompatibility complex genes. SNPs in linkage disequilibrium have been 
associated with Systemic Lupus Erythematosus 
rs12438760_T 15q14 0.109 0.023 2.1x10-6 C15orf41 Unknown 
rs17134374_T 15q11 -23.293 5.033 3.7x10-6 POTEB Unknown 
rs238150_T 20q13 -0.078 0.0171 4.5x10-6 DDX27 DEAD box proteins, characterized by the conserved motif Asp-Glu-Ala-Asp (DEAD), are putative 
RNA helicases. They are implicated in a number of cellular processes involving alteration of RNA 
secondary structure such as 
translation initiation, nuclear and mitochondrial splicing, and ribosome and spliceosome assembly. 
Based on their distribution patterns, some members of this family are believed to be involved in 
embryogenesis, 
spermatogenesis, and cellular growth and division. This gene encodes a DEAD box protein, the 
function of which has not been determined. [provided by RefSeq, Jul 2008] 
rs9940645_A 16q12 0.066 0.0145 5.8x10-6 ZNF423 The protein encoded by this gene is a nuclear protein that belongs to the family of Kruppel-like C2H2 
zinc finger proteins. It functions as a DNA-binding transcription factor by using distinct zinc fingers in 
different signaling pathways. It is thought that this gene may have multiple roles in signal transduction 
during development. 
[provided by RefSeq, Jul 2008] 
rs11683142_A 2q23 0.293 0.065 6.1x10-6 RBM43 Unknown 
rs1385504_A 8q24 0.094 0.021 7.1x10-6 TNFRSF11B The protein encoded by this gene is a member of the TNF-receptor superfamily. This protein is an 
osteoblastsecreted decoy receptor that functions as a negative regulator of bone resorption. This protein 
specifically binds to its ligand, osteoprotegerin ligand, both of which are key extracellular regulators of 
osteoclast development. 
Studies of the mouse counterpart also suggest that this protein and its ligand play a role in lymph-node 
organogenesis and vascular calcification. Alternatively spliced transcript variants of this gene have been 
reported, but their full length nature has not been determined. [provided by RefSeq, Jul 2008] SNPs in 
linkage disequilibrium have been associated with osteoporosis in genome wide association study meta-
analysis. 
rs2056666_T 8p23 0.067 0.015 7.3x10-6 CSMD1 Unknown 
rs9675157_C 17q23-24 0.185 0.042 9.6x10-6 AXIN2 The Axin-related protein, Axin2, presumably plays an important role in the regulation of the stability of 
betacatenin in the Wnt signaling pathway, like its rodent homologs, mouse conductin/rat axil. In mouse, 
conductin organizes a multiprotein complex of APC (adenomatous polyposis of the colon), beta-
catenin, glycogen synthase kinase 3-beta, and conductin, which leads to the degradation of beta-catenin. 
Apparently, the deregulation of beta-catenin is an important event in the genesis of a number of 
malignancies. The AXIN2 gene has been mapped to 17q23-q24, a region that shows frequent loss of 
heterozygosity in breast cancer, neuroblastoma, and other tumors. Mutations in this gene have been 
associated with colorectal cancer with defective mismatch repair. [provided by RefSeq, Jul 2008] 
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8 Appendix Table 4. The SNP selection criteria for candidate loci, utilizing Stage 1 meta-analysis data, for Stage 2 (replication). SNPs with 
P-value P < 1 x 10-7 or P < 1 x 10-5 in/near candidate genes were selected. One exception for peak weight velocity (PWV) was included 
with did not fulfill the selection criteria due to strong biological candidacy. 
Chr Phenotype Index SNP Proxy1 Proxy2 In/ nearest 
gene 
Top SNP m/a p-
value 
Justification for selection Proxy linkage disequilibrium (LD) 
with index SNP and proxy P-value 
fromStage1 meta-analysis 
1 BMI at AP rs9436303 rs9436301 rs9436302 LEPR/LEPRO
T 
4.15E-09 Low P-value Proxy1 LD R2=1 and P=6.4x10-8, 
proxy2 LD R2=0.786 and p=1.41x10-7 
16 Age at AR rs1421085 rs9939609 rs1558902 FTO 6.14E-08 Low P-value If already typed, use either of the 
published SNPs (index SNP or Proxy1). 
Proxy1 LD R2=0.931 and P=1.56x10-7, 
proxy2 LD R2 =1 and P=6.36x10-8 
5 Age at AR rs2956578 rs2956577 rs2967066 Intergenic 
between 
RANBP3L and 
SLC1A3 
6.73E-08 Low P-value Proxy1 LD R2=1 and P=6.73x10-8, 
proxy2 LD R2=1 and P=6.75x10-8 
4 BMI at AR rs10938397 rs12641981 rs13130484 GNPDA2 1.41E-07 Biology: known BMI locus (Willer et al, 
2009), LD with rs10938397 is very 
strong (R2=1) with top SNP. 
Rs10938397 BMI increasing allele (G) is 
associated with higher BMI at AR 
(p=5.4x10-6) 
Published SNP chosen as index SNP 
instead of top SNP. Proxy1 (top SNP) 
LD R2=1 and P=3.11x10-6, proxy2 LD 
R2=1 and P=3.37x10-6 
5 BMI at AP rs10515235 rs13153770 rs13158163 PCSK1 1.23E-06 Biology : mutations in this gene are 
associated with extreme obesity 
Proxy1 LD R2=0.961 and P=1.26x10-6, 
proxy2 LD r2=1 and P=3.39x10-6 
6 Age at AR rs2817419 rs2635727 rs4715208 TFAP2B 2.96E-06 Biology: known adiposity locus 
(Lindgren et al, 2009). rs987237 G = 
WC increasing allele is associated with 
lower age at AR (p=3.5x10-4), but LD is 
weak (R2=0.044) between the SNPs 
Proxy1 LD R2=0.865 and P=3.16x10-6, 
proxy2 LD R2=0.861 and P=3.17x10-6 
11 BMI at AR rs2055816 rs7116340 rs1354397 DLG2 5.41E-06 Biology: DLG2 may be involved in 
maintenance of glucose homeostasis 
(Palmer et al 2010). However, our SNP 
is not in the region of DLG2 they 
identified for association 
Proxy1 LD R2=1 and P=1.70x10-7, 
proxy2 LD R2=1 and P=1.72x10-7 
2 PWV* rs2860323 rs6548238 rs7567570 TMEM18 5.91E-05 Biology: known BMI locus (Willer et al, 
2009)135. rs6548238 is in high LD 
(R2=0.85) with rs2860323. rs6548238 
BMI increasing allele (C) is associated 
with higher PWV1 (P=1.6x10-4) 
If already typed, use the published SNP 
(proxy1 rs6548238). Proxy2 is in perfect 
LD (r2=1) with index SNP and its 
P=5.92x10-5 
 
*rs2860323 was selected as exception to the selection criteria due to strong candidacy as loci does not fulfill P-value criterion for candidates: 1.0 x 10-5 < P < 1.0 x 10-5
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9  Appendix Table 5. Description of the five top-hit loci associated with early growth phenotypes. 
CHR Location In/nearest 
gene 
Coded 
allele 
Measure Other Names Description Cellular component Biological processes Molecular processes Type 
1 1p31 LEPR/ 
LEPROT 
G BMIAP 
z-score 
CD295;  OBR Leptin receptor 
and leptin 
receptor 
overlapping 
transcript 
extracellular region, 
integral to plasma 
membrane, plasma 
membrane 
cell surface receptor 
linked signal 
transduction, energy 
reserve metabolic 
process, multicellular 
organismal development 
hematopoietin/interferon-
class cytokine receptor 
activity , protein binding 
protein-
coding 
5 5q15 PCSK1 G BMIAP 
z-score 
PCSK1;  NEC1;  
PC1;  PC3;  SPC3 
Proprotein 
convertase 
subtilisin/kexin 
type 1 
cytoplasmic vesicle cell-cell signaling, 
metabolic process, 
proteolysis 
calcium ion binding, 
peptidase activity, 
proprotein convertase 1 
activity, subtilase activity 
protein-
coding 
16 16q12.2 FTO C AGEAR 
z-score 
FTO;  KIAA1752;  
MGC5149 
Fat mass and 
obesity 
associated 
NA determination of 
left/right symmetry, 
embryonic limb 
morphogenesis 
NA protein-
coding 
6 6p12 TFAP2B G AGEAR 
z-score 
TFAP2B;  AP-2B;  
AP2-B;  
MGC21381 
Transcription 
factor AP-2 
beta (activating 
enhancer 
binding protein 
2 beta) 
nucleus kidney development, 
nervous system 
development, positive 
regulation of global 
transcription from RNA 
polymerase II promoter, 
regulation of 
transcription from RNA 
polymerase II promoter, 
transcription 
protein dimerization 
activity, sequence-specific 
DNA binding , 
transcription coactivator 
activity, transcription 
factor activity 
protein-
coding 
4 4p12 GNPDA2 G BMIAR 
z-score 
GNPDA2; SB52 Glucosamine-6-
phosphate 
deaminase 2 
NA N-acetylglucosamine 
metabolic process , 
carbohydrate metabolic 
process 
glucosamine-6-phosphate 
deaminase activity , 
isomerase activity 
protein-
coding 
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10 Table 6. Heterogeneity analysis of the five top-SNPs with the early growth phenotypes. For rs9436303, heterogeneity was observed 
between studies; the Table shows the three actions taken to address this.  
SNP Nearest gene Allele
a
 β(F)b 95% CIb β(R)c 95% CIc I2d PHET
e 
Steps taken
f
 
rs10515235 PCSK1 A/G -0.06 (-0.08, -0.03) -0.06 (-0.08, -0.03) 15.60% 0.2785   
rs1421085 FTO C/T -0.12 (-0.14,  -0.10) -0.12 (-0.14,  -0.09) 17.80% 0.2892   
rs2817419 TFAP2B G/A -0.08 (-0.05, -0.10) -0.08 (-0.05, -0.11) 30.20% 0.1866   
rs10938397 GNPDA2 G/A 0.08 (0.05, 0.10) 0.08 (0.05, 0.11) 30.20% 0.1866   
rs9436303 LEPR and 
LEPROT 
G/A 0.07 (0.06, 0.08) 0.08 (0.05, 0.11) 66.90% 0.0002 Action 1 
rs9436303 LEPR and 
LEPROT 
G/A 0.07 (0.04, 0.09) 0.07 (0.03, 0.11) 61.80% 0.0017 Action 2 
rs9436303 LEPR and 
LEPROT 
G/A 0.05 (0.02, 0.07) 0.05 (0.02, 0.07) 0% 0.8419 Action 3 
 
a
Minor allele/Major alllele. 
 
b
The value of beta (B) and 95% confidence interval (CI) under fixed model.  
c
The value of beta (B) and 95% confidence interval (CI) under random effect model. 
d
I
2 
describes the proportions of the total variability caused by heterogeneity by various studies in the meta-analysis. I
2
 <25% is considered as no heterogeneity, I
2
 =25-50% is 
considered as low heterogeneity, I
2
=50-70% is considered as moderate heterogeneity and I
2
 >75% is considered as strong heterogeneity. 
e
The P value of heterogeneity.  
f
Action 1. Both fixed effect and random effect model was used.  
Action 2. Removing EDEN from the study as it was showing most inflated results.  
Action 3. Removing EDEN and NFBC1966 (lambda=1.04) as both studies showing high variability inflation factor (VIF).
PhD Thesis 
 
250 
 
11 Appendix Figure1. World map showing countries which participated in the study. 
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12 Appendix Figure 2. Figure 3: Regional association and Forest plots of the five loci associated with 
early growth phenotypes (A, B, C).  Blue diamond indicates the most statistically significantly 
associated SNP, and other SNPs in the region are presented by circles with coloring from blue to red 
corresponding to r
2
 values from 0 to 1. The SNP position refers to the NCBI build 36.  Estimated 
recombination rates are from HapMap build 36 
356
. Forest plots from the meta-analysis for each of 
the identified loci are plotted abreast. Results by study, discovery, replication and combined meta-
analyses presented (for heterogeneity, see  note
#
)  
 
A) BMI at adiposity peak (AP) 
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B) Age at adiposity rebound (AR) 
 
C ) BMI at adiposity rebound (AR) 
 
#There was no evidence of heterogeneity between the studies, except at LEPR/LEPROT (I
2
=66.9%; PHET=0.0002), by two large and 
well-defined studies, NFBC1966 (n=3459) and EDEN (n=1127) (PHET=0.84 without these two cohorts). However, associations are 
overall directionally consistent between all the studies and further the GWAS analyses without NFBC1966 and EDEN show that results 
are not driven only by them.  For LEPR/LEPROT both fixed and random effect models give very similar results (shown above). 
 
